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Summary 
Exercise training is one of the few therapeutic interventions that improves health span by 
delaying the onset of age-related diseases and preventing early death. Despite the clear 
benefits to health conferred by exercise training, our understanding of the underlying 
molecular mechanisms remain crude. The primary purpose of this thesis is to determine and 
analyse the molecular biology changes that occur with strenuous aerobic exercise. 
Specifically, the main objectives were to investigate the impact of strenuous aerobic exercise 
training on structural DNA modifications, measured in context with cardiovascular health and 
fitness adaptations. 
In the first part of this thesis I investigated the influence of endurance exercise training on 
leukocyte telomere length and cardiovascular health. Leukocyte telomere length reflects 
biological age. Indeed, excessively short leukocyte telomeres are associated with age-related 
chronic diseases. Epidemiological studies indicate endurance athletes live longer than people 
from the general public who do not engage in extensive aerobic exercise training. In Chapter 
2, my literature review on the subject of exercise and telomere biology suggested that, at the 
time of this study, the impact of exercise training on leukocyte telomere length was 
equivocal. Therefore, to determine whether strenuous aerobic exercise training influences 
biological ageing (assessed by leukocyte telomere length), I conducted two cross-sectional 
studies on leukocyte telomere length differences between endurance athletes and healthy 
controls. 
The first study (Chapter 3) was a cross-sectional analysis of leukocyte telomere length 
between athletes and controls, determined by quantitative polymerase chain reaction (qPCR). 
This is a relative measurement of telomere length expressed as a telomere (T) to single copy 
gene (S) ratio. Relative to the healthy controls (n = 56), the ultra-marathon runners (n = 67) 
	 16 
possessed 11% longer leukocyte telomeres in age-adjusted analysis (ultra-marathon runners 
vs controls; average T/S ratio: 3.56 vs 3.16, p = 1.4 × 10-4) and the difference was not 
explained by the favourable cardiovascular health profile exhibited by the athletes (p = 2.2 × 
10-4). The difference in leukocyte telomere length indicated the athletes had reduced their 
biological age by 16.2 years. To elucidate the potential mechanism for the longer leukocyte 
telomeres observed in endurance athletes, I recruited another cohort of athletes and controls 
and measured leukocyte telomere length and gene expression of genes involved in telomere 
length regulation. In the second study (Chapter 4), I describe data replicating the finding that 
endurance athletes possess longer leukocyte telomeres compared to healthy controls (athletes 
v controls mean T/S ratio ± SE: 3.64 ± 0.06 vs 3.38 ± 0.06, p = 0.002). This difference was 
associated with a concomitant increased activity of two important telomere regulating genes, 
telomerase reverse transcriptase (TERT) and adrenocortical dysplasia homolog (TPP1) (2-
fold and 1.3-fold, respectively, both p < 0.05). The difference in leukocyte telomere length 
and leukocyte telomere-regulating gene (TERT and TPP1 mRNA) expression was 
ameliorated after adjusting for maximal oxygen uptake and resting heart rate (all p > 0.05). 
This finding indicates that cardiorespiratory fitness is an important determinant of telomere 
biology. Together, these two cross-sectional studies suggest that regular endurance exercise 
training is associated with longer leukocytes telomeres and that this is likely achieved 
through higher TPP1 and TERT mRNA expression gained through improved 
cardiorespiratory fitness. The findings in Chapters 3 and 4 provide evidence for extensive 
endurance exercise training as an effective lifestyle strategy to attenuate biological ageing. 
In parallel to telomere length changes, epigenetic modifications (e.g. DNA methylation) 
caused by environmental factors alter the transcriptomic milieu of cells. My thorough 
literature review (Chapter 5) revealed that exercise training seems to rearrange chromatin by 
modifying the DNA methylome in a variety of cells and that the extent is dictated by exercise 
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duration and intensity. Therefore, in the second part of my thesis, I investigated the DNA 
methylation changes in leukocytes (which are somatic cells) and sperm (male germ cells) 
from healthy men before and after sprint interval training (SIT). Unlike traditional, long 
duration training at moderate intensity training, SIT involves short, intense (>85% VO2max to 
supra-maximal) efforts followed by periods of rest (3–4 min), typically repeated 3–8 times. It 
is an effective type of training that improves cardiorespiratory fitness quicker than traditional 
long slow distance training. Thus, to establish the DNA methylome changes associated with 
SIT, I conducted two training studies and analysed the leukocyte and sperm methylomes 
using the Infinium HumanMethylation450 BeadChip (Illumina).  
My third study (Chapter 6) provides the first evidence showing an association between DNA 
methylation changes paralleled with improvements to lipid profile and cardiorespiratory 
fitness in humans. Twelve young men (18–24 years) undertook SIT (thrice weekly) for four 
weeks. Resting blood samples were obtained and whole-blood leukocytes were isolated by 
red blood cell lysis. Genome-wide DNA methylation was assessed using the 450K BeadChip 
(Illumina). Cardiorespiratory fitness, determined by maximal oxygen uptake, was improved 
by 2.1 ml.kg-1.min-1 and low-density lipo-protein cholesterol was decreased by 3.9% after SIT 
(p < 0.05). Notably, the leukocyte methylome was significantly affected by SIT, in regions 
throughout the genome in relation to CpG islands – CpG islands, North shores, N shelves, 
South shores and South shelve – and the nearest genes – 3’ untranslated region (UTR), 5’ 
UTR, exonic, intergenic, intronic, non-coding and promoter regions (all p < 0.001). Genes 
with differentially methylated CpG sites (q < 0.005) after SIT were enriched for 
cardiovascular gene ontology (GO) terms that included metabolic activity, biological 
adhesion and antioxidant activity. Similarly, pathway analysis revealed genes involved in 
focal adhesion, calcium signaling and mitogen activated protein kinase were modulated by 
SIT-induced DNA methylation changes. Amongst the 205,987 probes relating 32,445 
	 18 
transcripts differentially methylated after SIT (q < 0.05), with methylation changes between 
0.1 – 62.8%, the largest and most statistically significant demethylated site was in the 
epidermal growth factor (EGF) gene, causing decreased mRNA expression. As with EGF, 
the microRNA-21 and microRNA-210 genes (MIR21 and MIR210, respectively), known for 
their roles in cardiovascular disease (ischemic heart disease and coronary atherosclerosis), 
had modest but consistently statistically significant DNA methylation changes at numerous 
CpG sites, which altered mature microRNA abundance. Together, these data suggest that 
genome-wide DNA methylation changes occur after short-term intense exercise training 
concurrently with improvements to blood cholesterol profile and cardiorespiratory fitness.  
The data presented in this thesis provided evidence that the epigenome of somatic cells is 
malleable to exercise. There is mounting evidence supporting the premise that environmental 
perturbations cause DNA methylation changes and these are subsequently transgenerationally 
inherited, altering phenotypes of future generations. In the current study I also asked the 
question; can exercise training reconfigure the DNA methylome of male germ cells (sperm)? 
Therefore, my next study (Chapter 7) entails an analysis of the impact that three months of 
SIT has on genome-wide DNA methylation of sperm in healthy men. 
Thirteen subjects undertook twice-weekly SIT for three months, while the controls were 
asked not to change their current physical activity habits (if any). Sperm samples were 
donated before and after the three-month intervention. Mature sperm were isolated using 
density gradient centrifugation and DNA was extracted using the Purelink Genomic DNA 
Mini Kit (Life Technologies). Global and genome-wide DNA methylation was assessed using 
an enzyme-linked immunosorbent assay-based kit and the 450K BeadChip (Illumina), 
respectively. Relative to controls, the cases decreased their resting heart rate and had a higher 
maximal treadmill speed during exercise testing (both p < 0.05). Cases had decreased global 
DNA methylation after SIT compared to controls (p < 0.05). Genome-wide DNA methylation 
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analysis revealed numerous modest (0.3 – 6%) methylation changes to 7509 CpG sites, 
relating to 4602 transcripts (q ≤ 0.1). Differentially methylated CpG sites were in genes 
associated with developmental biology, which included GO terms, such as developmental 
process, anatomical structure, embryonic morphogenesis and organ development, together 
with known pathways regulated by exercise training (MAPK, ErbB and PI3K-Akt 
signalling). Genes with increased methylation were associated with numerous human 
diseases, with most overrepresented being psychiatric disorders (schizophrenia, Parkinson’s 
disease and autism). Notably, paternally imprinted genes associated with other diseases were 
also differentially methylated after SIT. Therefore, exercise training is associated with the 
modifications to genome-wide DNA methylation of both somatic and germ cells.  
In conclusion, the studies presented as a series of peer-reviewed publications, outlines 
investigations that describe an influence of strenuous exercise training on leukocyte telomere 
length regulation and the DNA methylome of both leukocytes and germ cells. Both of these 
molecular changes in leukocytes and sperm provide evidence for novel molecular 
mechanisms by which exercise improves cardiovascular health and fitness. Future 
investigations should focus on longitudinal studies determining whether these changes are 
required for improved health and fitness, and should establish whether exercise-induced DNA 
methylation changes are transgenerationally inherited, and if so, what impact this has to 
future generations. Such discoveries could change national physical activity guidelines and 
policies, by emphasising the benefit of regular exercise both in the present and to future 
offspring.  
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Chapter 1 Background 
Introduction 
Cardiovascular disease is the biggest financial burden to the Australian health care system 
and kills the most Australians each year.1 It is estimated that abolishing global physical 
inactivity alone would eliminate 6 to 10% of the world’s non-communicable diseases, 
including type 2 diabetes, breast and colon cancer, and coronary artery disease.2 Indeed, 
increasing physical activity is associated with a dose-dependent reduction in coronary artery 
disease risk.3 The health benefits of exercise are not confined to primary prevention, but 
exercise training can halt and regress atherosclerotic lesions in coronary artery disease 
patients.4,5 Furthermore, a superior cardiorespiratory fitness is associated with a reduced risk 
of heart failure-related mortality, regardless of the presence of other traditional cardiovascular 
disease risk factors, such as smoking, obesity, high blood pressure, a family history of 
cardiovascular disease and diabetes.6 Despite the clear cardiovascular health benefits 
conferred by regular exercise training, the molecular mechanisms important for 
cardiovascular health and the prevention of premature death are poorly understood. The study 
of exercise training induced cardiopulmonary adaptations and analysis of telomere biology 
and epigenetic modifications may delineate how exercise training prevents, manages and 
attenuates cardiovascular disease and improves health span.  
The thesis structure is presented in Figure 1. The following sections briefly discuss the 
biology of leukocyte telomere length and DNA methylation, as these topics are 
comprehensively covered in Chapters 2 and 5, respectively. * 
*References for Chapter 1 are located in Volume 2, pages 442-454. 
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Figure 1. Thesis structure. 
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Telomere biology 
Telomeres are repetitive DNA sequences (in mammals – 5’TTAGGGn3’) that prevent 
chromatin fusion events and maintain genomic integrity by capping chromosome ends.7 In 
the absence of telomerase and due to the end replication problem, telomeres shorten during 
each round of cell division.8,9 Once a critical length is reached, DNA damage pathways are 
triggered leading to cellular senescence,10 which in turn decreases tissue vitality and 
accelerates organismal ageing. Therefore, telomere length is reflective of cellular mitotic 
history and leukocyte telomere length is a marker of biological age.11  
Short leukocyte telomeres are implicated in the pathogenesis of age-related diseases, 
including coronary artery disease,12-14 type 2 diabetes15 and some cancers.16,17 Leukocyte 
telomere length holds prognostic value for adverse coronary artery events18,19 and is inversely 
correlated to mortality risk.20-22 A comprehensive review of literature on telomere length in 
context with age-related cardio-metabolic disease and exercise training is found in the 
proceeding section, to introduce the reader to telomere biology (Chapter 2). Exercise training 
is typically associated with a reduced risk of age-related diseases, particularly coronary artery 
disease.3 Therefore, it is possible that exercise partly prevents the pathogenesis of age-related 
diseases through telomere length maintenance.  
Rationale for telomere and epigenetic exercise physiology studies on leukocytes 
The majority of human studies have analysed telomere length in leukocytes. Most of the 
studies included in this thesis are on the analysis of telomere biology and DNA methylation 
in leukocytes. Therefore, a rationale for the study of leukocyte molecular exercise physiology 
is provided. There are several advantages of analysing telomere length and DNA methylation 
in whole-blood leukocytes: 1) they are easily collected by a relatively non-invasive, routine 
procedure; 2) leukocyte telomere length is correlated to that of other tissues, including 
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heart,23 adipocytes, skeletal muscle and skin cells;24 3) leukocytes circulate through the body, 
come in contact with and are affected by numerous organs that are otherwise unobtainable 
from healthy subjects (brain, colon, lung, heart, kidney, stomach, etc). Their gene expression 
profile mimics that of the organs, making them sentinels of healthy/diseased tissues;25,26 4) 
Low-grade chronic inflammation is associated with ageing (referred to as, ‘inflammaging’) 
and age-related chronic diseases, where the immune system is well known to play an 
important role;27-29 5) The exhaustion of stem cell proliferative capacity is a detrimental 
phenotype of ageing.30 The replicative history of leukocyte subsets, assessed by telomere 
length, mirrors that of hematopoietic stem cells;31,32 and 6) hypertension is a risk factor of 
more severe and fatal cardiovascular diseases (e.g. myocardial infarction and stroke), and 
leukocytes are thought to be involved in the development of hypertension, through up-
regulated toll-like receptor activity and inflammation.33 Monocytes and macrophages are also 
directly involved in the pathogenesis of atherosclerosis,34,35 making them an important tissue 
to study in context with cardiovascular health. Therefore, leukocytes are excellent biomarkers 
of disease and have a role in the pathogenesis of ageing and age-related chronic diseases. 
Considering the capacity of regular exercise training to lower circulating inflammation, 
improve immune function36 and reduce blood pressure,37 the aforementioned diseases and 
ageing may be partly prevented or attenuated by exercise-induced modifications to gene 
expression through telomere length and epigenetic mechanisms.   
Epigenetics and DNA methylation 
Epigenetics is the study of the change in gene expression independent of a change to DNA 
sequence. Epigenetic modifications encompass DNA (methylation, hydroxylation, etc) and 
histone modifications (methylation and acetylation), and depending on the definition used, 
may also include the change to gene expression regulated by other mechanisms (e.g. small 
non-coding RNAs – microRNAs, etc). MicroRNAs are 18–24 nucleotide RNA molecules 
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that degrade mRNA or block translation by binding to the 3’ UTR of mRNA.38 The studies 
outlined in my thesis primarily focused on DNA methylation. DNA methylation is the 
process whereby a cytosine neighbouring a guanine (dinucleotide) acquires a ‘methyl’ group 
– carbon with three hydrogen atoms bound – at the 5th carbon on the cytosine base.39 This 
alters the electromagnetic charge causing conformational changes40 to chromatin.41 DNA 
methylation works in concert with other histone modifications and heterochromatin proteins 
to cause changes to gene expression by blocking DNA binding proteins and transcription 
factor binding sites.42,43 Typically, DNA methylation is associated with transcriptional 
inactivation and activation when found in the gene promoter and gene body regions, 
respectively.44 There is significant cross-talk between DNA methylation and telomere length 
as changes to either influences the other, to ultimately influence gene expression and complex 
phenotypes.45-47  
DNA methylation and the environment 
DNA methylation plays a crucial role in embryonic and cellular development, and is 
vulnerable to environmental changes.40,42,48,49 A pioneering study revealed the DNA 
methylome is vulnerable to changes caused by lifestyle, through the analysis of monozygotic 
twins (individuals with identical genotypes).50 In early life (3 years old) the monozygotic 
twins DNA methylation and histone modifications were indistinguishable, yet in later life (50 
years old) their epigenomic profiles were discordant.50 More recently, the DNA methylomes 
of patients with different age-related disease are beginning to be characterised,51-55 allowing 
researchers to identify DNA methylation loci involved in lifestyle-related disease.  
As previously stated, many of the age-related diseases with aberrant DNA methylation 
changes are somewhat preventable or manageable by physical activity.56 Exercise training 
may attenuate the risk of developing or the progression of age-related diseases through the 
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modulation of epigenetic modifications, though experimental data is currently lacking. The 
reader is introduced the current paradigm of epigenetics and the influence of exercise on 
epigenetic modifications is discussed in a literature review in Chapter 5.57  
Transgenerational epigenetic inheritance 
Environmental-induced epigenetic modifications may be inherited across multiple 
generations (transgenerationally). Environmental toxins, plastics and endocrine disruptors 
administered to gestating rats caused ongoing dysfunctional DNA methylation changes with 
paralleled phenotype disturbances experienced through to the fourth generation of rats.40,58 It 
is, however, currently unclear as to whether positive lifestyle choices, such as healthy diet or 
exercise, can cause adaptive changes to DNA methylation and health-related phenotypes. 
Rats on a low-protein diet have produced offspring with up-regulated hepatic gene expression 
and DNA methylation changes in genes involved in lipid and cholesterol metabolism, such as 
the key lipid regulator, peroxisome proliferator-activated receptor alpha (PPARA).59Although 
our current understanding of exercise-epigenetics is relatively primitive, this area of research 
has enormous potential to impact national physical activity policies and our understanding of 
best practice for the health of current and future generations. 
Hypotheses  
The hypotheses that are the basis of this thesis are as follows: 
1) Regular endurance exercise training is associated with longer leukocyte telomeres, 
which in turn is associated with improved cardiovascular health risk factors including 
body mass index, blood pressure, cholesterol, triglycerides and circulating markers of 
inflammation (IL-6, CRP, leptin, ICAM-1, E-selectin). 
2) Engagement in endurance exercise training will lead to differential expression of 
genes involved in telomere length regulation. 
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3) Sprint interval training (SIT) improves cardiovascular health and fitness by causing 
changes in leukocyte DNA methylation of genes and microRNAs that regulates 
cardiovascular physiology. 
4) Exercise training contributes to changes in the human sperm DNA methylome in 
genes related to diseases.  
Aims 
The overarching aim of this thesis is to determine the impact of strenuous exercise training on 
leukocyte telomere, DNA methylation and corresponding gene expression changes measured 
in context with cardiovascular health and fitness in humans. 
To fulfil this aim, I conducted two cross-sectional studies analysing leukocyte telomere 
length between endurance athletes and healthy controls. Furthermore, I conducted two 
training studies to determine whether the improvement to cardiovascular health and fitness 
was associated with changes to the genome-wide DNA methylation in human leukocytes and 
sperm.   
The specific aims of this thesis were to: 
1) Determine whether endurance exercise training is associated with longer leukocyte 
telomeres (Chapter 3). 
2) Elucidate any differences in leukocyte telomere length and potential mediating 
cardiovascular risk factors between endurance athletes and healthy controls (Chapter 
3 and 4). 
3) Establish whether athletes also have differentially expressed genes important for 
telomere length regulation compared to controls (Chapter 4).  
4) Identify whether particular physical activity, sedentary behaviour or cardiorespiratory 
fitness parameters mediate the telomere length and gene expression difference 
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between endurance athletes and controls, and whether these are correlated to telomere 
length and telomere-regulating genes (Chapter 4). 
5) Establish the genome-wide leukocyte DNA methylation changes associated with four 
weeks of SIT in healthy young men, and if these changes are paralleled by 
improvements to cardiovascular health parameters and cardiorespiratory fitness 
(Chapter 5). 
6) Identify if the SIT-induced changes in leukocyte DNA methylation are associated 
with gene expression changes in microRNA and or genes related to cardiovascular 
health and disease (Chapter 6).   
7) Delineate the genome-wide DNA methylation changes in human sperm after three 
months of SIT, determine the genomic location of these changes and whether these 
are associated with genes involved in the pathogenesis of disease (Chapter 7). 
Significance 
Cardiovascular disease is the world’s biggest health problem, contributing to 30% of all 
deaths.60 Over three million physical inactivity-related deaths occur annually,2 making 
physical inactivity the fourth deadliest killer.61 A greater understanding of the molecular 
processes by which exercise improves cardiovascular health will provide crucial knowledge 
that will lead to discoveries that could significantly reduce the global cardiovascular disease 
burden. 
Accumulating evidence indicates telomere shortening in the manifestation of cardiovascular 
disease.13 Considering telomere elongation occurs through the recruitment and up-regulation 
of telomerase,9,62,63 controlled, telomerase reactivation therapies or lifestyle strategies up-
regulating telomerase activity may treat and prevent cardiovascular disease. In fact, cardiac-
specific gene (telomerase reverse transcriptase, TERT) therapy administered after myocardial 
infarction improves cardiac function, telomere extension and life-span of mice.64 Therefore, it 
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is vital to establish if exercise training attenuates telomere attrition and the underpinning 
molecular mechanisms. Understanding the molecular signals leading to improved 
cardiovascular health will one day allow the development of novel pharmaceuticals to mimic 
the impact of exercise. Given the eradication of physical labour in the workplace and the 
prevalence of physical inactivity,61,65 a development such as the ‘exercise pill’ will be a vital 
development. Furthermore, molecular signatures associated with the exercise response or 
non-response will be useful for monitoring exercise training interventions and precision 
exercise prescription.  
Some environmentally induced epigenetic modifications to one generation of mammals are 
trans-generationally inherited and affect the health of the offspring.40,58,59,66 If exercise could 
favourably influence the epigenome and if these changes were trans-generationally heritable, 
then the ideal exercise that improves the health of future generations must be elucidated. 
Identifying the optimal type and amount of exercise training that confers the healthiest 
offspring would have the capacity to changes exercise and physical activity guidelines and 
policies, to ultimately decrease the burden of disease.  
The results included in my thesis have provided evidence showing the capacity for aerobic 
exercise training to: 1) prevent telomere shortening and that this effect is partly due to 
cardiorespiratory fitness adaptations (higher maximal oxygen uptake and lower resting heart 
rate); 2) influence the leukocyte DNA methylome in conjunction with improved lipid profile 
and cardiorespiratory fitness; and 3) increase sperm methylation in genes related to common 
human diseases. Consequently, these proof-of-principle results may spawn future studies to 
determine the optimal frequency, intensity, time and type of exercise that improves human 
health span through telomere length maintenance and modulation of somatic and germ-cell 
epigenomes. If identified and translated into practice, this knowledge would spare the health 
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care system substantial financial constraints, and prevent disease-related hospitalisations and 
deaths. This, in turn, would improve the healthy living and ageing of the population.   
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Key points 
• Telomere shortening is a hallmark of ageing and is associated with a host of cardio-
metabolic diseases prevented or managed by exercise training. 
• Exercise training, a superior cardiorespiratory fitness and limited sedentary behaviour 
may prevent age-related cardio-metabolic disease through telomere length 
maintenance, though the molecular mechanisms responsible are incompletely 
understood. 
• Future investigations are required to determine the optimal exercise prescription and 
the regulating factors – including epigenetic modifications, non-coding RNAs, 
oxidative stress and the telomere position effect – that avoid excessive telomere 
shortening to prevent premature biological ageing and disease. 
Abstract 
Telomeres are tandem repeat DNA sequences located at distal ends of chromosomes that 
protect against genomic DNA degradation and chromosomal instability. Excessive telomere 
shortening leads to cellular senescence and for this reason telomere length is a marker of 
biological age. Abnormally short telomeres may culminate in the manifestation of a number 
of cardio-metabolic diseases. Age-related cardio-metabolic diseases attributable to an inactive 
lifestyle, such as obesity, type 2 diabetes mellitus and cardiovascular disease, are associated 
with short leukocyte telomeres.  
Exercise training prevents and manages the symptoms of many cardio-metabolic diseases 
whilst concurrently maintaining telomere length. The positive relationship between exercise 
training, physical fitness and telomere length raises the possibility of a mediating role of 
telomeres in chronic disease prevention via exercise. Further elucidation of the underpinning 
molecular mechanisms of how exercise maintains telomere length should provide crucial 
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information on how physical activity can be best structured to combat the chronic disease 
epidemic and improve the human health span. Here, we synthesise and discuss the current 
evidence on the impact of physical activity and cardiorespiratory fitness on telomere 
dynamics. We provide the molecular mechanisms with a known role in exercise-induced 
telomere length maintenance and highlight unexplored, alternative pathways ripe for future 
investigations.   
1 Introduction 
Telomeres are repetitive DNA sequences located at the ends of chromosomes that function to 
maintain genome integrity 67. In most human cells, telomeres shorten with each round of cell 
division 68,69 and as such telomere length is reflective of cellular replicative history. 
Telomeres shorten with ageing and environmental stress, making telomere length a biomarker 
of biological age. Given the telomere length correlation and synchrony of telomere 
shortening between somatic cells, leukocyte telomere length is a useful biomarker of 
telomere lengths from other tissues 24. 
Shorter average leukocyte telomere length is typically associated with age-related chronic 
diseases, such as cardiovascular disease 14,19,70, type 2 diabetes mellitus (T2DM) 15,71, some 
cancers 17, and psychological stress 72,73. Furthermore, telomere dysfunction is involved in the 
pathogenesis of rare genetic diseases, called telomere syndromes (reviewed elsewhere 74). 
Telomere shortening may also cause the manifestation of non-communicable, age-related 
diseases. Importantly, the aforementioned diseases associated with short leukocyte telomeres 
are partly prevented, managed or even regressed by regular physical activity 75-77. The aim of 
this review is to discuss and synthesise the current literature on the impact of exercise on 
telomere biology and discuss potential mechanisms underlying how exercise influences 
telomere dynamics. Directions for future research will be provided but initially the reader will 
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be introduced to telomere biology and a brief review of leukocyte telomeres and cardio-
metabolic disease is provided. 
2 Telomere biology 
2.1 Telomeres and telomere-associated proteins (shelterin) 
Mammalian telomeres are repetitive stretches of non-protein coding DNA (5-TTAGGG-3n) 
positioned at the distal ends of linear chromosomes (Figure 1a). Human leukocyte telomere 
length varies between ~5–15 kilobases (kb) 24,78 and shortens by approximately 20–50 base 
pairs (bp) yearly 79. Telomeres shorten due to inability of DNA replication enzymes to copy 
the entire 3’ end of the leading (G-rich) strand (Figure 1a) 80. Furthermore, oxidative stress 
accelerates telomere attrition, with the telomeric DNA GGG triplet most vulnerable to 
reactive oxygen species 81,82, and antioxidant compounds attenuate telomere shortening in 
vitro 83. It is currently unclear precisely how excess inflammation shortens telomeres. It could 
be that elevated inflammation exacerbates oxidative stress and promotes cellular turnover 
causing telomere shortening. Once telomere shortening has reached a critical length, telomere 
dysfunction ensues and signals cellular senescence through DNA damage pathways – ataxia 
telangiectasia mutated (ATM), ataxia telangiectasia and rad3 related (ATR), p21 and p53 
10,84,85. This, in turn, decreases the proliferative capacity of the tissue leading to an aged 
phenotype and overall decrease in tissue vitality. There are, however, telomere-associated 
proteins that repress DNA damage signalling pathways by regulating telomere length; this is 
primarily accomplished through the formation of unique telomere complexes.  
Six telomere-associated proteins (telomere repeat-binding factor 1 [TRF1], telomere repeat 
binding-factor 2 [TRF2], TRF1-interacting nuclear factor 2 [TINF2], adrenocortical dysplasia 
homolog [commonly referred to as TPP1], protection of telomeres 1 [POT1] and TRF2-
interacting protein [TRF2IP]), collectively known as shelterin, bind to the telomeres and 
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regulate their length (reviewed in de Lange 84 and Nandakuma and Cech 63) (Figure 1b and 
c). Telomeres and shelterin form unique structures (t- and d-loops 86 [Figure 1d]) and serve as 
protective caps at the ends of chromosomes to prevent chromosomal end-to-end fusion and 
allow the complete replication of protein-coding DNA. TRF1 and TRF2 are abundant 
telomere-binding proteins that play unique roles at the telomeres 87,88. While TRF1 negatively 
regulates telomere length 89, TRF2 protects telomere-mediated chromosomal end-to-end 
fusion and cellular senescence 90. TINF2 regulates and interacts with TRF1 and TRF2 91. 
TPP1 and POT1 bind to single stranded telomeric DNA (G-strand overhangs), and interact to 
recruit and increase the processivity of telomerase resulting in telomere elongation 92,93. 
TRF2 and POT1 independently protect telomeres from DNA damage response pathways 
(ATM and ATR, respectively) and inevitably prevent cellular senescence through telomere 
length maintenance 94. TRF2-interacting protein (TRF2IP) (alternatively known as RAP1) 
binds indirectly to telomeric DNA through its interaction with TRF2 and contributes to the 
prevention of telomere fusion events 95,96. RAP1, however, is dispensable as mice lacking a 
functional Rap1 gene are viable, unlike mice null for other shelterin components (Trf1 or 
Tpp1) 97. RAP1 also has extra-telomeric functions, as RAP1 silences sub-telomeric genes, but 
also acts as a transcription factor through interactions with other genomic locations 98. 
Therefore, shelterin aid in the stabilisation of telomere length, avoids adverse chromosomal 
events and represses the activation of DNA damage response signalling pathways at 
telomeres via the formation of t- and d-loops 99,100. Although not within the scope of this 
review, it is important to note telomeres have nucleosomes and histone proteins that are 
vulnerable to epigenetic modifications 46. Furthermore, sub-telomeric DNA is heavily 
methylated and telomere shortening is observed with accompanying epigenetic modifications 
required for open, transcriptionally active, chromatin 45,101. Open telomere chromatin may 
subsequently up-regulate telomere transcription to produce telomeric repeat-containing RNA 
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(TERRA). TERRA is a long non-coding RNA molecule that inhibits telomerase by binding to 
the telomerase RNA template through its complementary and repetitive RNA sequence (5’-
UUAGGG-3’) 102. The impact of exercise training on TERRA is currently unknown. Thus, 
epigenetic modifications and TERRA are added tiers of telomere length regulation. 
Nonetheless, progressive telomere shortening occurs in the absence of the enzyme 
telomerase.  
2.2 Telomerase 
Telomerase is a reverse-transcriptase ribonucleoprotein capable of adding telomeric repeats 
to DNA 9. In humans, telomerase is made up of two main proteins (telomerase reverse 
transcriptase [TERT] and telomerase RNA component [TERC]) and additional accessory 
proteins (dyskeratosis congenita 1 [DKC1] and NOP10 ribonucleoprotein [NOP10]) (Figure 
1d). Although telomerase activity is high in human ovaries and testis 103, somatic cells have 
variable telomerase activity. For example, leukocyte subsets express low to moderate levels 
of telomerase activity 104, yet telomerase is extremely low or undetectable in human skeletal 
myocytes 103,105. Conversely, telomerase activity is up-regulated in most human cancers and 
the majority of cancer cells have short telomeres 104,106,107. Remarkably, in vitro experiments 
involving the reintroduction of telomerase to human cells previously lacking telomerase 
activity extends telomeres and extends cellular life span 69,108. Thus, the rate of somatic cell 
telomere shortening that occurs during ageing is influenced by the proliferative rate of cells, 
shelterin and telomerase activity.  
The regulation of telomerase activity is a complex dynamic process, discussed in detail 
elsewhere 109,110. While POT1 and TPP1 recruit telomerase to telomeres and increase 
telomerase processivity – the capacity for telomerase to add telomeric DNA 93,111 – many 
other non-telomere-associated proteins also govern telomerase activity. Telomerase up-
regulatory factors modulated by exercise (acute or chronic) include Akt, insulin-like growth 
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factor 1 (IGF1) and interleukin 6 (IL6), amongst others 109,112. Interestingly, accumulating 
evidence indicates a role for telomerase in the regulation of biological pathways outside that 
of telomere biology 98,113.  
2.3 Alternative lengthening of telomeres 
Alternative lengthening of telomeres (ALT) is another mechanism with the capacity to 
elongate telomeres independent of telomerase. ALT may occur through telomere sister 
chromatid exchanges or homologous recombination-dependent DNA replication 114,115. 
Indeed, 10–15% of cancers lack telomerase activity and rely on ALT for telomere length 
maintenance. Whereas ALT has been reported largely in a relatively small subset of cancers 
116-118, recently ALT activity was observed in normal mouse cells in vivo 119. Common mouse 
strains, however, have significantly longer telomeres (10 to 80 kb) 120,121 and the induction of 
cellular senescence is different compared to humans 122. Nonetheless, ALT may be a normal 
part of telomere length regulation and whether exercise training influences telomere length 
through ALT is currently unknown. 
3 Telomeres and cardio-metabolic diseases 
Regular physical exercise is not only associated with the decreased risk of developing age-
related cardio-metabolic diseases (i.e. obesity, T2DM and heart disease), but exercise training 
also attenuates and manages particular disease symptoms 56,123,124. In this section, we discuss 
telomere length in context with cardio-metabolic diseases that exercise training is known to 
prevent or manage. While not discussed here, it is important to emphasise shorter average 
leukocyte telomeres are found in individuals with elevated psychological stress 72,73,125 and 
those consuming poor diets 126,127 – lifestyle factors that contribute to an increased risk of 
many cardio-metabolic diseases.  
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3.1 Obesity 
Most studies on leukocyte telomere length and obesity-related phenotypes – (e.g. body-mass 
index [BMI], weight and waist circumference) 128-133 – show inverse relationships, though 
some do not 134,135. Childhood obesity has been associated with shorter leukocyte telomeres in 
both sexes 136, and in boys only 137. There are reported sex differences, suggesting the adverse 
effect of obesity-related phenotypes on leukocyte telomere length may be more apparent in 
women than men 130,138. These inconsistencies may be due to the different races and ages of 
participants studied. Recently, data from weight-loss interventions involving dietary 
amendments with or without additional physical activity and counselling services support the 
relationship between leukocyte telomere dynamics and the regulation of obesity-related 
phenotypes. For instance, increased leukocyte telomere length was correlated with reduced 
body weight, BMI and waist circumference in middle-aged to older adults (n = 521) after a 
five-year Mediterranean dietary intervention 129. A shorter (two-month) intensive lifestyle 
intervention elicited weight-loss with leukocyte telomere lengthening in adolescents 139. The 
reduction in obesity phenotypes caused by the dietary interventions are consistent with the 
premise that telomere shortening elicits a causal influence on obesity-related phenotypes and 
that lifestyle strategies aimed at lengthening telomeres may effectively combat disease.  
3.2 Type 2 diabetes mellitus  
Patients with T2DM have shorter leukocyte telomeres compared to their non-diabetic 
counterparts 15,140-143 and the extent of telomere shortening is dependent on patient outcomes. 
T2DM patients with a history of myocardial infarction (MI) exhibited shorter leukocyte 
telomeres than those without a history of MI and healthy controls 142. Additionally, leukocyte 
telomeres are progressively shorter in T2DM patients with more diabetic complications (such 
as retinopathy, incipient nephropathy and cardiovascular disease) 141. The genetic 
predisposition to elevated oxidative stress could contribute to telomere shortening in T2DM 
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patients. The uncoupling protein 2 (UCP2) gene codes a protein important for the electron 
transport chain and down-regulates reactive oxygen species (ROS) production. T2DM 
patients with the functional variant allele UCP2 –866A exhibit shorter (~170 bp) leukocyte 
telomeres compared to their peers homozygous for the G allele, suggesting a genetic 
contribution to ROS-induced telomere attrition 15. Further, leukocyte telomere length 
shortening over 10 years was related to increases in BMI, insulin, glucose and homeostasis 
model assessment of insulin resistance 144. Whereas excessive telomere shortening in T2DM 
patients is established, whether leukocyte telomere length holds predictive value for T2DM 
risk is unknown, as two large prospective studies have yielded conflicting results 145,146. 
3.3 Cardiovascular disease 
Consistent with T2DM, the presence of cardiovascular disease is characterised by short 
leukocyte telomeres relative to healthy individuals 147-150. Accelerated biological ageing is 
shown in patients with atherosclerosis, such that their leukocyte telomeres are ~300 bp 
shorter than healthy controls; a difference equating to 8.6 years’ worth of telomere shortening 
70. Chronic heart failure patients not only had shorter leukocyte telomeres than age and sex-
matched controls, but the extent of telomere shortening was dependent on plaque formation; 
incrementally shorter telomeres were observed in patients with one, two or three 
atherosclerotic manifestations, defined as coronary, cerebrovascular and peripheral 
vasculature, or any combination 151. Shorter leukocyte telomeres are associated with coronary 
artery calcification in a cardiovascular disease-free, middle-aged population, suggesting that 
the leukocyte telomere shortening observed in atherosclerotic diseases may not be a 
consequence of the disease 14. The shortened leukocyte telomeres (~300 bp) observed in MI 
patients indicated patients were biologically 11.3 years older than their age-matched healthy 
controls 19. When patients were divided in telomere length quartiles, those with the shortest 
telomeres had a 3-fold increased risk for MI 19. Notably, these findings were supported by 
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some 152 but not others 18. In a large cohort (n >1500), risk of developing coronary heart 
disease was increased in subjects in the lowest tertile of telomere length and was attenuated 
by statin treatment 13. Whilst the current literature suggests short telomeres are predictive of 
future coronary heart disease, the predictive ability of telomere length for cerebrovascular 
disease is unclear 153. Leukocyte telomere length was not associated with ischemic stroke, in 
a cohort of 259 males who were initially free from disease that progressed to develop 
ischemic stroke 154. The predictive value of leukocyte telomeres in disease prognosis may be 
limited to middle-aged subjects and not older adults (>75 y) 155, yet older individuals (60 to 
97 years) with shorter telomeres have poorer survival due largely to infectious diseases and 
heart disease 20. While short baseline telomere length was associated with increased 
cardiovascular disease-related mortality risk in women, telomere shortening over 2.5-years 
was associated with greater mortality from cardiovascular disease in men aged 70 to 79 years 
156.  
3.4 Is telomere shortening a cause or consequence of cardio-metabolic disease? 
Considering the available human research, it is important to note that it is unclear as to 
whether the leukocyte telomere shortening in cardio-metabolic diseases is a cause or 
consequence of disease. Evidence from mouse and in vitro experiments support the former. 
Terc-/- mice, without detectable telomerase activity, exhibit short telomeres and age-related 
phenotypes – splenic and intestinal atrophy, reduced body weight, haematological 
abnormalities, reduced proliferative potential, hair loss and tumour formation 157-159. Terc-/- 
mice from mixed genetic backgrounds also suffer from hypertension 160, depleted 
haematopoietic progenitor cells 161 and T2DM 162. Endothelial dysfunction caused by 
telomere-mediated cellular senescence in Terc-/- mice was restored after treatment with 
antioxidant compounds 163. Low-grade chronic inflammation and oxidative stress are 
common symptoms and contribute to the pathogenesis of age-related cardio-metabolic 
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diseases 164-167. Both inflammation 168 and oxidative stress 82,169 cause telomere attrition in 
vitro.  
Telomere shortening alters the expression of neighbouring – subtelomeric – genes 170,171 and 
genes separated by large distances (10 kb) 172, a concept known as the telomere position 
effect. The change in gene expression may not be due to the telomere shortening per se but 
rather a loss of shelterin proteins or telomere chromatin formations 173. Therefore, telomere 
shortening may contribute to the manifestation of age-related disease by deregulating 
transcription of particular genes throughout the genome. Indeed, older versus younger human 
fibroblasts have shorter telomeres and increased expression of genes involved in chromatin 
modifying proteins 174, suggesting telomere shortening may facilitate chromatin remodelling 
through coordinated expression of chromatin modifying genes. Moreover, senescent human 
fibroblasts with shorter telomeres have differentially expressed sub-telomeric genes 
compared to quiescent fibroblasts 175.  
A genome-wide association study (GWAS) found seven loci containing candidate genes 
(TERC, TERT, NAF1, OBFC1 and RTEL1) were associated with leukocyte telomere length 
and risk of multiple cancers, idiopathic pulmonary fibrosis and coronary artery disease in 
humans, supporting a causal role of telomere shortening in the development of cardio-
metabolic diseases 176. Leukocyte telomere attrition rate over a 7 to 11-year time-period was 
inversely related to atherosclerosis progression, indicated by carotid intima thickness (cIMT) 
177. Furthermore, subjects with cIMT regression exhibited telomere elongation 177, indicating 
telomere lengthening is protective of vascular damage. Accordingly, compared to subjects 
with telomere maintenance or elongation after six years, those with telomere shortening had 
higher cIMT and an increased risk of cardiovascular events, independent of traditional 
cardiovascular disease risk factors 178. Similar associations whereby telomere elongation is 
observed with attenuated disease symptoms – or vice versa – have been observed in T2DM 
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144 and obese 129,139 patients. Although mouse and human studies support the concept that 
telomere shortening may facilitate disease manifestation and progression, it is important to 
emphasise other unmeasured factors may mediate telomere and disease dynamics. Lifestyle 
factors such as physical activity, diet and psychological stress are potential confounding 
factors that could influence telomere length and disease risk independently. These factors 
could also facilitate a pro-inflammatory or oxidative cellular environment which could, in 
turn, promote telomere attrition, cellular senescence and disease.  
Importantly, the cardio-metabolic diseases related to telomere shortening are somewhat 
preventable and managed by physical activity 75-77. The prevention or management of cardio-
metabolic disease conferred by exercise training could be partly driven by telomere length 
maintenance. Alternatively, exercise training could prevent disease through a reduction in 
disease-related risk factors (blood pressure, lipid profile, adiposity, etc.), systemic 
inflammation and oxidative stress, or psychological stress to ultimately prevent telomere 
shortening.  
4 Telomere biology and physical activity  
Regular engagement in exercise training is associated with longer telomeres and may 
attenuate telomere attrition. The optimal exercise recommendations for telomere length 
maintenance, however, remain elusive. Research has involved the analysis of telomere length 
in context with physical activity habits, predominantly assessed by physical activity 
questionnaires, case-control studies involving habitual exercisers and less-active or sedentary 
controls, and or physical fitness measures (i.e. maximal oxygen consumption [VO2max] or 
metabolic equivalent of task [METs]). In the next section, we discuss findings on the effect of 
physical activity and fitness on leukocyte telomere dynamics mainly in leukocytes and 
skeletal muscle (Table 1). 
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4.1 Telomere length and physical activity 
Physical activity was positively correlated to leisure-time physical activity levels in 2401 
twin volunteers 179. The leukocyte telomeres were 200 bp longer in individuals who 
performed the most physical activity compared to those who engaged in the least amount 179. 
Moreover, in twins discordant for physical activity levels, leukocyte telomeres were 80 bp 
longer in the twin engaging in the most physical activity 179. Supporting these results, a linear 
relationship between physical activity and telomere length was observed in a cohort of female 
nurses 180, suggesting that physical activity may be protective of telomere length. 
There may be a threshold for the amount of physical activity ideal for telomere length 
maintenance. An inverted-U relationship was observed when 69 healthy subjects were 
divided into estimated energy expenditure quartiles, with those expending moderate amounts 
of energy exhibiting the longest peripheral blood mononuclear cell (PBMC) telomeres 181. 
Strikingly, longer leukocyte telomeres and a lower percentage of short telomeres were found 
in men who engaged in moderate physical activity compared to men who engaged in low or 
high amounts of activity 29 years prior to telomere length assessment 182. Despite supporting 
an inverted-U relationship between physical activity and telomere length 181, physical activity 
was assessed from self-reported questionnaires  182 which often do not yield valid or reliable 
results. There are also some studies that do not show any statistically significant associations 
between physical activity and leukocyte telomere length 183-185. Interestingly, recreational 
physical activity may be more important for telomere maintenance as job-related physical 
activity was not associated with leukocyte telomere length in 981 individuals (aged 45–84 y) 
186. Physical fitness, however, was not measured in these studies and the lack of association 
between telomere length and physical activity may be partially explained by the physical 
activity assessment methods used.  
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Habitual or regular exercise training seems to protect against telomere shortening, 
particularly in postmenopausal women. In cross-sectional analyses, postmenopausal women 
who performed 60 min of resistance and aerobic exercise more than three times per week for 
an average of 19 months exhibited significantly longer PBMC telomeres compared to their 
sedentary peers 187. Postmenopausal women with stage I-III breast cancer, who participated in 
moderate to vigorous physical activity also have significantly longer PBMC telomere length 
compared to their sedentary counterparts 188, suggesting exercise intensity may be an 
important determinant of telomere length. Conversely, recent data indicates that sedentary 
behaviour is detrimental to leukocyte telomere length. In a large epidemiological study, 
screen-based sedentary behaviour was inversely associated with leukocyte telomere length in 
6405 adults (20 – 84 y) 189. Consistent with these findings, telomere lengthening was 
observed in older adults who reduced their sitting time, after a six-month intervention 
involving prescribed exercise and counselling 190.  
4.2 The impact of age on telomere length and physical activity 
The positive effects of physical activity on telomere maintenance may be restricted to certain 
age groups. In older adults (≥65 y, n = 2006) physical activity assessed by the Physical 
Activity Scale for the Elderly 191, was not associated with leukocyte telomere length. Rather 
than physical activity, physical capacity may have a greater impact on telomere length 
maintenance in older adults. For example, gait speed 192 and Barthel index 193,194 – an 
assessment of ability to perform activities of daily living, were positively correlated to 
telomere length in older adult populations. In a cohort of 548 same-sex Danish twins, 
leukocyte telomere length increased with every unit increase in physical ability score 195. 
Moreover, a 10 year longitudinal study indicated a decline in grip strength was related to a 
faster leukocyte telomere attrition, potentially caused by elevated circulating inflammatory 
markers (interleukin-1β and cortisol) 196. Sit to stand performance and walking distance were 
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associated with longer leukocyte telomeres in a cross-sectional analysis involving 582 older 
adults, while estimated energy expenditure and time to complete five chair stands were 
associated with attenuated telomere attrition over a 5-year period, suggesting physical activity 
and performance are important for telomere maintenance even in later years of life 197.  
Duration of physical activity may not be as important as the intensity of exercise for younger 
individuals. One study involving 667 adolescent subjects revealed physical activity, 
objectively assessed by accelerometers worn for seven days, was unrelated to leukocyte 
telomere length 198. Telomere length was, however, positively associated with exercise 
intensity 198, providing evidence that vigorous exercise may be protective of telomeres in 
young individuals.  
4.3 Endurance exercise, cardiorespiratory fitness and telomere length 
Endurance athletes have a superior level of cardiorespiratory fitness, resulting from 
prodigious amounts of aerobic exercise training. They also have a much lower risk of 
cardiovascular and cancer related mortality, and live longer than sedentary individuals 199. 
Interestingly, telomere attrition was attenuated in middle-aged (~51 y) German track and 
field athletes who ran an average of 80 km a week, such that they had similar PBMC 
telomere lengths compared to younger (~21 y) athletes and sedentary controls 200; findings 
that have been supported by others 201. Ultra-endurance athletes running an average of 40–
100 km per week possessed 11% longer leukocyte telomeres compared to healthy subjects, 
indicating these athletes had prevented approximately 16 years’ worth of age-related telomere 
shortening 202. Of note, we recently verified our previous findings that endurance athletes 
have longer leukocyte telomeres and attenuated biological ageing 202 in another cohort of 
endurance (triathletes, long distance runners and cyclists) subjects, such that the athletes 
possessed longer telomeres than controls and had prevented 10.4 years of telomere shortening 
caused by ageing 203. In a much smaller (athletes n = 17, controls n = 15) study, however, 
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athletes running ~33 km a week had similar granulocyte and lymphocyte telomeres to that of 
sedentary controls 204. The discrepancy maybe due to the leukocyte subsets analysed or 
method of telomere measurement – quantitative fluorescent in situ hybridization (qFISH). 
Therefore, the majority of available literature finds strenuous, endurance exercise training is 
associated with longer telomeres. The adherence to regular exercise training may be required 
in order to prevent telomere shortening as former Finnish elite athletes possessed comparable 
leukocyte telomere lengths to that of their sedentary counterparts 205. It is currently unclear as 
to why telomere length seems to be somewhat maintained in these athletes, but there is 
mounting evidence indicating a role for cardiorespiratory fitness. 
Maximal oxygen uptake was an independent predictor of leukocyte telomere length in a 
cohort of 57 young (21 y) and older (~62 y) adults, and explained 20% of the overall variance 
in leukocyte telomere length 201. Others have also demonstrated weak to moderate (r = 0.11 to 
0.44) positive correlations between leukocyte telomere length and VO2max 201,206. Leukocyte 
telomere length was ~169 bp longer in stable chronic heart failure patients with high (> 7 
METs) fitness compared to their unfit (< 5 METs) peers 207. In a large epidemiological study 
including 1764 US adults, predicted maximal oxygen uptake was associated with longer 
telomeres, such that individuals with moderate (39.1 ml.kg-1.min-1) or high (50.9 ml.kg-1.min-
1) cardiorespiratory fitness possessed longer leukocyte telomeres than those with poor fitness 
(30.7 ml.kg-1.min-1). The positive relationship between VO2max and telomere length is not 
exclusive to leukocytes, as skeletal muscle telomeres are longer in subjects with higher 
VO2max 208. Thus, improvement in cardio-respiratory fitness seems an important adaptation 
potentially involved in telomere length maintenance caused by exercise training.  
It is important to emphasise that while ample evidence indicates that endurance exercise is 
associated with longer leukocyte telomeres in athletes compared to less-active controls, data 
on skeletal muscle telomeres is not as consistent. Unlike highly proliferative leukocytes, 
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skeletal muscle telomeres are quiescent and the limited available data demonstrate 
recreational physical activity does not cause excessive telomere shortening in young or older 
adults 209.  Skeletal muscle telomeres may not succumb to chronological ageing. Conversely, 
the increased oxidative stress associated with ageing may facilitate telomere shortening, as 
older mobile adults have reduced reactive oxygen species and longer leukocyte and thigh 
skeletal muscle telomeres compared to their immobile peers 210. Endurance athletes, however, 
with exercise-associated fatigue possess short muscle telomeres 211. Healthy athletes have 
been documented to have longer 208 or comparable 212 muscle telomere lengths relative to 
sedentary controls. Resistance exercise-trained athletes have borderline significantly longer 
minimum and mean telomeres compared to controls 213. Therefore, current data on endurance 
exercise and resistance training suggest that endurance exercise is not detrimental to 
leukocyte or muscle telomere length maintenance, though there could be an upper limit to the 
protective effect of exercise, considering shorter muscle telomeres were inversely correlated 
to maximal strength 213 and training history (years and hours spent running) 212.  
4.4 Longitudinal, prospective studies on lifestyle changes and leukocyte telomere 
length 
Well-controlled lifestyle interventions are beginning to provide insights on the impact of 
exercise training on the age-associated telomere attrition. A three month intervention 
consisting of a healthy diet (high in natural food products), stress management, social support 
and 30 minutes of walking exercise six days a week significantly increased PBMC 
telomerase activity in low-risk prostate cancer patients, who refused traditional cancer 
treatment 214. After a 5-year follow-up, the experimental group had modestly longer 
telomeres, an effect mostly unobserved in the controls 215. Whilst these preliminary findings 
propose a healthy lifestyle may increase telomerase activity and telomere length the study 
was small (cases n = 10, controls n = 25) and some cases in the lifestyle intervention 
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experienced telomere shortening comparable to the controls. Similar findings were reported 
in a group of 59 middle-aged sedentary males after a much shorter (6-month) moderate-
intensity exercise training intervention 216, although a control group was not included. In a 
large, 12-month randomised controlled trial, women in either the control (n = 87), exercise-
only (n = 117), calorie-reduced diet only or exercise (n = 117) and calorie-reduced diet (n = 
118) groups showed a similar, minimal change in leukocyte telomere length that was not 
statistically significant 206. Therefore, it is premature to claim whether exercise training can 
solely prevent telomere shortening or induce telomere elongation. Additional controlled 
exercise training studies involving different exercise prescription will be required to identify 
whether exercise alone can prevent age-associated telomere shortening. 
Evidence indicates psychological stress is detrimental to telomere length maintenance 72,73. 
Importantly, the negative association between psychological stress and leukocyte telomere 
length was abolished in postmenopausal women achieving the Center for Disease Control and 
Prevention’s recommended physical activity levels (75 min of vigorous exercise per week) 
217. Strikingly, over a one year follow-up period, postmenopausal women who experienced 
more adverse life stressors experienced greater telomere attrition (~35 bp decrease for every 
life stressor), however telomere attrition was attenuated by a healthy lifestyle (more physical 
activity, better sleep quality and a healthier diet) 73. When telomere attrition and physical 
activity levels were analysed independently, a one standard deviation below or at the group 
average was associated with a significantly faster telomere attrition 73. Thus, exercise training 
may combat psychological stress-induced telomere shortening.  
Taken together, physical activity seems to confer a beneficial effect on leukocyte telomere 
length maintenance as shown by association studies. Despite positive correlations between 
physical activity levels and leukocyte telomere length, the ideal exercise prescription for 
telomere conservation is not yet established. Endurance athletic status is associated with 
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longer leukocyte telomeres predominantly in middle-aged subjects. No evidence indicates 
extensive aerobic exercise is associated with shorter telomeres in healthy subjects. The 
inconsistencies throughout the literature are likely due to genetic diversity of subjects, age 
ranges, DNA extraction methods 218, methods of assessing physical activity and telomere 
length quantitation 219-221, and the controlling of other confounding factors (eg. diet, 
psychological stress and socioeconomic status). Researchers should control for the 
aforementioned confounding factors to attempt to isolate the impact exercise training has on 
telomere biology. Notably, it is unclear as to whether individuals who inherited and were 
born with long telomeres have increased cardiorespiratory fitness and consequently engage in 
more exercise training. Indeed, there is a genetic propensity for VO2max 222 and the training-
induced responsiveness to VO2max 223, making it plausible that physical activity data may be 
purely associational and that genetic influence programs telomere maintenance. It is 
suggested that literature on telomere length and physical activity assessed solely by self-
reported physical activity questionnaires should be interpreted with caution as they have 
inherent issues such as recall-bias and over/under-estimation of actual physical activity levels 
is common 224-226. Whereas the benefits of aerobic exercise on telomere length are commonly 
reported, data on the effects of resistance training on telomere length are scarce. It is 
recommended future research should consider quantifying cardiorespiratory fitness in context 
with self-reported physical activity and telomere dynamics. Additional randomised, 
controlled exercise training interventions and longitudinal telomere length assessment with 
healthy and clinical populations will help discern the involvement of telomere regulation on 
disease management and regression. Further research is also required to elucidate the ideal 
exercise prescription required for telomere length maintenance in other unexplored tissues. 
This knowledge in turn can be used to optimise the physical training required to combat 
cellular ageing and prevent age-related cardio-metabolic disease. 
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5 Molecular mechanisms in exercise-induced telomere dynamics 
5.1 Telomerase activity 
Physical activity and exercise training are associated with longer telomeres but the molecular 
mechanisms underpinning the relationship are not very well understood. The ability of 
telomerase to extend telomeres and prevent telomere shortening-induced cellular senescence 
9,69 suggests a crucial role for increased telomerase activity mediating telomere length 
consequential to exercise training. Indeed, elevated telomerase activity after chronic exercise 
training has been demonstrated in a variety of tissues, including human PBMCs 214,216, mouse 
skeletal muscle 227, heart 228, aorta 200 and hippocampi 229. Endurance athletes who regularly 
engage in rigorous aerobic exercise exhibit a 2.5- and 1.8-fold increased telomerase activity 
compared to young and middle-aged sedentary subjects, respectively 200. Despite the capacity 
of chronic exercise training to influence telomerase activity, whether an acute bout of 
exercise has a similar effect remains to be explored. The exercise training-induced increase in 
telomerase activity is dependent on TERT and endothelial nitric oxide synthase (eNOS) 
protein expression, as long-term exercise training does not modulate telomerase activity in 
Tert-/- or eNos-/- mice 228. Mice treated with recombinant growth hormone or IGF1 exhibited 
an 8- and 14-fold increase in cardiac telomerase activity, indicating these growth factors are 
mediators for the up-regulation telomerase activity in cardiac myocytes of exercised mice 228. 
These data provided crucial evidence elucidating a role for growth hormone, IGF1, eNOS 
and TERT in the up-regulation of telomerase activity induced by exercise training.  
5.2 Shelterin expression 
Telomerase must be recruited to telomeres for telomere elongation to occur; a process tightly 
regulated by shelterin proteins 63,110. 30 minutes of aerobic exercise at 80% of peak oxygen 
consumption (VO2peak) significantly up-regulates leukocyte TRF2IP and TERT expression in 
healthy young men 230. Whereas acute aerobic exercise modulates some telomere-associated 
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genes in leukocytes, this may not effect protein abundance. For example, PBMC TRF1, TRF2 
and POT1 expression were all up-regulated the day following a seven-day ultra-marathon 
race in eight athletes, but this did not translate into increased protein abundance or telomerase 
activity 231. MicroRNAs (miRNAs) are small RNA molecules that negatively regulate 
translation or degrade messenger RNA (mRNA) targets, in turn, limiting protein abundance. 
The acute exercise-induced decrease in expression of the miR-96 and -186-targeted transcript 
TERF2IP was observed with a concomitant increase in miRNA molecules 230. miRNA 
regulation of shelterin genes is a possible explanation for the unchanged protein abundance 
observed previously 231. Whilst seven-days of intense endurance exercise may not facilitate 
shelterin protein abundance, the overall adaptation to endurance exercise may lead to altered 
shelterin protein expression.  57 endurance-trained athletes showed increased PBMC TF2 
mRNA and protein levels, with increased telomerase and longer telomeres compared to 
sedentary subjects 200. Similarly, aortic 200 and heart 228 TRF2 mRNA and protein levels are 
increased in mice after three weeks of voluntary wheel running. Therefore, some shelterin 
proteins particularly TRF2, are modulated by long-term exercise training in PBMCs, heart 
and aortic tissue. There is, however, limited evidence showing the acute effects of exercise on 
shelterin expression.  
Relative to other tissues, skeletal muscle shelterin may not be as responsive to exercise 
training. In athletes, no changes were observed in skeletal muscle TRF1, TRF2 or POT1 
expression after a seven-day ultra-marathon 231. However, the age-related increase in TRF1 
protein expression in plantaris muscle of sedentary mice was attenuated in exercised mice 227, 
possibly through p38 mitogen activated protein kinase (MAPK) inactivation 232. Considering 
TRF1 is a negative regulator of telomerase activity 110, the decreased TRF1 expression 
observed in conjunction with increased telomerase activity 227 may be a mechanism to 
counteract the telomere shortening observed in the exercised mice. TRF1 protein expression 
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is decreased after acute exercise in mouse skeletal muscle 232, but whether this is detrimental 
or occurs in conjunction with increased telomerase activity is currently unknown. 
5.3 Other mechanisms 
Exercise training prevents many age-related metabolic diseases including cardiovascular 
disease 233, T2DM 234 and obesity 235, and is reflected by a longer telomere phenotype. 
Conversely, age-related chronic diseases are associated with shorter mean leukocyte telomere 
length 236 and are all characterised by low-grade chronic inflammation and oxidative stress 
237. Cell culture experiments indicate the former accelerates telomere shortening 168. 
Oxidative stress also induces telomere attrition 83,238, with the telomere GGG sequence 
particularly vulnerable to damage caused by reactive oxygen species 82. Importantly, regular 
exercise training reduces both low-grade chronic inflammation and circulating oxidative 
stress 36,239. We, however, found no correlations between long-term exercise training, 
telomere length and inflammatory cytokines (interleukin-6, intercellular adhesion molecule-1 
e-selectin, C-reactive protein and leptin) 202. Additionally, a six month exercise training 
intervention in obese subjects improved antioxidant enzyme activity but did not alter 
leukocyte telomere length 240. Therefore, it is difficult to ascribe telomere shortening to 
oxidative stress or inflammation in vivo. The study of other oxidative/inflammatory 
compounds and longer exercise training regimes may help elucidate whether exercise 
attenuates telomere shortening via reduced ROS and inflammation.  
Small non-coding RNA, such as miRNAs are ~22 bp in length and serve as negative 
regulators of translation by targeting the 3’ untranslated region (UTR) on mRNA target 
transcripts or through mRNA degradation. While shelterin gene and protein expression have 
been studied in context with exercise training, little is known about the miRNAs regulating 
these. Data from our laboratory demonstrated decreased TERF2IP expression with increased 
miR-98 and miR-186 abundance after acute exercise training 230. In breast cancer tissue miR-
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155 is up-regulated and down-regulates TRF1 protein abundance consequently promoting 
genomic instability 241. Thus, the miRNA and other non-coding RNA, such as long non-
coding RNA (including subtelomeric transcribed RNA, TERRA 242), regulation of shelterin 
and telomere length changes associated with exercise is likely. Interestingly, miR-290-
dependent regulation of retinoblastoma-like 2 protein which in turn impacts DNA 
methyltransferase (DNMT) enzyme activity and subsequent DNA methylation modulates 
telomere length and recombination 243. To that end, telomere dynamics may also be 
influenced by epigenetic modifications and TERRA expression. 
A change in gene expression without a change to the genetic sequence is the definition of 
epigenetic regulation. Epigenetic regulators such as DNA methylation and histone 
modifications are crucial for biological development and aberrant epigenetic profiles are 
associated with many age-related diseases 244,245. The impact of exercise training on genome-
wide DNA methylation is beginning to be delineated and has been discussed in detail 
elsewhere – 57,246-248. The TERT gene has a cytosine neighbouring a guanine dinucleotide 
(CpG) island (a region abundant in CpGs) located in its promoter region regulating 
telomerase expression in telomerase-positive cells 249. There are, however, conflicting data on 
the effects of DNA methylation in the proximal promoter region of TERT in immortal and 
other cell lines 250. It will be important to identify the influence methylation status has on 
TERT expression in leukocytes from healthy human donors. Furthermore, the chromatin 
remodelling protein, CCCTC-binding factor, binds to exon 1 of TERT and represses TERT 
mRNA expression, highlighting the complex epigenetic regulation of TERT 251. DNA 
methylation in concert with histone acetylation acts to negatively regulate TERT expression 
252. Work from the Blasco laboratory has provided insight into the interactions between 
telomere length and epigenetic modifications 46,101,253. Telomere shortening in Terc-/- mice is 
accompanied by histone methylation and acetylation changes at telomeric and subtelomeric 
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regions, consistent with a more open, transcriptionally active chromatin 46. DNMT-null 
mouse embryonic stem cells show exceptionally elongated telomeres, potentially due to 
telomere recombination events 101. Thus, there is ample evidence supporting a role for 
epigenetic regulation in the exercise-induced changes to TERT and the expression of other 
telomere-associated genes, though this remains to be experimentally demonstrated. 
Therefore, it is likely that telomere length is tightly controlled by shelterin-mediated 
telomerase recruitment in context with the cellular proliferative activity, which would 
undoubtedly be accelerated by increased oxidative stress and inflammation. Considering 
inflammation and oxidative stress shorten telomeres in vitro, it is possible that exercise may 
attenuate telomere attrition by maintaining a beneficial redox status and preventing chronic 
low-grade inflammation. Whilst only beginning to be delineated, the role of epigenetic 
modifications, chromatin structures and non-coding RNA, particularly miRNA and TERRA, 
molecules may serve as fine-tuners of shelterin and telomerase activity. The aforementioned 
molecular and cellular factors could be responsible for the telomere maintenance in 
individuals routinely engaging in aerobic exercise training or accelerated telomere attrition 
observed in sedentary individuals (Figure 2). 
6 Conclusions 
The prevention of age-related cardio-metabolic diseases is an adaptation conferred by 
engagement in regular exercise training, but the underlying molecular mechanisms are to date 
poorly understood. Cellular ageing through telomere shortening is attenuated by physical 
activity and exercise training yet the most favourable exercise prescription that maintains 
telomere length will require future study. The analysis of telomere length, shelterin 
expression and telomerase activity with exercise training interventions involving different 
exercise prescription including mode, frequency, duration and intensity, are warranted. 
Further, the impact of resistance training on telomere length is relatively unknown and 
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deserves attention. Efforts should be made to establish additional molecular pathways by 
which exercise maintains telomere length. Analyses on oxidative stress, inflammation, 
epigenetic modifications, non-coding RNAs (miRNAs and TERRA) and the telomere 
position effect are recommended. These studies will help shed light on telomere-mediated 
healthy ageing and disease prevention through exercise training, to aid exercise prescription 
recommendations. 
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Figure Captions  
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Figure 1. Telomeres, shelterin and telomerase. Telomeric DNA can form multiple structures 
that prevent genomic recombination and fusion events. (a) Telomeres are comprised of the 
double (ds, leading strand) and single-stranded (ss, lagging strand) DNA sequence – 5’-
TTAGGG-3’ and 3’-AATCCC-5’, respectively. While ds telomere DNA varies between 5 
and 15 kilobases (kb) depending on age, disease status and lifestyle factors, ss telomeric 
DNA is usually between 100 and 200 nucleotides (nt) long. (b) Ds and ss telomeric DNA are 
bound by telomere-associated proteins collectively known as shelterin. TRF1 and TRF2 bind 
directly to ds telomeric DNA. TINF2 and TPP1 bind POT1 to TRF1 and TRF2. TERF2IP 
binds to TRF2. TPP1 and POT1 also bind to ss telomeric DNA. (c) Telomeres also form 
circular structures called t- and d-loops that prevent the abrupt ending of telomeric DNA and 
DNA damage response pathways. (d) In humans, telomerase is formed by the TERT protein 
and RNA molecule, TERC. The TERC RNA has a complementary sequence to telomeric 
DNA – 3’-AAUCCC-5’ – and serves as a template for telomere elongation through a reverse 
transcription process. TRF1, telomere repeat-binding factor 1; TRF2, telomere repeat-binding 
factor 2; TINF2, TRF1-interacting nuclear factor 2; TPP1, adrenocortical dysplasia homolog; 
POT1, protection of telomeres 1; TERF2IP, TRF2-interacting protein; TERC, telomerase 
RNA component; TERT, telomerase reverse transcriptase.   
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Figure 2. Mechanisms of telomere length maintenance conferred by exercise training.  
Exercise training potential facilitates telomere length maintenance through many molecular 
mechanisms. Conversely, a sedentary lifestyle or lack of exercise training may deregulate the 
telomere maintenance pathways. Telomere length is likely regulated by epigenetic 
modifications including histone modifications (methylation [me] and acetylation [ac]) and 
DNA methylation. Non-coding RNAs such as miRNA may target shelterin mRNA to 
negatively regulate protein abundance and TERRA inhibits telomere elongation by binding to 
the TERC RNA template of telomerase competing against the telomeric DNA. Differential 
	 79 
regulation of shelterin expression and telomerase activity would regulate telomere length. 
Finally, inflammation and oxidative stress shortens telomeres in vitro and are candidates for 
telomere shortening in vivo. The yellow arrows indicate whether the particular variable is 
increased or decreased, or possibly both – depending on the location or interaction with other 
factors – in context with exercise training. mRNA, messenger RNA; miRNA, microRNA, 
TERRA, telomeric repeat-containing RNA.
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Table 1 Current literature on exercise and telomere biology 
Cell type Participantsa,b,c,d,e Extraction 
method 
Telomere 
measurement 
Main result/s Reference 
Athlete/control     
Leukocytes 61 endurance 
athletes and 61 
healthy controls, M 
+ F, ~30, VO2max 
test and IPAQ.  
Purelink 
Genomic 
DNA Mini 
Kit 
qPCR Endurance athletes exhibited longer leukocyte 
telomeres and increased TERT and TPP1 
mRNA expression compared to controls. 
Denham et al. 203 
Buccal cells 20 endurance 
athletes and 42 
sedentary controls, 
M + F, ~45. 
QIAmp 
DNA Mini 
Kit 
qPCR Longer telomeres in athletes compared to 
controls. 
 
Borghini et al. 254 
Leukocytes 392 former Finnish 
elite athletes and 
207 controls, M, 
~71, questionnaire. 
? qPCR Former Finnish athletes have comparable age-
adjusted telomere length compared to 
controls. 
 
Laine et al. 205 
 
	
81 
Leukocytes 67 ultra-marathon 
runners and 56 
healthy controls, 
M, 43 ± 9.2. 
 
? qPCR Ultra-marathon runners have 11% longer (16 
years biologically younger) leukocyte 
telomeres compared to controls. 
Denham et al. 202 
Lymphocytes 
and 
granulocytes 
17 marathon 
runners and 15 
sedentary controls, 
M + F, 54 ± 4, 
VO2max test. 
n/a FISH Similar telomere lengths between marathon 
runners and control. No statistically 
significant correlation between telomere 
length and VO2max. 
Mathur et al. 204 
Skeletal 
myocytes 
5 young and older 
endurance athletes 
and healthy 
controls, M, young 
24 and old 69, 
VO2max test. 
GenElute 
Mammalian 
Genomic 
DNA 
Miniprep 
Kit 
qPCR Older but not young endurance athletes have 
longer telomeres compared to their peers.  
Strong, positive correlation between VO2max 
and telomere length. 
Osthus et al. 208 
 
	
82 
Skeletal 
myocytes 
18 runners and19 
sedentary controls, 
M + F, ~40. 
 
 
 
Phenol/ 
chloroform 
Southern Blot Similar minimum and average telomere 
length between runners and sedentary 
controls.  
Moderate, inverse correlations between 
training history (years spent running and 
training hours) and minimum telomere length. 
Rae et al. 212 
Leukocytes  27 (10 young and 
17 older) 
endurance-trained 
individuals and 30 
(15 young and 
older) sedentary 
controls, M + F, 
young 22 ± 1 and 
older 63 ± 2, 
VO2max test.  
? Southern Blot Older but not young, endurance-trained 
individuals had significantly longer leukocyte 
telomeres compared to their sedentary peers 
by ~900 bp. 
Moderate, positive correlation between 
VO2max and telomere length. 
LaRocca et al. 201 
 
	
83 
Mononuclear 
cells 
Lymphocytes 
and 
granulocytes 
57 (32 young and 
25 older) 
endurance-trained 
individuals and 47 
(26 young and 21 
older) sedentary 
controls, M + F, 
young 21 and old 
51, VO2max test. 
 
QIAmp 
DNA Blood 
Mini Kit 
FISH and qPCR Older sedentary individuals exhibited shorter 
mononuclear cell telomeres compared to all 
other groups.  
Up-regulated mononuclear cell telomerase 
activity in athletes (young and old) compared 
to sedentary controls. 
Werner et al. 200 
Skeletal 
myocytes 
7 power lifters and 
7 sedentary 
controls. 
Phenol/ 
chloroform   
Southern Blot A trend between higher minimum and 
average telomere length in power lifters 
compared to sedentary controls. 
Strong, inverse correlations between lower 
leg strength (squat and deadlift 1 repetition 
maximum) and minimum telomere length.  
Kadi et al. 213 
 
	
84 
Skeletal 
myocytes 
 
13 FAMS and 13 
healthy athletes, M 
+ F, young, ~42 ± 
11, VO2max test. 
Phenol/ 
chloroform   
Southern Blot Shorter minimum telomere length in FAMS 
compared to healthy athletes 
 
. 
Collins et al. 211 
Physical activity     
Leukocytes 6405, M + F, 20 – 
84, questionnaire. 
? qPCR Dose-dependent positive association between 
telomere length and physical activity levels. 
Loprinzi et al. 255 
Leukocytes  582 older adults, M 
+ F, 73 ± 5, 
modified 
Minnesota Leisure-
Time Activities 
Questionnaire, 
timed 15-ft walk, 
chair stands and 
grip strength. 
? Southern Blot Superior chair stand performance and greater 
walking distance associated with longer 
telomeres. 
Increasing physical activity and chair stand 
performance was associated with less 
telomere attrition in prospective analyses. 
Soares-Miranda et 
al. 197 
 
	
85 
Leukocytes 6405, M + F, 20 – 
84, questionnaire. 
? qPCR Every additional hour of screen-based 
sedentary behaviour is associated with 7% 
increased chance of possessing short 
telomeres.  
Loprinzi 189 
Leukocytes 4576, M + F, ~55, 
binary. 
Qiagen 
Blood Kit 
qPCR Long telomeres are associated with physical 
activity (at least 4 hr.week-1). Change in 
telomere length over 10 years is unaffected by 
physical activity. 
 
 
 
Weischer et al. 256 
Leukocytes 
and skeletal 
myocytes 
36 (12 young, 12 
old-mobile and 12 
old-immobile), M 
+ F, young (25 y) 
and old (87.5 y). 
QIAmp 
DNA Mini 
Kit 
qPCR Relative to old-immobile subjects, mobile 
older adults have attenuate oxidative stress 
and age-related telomere shortening in thigh 
muscle and leukocytes. 
Venturelli et al. 210 
 
	
86 
Leukocytes 239, F, 50-65, 
Stanford Brief 
Activity Scale. 
QIAmp 
DNA Mini 
Kit 
qPCR Life-stress associated telomere attrition is 
attenuated by increased physical activity 
levels.   
Puterman et al. 73 
 
PBMC 392, F, 62 ± 10, 
IPAQ. 
? Southern Blot Postmenopausal breast-cancer patients who 
engage in moderate to high amounts of 
physical activity had longer telomeres than 
those not engaging in any physical activity by 
~270 bp. 
Garland et al. 188 
Leukocytes 204, M, 76, 
questions. 
Gentra 
PureGene   
Blood Kit 
Southern Blot Compared to those engaging in low and high 
amounts of physical activity, those with self-
reported moderate physical activity levels had 
the longest telomeres with less proportion of 
short telomeres. 
Savela et al. 182 
Leukocytes 981, M + F, 45–84, 
Job Content 
Questionnaire 
? qPCR 
 
No association with job-related physical 
activity. 
Fujishiro et al. 186 
 
	
87 
Leukocytes 5862 nurses, F, 
58.7, questionnaire. 
QIAmp 96 
spin Blood 
Protocol 
qPCR Physical activity not associated with telomere 
length. 
Positive relationship between healthy lifestyle 
(non-smoking, moderate alcohol 
consumption, healthy body weight, moderate 
to high physical activity) and telomere length.  
Sun et al. 257 
Leukocytes 44, F, 57.4 ± 5.6, 
card scanning. 
G-spin 
Genomic 
DNA 
Extraction 
Kit 
qPCR Postmenopausal women regularly exercising 
(60 min, >3days/week) have longer telomeres 
than sedentary women. 
Kim et al. 187 
Leukocytes 895, M + F, 33–79, 
three-point scale. 
QIAmp qPCR Exercise frequency is an independent 
predictor of  leukocyte telomere length . A 
healthy lifestyle explained 40% of the 
association between intelligence and 
leukocyte telomere length. 
Kingma et al. 258 
 
	
88 
Leukocytes  7813 nurses, F, 43 - 
70, questionnaire. 
QIAmp 96-
Spin 
Protocol 
qPCR Longer telomeres in nurses who engaged in 
moderate or high amounts of physical 
activity, and moderate to vigorous intensity 
activities.  
Du et al. 180 
 
Leukocytes 667 healthy 
adolescents, M + F, 
14 – 18, 
accelerometer. 
? qPCR Positive association between vigorous 
physical activity and telomere length in girls. 
Zhu et al. 198 
Leukocytes 2284 nurses, F, 30 
– 55, questionnaire. 
QIAmp 96 
DNA Blood 
Kit 
qPCR No association between physical activity and 
telomere length. 
Cassidy et al. 184 
Leukocytes 63 healthy 
postmenopausal 
women, F, 62, 
questions. 
Puregene 
DNA 
Isolation 
System 
 
qPCR Regular physical activity ameliorates the 
negative relationship between psychological 
stress and telomere length. 
Puterman et al. 217 
 
	
89 
Leukocytes 82, M + F, 18 – 80, 
questions. 
Puregene 
Blood Core 
Kit 
qPCR No correlation between exercise and telomere 
length. 
Song et al. 183 
Leukocytes 318 healthy 
individuals, M + F, 
51.3, questions. 
Gentra 
Puregene 
Blood Kit 
qPCR No interaction between telomere length and 
exercise and the presence of coronary artery 
calcium. 
Diaz et al. 185 
Leukocytes 612 advanced 
prostate cancer 
patients and 1049 
controls, M, 55 – 
74, ?  
QIAmp 96 
DNA Blood 
Kit  
qPCR No correlation between physical activity and 
telomere length. 
Positive correlation between a healthier 
lifestyle (physical activity, diet, low BMI and 
low or no cigarette smoking) and telomere 
length. 
 
 
 
 
Mirabello et al. 259 
 
	
90 
Leukocytes 2006, M + F, 72 ± 
5, PASE. 
? qPCR No association between physical activity and 
telomere length. 
Woo et al. 260 
PBMC 69, M + F, 60 ± 
4.9, YPAS. 
PureGene 
DNA 
Isolation 
System 
qPCR Moderate estimated energy expenditure 
associated with longest telomeres compared 
to low and high energy expenditure. 
Ludlow et al. 181  
Skeletal 
myocytes 
16 young and 26 
older 
recreationally-
active individuals, 
M + F, young 25 ± 
4 and old 74 ± 4. 
 
 
 
 
Phenol/ 
chloroform   
Southern Blot Similar minimum and average telomere 
lengths between young and older 
recreationally-active individuals. 
Ponsot et al. 209 
 
	
91 
Leukocytes 2401 white twins, 
M + F, 18 – 81, 
Allied Dunbar 
National Fitness 
Survey. 
 
 
 
 
 
? Southern Blot Strong, positive relationship between physical 
activity and telomere length. 
More active twin had longer (~88bp) 
telomeres. 
Most active individuals had longer (~200bp) 
telomeres than their inactive peers. 
Cherkas et al. 179 
Physical fitness     
Leukocytes 1764, M + F, 20 – 
49, submaximal 
treadmill test.   
? qPCR Compared to individuals with poor predicted 
cardiorespiratory fitness (30.7 ml.kg-1.min-1), 
those with moderate (39.1 ml.kg-1.min-1) or 
high fitness (50.9 ml.kg-1.min-1) possessed 
longer leukocyte telomeres. 
Loprinzi 261 
 
	
92 
PBMC 2488, M, middle 
age, vertical jump 
test, handgrip test, 
sit to stand and 
spirometry test. 
? qPCR 
Universal STELA 
Number of short telomeres (<750 bp) are 
inversely associated with maximum jump 
height. 
Maynard et al. 262 
Leukocytes 277 individuals, M 
+ F, 76, grip 
strength. 
QIAmp 
DNA Maxi 
Kit 
qPCR Faster telomere attrition associated with the 
decrease in grip strength after a 10-year 
follow-up. 
Baylis et al. 196 
Leukocytes 117 elderly 
Koreans, F, 42 ± 
0.7. 
G-spin 
Genomic 
DNA 
Extraction 
Kit 
 
 
 
qPCR Medium, positive correlation between gait 
speed (6m) and telomere length. 
Lee et al. 192 
 
	
93 
Leukocytes 548 same-sex 
twins, M + F, 78.3, 
Physical Ability 
Score and five-
point scale. 
? Southern Blot Positive associations between physical ability 
score, physical activity and leukocyte 
telomere length. 
Bendix et al. 195 
Leukocytes 
 
44 Japanese 
patients, M + F, 74, 
physical 
assessment. 
? Southern Blot Physical capacity associated with greater 
proportion of long telomeres (>9400bp) in 
females. 
Maeda et al. 193 
Leukocytes 
 
944 coronary heart 
disease outpatients, 
M + F, ~67, 
questions. 
? qPCR Linear relationship between exercise capacity 
(maximum METs obtained during treadmill 
testing) and telomere length. 
Self-reported physically active individuals 
have longer telomeres (~73bp) than their 
inactive peers. 
 
Krauss et al. 207 
 
	
94 
Leukocytes 23 Japanese 
cerebrovascular 
disease patients, F, 
77.7 ± 6.4, physical 
assessment. 
 
 
? Southern Blot Physical capacity associated with greater 
proportion of long telomeres (>9400bp). 
Maeda et al. 194 
A single bout of exercise     
Buccal cells 20 endurance 
athletes and 42 
sedentary controls, 
M + F, ~45  
QIAmp 
DNA Mini 
Kit 
qPCR Relative to basal, athletes had significantly 
shorter telomeres mid-way and at completion 
of an ultra-marathon trail race. 
Borghini et al. 254 
Leukocytes  
T 
lymphocytes 
22, M, 24 ± 7. n/a n/a Acute, high-intensity exercise modulates 
leukocyte TERT, SIRT6, TERF2IP mRNA 
and microRNA (miR-15a, -96, -181 and -186) 
abundance. 
Chilton et al. 230 
 
	
95 
PBMC 
Skeletal 
myocytes 
8, M + F, 44 ± 2. Promega 
Wizard SV 
Kit 
qPCR Telomere-associated gene mRNA was 
increased in PBMC (TERF1, TERF2, POT1, 
KU70 and KU80) and skeletal (KU70 and 
KU80), without changes to protein content 
after a seven-day ultra-marathon race.  
No change to TERC and TERT mRNA 
abundance, telomere length or telomerase 
activity. 
Laye et al. 231 
T 
lymphocytes 
9 moderately 
trained (VO2max: 
56.9 ± 5.1), M, 26 
± 6.7. 
 
 
 
 
? qPCR Acute, high-intensity exercise increases CD8+ 
T-cell telomere length, but does not alter 
CD3+ or CD4+ T-cell telomere length. 
Simpson et al. 263 
 
	
96 
PBMC  10 young (median 
age: 23) and 10 
older (median age: 
78) physically 
active individuals, 
M + F. 
Qiagen 
Blood Kit 
Southern Blot Average telomere length decreases after acute 
exercise in young (PBMC and CD8+) and 
older (CD4+) individuals. 
Bruunsgaard et al. 
264 
Training studies     
PBMC 59, M, 45–65, 
VO2max test, ? 
 
 
 
 
 
 
? Southern Blot Longer telomere and elevated telomerase 
activity after six months of exercise training. 
Melk et al. 216 
 
	
97 
Leukocytes 49 sedentary and 
overweight older 
adults, M + F, 68 y, 
IPAQ, 6-month 
intervention 
involving 
counseling and 
prescribed exercise. 
? qPCR Reduced sitting time correlated to telomere 
lengthening. 
Sjögren et al. 190 
 
PBMC 10 cases and 25 
controls with 
prostate cancer, M, 
~62.5, n/a, walking 
30 min 6 
days/week for 3 
months (healthy 
diet, stress 
? qPCR Longer telomeres after a 5-year lifestyle 
intervention. 
Ornish et al. 215 
 
 
	
98 
management, 
meditation and 
counseling).  
Leukocytes  439 
overweight/obese, 
F, 58, VO2max test, 
45 min of moderate 
to vigorous (70-
80% HRmax) 
exercise 5 
days/week for 1 
year (with or 
without a calorie-
reduced diet). 
 
 
Qiagen 
Midi Kit 
qPCR Weak, positive correlation between telomere 
length and VO2max. 
No change to telomere length after 12-month 
intervention. 
Mason et al. 206 
 
	
99 
Leukocytes 190 cases and 188 
controls, M + F, 
~55, n/a, increase 
physical activity. 
 
 
Salting out 
method 
qPCR Lifestyle intervention did not have an effect 
on telomere length after a 4.5 y follow-up. 
Hovatta et al. 265 
PBMC 24 prostate cancer 
patients, M, 62.2 ± 
7.5, n/a, walking 30 
min 6 days/week 
for 3 months 
(healthy diet, stress 
management, 
meditation and 
counseling). 
 
n/a n/a Increased telomerase activity after lifestyle 
intervention. 
Ornish et al. 214 
 
	
100 
Leukocytes 
 
16 obese 
individuals, F, 46.8 
± 6.4, VO2max test, 
60 min of treadmill 
walking/running @ 
60% VO2 reserve 
thrice weekly for 3 
months. 
 
 
 
 
 
 
 
 
Wizard 
Genomic 
DNA 
 Kit 
qPCR  and Southern 
Blot  
No change to telomere length after exercise 
moderate intensity exercise training. 
Shin et al. 240 
 
	
101 
 
Rodent studies 
    
Hippocampu
s 
45 Sprague-
Dawley rats, M, 
pups, n/a, voluntary 
wheel running. 
AllPrep 
DNA/RNA 
Mini Kit 
qPCR Voluntary wheel running prevented telomere 
elongation associated with maternal 
separation – a model of developmental stress. 
Botha et al. 266 
Skeletal 
myocytes 
22 C57BI/6 mice, 
F, 6 weeks old, n/a, 
30 min of treadmill 
running @ 65% of 
Vmax. 
 
 
 
 
 
n/a n/a Acute exercise decreases Trf1 expression in 
conjunction with increased p38-MAPK 
phosphorylation.  
No changes to other shelterin gene 
expression. 
Ludlow et al. 232 
 
	
102 
Liver, 
skeletal and 
cardiac 
myocytes 
CAST/Ei J mice (6 
young 8-week old, 
11 1 year old 
sedentary and 10 1 
year old exercised), 
M + F, 8 weeks and 
1 year old, 
voluntary wheel 
running. 
PureGene 
DNA 
Isolation 
System 
qPCR Voluntary wheel running attenuates cardiac 
myocyte and hepatocyte telomere length 
attrition, but accelerates skeletal myocyte 
telomere shortening. 
Up-regulated telomerase activity in skeletal 
myocytes after voluntary wheel running.  
Voluntary wheel running attenuated the age-
related reduction in expression of telomere-
associated genes (Trf1, Trf2 and Pot1) in 
skeletal and cardiac myocytes but not 
hepatocytes. 
 
 
 
 
 
Ludlow et al. 227 
 
	
103 
Hippocampu
s 
4 nestin-green 
fluorescent protein 
(expressing) and 12 
C57BI/6, ?, n/a, 10 
days of voluntary 
wheel running. 
n/a FISH Voluntary wheel running restored lowered 
and further increased telomerase activity in a 
mouse-model of schizophrenia and controls, 
respectively. 
No change to telomere length after voluntary 
wheel running. 
Wolf et al. 229 
Aortic and 
spleen-
derived 
mononuclear 
cells  
C57BI/6 wild-type 
and Tert-/- and 
eNos-/- mice, ?, n/a, 
n/a, voluntary 
wheel running for 
either 3 weeks or 6 
months. 
 
 
 
n/a 
 
FISH Increased telomerase activity, Trf1 and Trf2 
expression, with decreased pro-apoptotic 
proteins (Chk2, p16 and p53) after 3 weeks of 
voluntary running in wild-type, but not Tert-/- 
and eNos-/- mice.  
No change to aortic telomere length after 
voluntary running. 
Werner et al. 200 
 
	
104 
 
a number and type of participants; b sex; c average age ± standard deviation or range; d method of assessing physical activity/estimated energy 
expenditure/exercise/fitness; e exercise training (other lifestyle interventions).  
M = male; F = female; n/a = not applicable; qPCR = quantitative polymerase chain reaction; FISH = fluorescence in situ hybridization; STELA 
= single telomere length analysis; VO2max = maximal oxygen consumption; bp = base-pairs; PBMC = peripheral blood mononuclear cell; TERT 
= Telomerase reverse transcriptase; TPP1 = adrenocortical dysplasia homolog; SIRT6 = Sirtuin-6; TERF2IP = Telomere repeat binding factor 2 
interacting protein; IPAQ = International Physical Activity Questionnaire; PASE = Physical Activity Scale for the Elderly; YPAS = Yale 
Cardiac 
myocytes 
and 
leukocytes 
C57Bl/6 wild-type 
and Tert-/- and 
eNos-/- mice,?, n/a, 
n/a, voluntary 
wheel running for 
either 3 weeks or 6 
months. 
n/a FISH While Tert and Trf2 protein expression and 
telomerase activity were up-regulated, pro-
apoptotic proteins (Chk2, p16 and p53) were 
ameliorated after 3 weeks and 6 months of 
voluntary running in wild-type, but not Tert-/- 
and eNos-/- mice.  
Left ventricular myocyte and leukocyte 
telomere length unchanged after voluntary 
running. 
Werner et al. 228 
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Physical Activity Survey; HRmax = heart rate maximum; -/- = deficient (gene); FAMS = fatigued-athlete myopathic syndrome; Vmax = maximal 
treadmill speed; eNos, endothelial nitric oxide synthase;  BMI = body mass index; MET = metabolic equivalent of task; MAPK = mitogen-
activated protein kinase; Pot1 = protection of telomeres-1; Trf = telomere-repeat binding factor; ? = unknown. 
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Abstract 
Telomere length is recognized as a marker of biological age, and shorter mean 
leukocyte telomere length is associated with increased risk of cardiovascular disease. It 
is unclear whether repeated exposure to ultra-endurance aerobic exercise is beneficial or 
detrimental in the long-term and whether it attenuates biological aging. We quantified 
67 ultra-marathon runners’ and 56 apparently healthy males’ leukocyte telomere length 
(T/S ratio) using real-time quantitative PCR.  
The ultra-marathon runners had 11% longer telomeres (T/S ratio) than controls (ultra-
marathon runners: T/S ratio = 3.5 ± 0.68, controls: T/S ratio = 3.1 ± 0.41; β = 0.40, SE = 
0.10, P = 1.4 × 10-4) in age-adjusted analysis. The difference remained statistically 
significant after adjustment for cardiovascular risk factors (P = 2.2 × 10-4). The 
magnitude of this association translates into 16.2 ± 0.26 years difference in biological 
age and approximately 324–648bp difference in leukocyte telomere length between 
ultra-marathon runners and healthy controls. Neither traditional cardiovascular risk 
factors nor markers of inflammation/adhesion molecules explained the difference in 
leukocyte telomere length between ultra-marathon runners and controls. Taken together 
these data suggest that regular engagement in ultra-endurance aerobic exercise 
attenuates cellular aging. 
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Introduction  
Regular high intense physical activity leads to an increase in cardio-respiratory fitness, which 
is thought to lead to subsequent reduction in risk of cardiovascular and total mortality 267-269. 
Perplexingly, the anti-aging effect seems to be partly independent of traditional 
cardiovascular and metabolic risk factors 270,271.  
Telomeres are the repeated DNA sequence located at the distal ends of linear chromosomes 
272. Without the addition of telomeric repeats by the enzyme, telomerase, somatic cell 
telomeres progressively shorten with each round of cell division 273. Therefore, telomere 
length is a well-known indicator of mitotic replicative history and biological age. 
Accumulating evidence suggests that moderate amounts of physical exercise correlates with 
longer leukocyte telomere length 179,181,274. Although moderate exercise has been shown as 
beneficial in the prevention of cardiovascular disease, chronic, excessive sustained endurance 
exercise such as ultra-marathon running has been reported to cause nil or even adverse effects 
particularly for the heart and large arteries 275. Association studies between endurance 
exercise and telomere length have shown conflicting results.  Previous marathon runners 
were found to exhibit unchanged telomere lengths in differentiated granulocytes, 
lymphocytes and muscle cells compared to sedentary controls 276,277.  In contrast, other 
studies have shown that endurance-trained athletes exhibit longer leukocyte telomeres 200,278. 
Therefore, the impact of repeated, ultra-endurance aerobic exercise on telomere length and 
biological aging remains unclear. 
An ultra-marathon is an example of extreme exposure to ultra-endurance aerobic exercise – 
athletes run in excess of 42 kilometers in one day. The ultra-marathon runners are an 
excellent model of fitness induced by repeated engagement in ultra-endurance aerobic 
exercise. We have previously demonstrated ultra-marathon runners have exceptionally 
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suppressed levels of low-grade inflammation and lower levels of low-density lipoprotein 
(LDL) cholesterol when compared to apparently healthy controls 279,280.  However, it is not 
clear whether ultra-marathon runners also benefit from attenuation of biological aging, 
independent of reduction in measures of cardiovascular risk. Conversely, the exposure to 
ultra-endurance aerobic exercise was associated with increased oxidative stress 281 that is a 
well-known correlate of telomere attrition rate in cellular studies 169.  
Here, we measured leukocyte telomere length of male ultra-marathon runners who regularly 
engage in ultra-endurance running and compared them to apparently healthy controls from 
the general population. We also investigated whether traditional cardiovascular risk factors 
(including blood pressure – BP – and lipids) as well as adhesive molecules and markers of 
inflammation play a role in the association between ultra-endurance aerobic exercise and 
telomere length.  
Materials and Methods 
Clinical phenotyping 
Sixty-seven male ultra-marathon runners and 63 age and sex-matched apparently healthy 
controls were included in this study. All individuals were of the same ethnicity (white 
Polish). The participants demographics have been outlined previously 280. Briefly, the ultra-
marathon runners had completed at least two ultra-marathons, had an average training 
distance of 40–100km per week and had trained for a minimum of two years 280. All 
participants gave informed written consent and the study was approved by the University of 
Ballarat Human Research Ethics Committee. (Supplementary Method S1).  
Biochemical analysis 
The biochemical analyses were described before 279,280 (Supplementary Method S1).  
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Telomere length quantification 
DNA from was extracted in the same laboratory from peripheral whole-blood by methods 
described elsewhere 280. Telomere length was measured using an established quantitative 
real-time PCR technique 282. This method expresses telomere length as a ratio (T/S) of 
telomere repeat length (T) to copy number of a single copy gene, 36B4 (S), within each 
sample (Supplementary Method S1).  
Statistical analysis 
Phenotypes with non-normal distribution underwent log-transformation before further 
analysis. The Student’s t-test or Mann-Whitney U-test were used to examine crude 
differences in quantitative traits between the two groups. Linear correlation estimates were 
calculated using Pearson’s method. Linear regression models were used to analyze telomere 
length in ultra-marathon runners and controls using multiple regression analyses with 
adjustment for age and other phenotypic covariates, and stepwise selection following 
adjustment for covariates. Significance was determined as P < 0.05. The difference in T/S 
ratio between ultra-marathon runners and controls was divided by the unstandardized β-
coefficient from linear regression model including age and T/S ratio from a large population-
based study (n > 45,000), conducted at the same laboratory using identical methodologies 283. 
This provides an estimate of difference in biological age between ultra-marathon runners and 
controls using age-related telomere attrition rate. Others who have quantified telomere length 
by measuring terminal restriction fragments using the Southern Blot technique, have shown 
the age-related telomere attritions is approximately 20–40 base pairs (bp) per year 283. To 
estimate the bp telomere length difference between cohorts, we multiplied the biological age 
difference (16.2 years) between ultra-marathon runners and controls by the average bp 
decline per year previously described – 20–40bp 283. In doing so, we were able to estimate the 
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approximate difference in telomere length (expressed as bps) between ultra-marathon runners 
and controls.     
 
Results 
Subject Demographics 
The demographic and phenotypic data are displayed in Table 1.  
Ultra-marathon runners had significantly lower mean body mass index (BMI), total 
cholesterol (TC), soluble intracellular adhesion molecule (sICAM-1), leptin and C-reactive 
protein (CRP), and significantly higher mean high density lipoprotein (HDL)-cholesterol than 
controls.  
Telomere Length and Aging 
Age was inversely related to telomere length in controls (r = -0.29) and weakly – in ultra-
marathon runners (r = -0.10) (Figure 1). The rate of telomere attrition (slopes of negative 
correlation between age and telomere length), however, was not statistically different 
between cohorts (P = 0.64) (Figure 1). The ultra-marathon runners had an 11% longer 
telomere length (T/S ratio) than controls (ultra-marathon runners: 3.5 ± 0.68, controls: 3.1 ± 
0.41; β = 0.40, SE = 0.10, P = 1.4 × 10-4) in age-adjusted analysis (Figure 2). 
The difference remained statistically significant after adjustment for differences between 
ultra-marathon runners and controls (age, BMI, TC, HDL-C, CRP, leptin, sICAM-1, PCR 
Plate, β = 0.44, SE = 0.14, P = 2.2 × 10-4) (Table 2). In the stepwise regression model 
(adjusting for age, interleukin-6 – IL-6, mean arterial pressure – MAP and PCR Plate) the 
telomere length was significantly higher in ultra-marathon runners than controls (β = 0.44, SE 
= 0.10, P = 4.2 × 10-5) (Table 2). After full adjustment, we estimated that the difference in 
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biological aging between ultra-marathon runners and controls was approximately 16.2 ± 0.26 
years. Therefore, we estimate the ultra-marathon runners have on average approximately 
324–648bp longer leukocyte telomeres compared to those of their less active peers. 
Telomere Length and Cardiovascular Risk Factors 
Apart from MAP, conventional cardiovascular risk factors (BMI, TC, HDL-cholesterol and 
triglycerides) were not associated with telomere length in ultra-marathon runners and controls 
(Table 3).  
There was a positive correlation between MAP and telomere length in ultra-marathon runners 
(r = 0.30, P = 0.015). CRP, leptin, adhesion molecules (serum E-selectin – sE-selecting – and 
sICAM-1) and IL-6, were not significantly associated with telomere length in ultra-marathon 
runners, controls or joint analysis of both groups (Table 3). 
 
Discussion 
To our knowledge, this is the largest study to show that ultra-marathon runners exhibit 
markedly longer leukocyte telomere length compared to age-matched apparently healthy 
controls who do not engage in ultra-endurance aerobic exercise. We also show the impact of 
aging on telomere length is attenuated in ultra-marathon runners and that telomeres are 
approximately 16.2 years biologically younger compared to less active controls. Our results 
support previous data obtained from endurance-trained athletes (engaging in a similar volume 
of aerobic exercise) and sedentary controls 200. However, we show that the difference in 
telomere length between ultra-marathon runners and controls cannot be simply explained by 
better cardiovascular risk profile. 
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Investigations on the effect of aerobic exercise on telomere length has so far provided no 
conclusive information on how much exercise is optimal and safe for immune cell 
chromosomal stability 179,181,200,260,274,276. Sedentary middle-aged individuals exhibit shorter 
telomere length compared to younger and age-matched track and field athletes and 
endurance-trained athletes (marathon runners and triathletes) 200. The analysis of telomere 
length in twin volunteers revealed the more physically active twin had longer telomeres than 
the less active twin 179. Furthermore, exercise intensity is beneficial for telomere dynamics in 
women, as telomere length was positively associated with engaging in more frequent 
vigorous physical activity 284 and vigorous physical activity ameliorated telomere attrition 
caused by psychological stress 217. Telomere length was also positively correlated with 
maximal oxygen uptake in older (55–72years) participants and it was suggested that telomere 
erosion was attenuated in middle-aged participants who exercise regularly 201. In contrast, 
daily amount of energy expenditure had an inverted ‘U’-type relationship with telomere 
length, in that moderate (991–2340 Kcal.wk-1) levels of energy expenditure were associated 
with longer telomeres compared to very low (< 991 Kcal.wk-1) and high energy expenditures 
(> 3541 Kcal.wk-1) 181. We have clearly demonstrated that men who engage in ultra-
endurance aerobic exercise have significantly longer telomeres compared to those who did 
not exercise extensively on a regular basis but otherwise were apparently healthy. Recently, 
marathon runners were reported to have similar lymphocyte and granulocyte telomere lengths 
compared to controls 276. Potential explanations for the discrepancy between the previous 
findings 276 and our results may be due to the larger sample size of our study, greater age-
range of participants and also due to the higher volume of aerobic exercise performed by the 
ultra-marathon runners included in our investigation. Interestingly, skeletal muscle telomeres 
are longer in endurance-trained cross-country skiers’ compared to non-athletes 208. Given the 
synchrony between leukocyte and skeletal muscle cell telomere shortening 285, our data along 
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with others’ 200,208,278 support the hypothesis that both endurance and ultra-endurance exercise 
are beneficial to leukocyte telomere maintenance.  
The longer telomeres observed in the ultra-marathon runners in our study may be a result of 
increased telomerase expression in leukocytes as a previous study by Werner et al. 200 showed 
that young and middle-aged athletes, had increased telomerase activity compared to sedentary 
controls 200. Werner et al. 200 also found that athletes have differentially expressed genes 
associated with the shelterin complex (TRF2, CHK2, Ku 70 and 80) compared to sedentary 
controls 200. Moreover, a significant increase in telomerase activity in mononuclear cells was 
observed after a three month intervention including 30 minutes of moderate physical activity, 
six days a week 214. Recently, it was reported that following a seven day ultra-marathon 
footrace, ultra-marathon runners exhibited greater leukocyte mRNA content of shelterin 
associated genes – TRF1, TRF2 and POT1 286. The above proteins, along with several others, 
protect chromosomal and telomere integrity through the formation of the shelterin complex 
99. Therefore, endurance-trained individuals may benefit from ameliorated leukocyte telomere 
attrition by modulated shelterin and telomerase dynamics. 
Our data also suggest that the difference in telomere length between ultra-marathon runners 
and controls cannot be simply explained by better cardiovascular risk profile in those who 
engage in regular ultra-endurance aerobic exercise. Indeed, neither traditional cardiovascular 
risk factors nor markers of inflammation/adhesion molecules showed association with 
telomere length, and their inclusion in the regression model had no effect on the association 
between telomere length and ultra-endurance aerobic exercise. Although there was no 
significant difference in the MAP between the ultra-marathon runners and controls we 
observed a positive correlation between leukocyte telomere length and MAP in ultra-
marathon runners but not the controls. The biological mechanisms of this somewhat 
paradoxical correlation are not clear. Interestingly, previous findings have shown that 
 
	
115 
telomere length is positively related to left ventricular mass 287, that in turn is a direct 
associate of blood pressure. In this context the correlation seen in our study may be explained 
(at least in part) by the adaptation to chronic endurance exercise. On the other hand, we 
should acknowledge that blood pressure is a rapidly changing physiological parameter and 
the value of single clinic measurements may not necessarily reflect the long-term effect of BP 
on cardiovascular system, in particular when taken in a relatively small group of individuals. 
Larger population samples are necessary to fully dissect the association between BP and 
telomere length in ultra-marathon runners.  
We should, however, acknowledge that several unmeasured intermediate phenotypes may be 
relevant here. Although not measured directly, cardiorespiratory fitness gained from previous 
extensive training would be significantly better in the ultra-marathon runners than controls.  
Maximal oxygen uptake has been positively correlated with telomere length in older, 
endurance-trained adults 201. Interestingly, patients with longer telomeres and greater exercise 
capacity had reduced mortality risk 207. Therefore, it is tempting to postulate that increasing 
amounts of ultra-endurance aerobic exercise may be beneficial to decreasing mortality risk 
through cardiovascular training adaptations, potentially leading to an extended lifespan. 
In the current study we found that biologically ultra-marathon runners are approximately 16.2 
years younger than less physically active controls, equating to an approximate 324–648bp 
longer telomeres than controls. Notably, endurance-trained athletes’ (> 55years) telomeres, 
measured by Southern Blot, were shown to have approximately 900bps longer leukocyte 
telomeres than sedentary individuals 278. Engaging in greater amounts of physical activity has 
been shown previously to have anti-aging effects. Ultra-endurance athletes have 17% greater 
longevity compared to the general population 288, and numerous studies have demonstrated 
decreased mortality with more frequent exercise 269,289. With telomere length a marker of 
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biological age, less active individuals exhibit 10 years biologically older leukocytes 
compared to their more active peers 179. Healthy individuals have 11 years biologically 
younger leukocytes compared to patients with CVD 290. Moreover, coronary artery disease 
patients with greater exercise capacity exhibited longer telomeres compared to patients with a 
lower exercise capacity, representing a four year difference in biological age 207. In this 
context, a 16 year difference in biological age between ultra-marathon runners and controls 
appears particularly significant and its implications for health and disease needs to be further 
elucidated.  
Our study has a number of limitations. Information on diet 291 and psychological stress 292 
which have been demonstrated to influence telomere dynamics were not recorded in our 
participants. Our study was cross-sectional in nature and therefore we were unable to assign 
direct causative nature to the association between telomere attrition and physical exercise. 
Future studies should investigate telomere erosion longitudinally, measuring telomeres at 
multiple time points in people engaging in different physical activity levels, to gain a better 
insight into the protective effect physical exercise may have on cellular aging. Moreover, 
delineation of the molecular pathways modulated by exercise, which are responsible for 
telomere maintenance, is of high priority.    
In conclusion, our results are the first to demonstrate that chronic ultra-endurance aerobic 
exercise is associated with slower cellular aging by attenuated telomere length attrition, 
independent of age and traditional markers of cardiovascular risk, as well as markers of 
inflammation/adhesion molecules. They also demonstrate that ultra-endurance exercise does 
not have adverse effects on the cardiovascular system through telomere attrition. 
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Figure legends 
 
Figure 1. Pearson's linear correlation between age and leukocyte telomere length in ultra-
marathon runners and controls. Ultra-marathon runners are indicated by filled circles and 
controls are indicated by empty circles. 
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Figure 2. Telomere length comparison between ultra-marathon runners and controls. Mean 
leukocyte telomere length is presented in arbitrary units as the telomere to single copy gene 
(T/S) ratio.  Error bars represent standard deviation. 
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Table 1. Clinical phenotypes of ultra-marathon runners and apparently healthy controls.  
 Ultra-marathon runners 
(n = 67) 
Controls 
(n = 56) 
P-value 
Age (years) 43.6 ± 9.2 42.8 ± 9.2 0.62 
BMI (kg/m2) 23.2 ± 2.0 25.2 ± 2.5 2.7 × 10-6 
MAP  95.8 ± 5.4 95.9 ± 8.2 0.92 
TC (mmol/L) 5.1 ±1.0 5.7 ± 1.0 0.0014 
HDL-C (mmol/L) 1.2 ± 0.3 1.0 ± 0.3 6.7 × 10-4 
Triglycerides (mmol/L) *  1.7 (1.37, 1.86)  1.6 (1.37, 1.86) 0.70 
CRP (mg/L) * 0.4 (0.34, 0.59) 1.4 (1.05, 1.91) 2.6 × 10-8 
IL-6 (pg/mL) * 1.3(1.11, 1.46) 1.5 (1.26, 1.74) 0.10 
Leptin (ng/mL) * 2.1 (1.76, 2.40) 5.6 (4.34, 7.20) 3.6 × 10-9 
sE-selectin (ng/mL) * 49.8 (44.51, 55.76) 46.1 (40.67, 52.18) 0.46 
sICAM -1 (ng/mL) * 202.1 (186.53, 219.06) 232.8 (210.38, 257.56) 0.015 
Data are from either Student’s t-test or Mann-Whitney U-tests and are expressed as means 
and standard deviations or geometric means and 95% confidence intervals (*); BMI – body 
mass index, MAP – mean arterial pressure, TC – total cholesterol, HDL – high-density 
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lipoprotein cholesterol, CRP – C-reactive protein, IL-6 – interleukin-6, sICAM-1 – soluble 
intercellular. 
 
 
Table 2. Difference in leukocyte telomere length between ultra-marathon runners and 
controls. 
Model Covariates adjusted for β-coefficient (95%CI) P-value 
Basic Age 0.40 (0.103) 1.4 x 10-4 
Fully adjusted 
model 1 (stepwise) 
Age, IL-6, MAP and PCR 
Plate 
0.44 (0.103) 4.2 x 10-5 
Fully adjusted 
model 2 (forced) 
Age, BMI, TC, HDL-C, 
CRP, leptin, sICAM-1, 
PCR Plate 
0.44 (0.140) 2.2 × 10-4 
The differences are expressed as unstandardized β-coefficients with standard errors from 
either stepwise linear regression (Fully adjusted model 1) or linear regression (Fully adjusted 
model 2 – Forced), MAP – mean arterial pressure, IL-6 – interleukin-6, PCR Plate – 
experiment used in measurement in LTL, BMI – body mass index, TC – total cholesterol, 
HDL-C – high-density lipoprotein cholesterol, CRP – C-reactive protein, sICAM – soluble 
intercellular adhesion molecule-1. 
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Table 3. Linear correlation between leukocyte telomere length and cardiovascular health 
markers, adhesion molecules, cytokines and inflammation markers. 
 All Ultra-
marathon   
runners 
Controls 
 r P-value r P-value r P-value 
Cardiovascular risk factors 
BMI (kg/m2) -0.13 0.15 0.08 0.50 -0.13 0.33 
TC (mmol/L) -0.04 0.69 0.05 0.69 0.14 0.33 
HDL-C (mmol/L) 0.03 0.76 -0.11 0.37 -0.04 0.75 
MAP 0.13 0.16 0.30 0.015 -0.03 0.80 
Triglycerides (mmol/L) 0.02 0.85 0.10 0.42 0.13 0.35 
Inflammation/adhesion molecules 
CRP (mg/L) -0.09 0.29 0.11 0.37 -0.03 0.84 
IL-6 (pg/mL) -0.12 0.20 -0.10 0.44 -0.06 0.68 
Leptin (ng/mL) -0.15 0.09 0.006 0.96 0.07 0.62 
sE-selectin (ng/mL) 0.02 0.85 0.01 0.92 -0.06 0.67 
sICAM -1 (ng/mL) -0.14 0.11 -0.05 0.69 -0.16 0.25 
BMI – body mass index, TC – total cholesterol, HDL-C – high-density lipoprotein 
cholesterol, MAP – mean arterial pressure, CRP – C-reactive protein, IL-6 – interleukin-6, 
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sE-selectin – serum E-selecin, sICAM-1 – Soluble intercellular adhesion molecule-1. Data 
from Pearson’s Correlations are expressed by r and p-values. 
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Abstract 
Leukocyte telomeres shorten with age and excessive shortening is associated with age-related 
cardio-metabolic diseases. Exercise training may prevent disease through telomere length 
maintenance though the optimal amount of exercise that attenuates telomere attrition is 
unknown. Furthermore, the underlying molecular mechanisms responsible for the enhanced 
telomere maintenance observed in endurance athletes is poorly understood.  
We quantified the leukocyte telomere length and analysed the expression of telomere-
regulating genes in endurance athletes and healthy controls (both n = 61), using quantitative 
PCR.  
We found endurance athletes have significantly longer (7.1%, 208–416 nt) leukocyte 
telomeres and up-regulated TERT (2.0-fold) and TPP1 (1.3-fold) mRNA expression 
compared to controls in age-adjusted analysis. The telomere length and telomere-regulating 
gene expression differences were no longer statistically significant after adjustment for 
resting heart rate and relative VO2max (all p > 0.05). Resting heart rate emerged as an 
independent predictor of leukocyte telomere length, TERT and TPP1 mRNA expression in 
stepwise regression models. To gauge whether volume of exercise was associated with 
leukocyte telomere length, we divided subjects into running and cycling tertiles (distance 
covered per week) and found individuals in the middle and highest tertiles had longer 
telomeres than individuals in the lowest tertile. These data emphasise the importance of 
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cardiorespiratory fitness and exercise training in the prevention of biological aging. They also 
support the concept that moderate amounts of exercise training protects against biological 
ageing, while higher amounts may not elicit additional benefits. 
 
Introduction 
Telomeres are repetitive DNA (in mammals, 5’-TTAGGG-3’) positioned at the ends of 
chromosomes that protect against genomic DNA degradation and chromosomal fusion events 
7,8. Due to the end replication problem, telomeres shorten in the absence of telomerase with 
each round of cell-division and as such telomere length is an established marker of ageing 293-
295. Telomeres and six telomere-regulating proteins (telomere repeat-binding factor 1 [TRF1], 
telomere repeat-binding factor 2 [TRF2], TRF1-interacting nuclear factor 2 [TINF2], 
adrenocortical dysplasia homolog [TPP1], protection of telomeres 1 [POT1] and TRF2-
interacting protein [TERF2IP]), collectively called shelterin, form nucleoprotein complexes 
that maintain genomic stability and regulate telomere length. Shelterin is crucial for 
telomerase-mediated telomere length maintenance and genomic stability, as removal of 
shelterin causes severe telomere and chromosomal aberrations 63,99,296. Telomerase is 
comprised of telomerase reverse transcriptase (TERT) and the telomerase RNA component 
(TERC), and can combat premature ageing by extending telomeric DNA 9,297. 
Telomere length of proliferative tissues, such as leukocytes, is longest at birth and shortening 
is dependent on genetic and lifestyle factors. Psychological stress 72, poor diet 126 and age-
related diseases including coronary artery disease 70, obesity 132 and diabetes 15 are all 
associated with excessive leukocyte telomere shortening. Conversely, mounting evidence has 
unveiled a positive influence of physical activity levels on leukocyte telomere length 179-
181,200,201,217,298. Lifestyle interventions including increases in moderate-intensity physical 
activity extends telomere length after a five-year period 215. Although exercise seems to 
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benefit telomere length, the ideal amount of exercise training for telomere length 
maintenance and the underlying molecular mechanisms remain elusive. 
We previously reported that relative to healthy controls, ultra-marathon runners had, on 
average, 11% longer leukocyte telomeres, indicating that they had prevented ~16 years’ 
worth of age-related telomere attrition 202. German National Track and Field athletes have 
increased TRF2 protein content and up-regulated telomerase activity in peripheral blood 
mononuclear cells (PBMC) compared to sedentary controls 200. Furthermore, PBMC shelterin 
gene (TRF1, TRF2 and POT1) expression was up-regulated after a seven day ultra-marathon 
event 231. Thus, shelterin and other telomere-regulating genes may underpin the longer 
leukocyte telomeres associated with long-term endurance exercise training. A comprehensive 
analysis of all shelterin and TERT gene expression between endurance athletes and healthy 
controls has not yet been performed.  
Subsequently, the purpose of our study was to extend previous findings by determining 
whether any association between telomere length and exercise was mediated through 
telomere-regulating gene expression in endurance athletes. A further aim was to establish 
whether linear associations exist between physical activity, cardiorespiratory fitness and 
leukocyte telomere length.  
 
Materials and Methods 
Participants 
A total of 122 Caucasian subjects were recruited from the general public and participated in 
this study. Subjects were deemed apparently healthy – non-smoking, not taking any 
medications and free from any age-related chronic diseases – according to self-reported 
health questionnaires. Endurance athletes (n = 61) and recreationally active controls (n = 61), 
aged 18 to 55 y were analysed. Endurance- athletes trained were cyclists, triathletes, middle- 
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or long-distance runners and ultra-marathon runners at state through to international level. 
Endurance athletes trained >3 times per week and had trained consistently for a minimum of 
one year. The apparently healthy controls were recreationally active but were not engaged in 
any structured aerobic or resistance exercise training.   
All participants gave written informed consent and this study was approved by Federation 
University Australia’s Human Research Ethics Committee. 
 
Procedures 
Subjects physical activity levels and psychological stress was assessed by the self-
administered International Physical Activity Questionnaire (IPAQ) Long form 299 and 
Perceived Stress Scale (PSS) 300, respectively. Data cleaning and analysis was performed 
according to the IPAQ guidelines and average weekly Metabolic Equivalent of task (MET) – 
minutes and sitting were calculated and included as continuous variables in statistical 
analyses. Height, weight and body mass index (BMI) were recorded and subjects were seated 
for approximately 10 minutes before BP assessment. The SphygmoCor device (AtCor 
Medical, Australia) was used to assess brachial blood pressure, averaged from three separate 
measurements, taken one minute apart with subjects seated. Subjects’ cardiorespiratory 
fitness, determined as maximal oxygen consumption (VO2max), was assessed through a 
maximal graded treadmill or cycle ergometer test via pulmonary analysis. While control 
subjects completed a maximal treadmill test, the endurance cyclist completed a cycle 
ergometer test. Triathletes obtain a comparable VO2max value regardless of exercise mode 301 
and as such, triathletes from the present study completed either a cycle or treadmill test.  
Before maximal exercise testing subjects were fitted with a two-way breathing valve (Hans 
Rudolph) and expired air was collected into an online metabolic system (Moxus, Modular, 
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USA) for O2 and CO2 analysis. The metabolic system was calibrated prior to each test using 
ambient air and gas of known composition. The treadmill commenced at 10 km.h-1 and was 
progressively increased by 1 km.h-1 every two minutes until volitional exhaustion. Cycle 
ergometer VO2max tests commenced at 100 W and the load was increased by 30 W.min-1 every 
two minutes until pedalling cadence dropped below 50 RPM for 10 seconds or until 
volitional exhaustion. Subjects were asked to maintain 90–100 RPM throughout cycle 
ergometer-assessed exercise tests. Individual VO2max was determined as the highest O2 value 
averaged over 60 seconds.  
 
Telomere length quantification 
A preprandial blood sample (~20 ml) was drawn from the antecubital vein into EDTA tubes 
using standard phlebotomy procedures. All subjects gave a seated resting blood sample 24 to 
48 hours after their last exercise session. DNA was extracted from whole-blood leukocytes 
using the Purelink Genomic DNA Mini Kit (Life Technologies, Australia). Telomere length 
was quantified using an established qPCR method 13,14,202,302, previously validated by 
terminal restriction fragment analysis 13. Within each sample, the telomere repeat copy 
number (T) is compared to a single copy gene copy number (S) and expressed in arbitrary 
units as a (T/S) ratio. Briefly, 10µl reactions comprised of 2 × SensiFast SYBER Lo-ROX 
master mix (Bioline, Australia), primer sets and 10ng of DNA, were run in triplicate on the 
ViiA7 Real Time PCR System (Life Technologies, Australia). Either 300nM of telomere-
specific forward (5’GGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT3’) and 
reverse (5’GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT3’) primers, or 
300nM of forward (5’CAGCAAGTGGGAAGGTGTAATCC3’) and 500nM of reverse 
(5’CCCATTCTATCATCAACGGGTACAA3’) primers for the 36B4 gene was used in 
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reactions. All samples were run with a positive and no template controls on a single 384-well 
plate to prevent any inter-plate variability. The cycling conditions telomere assays was as 
follows: a hold at 95° for 10 min, followed by 40 cycles at 95° for 15 s and 58° for 1 min. As 
a quality control, samples were excluded from the analysis if the difference between 
triplicates was greater than one cycle threshold (Ct), or the average of duplicates was taken 
for further analysis. The intra-assay coefficient of variation between triplicate samples was 
2.5% and 1.4% for the telomere and 36B4 gene, respectively. 
 
Gene expression analysis 
Leukocytes were isolated as previously described 248 and RNA was extracted using the 
miRVana miRNA Isolation Kit (Life Technologies, Australia), following the manufacturer’s 
guidelines. RNA was reverse transcribed to cDNA using the High Capacity Reverse 
Transcription Kit (Life Technologies). Telomere-regulating gene expression was quantified 
using SYBR or TaqMan chemistries. Primer-sets and TaqMan Assays (Life Technologies) 
are outlined in Table 1. An efficiency curve was generated for each primer-set using cDNA 
diluted 1:2 from 50ng to 3.125ng. The qPCR product was run on an agarose gel to ensure 
appropriate amplicon length and a single product. Triplicate samples were run on a single 
384-well plate with negative controls. The cycling conditions for primer-based assays was: a 
hold at 95° for 2 min, followed by 40 cycles at 95° for 5 s, 60° for 10 s and 72° for 20 s. 
Cycling for TaqMan assays was: a hold at 50° for 2 min and another at 95° for 20 sec, 
followed by 40 cycles at 95° for 1 s and 60° for 20 s. Relative gene expression was assessed 
using the 2–ΔΔCt method 303. Whilst differential gene expression between athletes and controls 
was represented by fold-difference, gene expression analysis involving all subjects was 
represented using relative gene expression compared to the control mRNA, GAPDH. The 
 
	
135 
coefficient of variation between triplicates for each of the mRNAs ranged from 0.66 to 1.49% 
(Table 1). 
 
Statistical analysis 
Using data from our previous cross-sectional study 202, our a priori power analysis revealed 
we required a sample size of 88 (44 in each group) in order to achieve >90% power to detect 
a difference (d > 0.7) in leukocyte telomere length between athletes and controls (G*Power, 
version 3.1.5). All statistical analyses were performed using IBM SPSS Statistics for 
Windows (Version 21, IBM Corp, NY). Data were tested for normality using the 
Kolmogorov-Smirnov and Shapiro-Wilk tests. Two-way independent samples t-tests or 
Mann-Whitney U-tests were used to examine differences in physical characteristics and 
fitness parameters, and telomere length between athletes and controls. To control for 
covariates, an ANCOVA was used to establish differences between athlete and control 
telomere length and telomere-regulating gene expression. An ANOVA was also used to 
determine telomere length differences between subjects divided into cycling and running 
distance tertiles. Spearman’s correlations were used on to examine associations between 
physical characteristics and fitness parameters, with telomere length and telomere-regulating 
gene expression. Stepwise linear regression was performed to identify predictors of telomere 
length and telomere-regulating gene expression. Statistical significance was set at p < 0.05. 
The difference in biological age and telomere length – expressed as nucleotides (nt) – 
between athletes and controls was estimated using the same calculations as described 
previously 202. 
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Results 
Physical characteristics  
The controls were five years younger than the athletes (p = 0.06). Relative to the controls, the 
athletes had a lower body weight, resting heart rate and had a higher cardiorespiratory fitness 
as indicated by their VO2max and maximal treadmill speed (all p < 0.001, Table 2). Athletes 
engaged in less sitting and were more physically active compared to their non-athletic peers 
(all p < 0.01, Table 2).  
 
Linear correlations between telomere length, age, health and exercise phenotypes 
Age was not statistically correlated to telomere length in all subjects or when athletes and 
controls were analysed separately (all p > 0.05, Table 3). When athletes and controls were 
pooled we found weak to moderate correlations between telomere length and weight, BMI, 
systolic blood pressure and resting heart rate (n = 122, all p < 0.05, Figure 1). Furthermore, 
we found correlations between cardiorespiratory fitness and physical activity parameters – 
Metabolic equivalent of task-min per week, time spent sitting and maximal treadmill speed – 
and leukocyte telomere length (all p < 0.05, Figure 2). In athletes, years spent training was 
not associated with telomere length (n = 60, r = -0.12, p = 0.37). 
 
Telomere length analysis 
Relative to the controls, the endurance athletes had 7.1% longer leukocyte telomeres after 
age-adjustment (T/S ratio ± SE: 3.64 ± 0.06 v 3.38 ± 0.06, p = 0.002, Figure 3A). The 
biological age difference between endurance athletes and controls translated to 10.4 years, 
meaning the athletes had prevented 10.4 years of biological ageing. We estimated the 
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biological age difference was equivalent to the athletes possessing 208–416 nt longer 
telomeres compared to the controls. Compared to controls, athletes had lower body weight 
and resting heart rate, and a higher cardiorespiratory fitness (Table 2, all p < 0.001). To 
determine whether these phenotypes mediated the leukocyte telomere length difference found 
between athletes and controls, we performed an additional analysis including these 
phenotypes as covariates. After adjusting for age, weight, resting heart rate and relative VO2max, however, the difference between athletes and controls was no longer statistically 
significant (T/S ratio ± SE: 3.58 ± 0.08 vs 3.45 ± 0.08, p = 0.36).  
We then performed a stepwise linear regression to determine predictors of leukocyte telomere 
length. After including health and fitness parameters – age, height, weight, body mass index, 
systolic, diastolic, mean arterial and pulse pressure, and relative VO2max – in the stepwise 
regression model, resting heart rate emerged as the only independent predictor of leukocyte 
telomere length amongst athletes and controls, such that it explained 10.1% of the overall 
variation (B = -0.012, CI: 3.85–4.625, p < 0.001). 
 
Telomere-regulating gene expression analysis 
Relative to controls, endurance athletes had 2.0-fold and 1.3-fold up-regulated TERT  (Figure 
3B) and TPP1 (Figure 3C) mRNA expression, respectively. No other telomere-regulating 
genes – TERC, TERF2IP, TINF2, TERF1, TERF2 and POT1 – were differentially regulated 
between athletes and controls (p > 0.05, Table 4). The up-regulated TERT and TPP1 mRNA 
expression remained statistically significant after adjusting for health phenotypes (p = 0.005 
and p = 0.05, respectively). After further adjustment for heart rate and relative VO2max, 
however, the difference was no longer statistically significant (p = 0.16 and p = 0.41). 
Besides TERC (r = -0.28, p = 0.003), there were no other statistically significant correlations 
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between telomere length and expression of any of the telomere-regulating genes analysed (p 
> 0.05, Table 5). TERT and TPP1 were both correlated with resting heart rate and relative VO2max (Figure 3D–G).  
Again, we performed stepwise regression including health and fitness parameters and found 
that resting heart rate was an independent predictor of TERT mRNA expression, explaining 
9.4% of the variation (Table 6). Age, height and resting heart rate were independent 
predictors of TPP1 mRNA expression, together explaining 9.5% of the variation (Table 6).  
 
Moderate amounts of exercise training associated with long telomeres and increased 
TERT and TPP1 mRNA expression 
To establish associations between volume of exercise training and telomere length, we 
divided subjects into tertiles for weekly running and cycling distance and analysed telomere 
length. We found that age-adjusted telomere length was significantly longer in subjects in the 
middle and highest tertiles for weekly running and cycling distance (Figure 4A and B, 
respectively) compared to those in the lowest tertile. A similar relationship was observed 
between weekly training distances and TERT and TPP1 mRNA expression (Figure 4D, E, G 
and H). Moreover, individuals with the highest cardiorespiratory fitness had longer leukocyte 
telomeres, up-regulated TERT and TPP1 mRNA expression compared to those in the lowest 
tertile with poor cardiorespiratory fitness (Figure 4C, F and I, respectively). No statistically 
significant differences were found between those in the middle and highest cardiorespiratory 
fitness tertiles for telomere length, TERT and TPP1 mRNA expression. 
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Lower resting heart rate is associated with longer telomeres 
To investigate the association between resting heart rate and telomere length we divided our 
subjects into resting heart rate tertiles and found a linear decrease in leukocyte telomere 
length with a higher resting heart rate (Figure 4J). Subjects with a resting heart rate below 50 
beats.min-1, on average, exhibited 14.4% and 8.5% longer telomeres compared to those with a 
resting heart rate 51–74 and >75 beats.min-1, respectively (Figure 4J). A similar relationship 
was also observed between resting heart rate and TERT and TPP1 mRNA expression (Figure 
4K and L, respectively). 
 
Discussion 
Endurance athletes who regularly engage in high volumes of exercise training have preserved 
leukocyte telomeres 200-202 though the underlying molecular and physiological determinants 
remain incompletely understood. Here, we not only verified that endurance athletes have 
significantly longer leukocyte telomeres, but we also wanted to determine if the longer 
telomeres observed in athletes was caused by the modulation of gene expression in telomere 
length regulating genes. We found that the adrenocortical dysplasia homolog (TPP1) and 
TERT genes were both up-regulated in leukocytes from athletes compared to controls. The 
longer leukocyte telomeres and increased TERT and TPP1 mRNA expression observed in 
endurance athletes appears to be associated with their lower resting heart rate and superior VO2max.  
The majority of previous research has shown physical activity is positively correlated to 
leukocyte telomere length 179-181,200,201,217, though the optimal amount for telomere length 
maintenance remains unclear. For instance, some researchers suggest moderate amounts of 
physical activity is ideal for telomere maintenance 181,182, whilst studies on endurance athletes 
– who regularly engage in strenuous endurance exercise training – supports the premise that 
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higher volumes of endurance exercise is conducive to telomere protection 200-202. Here, we 
verify previous studies 201,202 indicating endurance athletes possess significantly longer 
leukocyte telomeres (by 7.1%, 208–416 nt) compared to controls of average cardiorespiratory 
fitness. Our previous investigation on ultra-marathon runners revealed they had 324–648 nt 
longer telomeres, which translated to 16.2 years less telomere attrition compared to healthy 
controls 202. The endurance athletes in the present study were, on average, five years older 
than the controls yet possessed longer leukocyte telomeres to a relatively similar magnitude 
as found in our previous study 202. The average telomere length difference between endurance 
athletes and controls from the present study indicated the endurance athletes possessed 
telomeres as long as controls 10.4 years their junior, providing additional evidence that 
endurance exercise training attenuates biological ageing.  
Although previous studies 200-202 and our findings indicate endurance exercise training is 
associated with longer telomeres, the molecular mechanisms leading to longer leukocyte 
telomeres in endurance athletes is unclear. Up-regulation of telomerase is a likely mechanism 
of longer telomeres in athletes. German track and field and endurance athletes accumulating 
an average of >70 km of running per week, exhibited up-regulated peripheral blood 
mononuclear TRF2 mRNA and protein expression, with increased telomerase activity 200. 
Here, we found increased whole-blood leukocyte TERT and TPP1 mRNA expression in 
endurance athletes. It is possible that repeat bouts of exercise training may reprogram TERT 
and TPP1 mRNA expression, which would improve telomerase activity and processivity, and 
ultimately preserve telomere length. Previous analyses involving mononuclear cells 200, TRF2 
mRNA was not differentially expressed in our endurance athletes, potentially due to the 
different cell type studied – whole blood leukocytes. Increased mononuclear cell TRF1, TRF2 
and POT1 mRNA expression was observed in endurance athletes the day after a 183-mile 
ultra-marathon race 231, but these shelterin genes were not differentially expressed in our 
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athletes in a rested state. TERT is the major protein component of the reverse transcriptase, 
telomerase 304, with a known role in preventing replication-induced telomere shortening 
108,305. Interestingly, leukocyte TERT mRNA expression was increased (19.4-fold) after a 30-
min run at 80% of VO2max in healthy men 230. Therefore, considering POT1 together with 
TPP1 help recruit and increase the repeat processivity of telomerase 93, the increased TERT 
and TPP1 mRNA expression found in athletes from our study and up-regulated leukocyte 
telomerase activity in athletes’ from others 200 may contribute to the underlying molecular 
mechanisms by which endurance exercise training preserves leukocyte telomeres. Pathways 
activated by aerobic exercise training, such as the nitric oxide synthase, Akt protein kinase, 
insulin growth factor-1 signalling 200,228 and p38 mitogen-activated protein kinase 232 are 
candidate signalling cascades that may regulate telomerase activity-dependent telomere 
maintenance via TERT activation.  
Interestingly, age was not negatively correlated to leukocyte telomeres in athletes, control or 
pooled subjects. This may be due to the narrow age range (18–55 y) or alternatively because 
the controls were recreationally active. Body weight, body mass index, systolic BP, mean 
arterial pressure and resting heart rate were all inversely correlated to leukocyte telomere 
length. Consistent with previous studies 201,206-208, we found a positive correlation between 
cardiorespiratory fitness, assessed by VO2max testing, and telomere length. Interestingly, 
TERC mRNA expression was inversely correlated to telomere length. Potential explanations 
for this finding is that elevated TERC mRNA expression may not be required in the absence 
of excessive telomere shortening, experimental noise or because TERC is not the rate limiting 
factor for telomerase activity. Providing evidence that longer leukocyte telomeres are 
reflective of physical performance capabilities and physical activity, we found maximal 
treadmill speed and physical activity were positively correlated to leukocyte telomere length. 
A recent randomised, controlled trial revealed reduced time spent sitting was associated with 
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telomere lengthening in a group of sedentary older adult (68 y) men and women 190. We 
found time spent sitting per week was inversely correlated to leukocyte telomere length in 
younger (~30 y) subjects. Notably, the athletes in the present study reported sitting much less 
relative to controls (4.8 v 10.8 hr.day-1). It may be that the longer leukocyte telomeres 
possessed by endurance athletes is result of both extensive exercise training and less 
sedentary time (i.e. more physical activity). Therefore, these data suggest increased physical 
activity, cardiorespiratory fitness and limited time spent sitting contribute to telomere 
maintenance, in turn, protecting against cardiovascular disease and biological ageing. 
We also found TERT and TPP1 mRNA expression were positively and inversely correlated to VO2max and resting heart rate, respectively. To our knowledge we are the first to show such a 
relationship between parameters of cardiorespiratory fitness – VO2max and resting heart rate – 
and telomere-regulating gene expression. An increase in VO2max and lowering of resting heart 
rate are adaptations to endurance exercise training 306,307. Interestingly, the differences in 
leukocyte telomere length, TERT and TPP1 mRNA expression between athletes and controls 
was no longer statistically significant after adjustment for  VO2max and resting heart rate, 
indicating these parameters may be important for telomere length maintenance.  
Exceptional arterial health and cardiac capacity (primarily stroke volume) are required for a 
high VO2max and maybe the underlying biological mechanisms explaining the observed 
association with telomere length maintenance. The shorter leukocyte telomeres observed in 
patients with atherosclerosis is well known 13,14,70,308 and shortening of leukocyte telomeres is 
more pronounced in individuals with atherosclerotic progression over a six 178 and ten 177 
year time period. Leukocyte telomere length reflects the telomere length of haematopoietic 
stem cells 309, which are precursors for endothelial progenitor cells 310. Subsequently, 
endurance exercise training may attenuate telomere shortening in haematopoietic stem cells 
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and, in turn, conserve the replicative potential of endothelial progenitor cells to ultimately 
conserve arterial health and function.  
The stepwise inverse association between lower resting heart rate and leukocyte telomere 
length has multiple explanations. For example, exercise-training induced bradycardia 
involves decreased sympathetic nervous system activation and increased peripheral arterial 
compliance 306. Increased oxidative stress production in medulla of rats leads to sympathetic 
activation and hypertension 311. Telomeres are particularly vulnerable to shortening caused by 
inflammation 168 and oxidative stress 83,169, and both are implicated in cardiovascular disease 
312-314. Endurance athletes, however, have low circulating markers of inflammation 280 and 
exercise training leads to up-regulated antioxidant enzyme activity 315,316. Therefore, whilst 
speculative, ameliorated inflammation and oxidative stress, with up-regulate telomere-
associated genes caused by endurance exercise training may protect against telomere 
shortening, but this requires additional investigation.  
Most studies have found a positive relationship between the amount of physical activity and 
leukocyte telomere length, but the optimal amount of exercise for telomere preservation is 
not known. Another novel aspect of our study was that after dividing subjects into tertiles for 
running and cycling distance covered per week, we found individuals in the middle and 
highest tertiles for exercise training possessed similar leukocyte telomere lengths that were 
longer compared to those in the lowest exercise tertile. A similar relationship was observed 
with TERT and TPP1 mRNA expression, suggesting that exercise-induced benefits to 
telomere length maintenance maybe conferred by moderate and high amounts of exercise 
training. The practical application of these findings are that individuals who wish to maintain 
their leukocyte telomere length could benefit from running more than 10 km a week, but 
running more than 25 km a week may not provide additional telomere preservation. 
Similarly, cycling greater than 200 km a week may be unnecessary for telomere length 
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maintenance, rather a minimum of 30 km cycling a week could elicit attenuate age-related 
telomere attrition. These data are somewhat supported by findings from epidemiological 
studies on physical activity measured in context with cardiovascular disease and mortality 
risk. A meta-analysis indicated the risk of coronary heart disease is reduced by 14% and 20% 
in individuals engaging in the recommended 150 and 300 minutes, respectively, of moderate-
intensity physical activity per week 3. The relative risk of coronary heart disease, however, 
was only modestly lower in those engaging in the highest amount – 750 minutes – of physical 
activity per week 3. In a cohort of 55,137 adults, the relative risk reduction in all-cause and 
cardiovascular mortality was reduced in runners compared to non-runners but the decreased 
risk was achieved with as little as running ~10 km per week 317. We found a linear 
relationship between leukocyte telomere length and resting heart rate. Resting heart rate has 
long been recognised an independent risk factor for cardiovascular disease and all-cause 
mortality, with higher resting heart rates eliciting a greater risk 318-320. Leukocyte telomere 
length is also a predictor of cardiovascular disease 13,152 and all-cause mortality 22,321. 
Therefore, it is possible that aerobic exercise training-induced telomere maintenance could 
occur in conjunction with lowering of resting heart rate and this, in turn, may ameliorate the 
risk of cardiovascular disease and mortality. This study was not designed to investigate the 
possible causal role exercise-induced lowering of resting heart rate has on leukocyte telomere 
length and disease and mortality risk. Future research should establish how improvement to 
cardiorespiratory fitness and a reduction of resting heart rate maintains telomere length. 
We had over 90% power to detect a difference in leukocyte telomeres, which is a strength of 
the study. Whilst we acknowledge our data does not directly show that endurance exercise 
training maintains leukocyte telomere length, the alternative explanation would be that being 
born with long telomeres might be associated with a markedly higher cardiorespiratory 
performance and instinctive willingness to engage in extensive exercise training; an 
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alternative and plausible explanation. A limitation of the study is that dietary analysis was not 
performed therefore we cannot account for the potential impact of diet on leukocyte telomere 
biology. Leukocyte protein was not collected therefore future studies should confirm the 
TERT and TPP1 mRNA expression differences amongst athletes and controls at the 
translational level. Given that critically short telomeres promote cellular senescence 322, it 
would be advantageous to study the percentage of short telomeres in context with physical 
activity and cardiorespiratory fitness, rather than mean telomere length outlined in the present 
study. Although our statistical analysis indicated key cardiorespiratory fitness adaptations – 
lower resting heart rate and superior  VO2max – partly explained the telomere length difference 
found between athletes and controls, additional studies are required to delineate the 
physiological mechanism. Our data was correlative and does not infer causation. Future work 
should focus on the molecular mechanisms regulating telomere length dynamics in context 
with exercise training. It will be important to determine the genetic contribution of long 
telomeres from the influence of exercise training. Considering VO2max and resting heart rate 
are heritable traits, accounting for ~50% 222 and 13 to 60% 323-325 of the variation, 
respectively, it could be that endurance athletes from our study inherited long telomeres and 
their involvement in exercise training is coincidental. Longitudinal analyses are required to 
appreciate whether and what type of exercise training, and underlying physiological 
adaptations, attenuates the rate of telomere shortening in humans, to prevent biological 
ageing and disease.  
In summary, endurance athletes possess longer leukocyte telomeres and up-regulated TERT 
and TPP1 mRNA expression. Our findings indicate a role for  VO2max and lower resting heart 
rate in the benefits that endurance exercise training has on leukocyte telomere maintenance. 
We also found a plateauing effect between the amount of running and cycling distance 
covered per week and increasing leukocyte telomere length. Therefore, this suggests that 
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moderate amounts of exercise (running: 10 to 25 km.week-1; cycling: 30 to 200 km.week-1) 
may be as sufficient as large amounts of exercise to prevent age-associated telomere erosion.  
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Tables 
Table 1. Primer-sets and assay identification numbers. 
Gene symbol Primer-sets/Assay ID CV (%) 
TERT F: GAA GAA GCC ACC TCT TTG GA 
R: AGA GAG CTG AGT AGG AAG GAG 
1.36 
POT1 F: GCT CTG GCT TTG CAT CTT TG 
R: GGT GCC ATC CCA TAC CTT TAG 
0.82 
TINF2 F: CAA GTC CTG AAA GCC CTG AA 
R: CTT TCT CCA GCT GAC ACA AGT A 
1.32 
TPP1 F: CCA CGC TGC TTG TGT CT 
R: GCG GTC CAC CTG GAG ATA 
1.05 
TERF1 F: ACC CTT GAT GCA CAG TTT GA 
R: CTG CCT TCA TTA GAA AGG TTG ATG 
1.49 
TERF2 F: CAC ACC ACT GGA ATC AGC TAT C 
R: CAG GAT GGG CCA AGT TCT TT 
0.66 
GAPDH (control) F: GGG TGT GAA CCA TGA GAA GT 
R: AGT AGA GGC AGG GAT GAT GT 
0.98 
TERF2IP Hs00430292_m1 0.71 
TERC Hs03454202_s1 1.30 
GAPDH (control) Hs02786624_g1 1.03 
Legend: ID, identification number (Life Technologies); CV, coefficient of variation (intra-
plate).  
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Table 2. Characteristics of endurance athletes and controls. 
Variable Endurance athletes  
(n = 61) 
Controls  
(n = 61) 
p-value 
Men/women (n) 46/15 47/14  
Age (y) 33.7 ± 11.03 28.7  ± 10.64 0.06 
Ht (cm) 176.36 ± 10.10 173.82 ± 8.97 0.14 
Wt (kg) 70.56 ± 10.69 78.65 ± 10.96 < 0.001 
BMI (Wt/Ht2) 22.6 ± 2.23 26.02 ± 2.95 < 0.001 
SBP (mm Hg) 124.96 ± 10.91 125.75 ± 10.65 0.68 
DBP (mm Hg) 73.44 ± 8.08 75.95 ± 9.11 0.11 
PP (mm Hg) 51.52 ± 7.97 49.46 ± 9.45 0.20 
MAP* (mm Hg) 90.46 ± 8.3 92.44 ± 8.73 0.20 
Resting HR (beats.min-1) 51.62 ± 7.58 68.67 ± 10.62 < 0.001 VO2max (ml.kg-1.min-1) 58.77 ± 8.75 43.73 ± 7.03 < 0.001 
Maximum treadmill speed 
(km.h-1) 
17.02 ± 1.97 13.23 ± 1.92 < 0.001 
Maximum wattage (w) 370.23 ± 69.38 - - 
PSS 12.21 ± 4.81 11.36 ± 5.74 0.39 
Sitting (min.wk-1) 2010 (1290–2700) 4560 (2220–8460) < 0.001 
EEE (Mj.wk-1) 32.43 (23.23–55.7) 23.64 (8.92–40.65) 0.002 
METs (min.wk-1) 6976 (4878–13116) 3528 (1556.5–7520.5) < 0.001 
Years trained (y) 5.5 (2.62–12) 2.25 (0–8.5) < 0.001 
Run distance (km.wk-1) 40 (30–60) 2.5 (0–10) < 0.001 
Cycle distance (km.wk-1) 150 (0–237.5) - - 
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Swim distance (km.wk-1) 4.5 (0–8) - - 
Data are expressed as mean ± standard deviation or median (interquartile range) from two-
tailed independent samples t-tests or Mann-Whitney U-tests.  
Legend: Ht, Height; Wt, Weight; BMI, body mass index; SBP, systolic BP; DBP, diastolic 
BP; PP, pulse pressure (SBP-DBP); MAP, mean arterial pressure *calculated by 
( 2×diastolic +systolic)÷3; HR, heart rate; VO2max, maximal aerobic  (cardiorespiratory) 
fitness; PSS, perceived stress scale; EEE, estimated energy expenditure; METs, metabolic 
equivalent of task. 
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Table 3. Linear correlations between age and telomere length in athletes and controls.  
 All subjects 
(n = 122) 
Athletes  
(n = 61) 
Controls 
(n = 61) 
Variable r  p-value r  p-value r  p-value 
Age 0.03 0.74 0.04 0.78 -0.12 0.35 
Data are from Spearman’s correlations. 
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Table 4. Telomere-regulating gene expression in athletes and controls (p > 0.05). 
Gene FD 
TERC 1.27 
TRF1 0.91 
TRF2 0.93 
TINF2 0.90 
POT1 0.97 
TERF2IP 1.03 
Data are expressed as fold-difference relative to controls (FD = 1). 
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Table 5. Linear correlations between telomere length and telomere-associated gene 
expression. 
 All subjects 
(n = 121) 
Gene r p-value 
TERT 0.09 0.315 
TERC -0.28 0.003 
TRF1 -0.08 0.35 
TRF2 0.05 0.55 
TPP1 0.12 0.25 
TINF2 0.07 0.48 
POT1 -0.007 0.93 
TERF2IP 0.05 0.61 
Data are from two-tailed Spearman’s Correlation.  
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Table 6. Stepwise regression models for TERT and TPP1 mRNA expression. 
Dependent 
variable 
Predictors Unstandardised 
B-value 
SE t-value p-value r2 (adj) 
TERT  HR -1.24 0.34 -3.64 < 0.001 0.094 
TPP1  Age 
Height 
HR 
0.33 
0.45 
-0.26 
0.16 
0.18 
0.14 
2.01 
2.15 
-1.89 
0.047 
0.01 
0.06 
0.095 
Data are from stepwise linear regression. Variables excluded from the models for TERT 
include: age, height, weight, body mass index, systolic, diastolic, pulse and mean arterial 
pressure, and VO2max. Variables excluded from the models for TPP1 include: weight, body 
mass index, systolic, diastolic, pulse and mean arterial pressure, and VO2max. 
Legend: SE, standard error; HR, resting heart rate. 
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Figure legends 
 
Figure 1. Linear correlations between leukocyte telomere length and health parameters. 
Data are from Spearman’s correlations. 
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Figure 2. Linear correlations between leukocyte telomere length and exercise 
parameters. Data are from Spearman’s correlations. 
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Figure 3. Endurance exercise, telomere length, and TERT and TPP1 mRNA expression. 
A) Leukocyte telomere lengths adjusted for age are from an ANCOVA including 61 athletes 
and controls. Bars and whiskers indicate mean and standard error, respectively. Relative to 
controls, endurance athlete had increased TERT (B) and TPP1 (C) mRNA expression 
(athletes vs controls [relative expression ± SE]: 68.31 ± 7.03 vs 34.07 ± 4.3, p < 0.001 and 
31.39 ± 2.93 vs 21.53 ± 1.56, p = 0.004, respectively). Data are from Mann-Whitney U test. 
Correlations between TERT mRNA expression, VO2max (D) and resting heart rate (E). 
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Correlations between TPP1 mRNA expression, VO2max (F) and resting heart rate (G). Data 
are from Spearman’s correlations. **p < 0.01; ***p < 0.001. 
 
Figure 4. Moderate amounts of exercise training and lower resting hear rates are 
associated with longer leukocyte telomeres. Telomere length was analysed in context with 
running (A) and cycling (B) distance, and VO2max tertiles (C). Similarly, TERT (D, E and F) 
and TPP1 (G, H and I) mRNA expression was analysed in context with running, cycling and 
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VO2max, respectively. Heart rate tertiles were formed and analysed in context with telomere 
length (J), TERT (K) and TPP1 (L) mRNA expression. Bars and whiskers indicate mean±SE 
from an ANCOVA, adjusted for age. *p < 0.05; **p < 0.01; ***p < 0.001. 
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Figure Captions
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Figure 1. Impact of epigenetic modifications and microRNAs (microRNAs). DNA is 
wrapped around an octomer complex, known as a nucleosome, made up of four pairs of 
histone proteins, plus histone H1 (linker protein). Histone protein sites (eg. lysines and 
arginines) are vulnerable to epigenetic modifications, such as acetylation, methylation and 
several other chemical modifications; of which change the formation of chromatin to an 
open, transcriptionally active or a closed, transcriptionally repressed state. DNA methylation, 
however directly changes the structure of DNA and in doing so allows active transcription or 
silencing of genes, depending on the location. Although not working above the genome, 
miRNAs function by mostly targeting  specific 3’ untranslated regions (UTR) of messenger 
RNA (mRNAs) and negatively regulate protein abundance by post-transcriptional regulation 
of mRNA stability or through the degradation of mRNA molecules. The binding of 5’UTRs 
is also possible, leading to either up- or down-regulation of mRNA levels (not shown in 
figure).  
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Figure 2. Mechanisms of action of histone acetylation. (a) A gene (indicated by pink lines) is 
elegantly stored around three nucleosomes. The histone-3 proteins (yellow circles) are 
deacetylated at lysine-9 (H3K9) by histone deacetylase (HDAC) enzymes – an epigenetic 
mark of transcriptional repression. (b) Two nucleosomes housing a gene have been acetylated 
at histone-3 lysine-9 (H3K9ac) – an epigenetic mark of transcriptional activation, favouring 
gene transcription. This epigenetic modification is carried out by histone acetyltransferase 
(HAT) enzymes. 
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Figure 3. The effect DNA methylation has on gene expression is dependent on its location 
within the genome. (a) DNA methylation within a gene’s promoter region is associated with 
transcriptional repression. (b) Conversely, DNA methylation within the gene body is 
associated with transcriptional active DNA. DNA methylation is actively performed 
predominantly by DNA methyltransferase-1 (DNMT1), through the transfer of an accepted 
methyl group from a donating S-adenosylmethionine (SAM). DNMT3A and 3B, however, 
are vital for embryonic DNA methylation and early development.  Active and passive DNA 
demethylation is potentially conducted through many mechanisms (for detailed review the 
readers are referred elsewhere 326,327). 
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DNMT1 = DNA methyltransferase-1; DNMT3A = DNA methyltransferase-3A; DNMT3B = 
DNA methyltransferase-3B; TET = Ten-eleven translocation protein (1-7); AID = activation-
induced cytidine deaminase; BER = Base excision repair; NER = Nucleotide excision repair. 
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Figure 4. microRNA (miRNA) biogenesis and down-regulation by binding to the 3’ 
untranslated region (UTR) of a messenger RNA (mRNA). (a) A gene coding a miRNA is 
transcribed by RNA polymerase II (RNA pol II), (b) producing a primary-miRNA (pri-
miRNA). (c) The pri-miRNA is cleaved by the multi-protein complex, Drosha/Di George 
Syndrome critical region gene 8 (DGCR8), creating a preliminary-miRNA (pre-miRNA). (d) 
The pre-miRNA is transported from the cell nucleus to the cytosol by Exportin-5, (e) where it 
is further cleaved by Dicer, transforming it into the miRNA/passenger miRNA 
(miRNA/miRNA*) duplex. (f) The passenger miRNA (miRNA*) can be degraded or recently 
it has been suggested to have a role in mRNA regulation too. (g) Any one of several 
argonaute proteins (Ag) attaches to the mature miRNA, thereby creating the miRNA-induced 
silencing complex (miRISC) assembly. (h) The miRISC is able to either regulate protein (P) 
abundance by negative repression of transcribed RNA when the seeding region of the 
miRNA is partially complementary to the 3’UTR of the target mRNA (~7 bases in length), or 
 
	
177 
(i) it can lead to mRNA repression and subsequent degradation when the seeding region is 
completely complementary to the 3’UTR of the target mRNA.
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Abstract  
Most human phenotypes are influenced by a combination of genomic and environmental 
factors. Engaging in regular physical exercise prevents many chronic diseases, decreases 
mortality risk and increases longevity. The mechanisms involved, however, are poorly 
understood. The modulating effect of physical (aerobic and resistance) exercise on gene 
expression has been known for some time now and has provided us with an understanding of 
the biological responses to physical exercise. Emerging research data suggest that epigenetic 
modifications are extremely important for both development and disease in humans. In the 
current review, we summarise findings on the effect of exercise on epigenetic modifications 
and their effects on gene expression. Current research data suggests epigenetic modifications 
(DNA methylation and histone aceytlation) and microRNAs (miRNAs) are responsive to 
acute aerobic and resistance exercise in brain, blood, skeletal and cardiac muscle, adipose 
tissue and even buccal cells. Six months of aerobic exercise alters whole-genome DNA 
methylation in skeletal muscel and adipose tissue and directly influences lipogenesis. Some 
miRNAs are related to maximal oxygen consumption (VO2max) and VO2max trainability, and 
are differentially expressed amongst individuals with high and low VO2max. Remarkably, 
miRNA expression profiles discriminate between low and high responders to resistance 
exercise (miR-378, -26a, -29a and -451) and correlate to gains in lean body mass (miR-378). 
The emerging field of exercise epigenomics is expected to prosper and additional studies may 
elucidate the clinical relevance of miRNAs and epigenetic modifications, and delineate 
mechanisms by which exercise confers a healthier phenotype and improves performance.   
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Introduction 
The human phenotype is influenced directly, or in combination with, our genes and the 
environment. There is a genetic predisposition to many diseases.328-331 Interestingly, little is 
known as to how environmental stimuli impact our phenotype and what molecular 
mechanisms are involved  
Epigenetics is the study of changes to gene expression, independently of genotype that, in 
certain instances, are trans-generationally heritable. The epigenome consists of a plethora of 
DNA and chromatin modifications that influence gene expression by performing 
conformational changes inside the nucleus of cells and governs tissue specific gene 
expression.332,333 Aberrant epigenetic profiles are associated with numerous diseases.55,334,335 
Environmental stimuli may induce epigenetic modifications, which in turn, modulate gene 
expression. Furthermore, microRNAs (miRNAs) impact protein abundance through post-
transcriptional regulation of messenger RNA (mRNA) and the expression of numerous 
miRNAs become dysfunctional with disease.336,337 
Physical exercise is a financially viable and modifiable lifestyle choice underutilised by 
many. The health and fitness benefits conferred by regular aerobic and resistance exercise 
training include alleviated risk of developing and reduced severity of some cardiovascular, 
metabolic and pulmonary diseases, obesity and certain types of cancer.56,338,339  
In this review, we discuss data showing the influence that exercise has on DNA methylation, 
histone acetylation and miRNAs, and their impacts on gene expression and phenotype.   
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Biology of epigenetic modifications and microRNAs 
The interaction of genetic and environmental factors significantly influences human 
phenotypes, including the susceptibility to many common diseases. Despite the original idea 
the human genome is inert and imperturbable to structural changes, epigenetic studies have 
revealed quite the contrary.340 The epigenome consists of a plethora of potent gene regulatory 
mechanisms (histone acetylation, DNA methylation, etc; see Table I for definitions of key 
terms).341,342  Translated, ‘epi’ means above and ‘genome’ describes the heritable blueprints 
of an organism – the DNA. Therefore, these epigenetic modifications function by rearranging 
the conformation of DNA or the architecture of structures holding DNA (nucleosomes) inside 
the cell nucleus (Figure 1). In doing so, they act to encourage or prevent transcription, 
through an intricate interplay of molecular pathways to date not completely understood.332  
Although numerous epigenetic modifications are known,342 only DNA methylation and 
histone acetylation have been investigated in context with physical exercise. These include 
histone acetylation and DNA methylation, discussed below.343-346 A detailed examination and 
outline of the intricate pathways involved in signalling epigenetic modifications is outside the 
scope of this review; these have been outlined previously.332,347 Moreover there is great 
diversity in genetic assays for quantifying miRNA and epigenetic modifications, and these 
have been described elsewhere.348-352 
Histone Acetylation 
Nucleosomes consist of four, paired histone molecules (H2A, H2B, H3 and H4) and H1 
(linker protein) of which approximately 150 base-pairs (bp) of DNA is wrapped around and 
stored. Epigenetic modifications at histone proteins alters chromatin structure and modulates 
gene expression, and these are dependent on the location and type of epigenetic modification 
(acetylation, phosphorylation, deamination, ubiquitylation, sumoylation, etc.), or degree of 
histone methylation (mono-, di- or tri-methylation) (Figure 1).342 Not all chromatin 
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modifications have been profiled in response to exercise and therefore this review will focus 
on those previously analysed with exercise, specifically, histone acetylation and DNA 
methylation. Histone proteins acquire an acetyl group (acetylation) through mechanisms 
reliant on the enzyme, histone acetyltransferases (HATs); conversely deacetylation is 
conducted predominantly by deacetylase enzymes (HDACs) (1-11).353 Acetylation of histone 
proteins shifts nucleosome position and in doing so, either promotes or represses gene 
transcription by exposing sites necessary for the binding of the transcriptional machinery 
(Figure 2).332 
DNA Methylation 
Another widely studied epigenetic modification is DNA methylation. DNA methylation 
involves the addition of a methyl group to the 5th carbon of a cytosine neighbouring a guanine 
nucleobase (CpG – p indicates the phosphate ion between the nucleobases).354  The human 
genome is predominantly methylated at CpG sites,355,356 yet un-methylated CpG ‘islands’ are 
interspersed in repetitive groups throughout the genome and are most frequently found at the 
promoter region of genes.356 Although not as common as CpG sites, non-CpG DNA 
methylation is possible and may have regulatory roles in cellular functions and tumour 
pathogenesis.357  
The effect DNA methylation has on gene expression is dependent on its location within 
the genome. DNA methylation at the promoter and enhancer regions of genes is associated 
with transcriptional repression whereas the un-methylated state is related to a 
transcriptionally permissive state.356 Conversely, DNA methylation within the gene body is 
associated with active transcription (Figure 3).358 DNA methylation changes the 
conformational layout of chromatin to a more condensed state, inaccessible to the 
transcriptional machinery. Moreover, methyl-binding proteins mediate histone modifications 
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and direct DNA methylation cross-talk with histone modifications and also contribute to the 
DNA methylation related transcriptional silencing.359,360  
DNA methylation, in conjunction with other epigenetic modifications is vital for 
genomic imprinting, as well as the transcriptional silencing of a single female X-
chromosome.361-363 Moreover, the increased DNA methylation at the promoter regions of 
tumour suppressor genes and loss of long interspersed repeat sequences (LINE-1) DNA 
methylation is associated with the pathogenesis of cancer.364-367 Interestingly, discordant 
DNA methylation profiles are exhibited between monozygotic twins, who have phenotype 
discordances and who are otherwise genetically identical.340,368,369 Importantly, epigenetic 
landscapes are cell type specific and contribute to the unique gene expression profile.370  
 DNA methylation is actively regulated by the enzyme family, DNA methyltransferases 
(DNMT), consisting of DNMT1, DNMT3A, DNMT3B and DNMT3L (Figure 3).371 Whereas 
DNMT1 is primarily responsible for replicating DNA methylation in dividing cells371 and 
also for chromosomal stability,372 DNMT3A and 3B are required for establishing early 
embryonic development and corresponding DNA methylation patterns.373 DNMT3L, 
however, lacks the catalytic activity to methylate CpG sites but catalyses DNMT3A- and 
DNMT3B-induced DNA methylation.374 DNA methylation is conducted by DNMT1 through 
the acquisition of a methyl group donated by the methyl-donor, S-adenosylmethionine.375 
How CpG sites are demethylated is not completely understood, but a number of possible 
mechanisms have been hypothesised. These include, the conversion of carbon 5-
methylcytosine to 5-hydroxmethylcytosine by the ten-eleven translocation (TET) proteins 1-
3,376 base excision repair (BER) of 5-methylcytosine, deamination of 5-methylcytosine 
followed by BER, oxidative DNA demethylation and activation-induced deaminase (AID) 
and these have been discussed in recent reviews.326,327 
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microRNAs  
miRNAs are non-coding RNAs of approximately 18-24 bases long and regulate mRNA 
and/or protein abundance by binding to either the 3’ untranslated region (UTR) of bases 2-7 
(seed region) or 5’ UTR of mRNAs.349,377 The binding of miRNAs to a 3’UTR leads to the 
decrease in the stability of the mRNA, resulting in its degradation, or to the repression of the 
translation of the mRNA into protein.[13] More recently, the binding of miRNAs to the 5’ 
UTR of mRNAs has been found to either up or down-regulate translation.377,378 Although 
some recent investigations showed that miRNAs are also able to up-regulate gene expression, 
there are no such examples in the literature related to exercise, and therefore, this will not be 
discussed in this review. 
The miRNA biogenesis is illustrated in Figure 4. Briefly, RNA polymerase II transcribes 
a miRNA-coding region, commonly found within genes,379 but are also located across the 
genome,380,381 thereby producing a primary miRNA (pri-miRNA). The enzyme, Drosha, 
along with the protein, Di George Syndrome critical region gene 8 (DGCR8), aid the 
formation of a preliminary miRNA (pre-miRNA) by cleaving the pri-miRNA.382,383 Once 
transported from the cell nucleus to the cytosol by Exportin-5,384 the pre-miRNA is cleaved a 
second time by Dicer, consequently making the miRNA/passenger miRNA duplex.385,386 The 
mature, functional miRNA is finally added to the RNA-induced silencing complex (RISC) 
together with an argonaute protein and is now able to regulate translation.387,388  
Similarly, to epigenetic modifications, miRNA expression is cell type-specific.389 These 
miRNAs have enormous potential to regulate gene expression, as a single miRNA can have 
several mRNA targets. They are estimated to target more than 30% of the genes in the human 
genome and over 1,000 miRNAs are identified.390-392 Dysfunctional miRNA expression are 
observed in patients with cardiovascular disease, cancer and type 2 diabetes mellitus –393-395 
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these are diseases that are also partially prevented and attenuated by regular physical 
exercise.56  
Potential mRNA targets are predicted by matching their nucleotide sequence to that of a 
complementary miRNA sequence. Conveniently, databases are available to search for 
predicted mRNA targets for specific miRNAs using advanced algorithms, such as 
TargetScan, miRanda, PicTar and microRNA.org. Furthermore, other useful websites and 
software for miRNA assays and nomenclature include miRBase and MiRConverter, 
respectively. Notably, it is imperative to validate ‘predicted’ miRNA target gene transcripts, 
using luciferase assays or other in vitro experiments; this ensures justified conclusions are 
made regarding the biological function of the miRNA/s under investigation. Furthermore, 
there are numerous technical considerations, such as RNA extraction, platform and house-
keeping miRNA selection, when conducting miRNA studies and these have been extensively 
discussed by others.396-398 
 Therefore, epigenetic modifications and miRNAs have the capacity to significantly 
influence transcription and translation, which may result in physiological and subsequent 
phenotypic changes. Epigenetic modifications work through an intricate molecular network 
to either encourage or repress gene expression by performing conformation changes to 
chromatin. Similarly, post-transcriptional gene regulation by miRNAs adds further 
complexities to the heavily governed expression of genes. Most intriguingly, both epigenetic 
modifications and miRNAs are associated with human health and disease, and are influenced 
by physical exercise.   
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The influence of exercise on epigenetic modifications 
Modifiable lifestyle and environmental factors such as diet and exercise significantly 
influence gene expression, and this is in part orchestrated by epigenetic modifications (see 
Table II for summary of physical exercise-induced epigenetic responses). Here, we review 
the current literature on the influence that exercise has on histone acetylation and DNA 
methylation in different cell types.   
Brain  
Aerobic physical exercise produces numerous health benefits in the brain. Regular 
engagement in physical exercise elicits enhanced cognitive functioning, increased brain 
neurotropic proteins, such as brain derived neurotrophic factor (BDNF), and prevents 
cognitive diseases.399-401 Recent findings highlight a role for aerobic exercise in modulating 
chromatin remodelers.346,402-405 Histone-3 (H3) phosphorylation at serine-10 (Ser10) along 
with acetylation at lysine-14 (K14ac) was significantly increased in brain tissue (hippocampi) 
of rats, 15 minutes following the completion of 10 minutes of swimming exercise. 346 Histone 
H3 lysine 14 acetylation (H3K14ac) peaked two hours after swimming exercise, returned to a 
non-significant amount 24 hours after exercise had ceased. It was mediated by pathways 
involving the N-methyl-D-aspartate receptor, extracellular signal-regulated kinases 1/2, 
mitogen and stress related kinase 1 and 2.346 These results were the first to demonstrate acute 
and relatively short aerobic exercise modulates epigenetic modifications. The transient 
epigenetic modifications observed due to chronic running training have also been associated 
with improved learning and stress-coping strategies, epigenetic changes and increased c-Fos 
positive neurons in dentate gyrus of rats.403  
BDNF is a protein involved in neurogenesis, brain development and learning,406 and 
exercise promotes BDNF production.407 One week of voluntary running caused concurrent 
increased Bdnf mRNA (41%) and protein (30%) abundance with significant DNA de-
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methylation of the Bdnf exon 4 promoter region (CpG site, 148 bp downstream) in rat 
hippocampi.408 Using chromatin immunoprecipitation (ChIP) assays, the authors revealed 
exercised rats exhibited marked H3 acetylation (H3ac) but not H4ac, possibly as a result of 
decreased Hdac5 mRNA (25%) and protein (91%) abundance, and pathways involving 
cAMP-dependent, catalytic, α-protein kinase (cAMP), response element binding protein 
(Creb) and Ca2+/calmodulin-dependent protein kinase (Camk) phosphorylation.408 Histone 
acetyltransferase and deacetylase enzymes were up- and down-regulated, respectively, 
following acute but not chronic wheel running.409 In contrast to previous findings,408 exercise 
induced increase in HAT activity was found only on H4.409 Others have demonstrated that 
many of the histone deacetylase and methyltransferase genes are down-regulated by one 
week of voluntary wheel running in conjunction with increased cerebellum and hippocampus 
H3ac in juvenile mice.410 Intriguingly, the exercise-induced modulation of epigenetic 
machinery may be blunted by ageing. At the protein level, Dnmt1 and Dnmt3b were 
decreased after 20 minutes of treadmill exercise in young rats only.405 Unfortunately, the 
elevated stress experienced by rodents forced to swim or run may potentially confound 
results on epigenetic modifications found in the brain in response to exercise. Nonetheless, 
these studies demonstrate the existence of epigenetic changes after acute and chronic exercise 
and show they are associated with improved cognitive function and elevated markers of 
neurotropic factors and neuronal activity (BDNF and c-Fos). These exercise-induced changes 
seem to be mediated by DNA methylation and histone H3 and H4 modifications through 
DNMTs (DNMT1 and 3A/B), HATs and HDACs (eg. HDAC5-8). Further animal model 
studies, however, are required to elucidate whether epigenetic modifications and 
underpinning modifying enzymes, are required for the exercised-induced benefits in the 
brain.  
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Skeletal muscle  
An acute bout of interval-training-like exercise (five sets of 17 minute swimming efforts 
with a load equivalent to 3% of body weight) caused a paralleled elevation in CAMK-2 
phosphorylation, H3ac at the myocyte enhancer factor 2 (Mef2) on the glucose transporter-4 
(Glut4) gene, Mef2a, Glut4 mRNA and protein abundance in rat triceps muscle.402 The 
authors suggested the molecular alterations observed might be a result of the exercise induced 
CAMK-2 activation and subsequently, higher Glut4 expression, through accessible binding 
of Mef2a, promoting transcription.402 Notably, others have demonstrated elevated 
phosphorylated CAMK-2 and epigenetic modifications enhancing transcription after 
voluntary aerobic exercise in humans,345,408,411 supporting a role for CAMK-2-mediated 
chromatin remodelling. Additionally, epigenetic modifications may regulate muscle gene 
expression through motor unit recruitment, as neuronal activity modulates Mef2, HDACs and 
histone modifications in mice.412,413 An alternative potential mechanism may be that the 
transcriptional changes and epigenetic modifications induced by exercise involves the 
modulated cytosol calcium content, which has been shown to cause paralleled epigenetic and 
transcriptional changes in C2C12 muscle cells treated with caffeine.414 
Genetic predisposition to athletic performance has been the topic of intense 
investigation, as many single nucleotide polymorphisms (SNPs) and other molecular 
biomarkers are associated with muscle-growth, endurance performance and trainability.415-419 
DNA methylation was related to muscle growth and endurance performance, with a greater 
number of genetic polymorphisms associated with enzymes involved in DNA methylation 
(5,10-methylenetetrahydrofolate reductase, methionine synthase and methionine synthase 
reductase) found in elite endurance athletes compared to apparently healthy controls.420 Thus, 
there may be a heritable predisposition to a less-methylated genetic environment.420 In vitro 
analysis using murine C2C12 cells with chemically induced DNA-hypomethylation, 
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confirmed hypomethylation enhances intermediate and late myocyte differentiation, with 
myocytes and myotubes exhibiting greater myogenic gene expression and cross-sectional 
area, respectively.420 Although human myoblasts were not used for in vitro analyses, these 
results add compelling evidence suggesting hypomethylation in differentiating myoblasts 
may promote muscle growth and maintenance. For further discussion on the role epigenetic 
modifications in the adaptation to exercise and performance, the readers are referred to other 
publications.411,421,422 
Histone HDACs and HATs regulate the extent of histone acetylation and inevitably gene 
expression.342 Moderate and high intense aerobic exercise promotes chromatin remodelling 
and enzymes responsible for acetylation. Sixty minutes of cycling at approximately 75% of 
VO2peak increased H3K36ac, without H3K9 and H3K14ac in skeletal muscle of young 
men.345 These histone modifications were observed in conjunction with decreased nuclear 
HDAC4 and 5, along with increased AMP-activated protein kinase (AMPK) and CAMK 
phosphorylation immediately after exercise.345 Increased phosphorylation of HDAC4, 5 and 7 
was observed immediately after high-intense exercise (80% of VO2peak), and was 
accompanied by phosphorylated AMPK, CAMK, activating transcription factor and acetyl-
CoA carboxylase,423 supporting previous results noting AMPK and CAMK involvement in 
myocyte chromatin remodelling.345 Moreover, ameliorated HDAC4 protein abundance were 
reported in young and older humans six hours following acute resistance exercise in 
conjunction with altered miRNA dynamics,424 highlighting the interplay between epigenetic 
modifications and miRNAs in regulating gene expression. Additionally, in men, the miRNA 
processing enzymes (Drosha, Dicer and Exportin) and HDAC4 protein abundance was 
increased with modulated myomiRs, including decreased miR-31, in skeletal muscle of 
young men after acute aerobic exercise.425 Interestingly, miR-31 expression was further 
reduced after 10 days of exercise training.425 Through luciferase assays, miR-31 was 
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demonstrated to bind to and reduced HDAC4 and NRF1 mRNA expression – two genes 
responsible for transcriptional regulation.425 Indeed, other small non-coding RNAs are 
involved in DNA methylation by targeting of CpG sites and directing DNA 
methylation.426,427 
The physical exercise-induced decrease in specific cancer risk and increased longevity is 
intensity and dose-dependent.56,269,428-430 Similarly, physiological adaption to physical 
exercise is proportional to exercise-intensity and volume.56,431,432 Recently, an exercise-
intensity- and dose-dependent relationship was demonstrated at specific promoter regions of 
genes involved in skeletal muscle metabolism.344 Acute aerobic-exercise decreased global 
DNA methylation,344 an indicator that temporarily modulated transcriptional changes caused 
by exercise may be required for exercised-induced adaptations. Furthermore, the 
quantification of DNA methylation at CpG sites related to genes involved in metabolism – 
peroxisome proliferator-activated receptor-γ, coactivator 1-α (PPARGC1A), peroxisome 
proliferator-activated receptor-δ (PPARD) and mitochondrial transcription factor-α (TFAM), 
revealed decreased DNA methylation with paralleled increased gene expression after acute-
exercise.344 The reduction in DNA methylation described was dependent on exercise 
intensity, with more intense exercise causing greater post-exercise DNA demethylation.344   
While regular moderate amounts of physical activity confers health benefits, potentially 
through epigenetic modifications, physical inactivity is detrimental and also may regulate the 
epigenome.433,434 As little as nine days of physical inactivity (bed rest) is enough to increase 
insulin resistance and methylation of PPARGC1A CpG promoter region.434 Remarkably, after 
short-term physical inactivity, physical aerobic re-training did not fully alleviate the bed-rest-
induced DNA methylation.434 Therefore, both acute exercise 344 and nine days of physical 
inactivity 434 regulates PPARGC1A DNA methylation and gene expression in muscle. These 
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results also advocate the need for maintaining physical activity and highlight the potentially 
deleterious short-term epigenetic modifications caused by physical inactivity.  
The consequences of physical inactivity to health and disease risk are well known (eg. 
elevated risk of heart disease, cancer and type 2 diabetes). Interestingly, there are differences 
in the resting skeletal muscle DNA methylation profile of individuals with and without a 
family history of type 2 diabetes mellitus.435 Furthermore, six months of aerobic exercise 
altered DNA methylation in genes involved in unique pathways amongst men with and 
without a family history of type 2 diabetes mellitus.435 Of the 21 candidate genes for type 2 
diabetes mellitus two (THADA and RBMS1) were significantly down-regulated by aerobic 
exercise.435 Six months of aerobic exercise training also changed whole-genome DNA 
methylation in adipocytes.436 Specifically, the aerobic exercise training induced changes in 
DNA methylation in 24 and 45 CpG sites, corresponding to 18 candidate genes for obesity 
and 21 for type 2 diabetes mellitus, respectively.436 Importantly, the authors performed 
luciferase assays and small interfering RNA (siRNA) in vitro experiments to demonstrate the 
exercise-induced increased DNA methylation in the CpG sites relating to the promoter 
regions of RALBP1, NCOR2 and HDAC4 down-regulated gene expression and consequently 
increased lipogenesis.436 This novel study has provided compelling evidence that suggests 
adaptations conferred by exercise involves (to a certain extent) epigenetic modifications.  
Collectively, the acute and chronic (six months of aerobic exercise) aerobic exercise 
training induced changes to skeletal muscle DNA methylation have been studied. While the 
effect of acute aerobic exercise on specific CpG sites in some genes are known, there is scope 
for the profiling of acute exercise-induced changes to whole-genome DNA methylation. 
Moreover, acute aerobic exercise influences H3ac,345,402 but whether these histone 
modifications and other epigenetic changes directly influence, or are a response, to the 
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exercise-induced changes to phenotype requires explanation. Finally, the analysis of 
epigenetic changes in skeletal muscle caused by resistance exercise training is also warranted. 
 
Peripheral blood  
Physical activity and aerobic training alters DNA methylation status of 
leukocytes.194,343,437-441 Immune system dysfunction can result in chronic low-grade 
inflammation, which is a hallmark characteristic shared by numerous diseases, including 
cardiovascular disease, cancer, autoimmune disorders and ageing.312,442-444 Regular 
engagement in aerobic exercise training is associated with the lowering of basal levels of 
inflammation 280,445,446 and the mechanisms of this therapeutic effect may be mediated by 
DNA and chromatin remodelers.  
The majority of the human genome is methylated,355,356 and loss of leukocyte DNA 
methylation is observed with ageing.340,447 Furthermore, loss of DNA methylation and other 
aberrant DNA methylation signatures are involved in numerous disease pathophysiology and 
development.448,449 Methylation of promoter pro-inflammatory and apoptotic gene, apoptosis-
associated spec-like protein containing a caspase recruitment domain - PYCARD (ASC), 
declines with age.439 Six-months of moderate-intense aerobic training, however, attenuated 
the age-related loss of DNA methylation at CpG islands (exon 1) within the ASC gene in 
older adult circulating leukocytes.439   
Sub-telomeric DNA methylation is important for maintaining telomere dynamics and 
chromosomal stability. Telomeres are the genetically conserved repeated DNA sequences 
capping the ends of our chromosomes 67 and are implicated in ageing, chronic disease, 
mortality risk.20,450 Lifestyle factors, such as regular participation in aerobic endurance 
exercise, is associated with the attenuated telomere length attrition associated with ageing.451 
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Physical capacity and improvement in physical capacity is positively correlated with sub-
telomeric DNA methylation and with longer telomeres in previously deconditioned older-
adult patients with cerebrovascular disease.194 Tai Chi practitioners exhibit ameliorated 
epigenetic age-related DNA methylation changes at six specific CpG sites (two located at 
subtelomeric regions) compared to apparently healthy individuals.343 For additional 
comprehensive discussions on exercise-induced epigenetics modifications in relation to 
ageing and disease, the reader is directed elsewhere.452-454 While there seems to be a 
relationship between DNA methylation changes with ageing, whether these are blunted or 
prevented by exercise requires further clarification. 
Notably, those who exercised moderately, defined by 26-30 minutes per day (measured 
with accelerometers), demonstrated greater global leukocyte DNA methylation (LINE-1) 
compared to those who engaged in less and more physical activity.437 Self-reported physical 
activity levels during childhood, adolescence and in the 12 months before sample collection 
was positively associated with leukocyte LINE-1 DNA methylation in women.455 
Conversely, physical activity (assessed by questionnaires) was not correlated to LINE-1 and 
IL-6 promoter-specific leukocyte DNA methylation. 438 Also, average global DNA 
methylation was inversely related to physical activity levels in older adults (>70yrs).456 
Therefore, additional studies will help validate whether exercise may prevent the risk of 
cancer by mechanisms involving increased LINE-1 DNA methylation, as loss of LINE-1 
DNA methylation is associated with cancer and carcinogenesis.457,458 Physical activity seems 
to be constructive at ameliorating risk of certain cancers, and it is positively associated with 
mitigating dysfunction DNA methylation related to cancer.459-462 A stand-alone, randomized 
clinical trial demonstrated 43 genes were differentially expressed as a result of DNA 
methylation alterations induced by a six month, moderate-intense aerobic training 
intervention.440 A link was observed between reduced L3MBTL1 DNA methylation, 
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increased L3MBTL1 gene expression in blood and tumour samples, and patient survival.440 
They suggested peripheral blood DNA methylation may be a clinically relevant biomarker 
and reflective of epigenetic changes in other tissues.440  
DNA methylation changes may be a useful tool for monitoring exercise training 
interventions. Participant VO2max and physical activity levels were correlated to buccal cell 
DNA methylation at a number of CpG sites located in candidate genes for breast cancer.463 
Moreover, average buccal cell DNA methylation, quantified at over 27,000 CpG sites, 
significantly increased after a 12 month exercise promotion intervention.463 Furthermore, an 
epigenetic score calculated from leukocyte DNA methylation of 97 CpG sites after a 10-week 
multi-disciplinary health intervention (encompassing physical training, as well as diet and 
psychological support), related to decreases in body mass index.464  
Together, these studies identified the effects of physical activity levels and long-term 
(>12 months) exercise training has on leukocyte DNA methylation. Leukocyte DNA 
methylation changes caused by ageing may be somewhat attenuated by aerobic exercise 
training, but require further study. Notably, the acute effects of exercise on leukocyte DNA 
methylation are yet to be reported. Investigations into histone modifications in leukocytes 
after exercise are also yet to be studied. Notably, epigenetic changes caused by exercise in 
differentiated leukocytes are warranted to elucidate the specific biological impacts of these 
on cell-specific functions. Finally, identifying the sensitivity and the DNA methylation 
signatures altered by exercise training will further highlight its usefulness in monitoring 
exercise training.  
In summary, short and long-term exercise training results in dynamic changes to DNA 
methylation and histone modifications, in a variety of tissues. To our knowledge, the effects 
of resistance exercise training on epigenetic modifications have not yet been reported. 
	
	
194 
Delineating the cause or effect, relationship between exercise-induced adaptation to 
phenotype and epigenetic changes will be a challenge for future studies. 
 
Are exercise-induced epigenetic modifications trans-generationally inherited? 
Certain epigenetic modifications are passed on to subsequent generations and affect gene 
expression.59,465,466 Not only does the maternal and paternal environment impact on 
epigenetic modifications and gene expression, but it also influences that of the offspring. 
Environmental stimuli, such as endocrine disruptors 58,467 and various diets 466,468,469 causes 
distinct inheritance of epigenetic modifications, which have also been shown to be trans-
generationally heritable.59,467,469 For example, a maternal protein restricted diet throughout 
pregnancy produced lower hepatic Ppara promoter DNA methylation across the next two 
generations of rats.469 Similarly, paternal low protein diet from weaning until sexual maturity 
caused increased Ppara enhancer-region DNA methylation and markedly altered gene 
expression in mouse offspring compared to normal diet controls.59 Late-gestational calorie 
restriction in mice caused decreased placental DNA methylation and transcript expression in 
genes enriched for metabolic and cardiovascular system developmental pathways when 
compared to mice fed a normal chow diet.470 In humans, paternal obesity was inversely 
correlated with DNA methylation at three CpG sites upstream of exon 3 of the imprinted 
IGF2 gene from umbilical cord blood of new-borns.471 Notably, physical exercise modulates 
gene expression and DNA methylation of many metabolic genes affected by diet, including 
some of the peroxisome-proliferator activated receptor-associated genes.344,435 Physical 
exercise may be another environmental stimulus shaping epigenetic modifications and gene 
expression of not only the individual performing the physical exercise, but also their 
progenies’.  
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The influence of exercise on miRNA expression 
Contrasting epigenetic mediators, miRNAs also regulate gene expression and protein 
abundance via post-transcriptional modifications.349 Of the hundreds (>1000) of miRNA 
currently known, a relatively small subset are responsive to acute 472,473 and chronic 474,475 
physical exercise (refer to Electronic Supplementary Material Table S1 for a comprehensive 
outline of miRNAs responsive to physical exercise). 
Central nervous system 
The brain and spinal cord are highly plastic tissues. Damage to either organ can result in 
potential catastrophic and physically debilitating conditions. Aerobic exercise positively 
regulates neurotrophic factors and has been implicated in the rehabilitation of the central 
nervous system.476,477 Due to the highly invasive nature of collecting neuronal samples or 
brain tissue, human studies are not feasible. Therefore, rodents have been used. Interestingly, 
miRNAs have recently been implicated in spinal cord rehabilitation. Spinal-cord-injury-
associated inflammation and apoptosis was attenuated via reduced spinal cord miR-15b and 
elevated miR-21 after five, but not 20 days of aerobic exercise in rats.478 Therefore, initial 
exercise may be pivotal to preventing spinal cord injury-associated apoptosis and this may be 
in turn regulated by phosphatase and tensin homolog (Pten)/ mammalian target of rapamycin 
(mTor) signalling.478 Although these results are intriguing, tissue samples were taken one 
hour after the last training session, suggesting the authors were measuring the adaptation to 
acute response to exercise, which may not be as essential to rehabilitation as the overall 
training adaptation of miRNAs measured at rest. Nonetheless, attenuated spinal cord miRNA 
dynamics by exercise is possible and warrants further investigation. The aerobic exercise 
training induced changes to miRNA profile in the brain seems to be intensity-dependent.479 
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These few studies provide basis for further exploration into potential miRNAs involved in 
brain and neuronal development and recovery via aerobic exercise.  
  
Cardiovascular system 
Engaging in regular aerobic exercise causes a concomitant increase in non-pathological 
left ventricular hypertrophy that can be concentric or eccentric, depending on the mode of 
exercise and miRNAs are involved (for detailed review see papers by Fernandes et al. 480  and 
Gielen et al. 481). Contrasting pathological cardiac hypertrophy, non-pathological cardiac 
hypertrophy induced by physical exercise involves increased sarcolemma adjacent and in 
series in the heart muscle, without clinical molecular biomarkers (atrial natriuretic factor or 
perturbed skeletal muscle α-myosin heavy chain to β-myosin heavy chain ratio).480 This 
contributes to greater heart contractile capacity and subsequently cardiac output, 
cardiopulmonary efficiency and exercise performance. A ten-week aerobic training 
intervention caused a dose-dependent reduction in miR-1, -133a and -133b and increased 
miR-29a and -29c paralleled with cardiac hypertrophy in rats,482 results which were 
reproducible in different rats.483 Whether these miRNAs directly affect expression of genes 
related to the renin-angiotensin system, such as – the angiotensin converting enzyme (Ace) 
and Ace2, thereby causing cardiac hypertrophy, is unknown.483 Moreover, others have shown 
a role for miRNAs – miR-21, -124 -144 and -145 in phosphoinositide-3-kinase catalytic-α 
polypeptide (Pik3a)/Akt/mTor signalling pathway associated non-pathological cardiac 
hypertrophy after chronic swimming exercise in female rats.484 
Dysfunctional angiogenesis is observed in patients with arteriosclerotic disease.485 
Aerobic endurance training, however, promotes angiogenesis, which may be, in part, 
regulated by miRNAs. Treadmill running re-establishes normal expression of miR-16, -21 
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and -126 in the spontaneously hypertensive rat (SHR), increases biomarkers of 
vascularisation and decreases blood pressure.486 miR-126 is paramount for maintaining 
endothelial integrity, as deletion causes severe endothelial cell dysfunction.487,488_ENREF_21 
Furthermore, angiogenesis is enhanced by aerobic exercise-induced elevation in miR-126 
expression, leading to decreased Spred-1 protein and Pi3kr2 mRNA abundance by regulating 
mitogen-activated protein kinase 1 (MAPK) and PI3KR2 signalling pathways.489 These novel 
findings suggest miR-16, -21 and -126 as targets for blood pressure control and vascular 
functioning in cardiovascular disease. Notably, miR-21 expression increased after chronic 
exercise training and was related to non-pathological cardiac hypertrophy,484 as well as 
blunting of endothelial cell dysfunction and hypertension.486 Therefore, regulation of miR-21 
may be one mechanism by which exercise provides favourable benefits to cardiovascular 
health and performance. Whether miRNAs are manipulated by exercise to augment lower 
resting blood-pressure in hypertensive humans remains to be determined. 
 
Skeletal muscle 
Resistance exercise 
 
Acute resistance exercise causes anabolic gene expression, increasing myocyte 
transcription factors and protein synthesis.490-492 By identifying the pathways and molecular 
mechanisms regulating these muscle growth factors, we may not only be able to ameliorate 
muscular pathologies (eg. muscular dystrophies and sarcopenia), but enhance rehabilitation 
efficiency and sporting performance. Studies have implicated miRNAs in muscle anabolic 
mechanisms,424,493-495 such as miR-1, -26a, -29a, -133a, -378 and -451. Additional studies, 
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however, are required to validate and further establish the functional biological relevance of 
these miRNAs.  
It is well known that miRNA expression is cell type-specific, and this is consistent with a 
novel study that indicated differential basal miRNAs and pri-miRNAs expression between 
mouse soleus and plantaris muscles.495 In mice, muscle under mechanically-induced 
functional overload increased expression of pri-miR-1-2, 133a-2 and -206 after seven days, 
with concomitant increases in the activity of miRNA-processing enzymes Drosha and 
Exportin-5, but not Dicer.495 Along with the observed changes to miRNAs and processing 
enzymes, there was a 45% increase in plantaris muscle wet-weight.495 These early results 
emphasise miRNAs are muscle specific, and their involvement in skeletal muscle 
hypertrophy. Furthermore, these data provide insights into miRNA biogenesis enzyme 
activity, during hypertrophic stimuli.  
Sarcopenia is an age-related disease, involving the muscle atrophy and the laying down 
of connective tissue. Indeed, the ability to maintain lean muscle mass is hindered with ageing. 
Similarly, miRNA dynamics are also disturbed with ageing.496,497 In humans, young and older 
adults’ pri-, pre-miRNA expression and miRNA biogenesis enzyme mRNA (Exportin-5 and 
Drosha) expression differs in response to acute resistance exercise with complementary 
leucine-enriched essential amino acid ingestion.424 Interestingly, myocyte miR-1 expression 
was reduced in young adults and was unchanged in older adults resulting from leg extension 
resistance exercise (8 set of 10 repetitions with 70% of one repetition maximum (1RM)) with 
essential amino acid ingestion.424 miR-1 is a muscle-specific miRNA and a well-defined 
facilitator of muscle cell growth and regeneration.498-500 _ENREF_30Perplexingly, there are 
no clear patterns of miR-1 expression in response to resistance and aerobic exercise training. 
Twelve weeks of resistance training attenuated basal miR-1 expression in older adult human 
volunteers.494 In young men, however, basal miR-1 expression was unchanged following a 
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similar 12-week resistance training intervention.493 Acute aerobic endurance exercise up-
regulates miR-1 expression,425,475,501 and is subsequently down-regulated at basal levels in 
healthy males after 12 weeks of aerobic exercise training.475 Others, have found increased 
basal miR-1 and miR-29b expression after 10 days of aerobic exercise training.425 
Conversely, miR-1 expression is attenuated after seven days of bed-rest and unchanged 
following acute one-legged knee extension exercise in men.433 The function of miR-1 in the 
adaptation to exercise, is therefore, unclear, but may be delineated with additional functional, 
animal and in vitro studies. 
Through the analysis of SNPs and gene expression profiles, researchers have 
differentiated between high and low responders to aerobic exercise, suggesting that genes are 
correlated to physical performance.415-417,502,503 In an attempt to distinguish genetic 
predisposition and anabolic response to resistance exercise using miRNAs, young adults were 
divided into low and high responders according to gains in lean muscle mass and muscle 
cross-sectional area.493 Of the 21 miRNAs investigated, miR-378 and -29a were lower and 
miR-451 was higher in low responders compared to the high responders.493 Additionally, 
miR-378 was significantly correlated with gains in lean body mass.493 Sedentary behaviour 
also induced expression changes in subsets of miRNAs (lower miR-1 and -133a,433 miR-107, 
-221 and -499 504). Importantly, miR-499 was validated by luciferase transfection assays to 
target the transcription factor, Sox6.504 These results provide evidence supporting the 
involvement of miRNAs in regulating skeletal muscle phenotype through physical inactivity 
and exercise training. Identifying other miRNAs differentially expressed in high and low 
responders to exercise and discovering how these miRNAs function and influence phenotype 
are likely to be the next step. 
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Aerobic exercise 
 
Data from miRNA arrays has suggested moderate-intense aerobic exercise induces the 
differential expression of numerous miRNAs, involving pathways such as regulation of 
transcription, metabolism, cell and muscle development and other cellular processes.417 The 
regulation of metabolic genes involved in disease and endurance performance are also 
mediated by miRNAs. For example, expression of miR-23, predicted to target Ppargc1a – 
the transcriptional co-activator and positive regulator of genes involved in mitochondria 
activity, glucose and lipid metabolism – is decreased in conjunction with higher Ppargc1a 
mRNA and protein abundance, in response to prolonged aerobic exercise in mice.501 
Similarly, Ppargc1a miRNA regulating candidate, miR-696, was lower in mouse skeletal 
muscle after four weeks of progressive aerobic exercise training and higher after unilateral 
hind-limb immobilisation.505 Cultured myocyte experiments subsequently validated miR-696 
as a negative regulator of Ppargc1a protein abundance in C2C12 myoblasts.505 Whether the 
stress associated with hind-limb suspension mediated the change to miR-696 is unknown, as 
stress can modulate miRNA dynamics.506 Ppargc1a is a transcriptional co-activator 
controlling exercise induced angiogenesis,507 muscle fibre type,508 and mitochondrial 
biogenesis509,510 and for this reason it is a gene doping candidate for enhancing sporting 
performance._ENREF_38511 Downstream molecules of Ppargc1a signalling cascade (PDK4 
and COXII) are targeted by miR-696 which decreases after aerobic exercise training in mice, 
thereby contributing to increased fatty acid oxidation and mitochondrial biogenesis.505 
Moreover, through luciferase and in vitro knockdown experiments, miR-494 was validated to 
target Tfam and forkhead box j3 (Foxj3).505 Acute aerobic endurance exercise increased Tfam 
and Foxj3 protein abundance, along with increased Ppargc1a expression and mitochondrial 
biogenesis, through lowering miR-494 expression in mice.512  
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The miRNAs biogenesis is regulated by a subset of enzymes with specific roles involved 
in producing a functional miRNA (Figure 1). Drosha, DGCR8 and Dicer, are unaltered three 
hours after an acute prolonged bout of aerobic exercise.501 Drosha and Exportin-5 are, 
however, increased in response to mechanically-induced functional overload, without 
changes to dicer content, in mice.495 Therefore, further studies may elucidate how the miRNA 
processing enzymes govern miRNA dynamics with exercise training. 
The acute, exercise-induced effect of aerobic and resistance exercise is indicative of an 
immediate damage-response, which in turn produces numerous molecular cascades to 
inevitably cause a super-compensation and adaption to the exercise stimulus. This may 
consequently alter resting miRNA/gene expression profiles and blunt the physiological 
response to the initial physical exercise stimuli. A 12-week aerobic endurance training 
intervention caused an ameliorated response to acute exercise-induced miR-1 and -133a 
expression.475 Moreover, basal miR-1, -133a/b and -206 expression were also reduced as a 
result of the aerobic training intervention.475 The reduced basal miRNA expression, however, 
returned to the pre-exercise profile following two weeks without structured physical exercise 
training.475 The attenuated miRNA expression may have been a result of increased VO2max 
and more favourable body composition observed in participants.475 Furthermore, there may 
be a direct relationship between histone deacetylase activity and miRNAs. In men, the 
miRNA processing enzymes (Drosha, Dicer and Exportin) and HDAC4 protein abundance 
was increased in conjunction with modulated myomiRs, including decreased miR-31, in 
skeletal muscle of young men after acute aerobic exercise425 Interestingly, basal miR-31 
decreased after 10 days of exercise training and it was demonstrated to target and 
subsequently reduced HDAC4 and NRF1 expression – two genes responsible for 
transcriptional regulation – in vitro.425 Skeletal muscle biopsies are invasive and sample 
collection across multiple time-points is sometimes not feasible. Trends, however, exist 
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between aerobic exercise performance and expression of specific miRNAs from circulating 
blood and their use as biomarkers. 
Aerobic exercise influences miRNAs in blood 
The miRNAs from plasma and serum are not only indicative of immune system function, 
they have been proposed as biomarkers of physical fitness and performance because they 
originate from numerous tissues and are mobilised into peripheral circulation. Plasma miR-
146a and miR-20a predict VO2max and the trainability of VO2max, respectively.474 Similarly, 
serum miR-21 and miR-210 are inversely related to VO2max and are more highly expressed in 
individuals with categorically low VO2max compared to those with a high VO2max.513 It was 
also found that miR-210 expression alone or combined with miR-21 accounted for 12% and 
15% of the variation in 100 individuals’ VO2max values, respectively.513 Serum miR-486 was 
down-regulated after acute and 4 weeks of three times a week cycling and the change in 
expression was negatively correlated to VO2max.514 Therefore, miRNAs from blood may be 
useful biomarkers for exercise capacity and trainability. Plasma miRNAs have been 
implicated as biomarkers of health and disease risk.515 Notably, to date, no one has 
investigated whether physical exercise can attenuate dysfunctional miRNA biomarkers of 
human disease. Using the miRNAs, miR-126 and miR-133, as surrogate biomarkers for 
endothelial cell and muscle cell damage, respectively, the effects of different exercise modes 
were investigated.516 Interestingly, while miR-126 expression was increased  after both a 
maximal cycle ergometer VO2max test (by 2.1-fold) and a four hour cycle at 70% of VO2max 
(4-fold), miR-133 expression increased after resistance exercise training (2.1-fold).516 After a 
marathon, however, both miR-126 and miR-133 expression increased dramatically (3.4-fold 
and 8.9-fold, respectively).516 Although the authors could not account for the potential effects 
that gender and fitness levels (or physical activity levels) of participants in each of the 
exercise group had, these results suggest a role for miRNAs in monitoring adverse effects 
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caused by acute-exercise. Additionally, positive relationships have been identified between 
specific miRNAs and cardiovascular risk factors – C-reactive protein (miR-21), aspartate 
aminotransferase (miR-210), Finish Type 2 Diabetes Risk Score (miR-21) and age (let-7d 
and miR-103).513 Additionally, replication studies are required to reproduce miRNA 
responses to exercise, to further establish their relevance as biomarkers.  
The miRNA profile of differentiated white blood cells represent genes involved in 
immune processes, cell adhesion and cytokine production, and are more reflective of vascular 
health and immunity. It was reported that individuals who completed 30 minutes of 
intermittent (2 minute) bouts of cycling at approximately 76% of VO2max exhibited altered 
expression of 38 miRNAs, potentially targeting 4,724 genes in neutrophils.517 Additionally, 
34 miRNAs were altered by the same exercise protocol, including six similarly expressed 
between neutrophils and leukocytes.472,517 Although the authors validated four and seven 
miRNAs in the consecutive studies, respectively, further studies are required to validate their 
miRNA mRNA targets. Finally, results from the same laboratory revealed 23 modulated 
miRNAs and gene expression patterns in natural killer cells as a result of acute aerobic 
exercise.473 Specifically, gene pathways altered included those involved in type 1 diabetes 
mellitus, prostate cancer, chemokine signalling, leukocyte trans-endothelial migration and 
p53 signalling pathway.473 Interestingly, after acute aerobic running exercise at 80% of 
VO2max, expression of miRNAs – miR-21-5p, -24-2-5p, -27a-5p and -181a-5p were increased 
in National-level ski athletes’ leukocytes.518 In silico prediction was employed and showed 
enrichment for genes involved in metabolic pathways, immune response, transcriptional 
regulation and apoptosis.518 Finally, acute resistance exercise increased serum miR-149* and 
decreased miR-146a and miR-221 expression three days after exercise, which along with 
other miRNAs were correlated to growth hormone, IGF-1 and testosterone concentration.519 
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Interestingly, the resistance exercise-induced change to miR-146a and -221 trended in the 
opposite direction to that observed after acute aerobic exercise in plasma.474 
Thus, a number of blood miRNAs have been correlated to VO2max and VO2max 
trainability. Similarly, expression of specific miRNAs are associated with cardiovascular 
disease risk factors and adverse effects of acute exercise. Their validity and reliability for 
biomarkers of VO2max and adverse risk factors will require further testing. Furthermore, 
whether unique miRNA dynamics are perturbed with overtraining or overreaching is 
unknown.  Modulated miRNAs in blood and other tissues will need to be validated and 
subsequently functionally tested in order to reveal their biological function and make clear 
interpretations of how they regulate a phenotype through exercise training. 
Conclusions and future directions 
Epigenetic modifications and miRNAs dynamics become dysfunctional with disease and 
ageing. While the current evidence supports physical exercise as a modulator of histone 
acetylation, DNA methylation and expression of various miRNAs, the effects other 
epigenetic modifications (eg. histone methylation, sumoylation, deimination and 
ubiquitylation) are left for investigation. These gene expression regulators seem to be 
intensity- and volume-specific. Apart from a single study analysing miRNAs in serum and 
those analysing skeletal muscle, the effects of resistance exercise on miRNAs in human 
blood cells and other types of tissues are unknown. Similarly, the effect of resistance exercise 
on epigenetic modifications in human tissues requires further study. Few studies have 
validated ‘predicted’ gene targets and demonstrated a biological function of miRNAs 
influenced by physical exercise in humans. Data on the effect of exercise on miRNA or 
epigenetic modifications in clinical or athletic human populations is sparse. Further studies 
may provide us with molecular (epigenetic, miRNA and gene expression) signatures specific 
to health benefits conferred by exercise, as well as attenuation of disease. More data on the 
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time-course of epigenetic and miRNA changes caused by exercise are required. Additionally, 
identification of novel molecular biomarkers in the form of miRNAs and epigenetic 
modifications may be suitable for monitoring training interventions. The comprehensive 
study of DNA methylation and other epigenetic modifications in various tissues in response 
to different modes and volumes (intensity, frequency and duration) of exercise will aid our 
understanding of the ability of exercise to influence our epigenome. Finally, animal model 
experiments will help determine the cause or effect relationship between epigenetic 
modifications and miRNAs with exercise-induced adaptations. The emerging field of 
exercise epigenomics is expected to prosper and further studies may elucidate the clinical 
relevance of miRNA and epigenetic modifications, and demonstrate how exercise benefits 
health and physical performance.  
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8.0 Tables  
Table I. Definition of key terms. 
 
Chromatin The elongated and condensed form of DNA housed 
inside the cell nucleus.  
 
DNA methylation Epigenetic modification encompassing the addition of 
a methyl group to DNA CpG and non-CpG sites. 
 
DNA methyltransferase Actively performs and catalyses DNA methylation. 
The  methyltransferase enzymes include DNMT1, 
3A, 3B and 3L. 
 
Epigenome  All epigenetic modifications including DNA 
methylation and numerous histone modifications 
described elsewhere.342 These epigenetic modification 
all share common characteristics, specifically, they 
act on DNA or proteins associated with DNA 
packaging, to manipulate their structure. In doing so, 
these mechanisms either encourage or repress 
transcription, depending on the location of the 
modification. 
 
Histone acetylation The chemical reaction involving the addition of an 
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acetyl molecule to histone proteins.   
  
Histone acetyltransferase Family of enzymes that catalyse histone acetylation.  
 
Histone deacetylase Family of enzymes involved in the removal of acetyl 
groups from histone proteins. 
 
Histone proteins Constitutes five histone proteins (histone H1, H2A, 
H2B, H3 and H4) involved in DNA packaging. Four 
paired histone proteins, H2A, H2B, H3 and H4, form 
an octamer and contributes to the formation of a 
nucleosome. 
 
Lysine Protein sites vulnerable to acetylation and 
methylation changes along histone proteins.  
 
microRNA Small non-coding RNA molecule, approximately 18-
24 bases in length.  
 
Nucleosome Repeated structural unit for DNA packaging 
consisting of eight histone proteins. 
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Abstract  
Physical exercise has proven cardiovascular benefits yet there is no clear understanding of the 
related molecular mechanisms leading to this. Here we determined the beneficial epigenetic 
effects of exercise after sprint interval training, a form of exercise known to improve cardio-
metabolic health. 
We quantified genome-wide leukocyte DNA methylation of 12 healthy young (18–24 y) men 
before and after four weeks (thrice weekly) of sprint interval training using the 450K 
BeadChip (Illumina) and validated gene expression changes in an extra seven subjects. 
Exercise increased subjects' cardio-respiratory fitness, maximal running performance and 
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decreased low-density lipoprotein (LDL)-cholesterol concentration in conjunction with 
genome-wide DNA methylation changes. Notably, many CpG island and gene promoter 
regions were demethylated after exercise, indicating increased genome-wide transcriptional 
changes. Amongst genes with DNA methylation changes, epidermal growth factor (EGF), a 
ligand of the epidermal growth factor receptor known to be involved in cardiovascular 
disease, was demethylated and showed decreased mRNA expression. Additionally, we found 
that microRNAs, miR-21 and miR-210 gene DNA methylation were altered by exercise 
causing a cascade effect on the expression of the mature microRNA involved in 
cardiovascular function.  
Our findings demonstrate that exercise alters DNA methylation in circulating blood cells in 
microRNA and protein coding genes associated with cardiovascular physiology. 
 
 
Keywords: Epigenetics, sprint interval training, DNA methylation, cholesterol, miRNA 
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Introduction 
Exercise training can prevent and attenuate symptoms of cardio-metabolic diseases, such as 
insulin resistance, elevated blood pressure (BP), excess adiposity and vascular impairment 
521. The exact molecular mechanisms underpinning the health benefits gained from regular 
exercise training, however, are not known. DNA methylation affected by environmental 
factors modulates gene expression and may therefore mediate the health benefits gained from 
exercise training 57.  
Recently, individuals involved in a six month moderate intensity exercise training program 
displayed genome-wide skeletal myocyte and adipocyte DNA methylation changes in genes 
associated with type 2 diabetes 522,523. Additionally, older adult leukocyte DNA methylation 
increased in the pro-inflammatory PYCARD gene after six months of aerobic exercise 
training, to levels observed in their middle-aged peers 524. Although six months of moderate 
intensity aerobic exercise modulates the DNA methylome, it is unknown whether shorter 
training regimes impact DNA methylation. Moreover, while leukocytes are known to 
contribute to vascular disease 525, it is not known whether exercise is an environmental factor 
that regulates the leukocyte methylome and, in turn, contributes to improved vascular health. 
Given the effects of acute exercise on DNA methylation are intensity-dependent 526, we 
aimed to determine whether leukocyte DNA methylation changes occur after short-term (four 
weeks) yet intense exercise training. We used sprint interval training as a form of exercise 
training because it rapidly improves vascular functioning 527,528, insulin sensitivity 529, cardio-
respiratory function and physical performance (reviewed in 530,531). We aimed to: 1) identify 
the effects of four weeks of thrice weekly exercise on genome-wide leukocyte DNA 
methylation in healthy young men; 2) establish whether specific DNA methylation changes 
occurred reciprocally with altered gene expression and; 3) identify the acute effect of 
maximal exercise on genes and microRNAs (miRNAs) related to cardiovascular disease. We 
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hypothesised that four weeks of exercise training would cause significant changes in DNA 
methylation in genes and miRNAs related to pathways involved in cardiovascular health. 
 
Materials and Methods 
Participants 
Twenty-six healthy young men not already engaged in intense exercise training were 
recruited for this study. Participants were initially screened for any chronic diseases by health 
and physical activity readiness questionnaires. During the initial assessment, participants’ 
height, weight and body-mass-index (BMI) were recorded. Resting BP was measured with 
the subjects seated using an electronic BP monitor (Microlife BP 3AQ1). Subjects’ BP was 
measured after a 10 minute rest and was the average of two measurements broken up by a 
one minute rest period. Body fat percentage was estimated by summing seven skinfolds as 
described previously 532.  
All subjects gave written informed consent and this study was approved by Federation 
University Australia’s Human Research Ethics Committee. 
Cardiopulmonary exercise testing and training  
In order to assess cardiorespiratory fitness, participants completed one maximal oxygen 
consumption (VO2max) test, on the same day of the initial assessment and 48-96 hours 
following their final exercise session. Participants began training three days but no longer 
than one week after their VO2max test and completed twelve training sessions (three per week) 
over four weeks. Participants completed two maximal treadmill exercise (VO2max) tests before 
and after exercise training. Before the VO2max test participants were fitted with a two-way 
breathing valve (Hans Rudolph, USA) and expired air was collected into an online metabolic 
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system (Moxus, USA) for gas (O2 and CO2) analysis. The metabolic system was calibrated 
before each test using ambient air and gas of known composition. After a standardised five 
minute warm-up, the treadmill speed was increased one kilometre per hour every minute until 
the participant reached volitional exhaustion. Subject’ VO2max were determined as the highest 
oxygen consumption over one minute and was expressed as a relative value in ml.kg.min-1 by 
dividing the VO2max by body weight.  
So as to restrict any potential DNA methylation changes to the exercise program, participants 
were requested not to deviate from their normal physical activity and recreational exercise 
training habits, as physical activity and exercise training habits influence leukocyte DNA 
methylation 57. Participants were also requested not to make changes to their normal diet, as 
dietary changes have been associated with DNA methylation alterations 533,534. Participants 
had 48-72 hours recovery before the subsequent training session, to allow adequate recovery.  
Before each exercise session, participants were instructed to perform a warm-up involving a 
brief low-intensity run (5 min), dynamic stretches and some short (20 m) high-intensity runs. 
Table 1 outlines the training schedule performed. Briefly, participants were required to 
complete three sprints at maximal intensity. To prevent overtraining, a two-up one-back 
training model was used. For example, during week one of training, participants completed 
three sprints on the first session, four sprints on the second session and five on the third and 
final session of week one. Participants then completed four sprints on the first session of 
week two (Table 1). The training was progressively overloaded until participants performed 
eight sprints on the final exercise session. Exercise sessions were monitored and supervised 
by an Accredited Exercise Physiologists (with Exercise and Sports Science Australia) to 
ensure the safety of participants. Training was performed on a university athletics oval. 
Participants were requested to run at maximal intensity for each 30 sec effort. To ensure 
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participants were running at maximal intensity, participants received constant verbal 
motivation. Participants began each effort at one end of the oval and individually ran around 
the oval until a whistle was blown to indicate the 30 sec had been completed. Participants 
were then given a 4 min rest, which involved a slow walk back to where they had started the 
test, followed by passive rest.  
Blood processing 
Participants donated a resting blood sample before and after their initial and final (after four 
weeks of exercise training) treadmill tests. Participants were asked to refrain from consuming 
alcohol or caffeinated beverages 24 hours before blood draw and were seated for 
approximately 30 minutes prior to their donations before and after the exercise intervention. 
Circulating blood was drawn from the antecubital vein into a serum separating tube and an 
EDTA tube with participant seated. All resting blood samples were collected from 
participants in the morning following an overnight fast. The final blood collection was 
obtained 48-96 hours after the final exercise session. Blood was temporarily stored on ice 
before further processing. The serum separating tube was left to clot at room temperature 
before centrifugation (3500 RPM) and was subsequently used to quantify blood lipid 
concentration using the CHOL2, TRIGL and HDLC3 reagents that were run on the Roche 
c701 instrument at Melbourne Pathology (Melbourne, Australia). All DNA and RNA were 
extracted on the same day, within three hours of blood draw to prevent possible de nova 
influences on DNA methylation and gene expression. DNA and RNA were extracted from 
whole blood stored in EDTA tubes using the PureLink Genomic DNA Mini Kit (Life 
Technologies) and miRNeasy Mini Kit (Qiagen), respectively, following the manufacturers’ 
recommendations. The whole blood leukocytes were washed twice with the erythrocyte lysis 
wash buffer (included in the miRNeasy Mini Kit) to isolate leukocytes from plasma, serum, 
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platelets and lysed erythrocytes. Therefore, only whole blood leukocyte miRNA and gene 
expression were analysed in our study.  
Genome-wide DNA methylation and EpiTYPER assay 
While 19 participants completed the exercise intervention, whole-genome DNA methylation 
analysis was performed in 12 subjects at rest before and after the four week exercise 
intervention. The 450k BeadChip uses two types of Illumina chemistry to provide a 
comprehensive DNA methylation status of over 480,000 CpG sites spanning 99.9% of refseq 
genes. DNA methylation is represented as a β-value which corresponds to the percentage of 
methylation at a given CpG site. All samples quantified on the BeadChip passed the 
GenomeStudio Methylation Module’s quality control procedure. To identify technical 
variation and increase the chances of detecting DNA methylation changes caused by exercise, 
raw β-values underwent Subset-quantile Within Array Normalization (SWAN) 535. Data was 
subsequently imported into and analysed using the bioinformatics software, Partek (Genomic 
Suite, version 6.6, Singapore). All β-values were log-transformed into M-values using the 
logit function (log2 (β/(1- β))). M-values are a more valid alternative for detecting DNA 
methylation changes, as they eliminate the heteroscedasticity of higher- and lower-end β-
values 536. Whereas M-values are more appropriate for analysing DNA methylation, β-values 
are more suitable for displaying biological relevance, as they correspond to the DNA 
methylation percentage of an individual CpG site. For this reason, M-values were converted 
back to β-values for all graphs and tables. Hierarchical clustering and pathway analysis was 
analysed using the software, Partek (Genomic Suite, version 6.6, Singapore). Due to the 
uneven CpG distributions between the two chemistries used on the Infinium 
HumanMethylation450 BeadChip (Illumina) – Infinium I (135,501) and Infinium II 
(350,076), we analysed these separately. Whole-genome DNA methylation was quantified 
using an Infinium HumanMethylation450 BeadChip (Illumina) according to the 
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manufacturer’s guidelines and with the assistance of the Australian Genome Research 
Facility (Melbourne, Australia).  
The EpiTYPER (Sequenom) was used to validate the DNA methylation change of the 
epidermal growth factor (EGF, cg12093976) and uracil-DNA glycosylase (UNG, 
cg20982606) genes, and these assays were performed by GeneWorks (Melbourne, Australia). 
Experiments were conducted according to the manufacturer’s procedures. Briefly, 1µg of 
DNA was bisulfite converted and PCR amplified using the following primer sets: 
cg12093976: sense, aggaagagagAGTTATAATTTTTGGATTGGGGTTG and antisense, 
cagtaatacgactcactatagggagaaggctTAATTTAATTTTATCTCCATCCTTCCAA; cg20982606: 
sense, aggaagagagGATTATTTTGGAGTTGAGGAGGTAG and antisense, 
cagtaatacgactcactatagggagaaggctCCTTAAAAACCTATCCAAAAAACAA. Base-specific (C 
and T) cleavage and in vitro transcription was performed, followed by mass spectrometry 
(MALDI-TOF). Data was analysed using the EpiTYPER 1.2 software (Sequenom). 
Gene and miRNA expression  
The gene and miRNA expression of blood collected before and after initial and final 
treadmill exercise testing was assessed by qPCR using TaqMan assays (Life Technologies). 
RNA samples were reverse transcribed using the High Capacity Reverse Transcription Kit 
and the TaqMan MicroRNA Reverse Transcription Kit for gene and miRNAs, respectively, 
following the manufacturer’s procedures (Life Technologies, Australia). Experiments on 384-
well plates comprised of samples, endogenous positive and negative controls, all in duplicate 
were run on the ViiA 7 Real-Time PCR System (Life Technologies, Australia). Standard 
TaqMan assay procedures were followed and TaqMan assays used in the experiments are 
outlined in Table 2. The cycle threshold (Ct) of genes and miRNAs were compared to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and the small-nucleolar RNA, RNU44, 
respectively. The relative expression was calculated using the 2−ΔΔCt method 303 and the 
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results were graphically represented as fold change. The cycling conditions were as follows: 
a hold at 50° for 2 min and at 95° for 20 sec, followed by 40 cycles at 95° for 1 sec and 60° 
for 20 sec. As a quality control, duplicate samples greater than one Ct apart we re-run before 
being included in the analysis. All qPCR experiments were performed by the same 
researcher. 
Statistical analyses 
Participant phenotypes were assessed for normality using Kolmogorov-Smirnov and Shapiro-
Wilks tests. Parametric data are expressed as mean ± standard deviation (SD) and non-
parametric data are expressed by median (interquartile range). Non-parametric data was log-
transformed before further analyses. While paired t-test was used to identify statistically 
significant changes to phenotypes, repeated measures ANOVA were used to show gene 
expression changes after four weeks of exercise training using the statistical software, IBM 
SPSS Statistics (version 21.0). Genome-wide DNA methylation changes in relation to CpG 
islands and gene regions were assessed using Chi2 and Wilcoxon matched-pair signed ranked 
tests. DNA methylation changes caused by exercise training were determined using two-way 
ANOVA after β-values were log-transformed. In order to control for the discovery of false-
positives, a false discovery rate (FDR) correction was applied to the whole-genome DNA 
methylation P-values by converting P-values to q-values. Whole genome data was analysed 
using the software, Partek Genomic Suite (version 6.6). Gene and miRNA expression were 
analysed using a two-way repeated measures ANOVA. The miRNA-mRNA targets were 
predicted using the miRWalk website 537, which includes predictions from the most 
commonly used prediction databases, and pathway analysis was conducted using Database 
for Annotation, Visualization and Integrated Discovery (DAVID, version 6.7) 538,539. 
Statistical significance was determined as P<0.05.  
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Results 
Exercise adherence 
Of the 26 participants recruited into the intervention, 19 successfully completed the 12 
exercise sessions. One participant withdrew due to a quadriceps musculoskeletal injury 
during training, one had a previous injury that was exacerbated by the exercise, another 
experienced an unrelated health concern and three stopped training for undisclosed reasons. 
The exercise adherence was approximately 73%.  
Exercise improves cardiorespiratory health and fitness 
Participants’ phenotypes before and after exercise training are shown in Table 3. Exercise 
training increased cardiorespiratory fitness (VO2max) by 2.1ml.kg.min-1 (4.7%, P=0.03). 
Maximal running speed during VO2max testing improved by 1km.hr-1 (4%, P=0.001) and LDL 
cholesterol was decreased after the intervention (-3.9%, P=0.047). Resting heart rate (-4%, 
P=0.05), diastolic BP (-4.3%, P=0.06) and total cholesterol (-3.3%, P=0.06) were reduced, 
while pulse pressure was increased (7.6%, P=0.07), all with borderline statistical 
significance.  
Whole-genome leukocyte DNA methylation changes after exercise training 
We analysed whole-genome DNA methylation using the 450 BeadChip (Illumina) to 
determine whether exercise altered the leukocyte methylome. The principle component 
analysis demonstrated separation between paired subject DNA methylation from samples 
taken before and after exercise training, indicating large changes to genome-wide DNA 
methylation (data not shown). DNA methylation changes occurred across the leukocyte 
genome in relation to gene regions and CpG islands (Figure 1). To gather an overview of 
where these DNA methylation changes had occurred, we determined the average DNA 
methylation before and after exercise in relation to CpG islands and location in relation to the 
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nearest gene. DNA methylation in relation to the nearest gene decreased in the promoter and 
intron regions for Infinium I and II assays, but increased in the 3’ untranslated regions (UTR) 
for Inifinium I assay (Figure 2A, P<0.0001). There was a decrease in 5’UTR and exon DNA 
methylation in Infinium II assay (Figure 2A, P<0.0001). CpG island DNA methylation 
decreased in both Infinium I and II assays (Figure 2B, P<0.0001). Whereas Infinium II-
assessed northern shore (N shore) DNA methylation deceased, southern shore (S shore) and 
northern shelf (N shelf) DNA methylation increased (P<0.0001, Figure 2B). Although the 
impact of specific regional DNA methylation changes are not completely understood, the 
CpG island and promoter region demethylation indicate an increase in transcriptional activity 
or gene un-silencing. Therefore, DNA methylation changes occurred across the leukocyte 
methylome after exercise training. 
CpG methylation after exercise training 
Out of the 485,577 CpG sites quantified for DNA methylation status on the Infinium 
HumanMethylation450 BeadChip (Illumina), exercise induced DNA methylation changes, 
ranging from 0.1–62.8%, at 205,987 sites relating to 32,445 transcripts after FDR (q<0.05). 
While 81,576 CpG sites relating to 16,256 transcripts became more methylated (Figure 2C, 
q<0.05), 124,411 CpG sites corresponding to 27,263 transcripts were de-methylated after 
exercise (Figure 2D, q<0.05).  
In the search for biologically relevant changes to CpG site methylation, we identified CpG 
sites with a change of ≥5% after exercise (q≤0.05) (Figure 3). Due to the large number of 
CpG sites (n=2,909) with a difference of ≥5%, we narrowed our focus to CpG sites (n=81) 
with a change of ≥10% (q<0.005, Table 4) and ≥20% after exercise (q<0.005, Table 5). Of 
the CpG sites that had large changes (≥20%) in DNA methylation after exercise, eight had 
increased methylation and 11 had less methylation after exercise. Next, after applying a 
stringent FDR (q<0.001) we used gene ontology to identify DNA methylation changes in 
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genes enriched for numerous cellular and molecular processes, including those involved in 
metabolic activity, biological adhesion and antioxidant activity (Figure 4). Using pathway 
analysis, we found that CpG sites altered by exercise (q<0.005) were those of genes related to 
pathways important for cardiovascular physiology, including focal adhesion, calcium 
signalling and MAPK signalling (q<0.05, Table 6). Therefore, differentially methylated CpG 
sites after exercise are enriched for pathways crucial for cardiovascular health.  
DNA methylation validation 
DNA methylation within a gene promoter region is typically associated with decreased gene 
expression, thus we focused on CpG sites with the largest and most statistically significant 
DNA methylation changes within gene promoter regions (≥10% and P<1.0×10-5). To that 
end, we analysed CpG sites within the EGF (cg12093976) and uracil-DNA glycosylase 
(UNG) (cg20982606) promoter regions using the EpiTYPER (Sequenom). We were unable 
to obtain meaningful data, due to the acquisition of peaks from additional fragments other 
than the fragment of interest. 
Exercise-induced gene and miRNA expression 
We then aimed to identify whether a change in DNA methylation caused by exercise would 
alter gene mRNA expression. We quantified the expression of genes that had a DNA 
methylation change (>10%) that were most statistically significant (q<0.001) within the 
promoter region or gene body (Figure 5A–F). We also quantified mature miR-21 and miR-
210 as their genes had a modest (1.3–4.2%) change in DNA methylation at multiple regions 
across the gene (q<0.05, Table 7). These miRNAs are inversely correlated to 
cardiorespiratory fitness and implicated in cardiovascular disease 540. 
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Gene expression changes after the initial VO2max test, at rest after exercise training and after 
the second VO2max test (after exercise training) are displayed in Figure 5. We were unable to 
successfully amplify insulin-like family member 3 (IGFL3) mRNA, suggesting that this gene 
is lowly expressed in leukocytes. Genes fitted into one of five categories; specifically, 1) 
genes that were responsive after acute exercise at the beginning of exercise training only (cell 
division cycle 20, CDC20); 2) genes that responded to acute exercise before and after 
exercise training (isthmin 1, ISM1); 3) genes that responded to acute exercise before and after 
exercise training and that had altered gene expression at rest after exercise training (EGF, 
UNG and miR-210); 4) those that were only altered at rest after exercise training (miR-21); 
and finally, 5) those that were unchanged by acute or chronic exercise (chromobox homolog 
7, CBX7 and synuclein α interacting protein, SNCAIP, data not shown). Interestingly, the 
demethylated (11.6% and 12.9%, respectively) EGF and UNG promoter was accompanied by 
a significant decrease and increase in mRNA expression, respectively (relative expression ± 
SEM, 10.75±1.68 to 8.25±0.95, P<0.05 and 1.72±0.14 to 2.12±0.15, P=0.05). These data 
suggest exercise training-induced DNA methylation changes within genes (including miRNA 
genes) cause changes to mRNA and mature miRNA levels (Figure 6).  
miRNA-mRNA targets 
Finally, we used miRWalk,537 to predict mRNA targets of miR-21 and miR-210. We then 
used DAVID 538,539 to identify pathways and diseases associated with mRNA molecules 
targeted by miR-21 and miR-210. Notably, miR-21 mRNA targets were enriched for 
pathways including MAPK signalling, Toll-like receptor signalling, apoptosis and fatty acid 
metabolism. Moreover, mRNA targets of miR-210 were enriched for genes relating to 
calcium signalling, B-cell receptor signalling and TGF-beta signalling pathways. While the 
mRNA targets of miR-21 were from genes associated with diseases, such as ischemic heart 
disease (n=6), nephropathy (n=5) and coronary atherosclerosis (n=11), miR-210 mRNA 
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targets were from genes associated with focal dystonia (n=2). Collectively, these data suggest 
a role for miR-21 and miR-210 in the positive cardiovascular adaptations associated with 
short-term intense exercise training. 
 
Discussion 
Our study is the first, to our knowledge, to show genome-wide leukocyte DNA methylation 
changes caused by short-term exercise in healthy young men. We found global and specific 
leukocyte DNA methylation changes with concomitant changes to mRNA and miRNA 
expression, in addition to favourable cardiovascular health adaptations after four weeks of 
exercise training. Specifically, we observed DNA methylation changes to CpG islands and 
gene promoter and gene bodies. We showed exercise training-induced demethylation of 
cg12093976 and cg20982606, which decreased and increased the mRNA expression of the 
EGF and UNG genes, respectively. Furthermore, exercise training-induced leukocyte DNA 
methylation changes across miRNA genes (MIR21 and MIR210) known to influence 
cardiovascular physiology 541,542, subsequently influencing their mature miRNA expression. 
Sprint interval training causes cardiopulmonary and metabolic adaptations similar to that of 
traditional long duration aerobic training, but demands dramatically less time commitment 
543. Given a common barrier to engagement in exercise is lack of time, sprint interval training 
may be an attractive alternative exercise training regime that improves health and fitness. We 
demonstrated that four weeks of sprint interval training increased VO2max and reduced total 
and LDL cholesterol in healthy young men, thereby improving cardiorespiratory fitness and 
blood lipid profile. We are, to our knowledge, the first to demonstrate that four weeks of 
sprint interval training can significantly decrease LDL cholesterol in young men. Although 
some have demonstrated eight weeks of sprint interval training, in the form of running, is 
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effective at reducing LDL and total cholesterol 544, other shorter (six week) sprint interval 
training interventions have not reduced LDL cholesterol 545. Considering the role of LDL 
cholesterol in blood vessel health 546,547, sprint interval training may be a cheap and effective 
short-term strategy to promote a favourable blood lipid profile. 
Global leukocyte DNA methylation changes seem to be influenced by physical activity and 
exercise training but data is equivocal. Although global leukocyte DNA methylation is 
increased in middle-aged individuals performing moderate 548 or high amounts 549 of physical 
activity in some studies, in others, global methylation is inversely 550,551 related to physical 
activity or unrelated 552. The DNA methylation of exon 1 of the PYCARD gene was increased 
in older adults who engaged in six months of moderate intensity exercise, to levels 
comparable to that of their younger peers 524. We are the first to analyse the exercise training-
induced changes to genome-wide leukocyte DNA methylation in healthy subjects. Notably, 
we found a subtle decrease in leukocyte global methylation, consistent with previous findings 
550,551. These data may indicate wide-spread transcriptional changes to leukocytes. In 
particular, we found CpG island and gene body and promoter regions were, on average, 
demethylated after exercise training, indicating the modulation of transcriptional activity.  
The exercise-induced changes to skeletal myocyte 522 and adipocyte 523 genome-wide DNA 
methylation have been analysed previously. Strikingly, the exercise training-induced changes 
to DNA methylation found in our study included CpG sites in genes involved in pathways 
similar to that previously shown to be affected in skeletal myocytes after six months of 
exercise training 522. For example, six months of moderate intensity exercise altered skeletal 
muscle DNA methylation in genes related to MAPK signalling, progesterone-mediated 
oocyte maturation, Wnt signalling, Melanogenesis, hedgehog signalling and calcium 
signalling pathway 522 – pathways also modulated in leukocytes of individuals from our study 
(Table 6). Furthermore, some of the mentioned pathways regulated by DNA methylation 
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changes caused by exercise may also be governed by miRNA-mediated mRNA regulation, as 
indicated by our miRNA pathway analysis. 
Whereas skeletal myocytes and adipocyte DNA methylation changes are predominantly 
indicative of metabolic transcriptional changes caused by exercise, leukocytes changes could 
be used as biomarkers of systemic changes to health and fitness. Leukocytes circulate 
through the body and their gene expression mimics that of their internal and external 
environments, making them useful biomarkers 25. Likewise, the epigenetic landscapes are 
malleable to the internal (biological) and external environments (such as physical exercise) 
553,554. Therefore, leukocyte changes to epigenetic modifications could be relevant biomarkers 
of phenotype changes and in this case, biomarkers of the changes in cardiorespiratory fitness 
and accompanying health and performance adaptations (total and LDL cholesterol, and 
maximal running speed). Leukocytes are also implicated in the pathogenesis of 
atherosclerosis 525 and the DNA methylation changes observed in our study provide 
mechanistic insights into how exercise attenuates the risk of atherosclerosis.  
 
Interestingly, exercise training caused DNA methylation changes with paralleled miRNA 
changes. DNA methylation can down-regulate gene expression by working in concert with 
other epigenetic modifications (e.g. Histone protein methylation and acetylation) and DNA 
binding proteins to compact chromatin and, in turn, inhibit transcription factor binding 44,555-
557. We identified that DNA methylation changes to MIR21 and MIR210 genes influenced the 
mature miR-21 and miR-210 expression. The microRNAs miR-21 and miR-210 are 
ubiquitously expressed hypoxamirs involved in cardiovascular diseases, inflammation and 
angiogenesis 558,559. Indeed, miR-21 is up-regulated in atherosclerotic  
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plaques 560 and acute coronary syndromes 561. The increased miR-21 expression, however, 
may be a protective response to the disease and acute coronary damage. For example, up-
regulated miR-21 was protective against ischemia-induced cell apoptosis by down-regulating 
programmed cell death 4 (PDCD4) mRNA after myocardial infarction in rats 562. Previous in 
vitro experiments showed miR-21 attenuates vascular smooth muscle cell apoptosis caused 
by reactive oxygen species (hydrogen peroxide, H2O2) through down-regulation of 
programmed cell death 4 (PDCD4) 563. Additionally, human endothelial cell miR-21 was 
augmented by shear stress and lead to decreased phosphatase and tensin homolog (PTEN)-
mediated apoptosis, facilitated endothelial nitric oxide synthase (eNOS) phosphorylation and 
nitric oxide (NO) production 564; an effect exerted by exercise training 565,566. miR-21 is 
particularly responsive to exercise training as it is up-regulated after chronic exercise training 
in serum 567, spinal cord 568, cardiac 569 and skeletal myocytes 570 in mammals. Thus, exercise 
may maintain vascular integrity and prevent vascular disease through up-regulating miR-21 
expression. This, in turn, contributes to modulation of miR-21 downstream mRNA targets 
involved in the eNOS pathway, oxidative stress and apoptosis. 
 
miR-210 is induced by hypoxia and is up-regulated in numerous cardiovascular diseases, 
especially those associated with ischemia 542. Similar to miR-21, miR-210 is up-regulated in 
atherosclerotic plaques 560 and myocardial infarction 571, possibly by oxidative damage and 
cellular senescence. Reactive oxygen species (ROS) up-regulates miR-210 through 
phosphorylation of AKT, ERK1/2 and platelet-derived growth factor receptor β 572. miR-210 
is also known to facilitate ROS production and to induce double-stranded DNA breaks in 
human cells undergoing replicative senescent 573. Interestingly, serum miR-21 and -210 were 
shown to be inversely correlated to VO2max in a cohort of 100 healthy subjects 540. Our data 
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also suggests miR-210 may be indicative of VO2max, as our participants exhibited elevated VO2max with decreased leukocyte miR-210 expression after exercise training. We showed 
predicted targets of miR-21 are particularly enriched for mRNA from genes associated with 
cardiovascular pathology (ischemic heart disease and coronary atherosclerosis) that supports 
the concept but warrants further study. The impact of these exercise-induced miRNA changes 
on genes and biological implications is also left for future research. Collectively, it is likely 
that miRNAs, miR-21 and miR-210, are exercise-responsive miRNAs that underpin the 
salubrious adaptations associated with exercise training. 
Demethylation of EGF and UNG gene promoter regions attenuated and augmented the 
mRNA levels, respectively. Promoter demethylation is generally associated with gene 
activation 44, but not exclusively, as promoter demethylation does not always increase gene 
expression 574-576. Alternatively, the observed decrease to EGF mRNA expression could be 
due to other means of transcriptional regulation such as histone modifications, small non-
coding RNA molecules or transcription factor activity. Importantly, EGF is a ligand for the 
epidermal growth factor-receptor (EGFR), which is hyperactive in atherosclerosis 577. The 
increased EGFR activity by elevated EGF may facilitate increased inflammation and blood 
vessel damage, leading to atherosclerosis 577. Acute exercise training increases peripheral but 
not central artery distensibility 528, which is an effect established after chronic exercise 
training 527. Moreover, exercise training increases and decreases muscle microvascular 
density and arterial stiffness, respectively 578. Therefore, the present study indicates that the 
attenuation of the EGFR-ligand, EGF, expression by promoter DNA methylation changes 
caused by exercise training could benefit vascular health. Similarly, the observed DNA 
methylation and gene expression change of UNG could serve as a mechanism for the 
demethylation of most genes analysed in the present study. Active DNA demethylation 
occurs via the hydroxylation of 5-methylcytosine to 5-hydroxymethylcytosine by ten-eleven 
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translocation (TET) proteins (1-3), followed by the active base-excision repair initiated by 
UNG 579,580. Together, these data demonstrate the complex regulation of gene expression; 
where DNA methylation can directly regulate mRNA levels or, indirectly modulate gene 
expression through the modulation of miRNA expression subsequently influencing gene 
expression and cardiovascular phenotypes. 
Although not measured, the numerous changes to DNA methylation observed in the present 
study could be a result of the altered DNA methyltransferase enzymes (DNMT1, 3A and 3B). 
While DNMT1 is responsible for maintaining DNA methylation during mitosis, DNMT3A 
and -3B are responsible for de novo methylation changes 581. It is possible that exercise 
training-induced changes to activity of DNMT enzymes could have impacted the leukocyte 
methylome as there expression was altered in the hippocampi of mice after seven days of 
voluntary wheel running 582. Passive loss of DNA methylation during cell division is an 
alternate explanation for the DNA methylation changes observed in our study. This is, 
however, unlikely because of the short duration of study intervention period. The DNA 
methylation changes (up to 62.8%) caused by exercise training in our study could be 
explained by the intensity of exercise training. Previous work 526 revealed skeletal myocyte 
global and metabolic gene (PPARGC1A, TFAM, PPARD, MEF2A) DNA demethylation is 
intensity dependent, where higher intensity exercise elicited greater DNA demethylation. 
Moreover, the acute increase in reactive oxygen species and other metabolites may influence 
TET proteins and histone acetyltransferase and deacetylase activity to alter DNA methylation 
583, but this remains to experimentally demonstrated.  
Our study has some limitations. Blood leukocyte counts were not quantified before and after 
exercise training and it is possible that shifts in leukocyte subsets could be responsible for the 
change in leukocyte DNA methylation observed in our study. This is, however, unlikely as 
we quantified leukocyte DNA methylation from resting blood samples unaffected by the 
Exercise Changes the DNA Methylome	
252 
 
leukocytosis associated with acute exercise. Furthermore, there is no evidence to suggest 
leukocyte subsets change with chronic exercise training and a similar high-intensity exercise 
training study did not alter leukocyte subsets 584. Whist we did not include any experimental 
controls (who did not participate in any exercise for four weeks), data from our laboratory 
indicates that genome-wide leukocyte DNA methylation is stable over the course of eight 
weeks, as no changes were observed in a cohort of eight young men not engaging in any 
high-intensity aerobic exercise (unpublished data). We could not successfully validate the 
450K DNA methylation results using EpiTYPER due to issues with the genomic regions 
being analysed. Exercise training was not performed in a laboratory setting and participants 
exercise intensity was not directly monitored during the course of the intervention. Lastly, we 
cannot rule-out potential changes to participants’ diet caused DNA methylation changes.  
In conclusion, we have demonstrated that four weeks (249 min) of exercise training 
significantly alters the leukocyte methylome. These DNA methylation changes influenced 
miRNA and mRNA levels, improved cardiorespiratory fitness and enhanced the blood lipid 
profile of healthy, young men. These DNA methylation changes could be relevant 
biomarkers for monitoring adherence to exercise interventions and demonstrates a dynamic 
role for epigenetic regulation in the change to cardiovascular health and fitness caused by 
short-term exercise training. 
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Figure Captions 
 
Figure 1 DNA methylation changes in relation to CpG islands (A and B) and the nearest gene 
(C and D), respectively. Data are from Chi2 tests. 
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Figure 2. Whole-genome DNA methylation changes caused by exercise. Genome wide DNA 
methylation across all 485,577 CpG sites analysed on the Infinium HumanMethylation450 
BeadChip (Illumina, Australia) were compared before and after exercise in relation to A) 
nearest gene and B) CpG island. Data are from Wilcoxon matched-pair signed ranked test 
and are expressed as mean ± SEM. Number of CpG sites with C) increased methylation and 
D) decreased methylation, with magnitude of DNA methylation change after exercise 
(q<0.05).  
Legend: ***P<0.0001; N: northern; S: southern; 3’UTR: 3-prime un-translated region; 
5’UTR: 5-prime un-translated region; Promoter: gene promoter region (1–1500 bases 
upstream of the transcription start site). 
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Figure 3. Hierarchical clustering of CpG methylation before and after exercise training. 
The CpG methylation status is indicated by green (low methylation) and red (high 
methylation) in 12 subjects pre (grey bar) and post (blue bar) exercise training. Each branch 
of the array tree on the left of the grey and blue bars are subjects and are separated before and 
after the exercise training. The array tree at the top of the hierarchical cluster indicates 
clusters of CpG sites modified by exercise. 
Data are from CpG sites with a fold-change of >5% (q<0.001). 
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Figure 4. Gene ontology for genes with CpG DNA methylation changes after exercise. Gene 
ontology is based on CpG sites with altered DNA methylation (q<0.001) after exercise 
training. Gene ontology enrichment scores are given and organised by A) biological 
processes; B) cellular components; and C) molecular functions. 
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Figure 5. Gene and miRNA expression changes caused by exercise. Data are from two-way 
repeated-measures ANOVA and are expressed as fold change of genes and mature miRNA 
expression (mean ± SEM). A significant difference between basal and other time-points is 
indicated by asterisks. 
Legend: *P<0.05; **P<0.01; ***P<0.001 vs basal.  
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Figure 6. Schematic of DNA methylation regulation on cardiovascular physiology. 
Exercise training, in the form of sprint interval training (SIT), influences the leukocyte DNA 
methylome. This, in turn, modulates the expression (mRNA levels) of protein-coding genes 
(EGF and UNG) and also microRNAs (miR-21 and -210). MicroRNAs, miR-21 and miR-210 
would subsequently regulate other protein-coding genes to inevitably influence 
cardiovascular physiology and enhance cardiovascular health and performance. 
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Tables 
Table 1. Description of the four week exercise program.  
Week Session # Training load* Training sprint time (min) Total session time (min) 
1 1 3 sprints 1.3 9.5 
 
2 4 sprints 2 14 
 
3 5 sprints 2.5 18.5 
2 4 4 sprints 2 14 
 
5 5 sprints 2.5 18.5 
 
6 6 sprints 3 23 
3 7 5 sprints 2.5 18.5 
 
8 6 sprints 3 23 
 
9 7 sprints 3.5 27.5 
4 10 6 sprints 3 23 
 
11 7 sprints 3.5 27.5 
 
12 8 sprints 4 32 
  Total Time 66 33 249 
Legend: # number; * all sprints were completed at maximum intensity and separated by four 
minutes of passive recovery. 
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Table 2. TaqMan Assay information. 
Gene/microRNA TaqMan ID 
CBX7 Hs00545603_m1 
CDC20 Hs00426680_mH 
EGF Hs01099999_m1 
GAPDH (mRNA reference gene) Hs02786624_g1 
IGFL3 Hs00419511_g1 
ISM1 Hs01382748_m1 
SNCAIP Hs00917423_m1 
UNG Hs01037093_m1 
hsa-miR-21  000397 
hsa-miR-210 000512 
RNU44 (miRNA reference gene) 001094 
 
 
 
 
 
 
 
 
Table 3. Participant phenotypes before and after exercise training. 
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 Before exercise After exercise   
Phenotype Mean±SD Mean±SD % Change P-value 
n=19 
Age (years) 21.1±2.7  
Height (cm) 180.6±7.4  
Anthropometric   
Weight (kg) 78.1±9.4 78.1±9.8 -0.03±2.3 0.99 
BMI (kg/m2) 23.9±2.3 23.9±2.4 -0.2±2.4 0.68 
Waist (cm) 79.2±5.3 78.9±4.8 -0.4±2.5 0.50 
Hip (cm) 82.8±6.0 82.4±5.4 -0.3±1.8 0.37 
WHR 0.96±0.02 0.96±0.02 -0.1±2.3 0.94 
∑ 7 skinfolds (cm) 98.1±38.3 91.3±30.7 -4.5±13.2 0.13 
Body density 1.07±0.01 1.07±0.01 0.2±0.5 0.13 
Fat % 13.0±4.9 12.2±4.1 -4.2±12.7 0.11 
Cardiovascular    
RHR (beats/min) 64.1±10.8 59.5±9.3 -4.0±18.2 0.055 
SBP (mmHg) 124.0±12.1 124.8±7.8 1.1±10.5 0.77 
DBP (mmHg) 72.0±6.7 69.5±7.0 -3.4±7.9 0.06 
MAP (mmHg) 89.4±7.9 87.9±6.7 -1.3±8.8 0.42 
PP (mmHg) 51.9±8.4 55.4±5.8 7.6±16.8 0.07 
Total CHOL (mmol/L) 4.42±0.79 4.24±0.67 -3.3±9.3 0.06 
Triglycerides (mmol/L) 0.97±0.35 0.95±0.48 -4.2±22.4 0.70 
HDL-C (mmol/L) 1.34±0.24 1.31±0.20 -0.9±11.7 0.50 
LDL-C (mmol/L) 2.64±0.78 2.48±0.61 -3.9±11.2 0.047 
LDL-C/HDL-C (mmol/L) 2.06(1.5–2.8) 2.0(1.5–2.5) -1.6±15.0 0.24 
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CHOL/HDL-C (mmol/L) 3.41(2.7–4.2) 3.31(2.7–4.2) -2.0±9.1 0.35 
Cardiorespiratory fitness   
VO2max (ml.kg.min-1) 49.5±4.7 51.6±3.9 4.7±10.1 0.03 
Final treadmill Speed 
(km.hr-1) 
19(18–21) 20(19–21) 4.0±5.1 0.001 
Data are expressed as mean ± standard deviation or as mean (interquartile range) from paired 
t-tests or related samples Wilcoxon signed rank test, respectively. 
Legend: ∑, sum of; % change, percentage change;  BMI, Body mass index; WHR, waist to 
hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial 
pressure; PP, pulse pressure; CHOL, cholesterol; HDL-C, high-density lipoprotein 
cholesterol; LDL-C, low-density lipoprotein cholesterol. 
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Table 4. D
N
A
 m
ethylation changes after four w
eeks of exercise training (≥10%
, q≤0.005). 
Location in relation to 
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) 
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(≤0.005) 
cg19933985 
 
  
S shelf 
5 
53.8±4.4 
70.8±4.1 
17 
1.93×10
-7 
1.49×10
-5 
cg10633981 
C
11orf58 
3’U
TR
 
O
pen sea 
11 
49.5±6.7 
66.4±5.1 
16.9 
2.13×10
-8 
3.97×10
-6 
cg02732134 
D
N
M
BP 
5’U
TR
 
O
pen sea 
10 
42.3±2.8 
57.9±3.6 
15.6 
4.79×10
-8 
6.26×10
-6 
cg01287788 
SN
O
RD
94 
TSS200 
O
pen sea 
2 
49.5±4.2 
65.0±5.2 
15.5 
2.96×10
-7 
1.96×10
-5 
PTC
D
3 
B
ody 
cg27379715 
  
 
O
pen sea 
2 
55.1±3.3 
70.0±3.3 
14.8 
8.39×10
-9 
2.39×10
-6 
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35.7±1.5 
24.3±2.2 
11.4 
1.45×10
-8 
3.23×10
-6 
cg25474648 
ZD
H
H
C
14 
3’U
TR
 
S shore 
6 
74.2±2.5 
62.7±4.8 
11.5 
2.62×10
-6 
7.58×10
-5 
cg01994308 
PLAG
1 
5’U
TR
 
N
 shore 
8 
40.0±6.7 
28.5±4.2 
11.5 
0.0005 
0.002 
C
H
C
H
D
7 
TSS1500 
cg12093976 
EG
F 
TSS200 
O
pen sea 
4 
34.3±2.5 
22.8±3.0 
11.6 
7.18×10
-9 
2.20×10
-6 
cg12861974 
C
Xorf57 
TSS200 
Island 
X
 
33.4±4.8 
21.8±2.9 
11.6 
3.04×10
-6 
8.32×10
-5 
cg20929922 
C
5orf28 
TSS1500 
S shore 
5 
37.7±3.1 
26.0±3.4 
11.7 
3.23×10
-5 
0.0004 
cg19349861 
O
PC
M
L 
5’U
TR
  
O
pen sea 
11 
34.7±3.0 
22.9±2.3 
11.7 
1.62×10
-8 
3.41×10
-6 
1
st Exon 
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cg03909902 
PRD
M
4 
5’U
TR
 
Island 
12 
35.6±2.8 
23.8±1.7 
11.8 
1.75×10
-8 
3.54×10
-6 
cg04981696 
ABC
C
1 
B
ody 
S shore 
16 
41.5±4.3 
29.5±4.0 
12 
3.30×10
-6 
8.76×10
-5 
cg05005382 
C
H
TF18 
B
ody 
Island 
16 
68.5±3.3 
56.4±5.0 
12.1 
0.0003 
0.001 
cg00556029 
M
ARC
K
SL1 
TSS200 
Island 
1 
30.9±4.8 
18.7±2.6 
12.2 
3.22×10
-5 
0.0004 
cg03252499 
 
 
O
pen sea 
11 
63.3±7.4 
51.0±5.3 
12.3 
0.001 
0.004 
cg25501666 
 
 
N
 shelf  
2 
65.8±4.5 
53.1±4.8 
12.7 
3.68×10
-6 
9.35×10
-5 
cg20982606 
U
N
G
 
TSS1500 
Island 
12 
29.1±3.0 
16.2±2.4 
12.9 
9.23×10
-9 
2.52×10
-6 
TSS200 
cg16379462 
SAM
D
4A 
B
ody 
O
pen sea 
14 
64.6±3.8 
51.6±6.4 
12.9 
0.0004 
0.002 
cg14266237 
K
LF1 
3’U
TR
 
N
 shore 
19 
49.8±6.9 
36.8±8.3 
13 
3.93×10
-8 
5.62×10
-6 
cg21393587 
 
 
N
 shore 
X
 
74.4±2.4 
61.4±4.0 
13 
5.53×10
-8 
6.76×10
-6 
cg06808467 
LO
C
339290 
TSS1500 
Island 
18 
39.2±2.4 
25.6±3.1 
13.6 
2.56×10
-8 
4.36×10
-6 
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C
18orf18 
B
ody 
cg17092349 
D
ALRD
3 
5’U
TR
 
N
 shore 
3 
47.5±6.6 
33.8±5.8 
13.7 
5.10×10
-5 
0.0005 
N
D
U
FAF3 
TSS1500 
M
IR425 
TSS1500 
M
IR191 
TSS200 
cg26081875 
 
 
O
pen sea 
6 
36.2±7.9 
22.3±5.3 
13.9 
0.001 
0.004 
cg01525244 
C
BX7 
TSS200 
N
 shore 
22 
30.3±1.2 
16.3±1.9 
14 
4.20×10
-10 
5.96×10
-7 
cg09844907 
M
PV17L 
5’U
TR
 
 
Island  
16 
34.0±1.5 
19.4±2.6 
14.6 
1.87×10
-8 
3.70×10
-6 
 
cg27494111 
 
 
N
 shore 
19 
67.6±5.1 
52.5±10.4 
15.1 
3.25×10
-6 
8.68×10
-5 
cg26186549 
 
 
S shore 
6 
68.7±11.4 
53.3±11.9 
15.4 
2.77×10
-5 
0.0003 
cg16524049 
LM
X1A 
B
ody 
Island 
1 
43.1±2.7 
27.1±4.6 
16 
4.54×10
-6 
0.0001 
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D
ata are expressed are beta values ± standard deviation. 
Legend: C
hr, chrom
osom
e num
ber; D
iff, difference; 3’, three prim
e; 5’, five prim
e; U
TR
, untranslated region; TSS1500, 1500 bases upstream
 of 
transcription start site; TSS200, 200 bases upstream
 of transcription start site; *D
M
R
, differentially m
ethylated region; †C
D
M
R
, cancer 
differentially m
ethylated region; ‡R
D
M
R
, reprogram
m
ed differentially m
ethylated region.
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Table 5. DNA methylation changes after four weeks of exercise training (≥20%, q≤0.005). 
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Location in relation to  DNA methylation (%)  
    
CpG Closest 
gene 
Gene 
region 
CpG 
island 
Ch
r 
Before  
exercise  
After 
exercise 
Diff P-value q-value 
(≤0.005) 
cg21036194 SNCAIP Body Open 
sea 
5 24.1±23.
1 
86.2±1.8 62.1 5.05×10-7 2.76×10-5 
cg22588144 ISM1 TSS1500 Island  20 4.9±1.0 53.1±8.3 48.2 1.69×10-12 5.35×10-8 
cg01309395 HLA-DPB2 Body Open 
sea 
6 37.9±34.
7 
82.1±4.1 44.2 0.0004 0.002 
cg07658590 SLC19A1 TSS1500 S shore 21 15.6±18.
2 
47.6±3.9 32.0 0.0004 0.002 
cg18531559 ULK4 TSS200 S shore 3 8.4±1.9 36.1±0.6 27.7 1.70×10-11 1.56×10-7 
cg11950805 
 
CDC20 TSS1500 Island 1 1.7±0.5 25.8±15.
0 
24.1 5.47×10-5 0.0005 
cg26919805 PPPDE2 
 
XRCC6 
5’UTR 
1st Exon 
TSS1500 
Island 22 1.9±0.5 25.2±18.
2 
23.3 0.001 0.003 
cg09459740   Open 
sea 
11 74.1±1.2 96.2±5.2 22.1 9.12×10-8 9.34×10-6 
cg07170824 ACVRL1 5’UTR 
1st Exon 
Island 12 52.7±3.1 32.7±5.3 -20.0 2.51×10-7 1.75×10-5 
cg16700025 CMIP Body Open 
sea 
16 62.2±15.
4 
36.1±0.6 -26.0 0.0001 0.001 
cg18684755 RYR1 Body S shelf 19 86.9±1.6 56.7±25.
4 
-30.2 0.002 0.005 
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Data are average beta-values ± standard deviation. 
Legend: Chr, chromosome number; Diff, difference; 3’, three prime; 5’, five prime; UTR, 
untranslated region; TSS1500, 1500 bases upstream of transcription start site; TSS200, 200 
bases upstream of transcription start site. 
 
 
 
cg06390613 TMEM198 3’UTR N shelf 2 76.2±2.0 43.9±18.
2 
-32.3 0.0001 0.0009 
cg03229033   Island 1 44.5±5.8 12.0±21.
6 
-32.4 0.0001 0.0009 
cg15224432 IGFL3 TSS1500 Open 
sea 
19 73.8±1.8 36.1±0.6 -37.7 7.17×10-16 4.55×10-11 
cg04600795   Open 
sea 
6 88.7±1.2 45.1±20.
9 
-43.7 1.50×10-5 0.0002 
cg10580110 KRT6A TSS1500 Open 
sea 
12 88.5±1.7 44.8±29.
6 
-43.7 1.40×10-5 0.0002 
cg08975528 
 
ZBTB12 3’UTR Island 6 74.6±2.9 19.8±34.
1 
-54.7 0.0002 0.001 
cg17415355 TOLLIP Body S shelf  11 86.5±1.5 24.9±35.
8 
-61.6 8.60×10-5 0.0007 
cg24810735 ANGPT1 Body Open 
sea 
8 79.3±3.5 16.5±32.
2 
-62.8 1.95×10-5 0.0003 
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Table 6. Pathways modulated by exercise training (q≤0.05). 
Pathway name 
Enrichment 
score 
Enrichment 
P-value 
Enrichment 
q-value 
# of 
Genes 
Pathway ID 
Endocytosis 16.44 7.23×10-8 1.22×10-5 115 kegg pathway 211 
HTLV-I infection 13.52 1.35×10-6 0.0001 154 kegg pathway 251 
Wnt signaling 
pathway 
11.93 6.61×10-6 0.0003 88 kegg pathway 142 
Proteoglycans in 
cancer 
11.71 8.21×10-6 0.0003 122 kegg pathway 164 
Pathways in cancer 11.15 1.44×10-5 0.0005 171 kegg pathway 128 
Axon guidance 10.8 2.04×10-5 0.0006 77 kegg pathway 176 
Gap junction 10.44 2.92×10-5 0.0007 58 kegg pathway 127 
Regulation of actin 
cytoskeleton 
9.97 4.66×10-5 0.001 120 kegg pathway 179 
Glutamatergic 
synapse 
9.05 0.0001 0.002 67 kegg pathway 182 
Calcium signaling 
pathway 
9.03 0.0001 0.001 101 kegg pathway 263 
Hippo signaling 
pathway 
9.02 0.0001 0.002 92 kegg pathway 20 
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MAPK signaling 
pathway 
8.93 0.0001 0.002 129 kegg pathway 119 
p53 signaling 
pathway 
8.6 0.0002 0.002 32 kegg pathway 149 
Melanogenesis 8.28 0.00025 0.003 64 kegg pathway 206 
Cholinergic 
synapse 
7.94 0.00035 0.004 69 kegg pathway 237 
Amphetamine 
addiction 
7.53 0.0005 0.006 37 kegg pathway 50 
Focal adhesion 7.13 0.0008 0.008 103 kegg pathway 5 
Circadian 
entrainment 
7.07 0.0008 0.008 56 kegg pathway 51 
Basal cell 
carcinoma 
7.02 0.0009 0.008 39 kegg pathway 35 
Dopaminergic 
synapse 
6.99 0.0009 0.008 68 kegg pathway 91 
Dilated 
cardiomyopathy 
6.34 0.002 0.01 53 kegg pathway 134 
Epstein-Barr virus 
infection 
6.05 0.002 0.02 113 kegg pathway 252 
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Cocaine addiction 5.92 0.003 0.02 28 kegg pathway 107 
Long-term 
potentiation 
5.88 0.003 0.02 35 kegg pathway 208 
Hedgehog 
signaling pathway 
5.32 0.005 0.03 33 kegg pathway 167 
Chronic myeloid 
leukemia 
5.17 0.006 0.03 42 kegg pathway 240 
Melanoma 5.17 0.006 0.03 42 kegg pathway 249 
Fc gamma R-
mediated 
phagocytosis 
5.16 0.006 0.03 45 kegg pathway 77 
Glioma 4.95 0.007 0.04 38 kegg pathway 161 
B cell receptor 
signaling pathway 
4.95 0.007 0.04 38 kegg pathway 188 
ECM-receptor 
interaction 
4.94 0.007 0.04 47 kegg pathway 41 
Glycosaminoglycan 
biosynthesis - 
chondroitin sulfate 
/ dermatan sulfate 
4.92 0.007 0.04 17 kegg pathway 248 
Other types of O- 4.92 0.007 0.04 17 kegg pathway 38 
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glycan biosynthesis 
PI3K-Akt signaling 
pathway 
4.74 0.009 0.04 166 kegg pathway 45 
Oocyte meiosis 4.69 0.009 0.04 60 kegg pathway 22 
T cell receptor 
signaling pathway 
4.6 0.01 0.046 54 kegg pathway 70 
Aminoacyl-tRNA 
biosynthesis 
4.59 0.01 0.046 27 kegg pathway 116 
Spliceosome 4.5 0.01 0.049 75 kegg pathway 131 
Small cell lung 
cancer 
4.48 0.01 0.049 42 kegg pathway 114 
Progesterone-
mediated oocyte 
maturation 
4.36 0.01 0.05 50 kegg pathway 254 
Legend: #, number.  
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Table 7. M
IR21 and M
IR210 D
N
A
 m
ethylation after four w
eeks of exercise training (q<0.05). 
Location in relation to 
  
D
N
A m
ethylation (%
) 
  
  
  
 
  
C
pG
 
C
losest 
gene 
G
ene region 
C
pG
 
island 
C
hr 
B
efore  
E
xercise 
A
fter 
exercise 
D
iff 
P-value 
q-value 
(≤0.005) 
cg27023597 
M
IR21 
TS1500 
O
pen 
Sea 
17 
67.4±3.6 
64.4±4.0 
-3 
0.007 
0.01 
cg04276626 
M
IR21 
TSS200 
O
pen 
Sea 
17 
79.3±3.4 
76 
-3.3 
0.008 
0.01 
cg02515217 
M
IR21 
TSS200 
O
pen 
Sea 
17 
80.0±2.4 
78.5±2.1 
-1.5 
0.009 
0.01 
cg07181702 
M
IR21 
B
ody 
O
pen 
17 
78.4±3.0 
74.6±3.9 
-3.8 
0.02 
0.03 
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Sea 
cg02471760 
M
IR210 
TSS1500 
S Shore 
11 
54.6±4.7 
50.4±4.6 
-4.2 
0.002 
0.004 
cg08200293 
M
IR210 
TSS1500 
Island 
11 
13.2±1.2 
11.8±2.1 
-1.4 
0.01 
0.02 
cg05858042 
M
IR210 
TSS1500 
Island 
11 
24.5±3.9 
21.7±5.1 
-2.7 
0.005 
0.009 
cg07410811 
M
IR210 
TSS1500 
Island 
11 
8.1±1.2 
6.7±1.5 
-1.4 
0.003 
0.007 
cg15482500 
M
IR210 
TSS200 
Island 
11 
11.6±0.7 
9.3±0.7 
-2.3 
9.39×10
-5 
0.0007 
 
cg01277369 
M
IR210 
TSS200 
Island 
11 
7.5±1.1 
6.2±0.9 
-1.3 
0.007 
0.01 
cg03880841 
M
IR210 
B
ody 
Island 
11 
18.5±0.01 
15.9±1.2 
-2.6 
 6.2×10
-5 
0.0005 
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D
ata are average beta-values ± standard deviation. 
Legend: C
hr, chrom
osom
e num
ber; D
iff, difference; TSS1500, 1500 bases upstream
 of transcription start site; TSS200, 200 bases upstream
 of 
transcription start site. 
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Abstract 
Aim: DNA methylation programs gene expression and is involved in numerous biological 
processes. Accumulating evidence supports transgenerational inheritance of DNA 
methylation changes in mammals via germ cells. Our aim was to determine the effect of 
exercise on sperm DNA methylation. 
Materials and Methods: Twenty-four men were recruited and assigned to an exercise 
intervention or control group. Clinical parameters were measured and sperm samples were 
donated by subjects before and after the three month time-period. Mature sperm global and 
genome-wide DNA methylation was assessed using an ELISA assay and the 450K BeadChip 
(Illumina). 
Results: Global and genome-wide sperm DNA methylation was altered after three months of 
exercise training. DNA methylation changes occurred in genes related to numerous diseases 
such as Schizophrenia and Parkinson’s disease.  
Conclusions: Our study provides the first evidence showing exercise training reprograms the 
sperm methylome. Whether these DNA methylation changes are inherited to future 
generations warrants attention. 
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Executive summary 
Aim 
• To determine the impact of exercise training on human sperm DNA methylation. 
Materials and Methods 
• Twenty-four healthy young men were recruited and allocated to an exercise training 
or control group. 
• Health and fitness parameters were measured and sperm samples were collected 
before and after three months. 
• Global and genome-wide DNA methylation was quantified using an ELISA assay and 
the Infinium HumanMethylation450 BeadChip (Illumina), respectively.  
• Significant alterations in CpG methylation and corresponding gene pathways 
modulated by exercise training were analysed using Partek (Genomic Suite). The 
disease association was performed using the Database for Annotation, Visualization 
and Integrated Discovery (DAVID). 
Discussion 
• Exercise training was associated with global demethylation of human sperm. 
•  DNA methylation changes occurred across the genome after exercise training in 
genes enriched for numerous developmental processes and pathways associated with 
the adaptation to exercise training.  
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• Genes related to disease were methylated after exercise, indicating transcriptional 
silencing. 
Conclusions 
• We provide the first evidence demonstrating exercise training regulates the human 
sperm methylome at CpG sites in genes associated with disease. 
 
 
 
Introduction 
DNA methylation is crucial for long-term gene expression regulation 41,585. DNA methylation 
is, however, reprogrammable through environmental conditions 586,587. Aberrant DNA 
methylation signatures are associated with age-related diseases such as cancer 588-590, 
atherosclerosis 53,591, type 2 diabetes mellitus 51,592, Alzheimer’s disease 593 and major 
psychosis disorders 594,595.  
Mounting evidence indicates that environmentally induced DNA methylation changes are 
inherited by subsequent generations and affects their phenotypes 58,59,596-601. A likely 
mechanism for inheritance of DNA methylation profile is via the germ cells. Interestingly, 
aging is associated with sperm DNA methylation changes and may influence disease risk of 
future generations 602,603. The differentially methylated regions in sperm obtained from old 
(12–14 month-old) versus young (3-month-old) mice were observed in the brain of the 
subsequent offspring, causing altered gene expression and increased behaviors associated 
with psychiatric disorders (schizophrenia and autism spectrum disorder) 603. Although aging 
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has been investigated in context with sperm DNA methylation, the influence of other 
favorable environmental stimuli are yet to be determined.  
We recently found that exercise training significantly improves cardiorespiratory fitness and 
lipid profile in conjunction with genome-wide leukocyte methylation changes in young men 
604. Others have shown that exercise training modulates skeletal myocyte 522,605,606 and 
adipocyte 523 DNA methylation as well as improving health and fitness phenotypes. Thus, 
somatic cells are vulnerable to epigenetic changes caused by exercise training, but whether 
exercise training regulates DNA methylation is germ cells (oocyte or sperm) is currently 
unknown. 
The aim of this study was to determine the impact of exercise training on human sperm DNA 
methylation. Considering the mounting evidence supporting exercise training as an 
environmental modulator of somatic cell DNA methylation 522,523,604-606, we hypothesized that 
exercise training would significantly modify sperm DNA methylation in genes related to 
human diseases. 
 
Materials and methods 
Subjects 
Twenty-four healthy young men were recruited for this study. Subjects were non-smoking, 
not taking any medications and free from any age-related chronic diseases, according to self-
administered health questionnaires. Subjects were eligible if they had not engaged in any 
structured high-intensity aerobic exercise training during the past six months and were 
recruited predominantly from the University by flyers and by word-of-mouth.  
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The subjects’ characteristics are outlined in Table 1. All subjects gave written informed 
consent to participate and this study was approved by the Federation University Australia 
Human Research Ethics Committee. 
Procedures 
On the initial day of testing, subjects were asked to complete health and physical activity 
questionnaires in order to establish their eligibility to participate in the study. Subjects were 
also familiarized with the testing procedures to follow and were given a collection tube for 
their sperm donation.  
The second testing session involved a sperm donation, blood donation, physical measures and 
a test of maximal oxygen uptake (VO2max) on a treadmill. All testing sessions were performed 
in the morning (7–10 AM). Height, weight and body mass index were recorded using scales 
and a stadiometer. Blood pressure was measured and augmentation index was assessed by 
non-invasive applanation tonometry using the SphygmoCor instrument (AtCor, Australia). 
Subjects completed a maximal treadmill exercise test to assess VO2max. After a three minute 
warm-up, subjects began running at 10 km.h-1 and the treadmill speed was progressively 
increased by 1 km.h-1 every second minute until the volitional exhaustion or the supervising 
Exercise Physiologist deemed it appropriate to stop the test. Participants were fitted with a 
two-way breathing valve (Hans Rudolph) and breath-by-breath analysis was performed by 
the online metabolic system (Moxus, Modular, USA). VO2max was determined as the highest 
O2 value averaged over 60 s. Maximal treadmill speed was deemed the highest speed 
successfully completed and was adjusted for time so that participants were encouraged to 
exercise to their limit. The same testing procedures were completed 3–5 days after the cases’ 
final exercise session or three months after their initial donation for controls. 
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Sperm and blood processing 
Subjects gave resting preprandial sperm and blood donations before and after the three month 
exercise intervention. Following an overnight fast, subjects extracted their sperm by 
masturbating at home and donated their sample to the researchers at the University within 30 
min of extraction. All sperm donations and analyses were performed according the World 
Health Organization’s recommendations. Sperm cell number and vitality was assessed by the 
same researcher using a sheep-counter. Mature, motile sperm were isolated from 
lymphocytes, epithelial cells, immature or abnormal sperm and other cellular debris using the 
PureSperm 40/80 reagents (Nidacon). Briefly, 2 ml of PureSperm 40 was carefully layered on 
top of PureSperm 80, followed by gently aliquoting 1.5 ml of ejaculate onto the density 
gradient. The density gradient was spun at 300 G for 20 min. The mature sperm were pelleted 
and supernatant was removed. The pellet was washed twice by resuspending it in 5 ml of 
PBS before being spun at 500 G for 10 min. DNA was extracted from mature sperm 
suspended in 200 µl of PBS using the Purelink Genomic DNA Mini kit (LifeTechnologies) 
following the manufacturer’s recommendations with some small adjustments. To deform the 
tightly packaged DNA in mature sperm, 0.03 mmol of DL-Dithiothreitol solution (Sigma-
Aldrich) was added to the sample before the addition of proteinase K solution and the protein 
digestion step (incubation at 55°C) was extended from the recommended 10 min to 90 min. 
All extractions were performed immediately after sperm donation to prevent any temporal de 
novo influences on DNA methylation. DNA yield was assessed using the Nanodrop 2000 
Spectrophotometer (Thermo Scientific) before being stored at -20°C. 
A preprandial blood sample (24 ml) was drawn from the antecubital vein into serum 
separating tubes with the subject seated, using standard phlebotomy procedures. Blood was 
immediately stored on ice before further processing. Blood lipid assays were performed as 
described previously 604.  
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Global DNA methylation analysis 
Average global DNA methylation of sperm from all subjects was quantified using the 5-mC 
ELISA Kit (Zymo Research, USA). All experiments were performed according to the 
manufacturer’s procedures. All paired samples before and after the intervention were run on 
the same plate, as well as 100% methylated and 0% methylated controls, all run in duplicate 
with a standard curve. Absorbance was measured at 450 nm using the Multiskan FC 
Microplate Photometer (Thermo Scientific, Australia) and average DNA methylation was 
calculated using the formula generated from the standard curve. The average intra-assay 
coefficient of variation for duplicate samples was 4.85%. 
Genome-wide DNA methylation analysis 
Genome-wide sperm DNA methylation was quantified in 12 cases before and after the 
exercise intervention using the Infinium HumanMethylation 450K BeadChip (Illumina) as 
previously described 604. Experiments were conducted following the manufacturer’s 
guidelines, with the help of the Busselton Population Medical Research Institute. Briefly, raw 
β-values underwent Subset-quantile Within Array Normalization (SWAN) and were 
transformed to M-values using the logit function (log2 (β/(1- β))) before analyzing 
differentially methylated CpG sites after exercise training. M-values were converted to β-
values for representation of differentially methylated CpG sites in tables and graphs because 
they correspond to the percentage of CpG methylation and are a good biologically relevant 
representation. Genome-wide DNA methylation data was analyzed using Partek (Genomic 
Suite, version 6.6). 
Exercise training 
Subjects were randomly allocated to either an exercise training (cases) or control group. 
Cases completed sprint interval training twice weekly for three months. Three months of 
exercise training was chosen because it covered one human spermatogenesis cycle. The 
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controls did not engage in any form of training but were asked not to deviate from their 
routine physical activity habits. All subjects were asked to adhere to their normal diet. The 
sprint interval training schedule is outlined in Table 2. Sprint interval training is an effective 
type of exercise training that rapidly improves cardiorespiratory fitness and endurance 
performance 531,607-609.  
The exercise training protocol of this study was based on research shown to improve 
cardiorespiratory fitness and endurance performance 604,610, but with some adjustments, to 
avoid overuse injuries that could occur with an extended training period (three months). 
Subjects completed 30 s sprints at maximal intensity with a passive four minute rest period 
between efforts. Training began with three sprints and was progressed by one effort every 
fortnight until week 7, when sprints were kept at six efforts for the remaining six weeks of the 
intervention. Before each session, subjects completed a short warm-up entailing a light 5 min 
jog, dynamic stretches and some 20 m sprints at 70, 80, 90 and 100% of maximal effort. 
Training was performed on the University’s athletics oval and subjects were supervised and 
given constant encouragement during sprints by an Exercise Physiologist. 
Statistical analyses 
Kolmogorov-Smirnov and Shapiro-Wilks were performed to assess normality. Two-tailed 
paired t-tests were used to assess within-subject changes to physical, health and fitness 
variables. A repeated measures ANOVA was used to determine the interaction between 
global sperm DNA methylation before and after the intervention in relation to cases and 
controls using IBM SPSS for Windows (version 21). Differentially methylated CpG sites in 
cases were determined by repeated measures ANOVA using Partek (Genomic Suite, version 
6.6). In order to control for false positives, a false discovery rate correction (FDR, q≤0.1) was 
applied to genome-wide data by converting p-values to q-values. Hierarchical clustering, 
gene ontology and pathway analysis on genome-wide CpG methylation data were performed 
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using Partek (Genomic Suite, version 6.6). Disease annotation analysis was conducted using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID, version 6.7). 
Statistical significance was set at p<0.05. 
 
Results  
Exercise training improved cardiorespiratory fitness 
To determine whether exercise training alters human sperm DNA methylation, 13 untrained 
male volunteers completed three months of exercise training using a modified training 
protocol (Table 2) previously shown to improve cardiorespiratory fitness and induce genome-
wide DNA methylation changes in leukocytes 604. Although VO2max was unchanged (2.2%, 
p=0.35), relative to baseline, the cases, on average, had a significantly lower resting heart rate 
by 10 beats.min-1 and completed an extra one min at a significantly higher maximal treadmill 
speed (p=0.01 and p=0.002, respectively), while controls showed no significant changes in 
these variables (Table 1).  
To assess whether exercise training influences average sperm DNA methylation, we assessed 
global sperm DNA methylation in cases and controls using ELISA-based chemistry. After 
adjusting for ELISA plate, relative to the unchanged global sperm DNA methylation 
observed in controls (n=11, 4.09%), sperm DNA was significantly de-methylated after three 
months of exercise training (n=13, -6.63%, interaction p=0.006) (Figure 1A and B). 
Based on the global DNA methylation results we only quantified genome-wide sperm DNA 
methylation in 12 cases before and after three months of exercise training using the 450K 
BeadChip (Illumina). After applying a FDR (q≤0.1), we found DNA methylation changes 
occurred throughout the genome in relation to the nearest gene and CpG islands (Figure 1C 
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and D). Of these, 7509 CpG sites relating to 4602 genes had significant DNA methylation 
changes ranging from 0.3 to 6.2% after exercise training (Figure 1E and 2). More CpG sites 
were demethylated rather than methylated after exercise training (4275 vs 3233, 
respectively). The top 25 methylated and demethylated CpG sites after exercise training are 
outlined in Table 3. 
To gain insight into the biological impact of the CpG methylation changes following 
exercise, we performed gene ontology and pathway analysis. Genes with altered CpG 
methylation were those enriched for crucial biological processes including developmental 
process, anatomical structure, embryonic morphogenesis and organ development (Figure 3 
and Supplementary Table 1). Pathway analysis revealed genes with CpG site DNA 
methylation changes were enriched for pathways such as MAPK signaling, PI3K-Akt 
signaling, pathways in cancer and ErbB signaling (Table 4).  
In the search for the most biologically relevant CpG methylation changes, we focused on 
CpG sites with a ≥1.5% increase (n=703) or decrease (n=1247) in methylation after exercise 
training and entered them into DAVID for disease annotation analysis. While genes with 
demethylated CpG sites were those relating to normal variation, those with increased 
methylation were enriched for numerous diseases, with the most overrepresented diseases 
being Schizophrenia, Parkinson’s Disease, autism, cervical cancer and leukemia (Figure 4).  
The global erasure of sperm CpG methylation that occurs after fertilization is well established 
611-613. The sperm CpG methylation at imprinted genes, however, are resistant to the global 
erasure after fertilization 614,615 and as such, these genes are key candidates for possible 
transgenerational inheritance through sperm. We found 16 paternally imprinted genes were 
differentially methylated after the three month exercise training intervention (Table 5), in 
genes associated with pathologies including EKG abnormalities (KCNQ1OT1 and KCNQ1), 
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autism and alcohol dependence (GABRG3), Tourette syndrome, obsessive compulsive 
disorder and dystonia (SGCE), and Alzheimer’s disease, obesity, type 2 diabetes mellitus, 
blood pressure and atherosclerosis (IGF2 and INS-IGF2).  
 
Discussion 
Unlike the genome, the epigenome is malleable to changing environments and these changes 
are somewhat heritable 586,587. Germ cells (sperm and oocytes) are likely vectors that transfer 
environmentally-affected DNA methylation profiles to future generations. We are the first to 
show the exercise training-induced DNA methylation changes in human sperm. We found 
exercise training significantly manipulated genome-wide DNA methylation and most 
strikingly, increased methylation in disease-associated genes indicating transcriptional 
silencing. Moreover, methylation changes occurred in paternally imprinted genes that are 
exempt from the DNA methylation erasure after fertilization 614,615. 
Mounting evidence has demonstrated the capacity of exercise training to influence the human 
DNA methylome in numerous tissues, including skeletal myocytes 522,605,606, adipocytes 523 
and leukocytes 604. Exercise training or increased physical activity tends to be associated with 
a reduced level of somatic cell global DNA methylation. Leukocyte DNA methylation was 
anti-correlated to levels of physical activity in 509 older adults (>70 y) 550 and we previously 
reported more demethylated leukocyte CpG sites in response to a four week exercise training 
intervention in young men 604. Furthermore, global and gene-specific demethylation occurred 
after acute exercise in human skeletal myocytes 526. In the present study, we found global 
sperm DNA methylation was reduced after three months of exercise training, suggesting that 
exercise may systemically demethylate both somatic and germ cells. Interestingly, older 
adults have more heavily methylated global sperm DNA compared to their younger 
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counterparts 602,616. Also defective human sperm exhibit nearly two-fold higher levels of 
global DNA methylation 617. To that end, the global demethylation observed in our subjects 
after exercise training could be favorable, possibly counteracting the increased DNA 
methylation associated with ageing. This, in turn, could positively influence fertility though 
future studies are necessary. 
Interestingly, exercise training was associated with sperm methylation changes to CpG sites 
in genes related to pathways and biological processes similar to those observed in skeletal 
muscle 522 and leukocytes 604 from previous studies. For example, pathways regulated by 
exercise training-induced leukocyte DNA methylation alterations 604 that were also observed 
in sperm include MAPK signaling, PI3K-Akt signaling and pathways in cancer. Similarly, 
overlapping pathways between skeletal muscle 522 and sperm pathways modulated by 
exercise training include MAPK signaling, insulin signaling and ErbB signaling. Therefore, it 
would seem that some exercise-responsive genes (CpG sites) are regulated by DNA 
methylation in human somatic cells and also in sperm. 
The genes with CpG methylation changes in the present study were enriched for numerous 
molecular and cellular processes including anatomical structure development and 
morphogenesis, single-organism development and embryonic morphogenesis. Genes with 
exercise-induced CpG methylation changes were also associated with many debilitating 
diseases such as Schizophrenia, Parkinson’s disease, cervical cancer, leukemia and autism. 
The genes associated with diseases were methylated after exercise training, indicating that 
these genes may have been transcriptionally silenced. Age-associated sperm CpG 
methylation patterns were observed in genes implicated in Schizophrenia in humans 602 and 
mice 603. Some of the adverse DNA methylation patterns found in sperm of aged mice was 
transmitted to the brain of their offspring, leading to transcriptional dysregulation of genes 
involved in schizophrenia and autism, facilitating the disease-related traits 603. Furthermore, 
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offspring (F1 to F3) of gestating female rats treated with endocrine disruptors (bisphenol-A, 
bis[2-ethlhexyl]phthalate and dibutyl phthalate and vinclozolin) have altered sperm DNA 
methylation and an increased risk of testis disease, obesity and infertility 58,66,467. These 
environmentally-induced DNA methylation aberrations led to transcriptional changes in 
common pathways across numerous somatic cells, including those regulated in the present 
study (MAPK signaling, insulin signaling and pathways in cancer) 618. Whether the altered 
sperm DNA methylation observed in our subjects will be transmitted to their offspring and 
prevent the development of disease is speculative and would require large human studies 
involving the analysis of multiple generations.  
Germ cells undergo global demethylation following fertilization 611,615. Consequently, the 
likelihood of such CpG methylation changes surviving this demethylation event is uncertain. 
We did, however, reveal a number of paternally imprinted genes (e.g. IGF2, INS-IGF2, 
SGCE and GABRG3) had differentially methylated CpGs after exercise training. These genes 
are exempt from the global demethylation after fertilization 614,615 and as such, are key 
candidates for exercise-induced transgenerational inheritance of DNA methylation gene 
programming. Our disease analysis using DAVID revealed the differentially methylated 
paternally imprinted genes after exercise training were related to neurological disorders 
(autism, Alzheimer’s disease, Tourette’s syndrome and obsessive compulsive disorder) and 
cardio-metabolic diseases (obesity, type 2 diabetes mellitus, high blood pressure and 
atherosclerosis). Whilst no evidence exists, it is tempting to speculate that exercise training 
may remodel the sperm methylome and that this epigenetic modification may reduce the 
disease risk of offspring. 
DNA methyltransferase enzymes (DNMT1, DNMT3A, DNMT3B and DNMT3L) as well as 
ten-eleven translocation (TET1, TET2 and TET3) proteins could be modulated by exercise 
training leading to altered DNA methylation. Our study was not designed to target the exact 
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physiological or molecular mechanism by which exercise training influences DNA 
methylation in sperm, rather it was designed to investigate whether exercise training 
influences sperm DNA methylation. Therefore, further research is required to identify the 
molecular mechanisms evoking the changes in the sperm methylome after exercise training. 
Our study has several limitations. Firstly, our study had a modest sample size and there was a 
statistically different global sperm DNA methylation between cases and controls at baseline. 
While we acknowledge this is not desirable, our statistical analysis accounted for the 
observed difference.  We do, however, recommend that our results should be verified in a 
larger population. The relative exercise workload was not standardized. We did, however, ask 
that all subjects perform each sprint maximally without pacing to ensure they are working at 
maximal intensity. Certain diets are associated with DNA methylation levels in somatic cells 
533,619. Despite asking our subjects not to deviate from their routine dietary habits, the lack of 
control for diet in our study should also be acknowledged. Finally, we did not control for 
genotype-DNA methylation interactions or quantify DNA methylation in context with other 
epigenetic modifications or gene expression. Nonetheless, our novel finding that exercise 
alters human sperm DNA methylation should encourage future investigations into the 
influence of exercise training on germ cell epigenetic modifications and gene regulation.  
 
Conclusions 
We report for the first time that exercise training significantly modifies the human sperm 
methylome. Whilst exercise training was associated with an increased global sperm 
demethylation overall, methylation in key genes associated with human disease was increased 
indicating transcriptional silencing of these genes.  
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Figure Legends 
 
Figure 1. Sperm DNA methylation changes after exercise training. Average percent 
(±SE) of global sperm DNA methylation is given for 13 cases (A) and 11 controls (B) after 
the three month intervention. Relative to the controls who showed no global methylation 
change, cases exhibited a global demethylation (-6.63%) after three months of exercise 
training (mean±SE: 39.1±3.85 to 43.2±3.6 and 52.95±3.56 to 46.3±3.4, respectively, 
interaction p=0.006). Data are from repeated measures ANOVA adjusting for ELISA plate 
number. Genome-wide DNA methylation changes at CpG sites in relation to the nearest gene 
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(C) and CpG islands (D) are shown. Data are from Chi2 tests. E) The number of CpG sites 
with increased methylation (black bars) and decreased methylation (grey bars) are given on 
the y-axis with the magnitude of change illustrated on the x-axis. Data are from differentially 
methylated CpG sites (q≤0.1).  
 
 
 
 
Figures 
 
Figure 2. Hierarchical clustering of CpG sites after three months of exercise training. 
The CpG methylation status is indicated by blue (low methylation) and yellow (high 
methylation) from 12 subjects before (grey bar) and after (purple bar) three months of 
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exercise training. Each branch of the array tree on the left of the purple and grey bars are 
subjects. The array tree at the top of the hierarchical cluster indicates clusters of CpG sites 
modified by exercise training. Data are from differentially methylated CpG sites (q≤0.1). 
  
Figure 3. Gene ontology for genes with differentially methylated CpG sites after 
exercise training. Genes with altered CpG site methylation after exercise are grouped for 
function on the y-axis with corresponding enrichment scores on the x-axis. Data are from 
differentially methylated CpG sites (q≤0.1). 
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Figure 4. Disease annotation analysis for genes with differentially methylated CpG sites 
after exercise training. Data are from genes with a ≥1.5% increase or decrease in 
methylation after exercise training (q≤0.1). The y-axis represents the number of genes for 
each annotated disease (x-axis). 
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Table 1.  Participant characteristics before and after three months of exercise training. 
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Variable Cases  
(n=13) 
 Controls 
(n=11) 
 Before 
Exercise 
After 
Exercise 
 Before After 
Age (y) 24.4±5.19  22.45±4.74 
Ht (cm) 181.1±6.54  177.95±4.07 
Wt (kg) 83.58±10.7 84.01±11.97  82.22±11.83 82.93±10.64 
BMI (Wt/Ht2) 25.53±3.34 25.89±3.61  25.94±3.5 25.9±3.08 
HR (beats.min-1) 78.54±15.64 68.23±7.15*  68.18±11.58 66.45±8.19 
SBP (mm Hg) 130.46±11.82 129.85±10.64  123.45±9.2 123.09±10.24 
DBP (mm Hg) 77.23±9.87 76.38±7.85  75.82±8.51 72.27±7.14 
CSBP (mm Hg) 110.92±9.86 111.08±8.43  106.91±8.38 105.72±9.32 
CDBP (mm Hg) 76.08±17.35 77.69±7.77  76.36±8.64 73.64±7.38 
Aix (%) -4.15±9.73 -4.15±8.73  -2.36±12.8 -1.18±11.71 
Cholesterol 
(mmol/l)^ 
4.82±0.88 4.77±1.04  4.01±1.0 3.97±0.77 
Triglyceride 
(mmol/l)^ 
1.01±0.48 1.07±0.46  0.9±0.38 0.82±0.18 
HDLC (mmol/l)^ 1.43±0.25 1.43±0.3  1.37±0.2 1.29±0.14 
LDLC (mmol/l)^ 2.92±0.79 2.87±0.88  2.22±0.75 2.32±0.74 
Glucose (mmol/l)^ 4.78±0.38 5.22±0.52  4.9±0.46 4.92±0.31 
Insulin (mmol/l)^ 6.94±2.72 10.72±6.44  7.15±3.65 12.78±16.42 !O2max (ml.kg.min-1) 47.43±5.64 48.47±6.0  45.85±7.34 44.92±5.49 
Maximal treadmill 
speed (km.h-1) 
14.4±1.12 14.9±1.11**  14.07±1.52 13.84±1.8 
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Legend: Ht, height; Wt, weight; BMI, body mass index; HR, resting heart rate; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; CSBP, central (aortic) blood pressure; CDBP, 
central (aortic) diastolic blood pressure; augmentation index; HDLC, high-density lipo-
protein cholesterol; LDLC, low-density lipoprotein cholesterol; VO2max, maximal oxygen 
uptake; ^, n=8; #, number; %, percentage. Data are from two-tailed paired t-test and 
expressed as mean±SD. Sperm analysis was conducted on semen samples and not from 
highly motile sperm isolated using the PureSperm 40/80 reagents (Nidacon). 
 
 
 
 
 
 
 
 
Sperm volume (ml) 4.7±1.4 5.17±0.87  3.95±1.7 3.97±1.79 
Sperm # 1.35×109± 
1.21×109 
1.39×109± 
1.41×109 
 1.58×109± 
1.56×109 
1.33×109± 
1.39×109 
Sperm alive (n) 9.12×108± 
1.09×109 
9.08×108± 
1.02×109 
 8.36×108± 
1.07×109 
6.05×108± 
4.68×108 
Sperm alive (%) 61.65±24.42 62.72±13.77  48.26±23.26 53.89±14.14 
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Table 2. Description of the three month exercise program.  
Week Session # Training load* Training sprint time (min) Total session time (min) 
1 1 3 sprints 1.5 9.5 
 
2 3 sprints 1.5 9.5 
2 3 3 sprints 1.5 9.5 
 
4 3 sprints 1.5 9.5 
3 5 4 sprints 2 14 
 
6 4 sprints 2 14 
4 7 4 sprints 2 14 
 
8 4 sprints 2 14 
5 9 5 sprints 2.5 18.5 
 10 5 sprints 2.5 18.5 
6 11 5 sprints 2.5 18.5 
 12 5 sprints 2.5 18.5 
7 13 6 sprints 3 23 
 14 6 sprints 3 23 
8 15 6 sprints 3 23 
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 16 6 sprints 3 23 
9 17 6 sprints 3 23 
 18 6 sprints 3 23 
10 19 6 sprints 3 23 
 20 6 sprints 3 23 
11 21 6 sprints 3 23 
 22 6 sprints 3 23 
12 23 6 sprints 3 23 
 24 6 sprints 3 23 
  Total Time 120 60 454 
Legend: # number; * all sprints were completed at maximum intensity, separated by a four 
minute passive recovery.
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Table 3. D
N
A
 m
ethylation changes after three m
onths of exercise training (q≤0.1). 
Location in relation to 
 
D
N
A m
ethylation (%
) 
 
 
 
 
 
 
 
C
pG
 site 
C
losest 
gene 
G
ene 
region 
C
pG
 
island 
C
hr 
B
efore 
(m
ean±SD
) 
A
fter 
exercise 
(m
ean±SD
) 
Δ 
p-value 
q-value 
(≤0.1) 
cg02598618 
- 
- 
O
pen sea 
10 
94.0±1.4 
98.6±1.1 
4.6 
1.79×10
-5 
0.06 
cg02655397 
- 
- 
N
 shelf 
11 
80.7±4.4 
85.1±3.3 
4.5 
0.0005 
0.08 
cg10243075 
C
AC
N
A1A 
B
ody 
N
 shore 
19 
23.2±3.6 
27.6±5.0 
4.4 
0.0004 
0.08 
cg27222157 
RBM
14 
TSS1500 
N
 shore 
11 
22.2±6.8 
26.5±8.5 
4.4 
0.0009 
0.08 
cg10413297 
RFPL3S 
TSS1500 
O
pen sea 
22 
25.6±6.7 
29.7±6.6 
4.1 
0.001 
0.09 
cg16533336 
W
BSC
R17 
B
ody 
O
pen sea 
7 
76.7±2.6 
80.8±2.3 
4.1 
1.17×10
-7 
0.02 
cg09194930 
M
T1L 
TSS200 
Island 
16 
14.7±9.5 
18.8±12.7 
4.1 
0.001 
0.09 
cg00685853 
- 
- 
N
 shore 
2 
14.4±3.9 
18.4±6.2 
4.0 
0.0001 
0.07 
cg27205941 
G
M
D
S 
TSS200 
Island 
6 
29.0±4.1 
32.9±3.5 
4.0 
0.001 
0.09 
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cg17745251 
C
10orf140 
B
ody 
Island 
10 
25.0±2.7 
29.0±3.0 
4.0 
0.002 
0.09 
cg25485435 
RAM
P1 
TSS1500 
N
 shore 
2 
16.9±3.5 
20.8±3.0 
3.9 
0.0002 
0.07 
cg11888420 
- 
- 
O
pen sea 
6 
33.0±2.7 
36.8±4.6 
3.8 
0.001 
0.09 
cg08715827 
- 
- 
O
pen sea 
12 
6.1±2.3 
9.8±5.8 
3.8 
0.001 
0.09 
cg15617548 
G
O
RASP2 
5'U
TR
 
1stExon 
Island 
2 
23.5±2.8 
27.1±2.8 
3.7 
0.0009 
0.08 
cg15488194 
M
BN
L1 
TSS1500 
5'U
TR
 
O
pen sea 
3 
23.9±11.9 
27.5±12.8 
3.7 
0.002 
0.097 
cg17271592 
H
IST2H
2AA4 
H
IST2H
2AA3 
TSS1500 
Island 
1 
13.8±3.1 
17.4±2.6 
3.6 
0.0006 
0.08 
cg06785129 
RFPL3 
TSS1500 
O
pen sea 
22 
18.6±3.2 
22.2±4.2 
3.6 
0.002 
0.09 
cg14047339 
RU
N
X2 
 SU
PT3H
 
B
ody  
5'U
TR
 
1stExon 
5'U
TR
 
Island 
6 
33.7±2.2 
37.3±2.9 
3.6 
0.002 
0.09 
cg13916261 
FN
BP1 
B
ody 
N
 shelf 
9 
24.4±3.9 
27.9±4.9 
3.5 
0.0003 
0.08 
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cg09303484 
- 
- 
O
pen sea 
7 
63.3±4.3 
66.8±3.6 
3.5 
0.0008 
0.08 
cg05528975 
- 
- 
O
pen sea 
2 
25.9±2.5 
29.4±3.1 
3.5 
0.0005 
0.08 
cg17627829 
H
C
G
18 
B
ody 
N
 shore 
6 
9.5±3.4 
13.0±4.1 
3.5 
0.002 
0.09 
cg05629323 
TFD
P3 
3'U
TR
 
1stExon 
O
pen sea 
X
 
8.8±2.7 
12.3±4.4 
3.5 
0.002 
0.09 
cg20681184 
PIK
3C
D
 
5'U
TR
 
S shore 
1 
14.5±2.8 
18.0±4.5 
3.5 
0.002 
0.09 
cg15069995 
H
O
RM
AD
1 
5'U
TR
 
O
pen sea 
1 
5.9±2.1 
9.3±3.9 
3.4 
0.0009 
0.08 
cg13062455 
SEL1L 
B
ody 
O
pen sea 
14 
88.2±2.3 
85.4±3.3 
-2.9 
1.27×10
-5 
0.05 
cg24360197 
- 
- 
O
pen sea 
15 
70.1±8.4 
67.2±7.9 
-2.9 
0.001 
0.09 
cg03359503 
C
LIC
2 
5'U
TR
 
1
st Exon 
O
pen sea 
X
 
87.7±4.1 
84.7±.5 
-3.0 
0.0009 
0.08 
cg24121979 
- 
- 
O
pen sea 
12 
94.9±3.2 
91.9±2.0 
-3.0 
0.0003 
0.08 
cg20909579 
PD
E6B 
TSS1500 
B
ody 
Island 
4 
89.6±2.9 
86.6±5.4 
-3.0 
0.0008 
0.08 
cg02507663 
N
C
RN
A00219 
SN
O
RA13 
B
ody 
TSS200 
S shore 
5 
54.9±8.4 
51.9±8.4 
-3.0 
0.001 
0.09 
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cg27569203 
C
ELSR1 
B
ody 
Island 
22 
90.2±2.4 
87.3±1.6 
-3.0 
0.002 
0.09 
cg26235273 
D
K
K
3 
3'U
TR
 
O
pen sea 
11 
71.0±4.0 
67.8±3.8 
-3.1 
0.0006 
0.08 
cg17518550 
C
1orf150 
TSS200 
O
pen sea 
1 
82.3±4.0 
79.2±6.4 
-3.1 
0.001 
0.09 
cg16514287 
SLC
25A36 
B
ody 
O
pen sea 
3 
94.0±1.4 
90.8±1.1 
-3.1 
1.7×10
-6 
0.03 
cg26057840† 
- 
- 
N
 shore 
20 
89.4±2.7 
86.2±2.6 
-3.2 
0.0005 
0.08 
cg24544876 
- 
- 
S shore 
5 
78.3±3.3 
75.1±2.5 
-3.2 
0.0008 
0.08 
cg14630692 
U
RM
1 
B
ody 
O
pen sea 
9 
86.4±1.7 
83.2±2.4 
-3.2 
0.001 
0.09 
cg03440485 
- 
- 
Island 
X
 
22.9±2.3 
19.7±2.1 
-3.2 
0.001 
0.09 
cg15832577‡ 
C
1orf53 
B
ody 
S shore 
1 
78.6±2.5 
75.3±3.2 
-3.3 
0.0002 
0.07 
cg17494438 
D
RG
X 
TSS1500 
N
 shelf 
10 
82.6±1.8 
79.2±2.8 
-3.3 
0.001 
0.09 
cg16320838 
D
N
AJB7 
XPN
PEP3 
TSS1500 
B
ody 
O
pen sea 
22 
92.5±14.5 
89.0±19.1 
-3.5 
0.0005 
0.08 
cg11342670 
K
IAA0319 
B
ody 
O
pen sea 
6 
78.9±9.3 
75.5±10.3 
-3.5 
0.001 
0.09 
cg03987985 
L1TD
1 
3'U
TR
 
O
pen sea 
1 
75.6±4.6 
72.0±5.6 
-3.6 
0.001 
0.09 
cg08377570 
LPAR6 
RB1 
TSS1500 
B
ody 
O
pen sea 
13 
87.5±2.1 
83.8±2.5 
-3.7 
0.0005 
0.07 
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        cg17486639 
- 
- 
N
 shelf 
19 
89.8±1.6 
86.0±3.1 
-3.8 
0.0006 
0.08 
cg03834767 
C
D
K
14 
3'U
TR
 
O
pen sea 
7 
90.6±2.0 
86.4±6.0 
-4.1 
0.002 
0.09 
cg16631698 
- 
- 
Island 
10 
81.7±4.2 
77.2±2.3 
-4.5 
0.002 
0.09 
cg08269188 
C
BX5 
5'U
TR
 
O
pen sea 
12 
83.7±2.7 
79.0±4.5 
-4.7 
5.17×10
-5 
0.06 
cg05946920 
G
G
A1 
B
ody 
Island 
22 
39.7±6.7 
33.6±3.4 
-6.2 
0.002 
0.096 
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 D
ata are expressed are beta values ± standard deviation. 
Legend: C
hr, chrom
osom
e num
ber; Δ, difference; 3’, three prim
e; 5’, five prim
e; U
TR
, untranslated region; TSS1500, 1500 bases upstream
 of 
transcription start site; TSS200, 200 bases upstream
 of transcription start site; *D
M
R
, differentially m
ethylated region; †C
D
M
R
, cancer 
differentially m
ethylated region; ‡R
D
M
R
, reprogram
m
ed differentially m
ethylated region.
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Table 4. Molecular pathways related to genes with differentially methylated CpG sites after 
exercise training (p≤0.05). 
Pathway Name Enrichment  
Score 
p-value # genes  Pathway ID 
Circadian entrainment  8.0 0.0003 24 kegg pathway 51 
Axon guidance 7.2 0.001 29 kegg pathway 176 
Endocytosis 7.0 0.001 39 kegg pathway 211 
Glutamatergic synapse 6.1 0.002 25 kegg pathway 182 
Protein digestion and absorption 5.9 0.003 22 kegg pathway 46 
ECM-receptor interaction 5.4 0.004 19 kegg pathway 41 
GABAergic synapse 4.7 0.01 22 kegg pathway 133 
Bile secretion 4.4 0.01 18 kegg pathway 74 
MAPK signaling pathway 4.4 0.01 41 kegg pathway 119 
Focal adhesion 4.3 0.01 34 kegg pathway 5 
PI3K-Akt signaling pathway 4.3 0.01 54 kegg pathway 45 
Huntington's disease 4.3 0.01 33 kegg pathway 53 
Transcriptional misregulation in 
cancer 
4.3 0.01 31 kegg pathway 94 
African trypanosomiasis 4.1 0.02 10 kegg pathway 69 
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Colorectal cancer 4.1 0.02 13 kegg pathway 148 
Viral myocarditis 3.9 0.02 15 kegg pathway 105 
Taurine and hypotaurine 
metabolism 
3.7 0.02 4 kegg pathway 195 
Galactose metabolism 3.7 0.03 8 kegg pathway 15 
Long-term depression 3.6 0.03 12 kegg pathway 250 
Endocrine and other factor-
regulated calcium reabsorption 
3.6 0.03 10 kegg pathway 258 
Retrograde endocannabinoid 
signaling 
3.6 0.03 21 kegg pathway 129 
Glycosaminoglycan 
biosynthesis - chondroitin 
sulfate / dermatan sulfate 
3.4 0.03 7 kegg pathway 248 
Nicotine addiction 3.4 0.03 10 kegg pathway 62 
Allograft rejection 3.4 0.03 10 kegg pathway 177 
Selenocompound metabolism 3.4 0.04 5 kegg pathway 135 
Morphine addiction 3.2 0.04 20 kegg pathway 86 
Amoebiasis 3.2 0.04 21 kegg pathway 56 
Graft-versus-host disease 3.1 0.04 10 kegg pathway 209 
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Maturity onset diabetes of the 
young 
3.1 0.04 7 kegg pathway 241 
Pathways in cancer 3.1 0.05 49 kegg pathway 128 
ErbB signaling pathway 3.1 0.05 15 kegg pathway 121 
Type I diabetes mellitus 2.9 0.05 10 kegg pathway 242 
Insulin secretion 2.9 0.05 17 kegg pathway 4 
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Table 5. Paternally im
printed gene C
pG
 m
ethylation changes caused by exercise training. 
 
Location in relation to 
 
D
N
A m
ethylation (%
) 
 
 
 
 
 
 
 
Paternally im
printed gene 
C
pG
 site 
G
ene 
region 
C
pG
 
island 
C
hr 
B
asal 
(m
ean±SD
) 
A
fter 
exercise 
(m
ean±SD
) 
Δ 
p-value 
q-value 
(≤0.1) 
G
RB10 
cg12358041 
5'U
TR
 
B
ody 
O
pen sea 
7 
92.3±1.2 
91.0±1.2 
-1.3 
0.0004 
0.08 
 
cg26050906 
5'U
TR
 
TSS200 
O
pen sea 
7 
91.8±1.1 
90.9±1.1 
-0.9 
0.003 
0.10 
SG
C
E 
PEG
10 
cg22090863* 
B
ody 
TSS1500 
N
 shore 
7 
4.0±0.6 
4.6±0.6 
0.7 
0.0007 
0.08 
SG
C
E 
PEG
10 
cg18139769 
TSS1500 
5'U
TR
 
S shore 
7 
10.5±2.0 
13.5±4.5 
3.0 
0.0006 
0.08 
D
LG
AP2 
cg27316067 
B
ody 
S shore 
8 
64.3±11.2 
62.2±11.3 
-2.1 
0.002 
0.09 
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SFM
BT2 
cg15362304 
B
ody 
S shelf 
10 
93.4±1.1 
92.5±1.1 
-0.9 
0.0007 
0.08 
IN
S-IG
F2 
IG
F2 
cg00273464 
B
ody  
1stExon 
5'U
TR
 
O
pen sea 
11 
89.8±1.7 
87.7±1.2 
-2.0 
0.00002 
0.06 
IN
S-IG
F2 
IG
F2 
cg17665927 
B
ody 
1stExon 
5'U
TR
 
O
pen sea 
11 
93.2±1.3 
91.6±1.4 
-1.5 
0.0002 
0.07 
IN
S-IG
F2 
IG
F2 
cg05384664 
B
ody 
B
ody 
S shore 
11 
88.6±2.2 
87.3±2.8 
-1.4 
0.001 
0.09 
K
C
N
Q
1O
T1 
K
C
N
Q
1 
cg20406758‡ 
B
ody 
B
ody 
O
pen sea 
11 
95.5±1.0 
94.1±1.0 
-1.4 
0.001 
0.09 
SLC
38A4 
cg12152384 
B
ody 
O
pen sea 
12 
93.4±1.0 
92.3±0.9 
-1.1 
0.002 
0.09 
W
IF1 
cg15862358 
TSS1500 
S shore 
12 
6.7±2.6 
8.6±5.5 
1.9 
0.001 
0.09 
D
LK
1 
cg17412258 
TSS1500 
C
pG
 island 
14 
2.0±0.5 
2.8±0.6 
0.8 
0.0005 
0.08 
 
cg06504820 
TSS1500 
N
 shore 
14 
21.5±6.7 
24.1±7.6 
2.5 
0.0003 
0.07 
RTL1 
cg23546343 
1stExon 
N
 shore 
14 
93.0±0.9 
91.8±1.0 
-1.2 
0.002 
0.10 
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D
ata are expressed are beta values ± standard deviation. 
Legend: C
hr, chrom
osom
e num
ber; Δ, difference; 3’, three prim
e; 5’, five prim
e; U
TR
, untranslated region; TSS1500, 1500 bases upstream
 of 
transcription start site; TSS200, 200 bases upstream
 of transcription start site; *D
M
R
, differentially m
ethylated region; ‡R
D
M
R
, reprogram
m
ed 
differentially m
ethylated region. 
    M
IR431 
M
IR433 
 
TSS200 
TSS1500 
 
G
ABRG
3 
cg08325929 
B
ody 
S shelf 
15 
86.2±2.5 
84.9±2.7 
-1.3 
0.003 
0.10 
ZIM
2 
cg16008476 
B
ody 
N
 shore 
19 
5.9±1.6 
7.6±2.7 
1.7 
0.0006 
0.08 
H
M
13 
PSIM
C
T-1 
cg06000530 
B
ody 
TSS200 
C
pG
 island 
20 
4.0±1.0 
5.6±2.2 
1.6 
0.002 
0.10 
E
xercise C
hanges the D
N
A
 M
ethylom
e	
337  
      
	
 
	
338 
 
Supplementary Table 1. Gene ontology for genes with DNA methylation changes after 
exercise training (q≤0.1). 
Function Type Enrichment  
score 
 p-value q-value 
 
# genes  Go ID 
Single-organism process BP 34.82 7.57×10-16 3.88×10-12 1428 44699 
Single-organism cellular 
process 
BP 26.32 3.70×10-12 9.50×10-9 1251 44763 
Biological process BP 23.74 4.89×10-11 8.22×10-8 1968 8150 
Cellular process BP 23.47 6.41×10-11 8.22×10-8 1678 9987 
Developmental process BP 21.96 2.89×10-10 2.97×10-7 591 32502 
Biological regulation BP 19.53 3.31×10-9 2.83×10-6 1227 65007 
Regulation of biological 
process 
BP 18.66 7.88×10-9 5.78×10-6 1168 50789 
Anatomical structure 
development 
BP 18.31 1.12×10-8 7.18×10-6 374 48856 
Anatomical structure 
morphogenesis 
BP 17.79 1.87×10-8 1.07×10-5 213 9653 
Cellular developmental 
process 
BP 17.46 2.62×10-8 1.29×10-5 312 48869 
Regulation of cellular BP 17.38 2.84×10-8 1.29×10-5 1113 50794 
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process 
Single-organism 
developmental process 
BP 17.32 3.01×10-8 1.29×10-5 405 44767 
Ras guanyl-nucleotide 
exchange factor activity 
MF 17.22 3.32×10-8 1.31×10-5 36 5088 
Guanyl-nucleotide 
exchange factor activity 
MF 17.04 3.97×10-8 1.45×10-5 50 5085 
Gtpase regulator activity MF 15.96 1.18×10-7 4.02×10-5 96 30695 
Sequence-specific DNA 
binding transcription 
factor activity 
MF 15.66 1.58×10-7 4.68×10-5 182 3700 
Pattern specification 
process 
BP 15.65 1.60×10-7 4.68×10-5 84 7389 
Nucleic acid binding 
transcription factor 
activity 
MF 15.52 1.81×10-7 4.68×10-5 182 1071 
Small gtpase regulator 
activity 
MF 15.52 1.82×10-7 4.68×10-5 71 5083 
Ion binding MF 15.49 1.88×10-7 4.68×10-5 867 43167 
Nucleoside-
triphosphatase regulator 
MF 15.47 1.91×10-7 4.68×10-5 97 60589 
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activity 
Multicellular organismal 
process 
BP 14.95 3.22×10-7 7.51×10-5 435 32501 
Embryonic 
morphogenesis 
BP 14.90 3.37×10-7 7.51×10-5 81 48598 
Single-multicellular 
organism process 
BP 14.75 3.91×10-7 8.37×10-5 428 44707 
Molecular function MF 14.47 5.18×10-7 0.0001 2015 3674 
Regulation of cell 
communication 
BP 14.16 7.09×10-7 0.0001 319 10646 
Regulation of signaling BP 14.14 7.22×10-7 0.0001 318 23051 
Regulation of cell 
development 
BP 13.86 9.59×10-7 0.0002 124 60284 
Cell junction CC 13.47 1.42×10-6 0.0003 136 30054 
Sequence-specific DNA 
binding 
MF 13.17 1.90×10-6 0.0003 127 43565 
Binding MF 12.88 2.55×10-6 0.0004 1597 5488 
Cell differentiation BP 12.46 3.88×10-6 0.0006 218 30154 
Regulation of 
neurogenesis 
BP 12.44 3.96×10-6 0.0006 80 50767 
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Regionalization BP 12.19 5.08×10-6 0.0008 53 3002 
Regulation of nervous 
system development 
BP 12.16 5.24×10-6 0.0008 87 51960 
Negative regulation of 
cell differentiation 
BP 11.75 7.85×10-6 0.001 88 45596 
Cellular response to 
stimulus 
BP 11.54 9.69×10-6 0.001 653 51716 
Extracellular matrix CC 11.31 1.22×10-5 0.002 65 31012 
Regulation of neuron 
differentiation 
BP 11.27 1.28×10-5 0.002 67 45664 
Motor activity MF 11.21 1.35×10-5 0.002 34 3774 
Extracellular matrix part CC 11.21 1.35×10-5 0.002 44 44420 
Organ development BP 11.20 1.37×10-5 0.002 159 48513 
Positive regulation of 
cellular process 
BP 11.08 1.55×10-5 0.002 471 48522 
Regulation of cell 
differentiation 
BP 10.78 2.08×10-5 0.002 174 45595 
Negative regulation of 
developmental process 
BP 10.76 2.12×10-5 0.002 103 51093 
Positive regulation of BP 10.76 2.13×10-5 0.002 210 31328 
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cellular biosynthetic 
process 
Dendritic spine CC 10.73 2.19×10-5 0.002 18 43197 
Synaptic transmission BP 10.72 2.22×10-5 0.002 81 7268 
Neuron part CC 10.65 2.36×10-5 0.002 105 97458 
System development BP 10.60 2.50×10-5 0.003 115 48731 
Response to external 
stimulus 
BP 10.57 2.57×10-5 0.003 168 9605 
Synapse part CC 10.35 3.21×10-5 0.003 71 44456 
Cell communication BP 10.34 3.22×10-5 0.003 148 7154 
Signal transduction BP 10.33 3.26×10-5 0.003 538 7165 
Axon guidance BP 10.31 3.32×10-5 0.003 68 7411 
Negative regulation of 
neuron differentiation 
BP 10.15 3.91×10-5 0.003 18 45665 
Neuron spine CC 10.15 3.91×10-5 0.003 18 44309 
Cation binding MF 10.14 3.94×10-5 0.003 581 43169 
Metal ion binding MF 10.07 4.23×10-5 0.004 572 46872 
Positive regulation of 
biosynthetic process 
BP 10.06 4.26×10-5 0.004 211 9891 
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Positive regulation of 
macromolecule 
biosynthetic process 
BP 10.05 4.33×10-5 0.004 196 10557 
Regulation of signal 
transduction 
BP 10.04 4.38×10-5 0.004 271 9966 
Phospholipid binding MF 9.97 4.66×10-5 0.004 93 5543 
Ion channel activity MF 9.89 5.05×10-5 0.004 73 5216 
Anterior/posterior 
pattern specification 
BP 9.83 5.40×10-5 0.004 36 9952 
Substrate-specific 
channel activity 
MF 9.68 6.24×10-5 0.005 74 22838 
Rho guanyl-nucleotide 
exchange factor activity 
MF 9.61 6.69×10-5 0.005 22 5089 
Negative regulation of 
signal transduction 
BP 9.56 7.04×10-5 0.005 110 9968 
Cell part CC 9.55 7.10×10-5 0.005 1907 44464 
Negative regulation of 
response to stimulus 
BP 9.48 7.66×10-5 0.006 131 48585 
Positive regulation of 
nucleobase-containing 
compound metabolic 
BP 9.45 7.84×10-5 0.006 194 45935 
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process 
Regulation of axon 
extension involved in 
axon guidance 
BP 9.42 8.13×10-5 0.006 7 48841 
Negative regulation of 
biological process 
BP 9.26 9.50×10-5 0.007 456 48519 
Regulation of small 
gtpase mediated signal 
transduction 
BP 9.26 9.55×10-5 0.007 56 51056 
Regulation of purine 
nucleotide metabolic 
process 
BP 9.24 9.69×10-5 0.007 72 1900542 
Cell development BP 9.12 0.0001 0.007 79 48468 
Negative regulation of 
cell communication 
BP 9.04 0.0001 0.008 114 10648 
Gated channel activity MF 9.03 0.0001 0.008 60 22836 
Ion gated channel 
activity 
MF 9.03 0.0001 0.008 60 22839 
DNA binding MF 9.00 0.0001 0.008 351 3677 
Response to stimulus BP 8.99 0.0001 0.008 827 50896 
	
 
	
345 
 
Positive regulation of 
nitrogen compound 
metabolic process 
BP 8.94 0.0001 0.008 196 51173 
Regulation of nucleotide 
metabolic process 
BP 8.91 0.0001 0.008 72 6140 
Channel activity MF 8.88 0.0001 0.008 76 15267 
Passive transmembrane 
transporter activity 
MF 8.88 0.0001 0.008 76 22803 
Organ morphogenesis BP 8.80 0.0002 0.009 76 9887 
Extracellular matrix 
disassembly 
BP 8.78 0.0002 0.009 22 22617 
Negative regulation of 
signaling 
BP 8.74 0.0002 0.009 113 23057 
Negative regulation of 
cellular process 
BP 8.67 0.0002 0.01 421 48523 
Neuron projection CC 8.64 0.0002 0.01 80 43005 
Cell projection part CC 8.61 0.0002 0.01 111 44463 
Positive regulation of 
cellular metabolic 
process 
BP 8.61 0.0002 0.01 292 31325 
	
 
	
346 
 
Positive regulation of 
RNA metabolic process 
BP 8.52 0.0002 0.01 173 51254 
Regulation of cellular 
component organization 
BP 8.51 0.0002 0.01 202 51128 
Intracellular part CC 8.51 0.0002 0.01 1607 44424 
Enzyme regulator 
activity 
MF 8.51 0.0002 0.01 161 30234 
Positive regulation of 
metabolic process 
BP 8.48 0.0002 0.01 306 9893 
Regulation of Ras 
protein signal 
transduction 
BP 8.45 0.0002 0.01 35 46578 
Regulation of 
multicellular organismal 
process 
BP 8.45 0.0002 0.01 275 51239 
Cation channel activity MF 8.40 0.0002 0.01 54 5261 
Negative regulation of 
canonical Wnt receptor 
signaling pathway 
BP 8.39 0.0002 0.01 22 90090 
Collagen metabolic 
process 
BP 8.39 0.0002 0.01 22 32963 
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Plasma membrane part CC 8.38 0.0002 0.01 284 44459 
Collagen CC 8.37 0.0002 0.01 24 5581 
Locomotion BP 8.34 0.0002 0.01 159 40011 
Regulation of 
multicellular organismal 
development 
BP 8.27 0.0003 0.01 178 2000026 
Regulation of Wnt 
receptor signaling 
pathway 
BP 8.25 0.0003 0.01 40 30111 
Collagen catabolic 
process 
BP 8.25 0.0003 0.01 20 30574 
Multicellular organismal 
metabolic process 
BP 8.20 0.0003 0.01 24 44236 
Regulation of 
localization 
BP 8.14 0.0003 0.01 214 32879 
Connective tissue 
development 
BP 8.08 0.0003 0.01 26 61448 
Positive regulation of 
transcription, DNA-
dependent 
BP 8.07 0.0003 0.01 164 45893 
Positive regulation of BP 8.06 0.0003 0.01 34 43547 
	
 
	
348 
 
gtpase activity 
Positive regulation of 
macromolecule 
metabolic process 
BP 7.97 0.0003 0.02 284 10604 
Neuron fate commitment BP 7.96 0.0004 0.02 11 48663 
Ionotropic glutamate 
receptor complex 
CC 7.96 0.0004 0.02 11 8328 
Synaptic membrane CC 7.95 0.0004 0.02 45 97060 
Multicellular organismal 
catabolic process 
BP 7.93 0.0004 0.02 21 44243 
Ion transmembrane 
transporter activity 
MF 7.90 0.0004 0.02 127 15075 
Cellular component 
organization 
BP 7.86 0.0004 0.02 491 16043 
Establishment of 
localization 
BP 7.84 0.0004 0.02 427 51234 
Embryonic placenta 
development 
BP 7.84 0.0004 0.02 10 1892 
Localization BP 7.84 0.0004 0.02 71 51179 
Tissue development BP 7.83 0.0004 0.02 96 9888 
	
 
	
349 
 
Regulation of canonical 
Wnt receptor signaling 
pathway 
BP 7.68 0.0005 0.02 30 60828 
Energy reserve 
metabolic process 
BP 7.67 0.0005 0.02 32 6112 
Regulation of cellular 
component biogenesis 
BP 7.67 0.0005 0.02 68 44087 
Membrane-bounded 
vesicle 
CC 7.66 0.0005 0.02 104 31988 
Intracellular signal 
transduction 
BP 7.65 0.0005 0.02 206 35556 
Regulation of Rho 
protein signal 
transduction 
BP 7.59 0.0005 0.02 23 35023 
Axis specification BP 7.52 0.0005 0.02 18 9798 
Ion channel complex CC 7.50 0.0006 0.02 41 34702 
Microtubule motor 
activity 
MF 7.48 0.0006 0.02 20 3777 
Signaling BP 7.46 0.0006 0.02 118 23052 
Single organism 
signaling 
BP 7.46 0.0006 0.02 118 44700 
	
 
	
350 
 
Negative regulation of 
Wnt receptor signaling 
pathway 
BP 7.44 0.0006 0.02 27 30178 
Embryonic organ 
morphogenesis 
BP 7.44 0.0006 0.02 27 48562 
Cell-cell signaling BP 7.44 0.0006 0.02 115 7267 
Positive regulation of 
gene expression 
BP 7.39 0.0006 0.02 174 10628 
Multicellular organismal 
macromolecule 
metabolic process 
BP 7.32 0.0007 0.02 22 44259 
Establishment or 
maintenance of cell 
polarity 
BP 7.32 0.0007 0.02 22 7163 
Regulation of 
developmental growth 
BP 7.32 0.0007 0.02 26 48638 
Lipid binding MF 7.30 0.0007 0.02 123 8289 
Regulation of cell 
proliferation 
BP 7.29 0.0007 0.02 183 42127 
Substrate-specific 
transmembrane 
MF 7.22 0.0007 0.03 134 22891 
	
 
	
351 
 
transporter activity 
Regulation of 
developmental process 
BP 7.21 0.0007 0.03 223 50793 
Taxis BP 7.16 0.0008 0.03 92 42330 
Chemotaxis BP 7.16 0.0008 0.03 92 6935 
Ligand-gated ion 
channel activity 
MF 7.15 0.0008 0.03 30 15276 
Ligand-gated channel 
activity 
MF 7.15 0.0008 0.03 30 22834 
Cell fate determination BP 7.15 0.0008 0.03 13 1709 
Vesicle CC 7.13 0.0008 0.03 116 31982 
Negative regulation of 
cell development 
BP 7.02 0.0009 0.03 27 10721 
Wnt receptor signaling 
pathway 
BP 7.02 0.0009 0.03 44 16055 
Cellular component 
organization or 
biogenesis 
BP 7.02 0.0009 0.03 491 71840 
Positive regulation of 
biological process 
BP 7.00 0.0009 0.03 513 48518 
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Membrane CC 6.94 0.0010 0.03 801 16020 
Regulation of metabolic 
process 
BP 6.92 0.0010 0.03 672 19222 
Positive regulation of 
transcription from RNA 
polymerase II promoter 
BP 6.90 0.0010 0.03 118 45944 
Negative regulation of 
axonogenesis 
BP 6.90 0.0010 0.03 13 50771 
Regulation of respiratory 
gaseous exchange 
BP 6.89 0.0010 0.03 8 43576 
Transport BP 6.87 0.0010 0.03 416 6810 
Transport vesicle 
membrane 
CC 6.86 0.0011 0.03 17 30658 
Energy derivation by 
oxidation of organic 
compounds 
BP 6.85 0.0011 0.03 37 15980 
Positive regulation of 
cell development 
BP 6.84 0.0011 0.03 33 10720 
Regulation of cell 
adhesion 
BP 6.82 0.0011 0.03 51 30155 
Actin filament-based BP 6.82 0.0011 0.03 54 30029 
	
 
	
353 
 
process 
Cell surface receptor 
signaling pathway 
BP 6.81 0.0011 0.03 312 7166 
Cell-cell junction CC 6.79 0.0011 0.03 52 5911 
Activation of Ras gtpase 
activity 
BP 6.79 0.0011 0.03 10 32856 
Chromatin binding MF 6.73 0.0012 0.04 62 3682 
Tissue morphogenesis BP 6.72 0.0012 0.04 63 48729 
Regulation of 
nucleobase-containing 
compound metabolic 
process 
BP 6.70 0.0012 0.04 487 19219 
Negative regulation of 
neurogenesis 
BP 6.69 0.0012 0.04 22 50768 
Microtubule associated 
complex 
CC 6.64 0.0013 0.04 29 5875 
Transcription, DNA-
dependent 
BP 6.59 0.0014 0.04 308 6351 
Early endosome 
membrane 
CC 6.57 0.0014 0.04 21 31901 
	
 
	
354 
 
Cation channel complex CC 6.52 0.0015 0.04 29 34703 
Positive regulation of 
neurogenesis 
BP 6.49 0.0015 0.04 26 50769 
Coated vesicle 
membrane 
CC 6.49 0.0015 0.04 25 30662 
Columnar/cuboidal 
epithelial cell 
development 
BP 6.42 0.0016 0.05 7 2066 
Regulation of steroid 
biosynthetic process 
BP 6.42 0.0016 0.05 13 50810 
ER to Golgi transport 
vesicle membrane 
CC 6.42 0.0016 0.05 11 12507 
Dynein complex CC 6.40 0.0017 0.05 12 30286 
Positive regulation of 
cellular component 
organization 
BP 6.40 0.0017 0.05 88 51130 
Site of polarized growth CC 6.39 0.0017 0.05 22 30427 
Skeletal system 
morphogenesis 
BP 6.37 0.0017 0.05 23 48705 
Negative regulation of 
intracellular protein 
BP 6.37 0.0017 0.05 23 10741 
	
 
	
355 
 
kinase cascade 
Common myeloid 
progenitor cell 
proliferation 
BP 6.33 0.0018 0.05 3 35726 
Regulation of 
somitogenesis 
BP 6.33 0.0018 0.05 3 14807 
Detection of 
monosaccharide 
stimulus 
BP 6.33 0.0018 0.05 3 34287 
Detection of glucose BP 6.33 0.0018 0.05 3 51594 
Detection of 
carbohydrate stimulus 
BP 6.33 0.0018 0.05 3 9730 
Detection of hexose 
stimulus 
BP 6.33 0.0018 0.05 3 9732 
Insulin-like growth 
factor-activated receptor 
activity 
MF 6.33 0.0018 0.05 3 5010 
Laminin-10 complex CC 6.33 0.0018 0.05 3 43259 
Cell projection CC 6.26 0.0019 0.05 139 42995 
Multicellular organismal 
development 
BP 6.25 0.0019 0.05 81 7275 
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Positive regulation of 
Ras gtpase activity 
BP 6.23 0.0020 0.05 23 32320 
Endoplasmic reticulum 
part 
CC 6.22 0.0020 0.05 142 44432 
Regulation of GTP 
catabolic process 
BP 6.21 0.0020 0.05 44 33124 
Regulation of nitrogen 
compound metabolic 
process 
BP 6.20 0.0020 0.05 495 51171 
Neuron recognition BP 6.19 0.0020 0.05 10 8038 
Negative regulation of 
cell proliferation 
BP 6.17 0.0021 0.05 88 8285 
Regulation of cellular 
metabolic process 
BP 6.16 0.0021 0.05 612 31323 
Negative regulation of 
axon extension involved 
in axon guidance 
BP 6.14 0.0022 0.05 5 48843 
Negative regulation of 
JAK-STAT cascade 
BP 6.14 0.0022 0.05 5 46426 
N-methyl-D-aspartate 
selective glutamate 
CC 6.14 0.0022 0.05 5 17146 
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receptor complex 
Regulation of 
axonogenesis 
BP 6.10 0.0022 0.05 22 50770 
Neuron differentiation BP 6.09 0.0023 0.06 38 30182 
Cytoskeleton 
organization 
BP 6.05 0.0024 0.06 93 7010 
Regulation of growth BP 6.05 0.0024 0.06 85 40008 
Regulation of nucleoside 
metabolic process 
BP 6.01 0.0025 0.06 48 9118 
Establishment of protein 
localization to 
membrane 
BP 5.98 0.0025 0.06 9 90150 
Integral to endoplasmic 
reticulum membrane 
CC 5.97 0.0025 0.06 21 30176 
Growth cone CC 5.97 0.0025 0.06 21 30426 
Cartilage development 
involved in 
endochondral bone 
morphogenesis 
BP 5.97 0.0025 0.06 6 60351 
Enzyme linked receptor 
protein signaling 
BP 5.96 0.0026 0.06 112 7167 
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pathway 
Intramembranous 
ossification 
BP 5.93 0.0027 0.06 4 1957 
Direct ossification BP 5.93 0.0027 0.06 4 36072 
Regulation of transport BP 5.91 0.0027 0.06 157 51049 
Embryonic skeletal 
system morphogenesis 
BP 5.90 0.0027 0.06 18 48704 
Regulation of catabolic 
process 
BP 5.90 0.0027 0.06 88 9894 
Regulation of gtpase 
activity 
BP 5.90 0.0027 0.06 43 43087 
Transmembrane receptor 
protein tyrosine kinase 
signaling pathway 
BP 5.90 0.0028 0.06 87 7169 
Extracellular vesicular 
exosome 
CC 5.85 0.0029 0.07 16 70062 
Antigen processing and 
presentation of 
exogenous peptide 
antigen via MHC class II 
BP 5.83 0.0029 0.07 21 19886 
Tight junction CC 5.83 0.0029 0.07 23 5923 
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Occluding junction CC 5.83 0.0029 0.07 23 70160 
Serine-type 
endopeptidase inhibitor 
activity 
MF 5.83 0.0029 0.07 22 4867 
Cellular component 
movement 
BP 5.83 0.0029 0.07 138 6928 
Membrane-enclosed 
lumen 
CC 5.78 0.0031 0.07 101 31974 
Vesicle membrane CC 5.77 0.0031 0.07 61 12506 
Regulatory region 
nucleic acid binding 
MF 5.77 0.0031 0.07 62 1067 
Regulatory region DNA 
binding 
MF 5.77 0.0031 0.07 62 975 
Regulation of primary 
metabolic process 
BP 5.76 0.0031 0.07 601 80090 
Regulation of purine 
nucleotide catabolic 
process 
BP 5.72 0.0033 0.07 47 33121 
Cartilage development BP 5.72 0.0033 0.07 19 51216 
Response to glucagon 
stimulus 
BP 5.71 0.0033 0.07 12 33762 
	
 
	
360 
 
Regulation of 
anatomical structure 
morphogenesis 
BP 5.70 0.0034 0.07 98 22603 
Cytoplasmic vesicle 
membrane 
CC 5.65 0.0035 0.07 59 30659 
Regulation of biological 
quality 
BP 5.65 0.0035 0.07 314 65008 
Regulation of nucleotide 
catabolic process 
BP 5.64 0.0035 0.07 47 30811 
Metal ion 
transmembrane 
transporter activity 
MF 5.64 0.0036 0.08 65 46873 
Ionotropic glutamate 
receptor activity 
MF 5.62 0.0036 0.08 7 4970 
Cell motility BP 5.60 0.0037 0.08 102 48870 
Regulation of stress-
activated MAPK 
cascade 
BP 5.60 0.0037 0.08 31 32872 
Single-organism 
transport 
BP 5.59 0.0037 0.08 323 44765 
Regulation of cellular BP 5.58 0.0038 0.08 111 60341 
	
 
	
361 
 
localization 
Antigen processing and 
presentation of peptide 
antigen via MHC class II 
BP 5.56 0.0038 0.08 21 2495 
Response to endogenous 
stimulus 
BP 5.56 0.0039 0.08 156 9719 
Actin cytoskeleton 
organization 
BP 5.55 0.0039 0.08 44 30036 
Anchoring collagen CC 5.55 0.0039 0.08 5 30934 
Axonal growth cone CC 5.55 0.0039 0.08 5 44295 
Mannose metabolic 
process 
BP 5.55 0.0039 0.08 5 6013 
Semaphorin-plexin 
signaling pathway 
BP 5.52 0.0040 0.08 6 71526 
Biological adhesion BP 5.52 0.0040 0.08 121 22610 
Cell adhesion BP 5.52 0.0040 0.08 121 7155 
Extracellular organelle CC 5.51 0.0040 0.08 16 43230 
Extracellular membrane-
bounded organelle 
CC 5.51 0.0040 0.08 16 65010 
Regulation of stress- BP 5.50 0.0041 0.08 31 70302 
	
 
	
362 
 
activated protein kinase 
signaling cascade 
Positive regulation of 
insulin secretion 
BP 5.50 0.0041 0.08 12 32024 
Macromolecule 
localization 
BP 5.47 0.0042 0.08 57 33036 
Intrinsic to endoplasmic 
reticulum membrane 
CC 5.46 0.0043 0.08 23 31227 
Homeostatic process BP 5.45 0.0043 0.08 152 42592 
Transmembrane 
transporter activity 
MF 5.44 0.0043 0.08 141 22857 
Endocytosis BP 5.44 0.0044 0.08 46 6897 
Negative regulation of 
cell adhesion 
BP 5.43 0.0044 0.08 20 7162 
Integral to lumenal side 
of endoplasmic 
reticulum membrane 
CC 5.41 0.0045 0.09 9 71556 
Embryonic skeletal 
system development 
BP 5.41 0.0045 0.09 10 48706 
Protein binding MF 5.40 0.0045 0.09 965 5515 
	
 
	
363 
 
Small gtpase mediated 
signal transduction 
BP 5.36 0.0047 0.09 71 7264 
Regulation of steroid 
metabolic process 
BP 5.35 0.0047 0.09 16 19218 
Secretion by cell BP 5.33 0.0048 0.09 63 32940 
Liver development BP 5.32 0.0049 0.09 17 1889 
Antigen processing and 
presentation of peptide 
or polysaccharide 
antigen via MHC class II 
BP 5.30 0.0050 0.09 21 2504 
Epithelial tube 
morphogenesis 
BP 5.29 0.0050 0.09 19 60562 
Regulation of response 
to stimulus 
BP 5.28 0.0051 0.09 348 48583 
Gtpase activator activity MF 5.27 0.0051 0.09 47 5096 
Organelle CC 5.27 0.0051 0.09 1126 43226 
Extracellular-glutamate-
gated ion channel 
activity 
MF 5.27 0.0051 0.09 7 5234 
Osteoblast development BP 5.27 0.0051 0.09 7 2076 
	
 
	
364 
 
Adherens junction CC 5.25 0.0053 0.10 37 5912 
Cardiac septum 
morphogenesis 
BP 5.22 0.0054 0.10 11 60411 
Cation transmembrane 
transporter activity 
MF 5.22 0.0054 0.10 94 8324 
Secretion BP 5.22 0.0054 0.10 75 46903 
Regulation of insulin 
secretion 
BP 5.21 0.0054 0.10 29 50796 
Regulation of peptide 
hormone secretion 
BP 5.21 0.0055 0.10 31 90276 
Regulation of hormone 
secretion 
BP 5.19 0.0056 0.10 36 46883 
Dorsal spinal cord 
development 
BP 5.19 0.0056 0.10 4 21516 
Peripheral nervous 
system myelin 
maintenance 
BP 5.19 0.0056 0.10 4 32287 
Positive regulation of 
superoxide anion 
generation 
BP 5.19 0.0056 0.10 4 32930 
Lipid particle BP 5.19 0.0056 0.10 4 34389 
	
 
	
365 
 
organization 
Morphogenesis of an 
epithelium 
BP 5.17 0.0057 0.10 50 2009 
Positive regulation of 
hormone secretion 
BP 5.17 0.0057 0.10 17 46887 
Establishment of protein 
localization to plasma 
membrane 
BP 5.17 0.0057 0.10 8 90002 
Rab guanyl-nucleotide 
exchange factor activity 
MF 5.17 0.0057 0.10 8 17112 
Negative regulation of 
osteoblast differentiation 
BP 5.17 0.0057 0.10 10 45668 
Response to chemical 
stimulus 
BP 5.16 0.0057 0.10 366 42221 
Ras gtpase activator 
activity 
MF 5.16 0.0057 0.10 25 5099 
Response to nitrogen 
compound 
BP 5.15 0.0058 0.10 96 1901698 
Axonogenesis BP 5.13 0.0059 0.10 24 7409 
Regulation of JNK 
cascade 
BP 5.13 0.0059 0.10 27 46328 
	
 
	
366 
 
Substrate-specific 
transporter activity 
MF 5.12 0.0059 0.10 146 22892 
Positive regulation of 
cell differentiation 
BP 5.12 0.0060 0.10 81 45597 
Cytoplasmic membrane-
bounded vesicle 
CC 5.11 0.0060 0.10 89 16023 
RNA biosynthetic 
process 
BP 5.11 0.0061 0.10 323 32774 
Regulation of secretion BP 5.10 0.0061 0.10 74 51046 
Regulation of cell-
substrate adhesion 
BP 5.10 0.0061 0.10 23 10810 
Neuropeptide receptor 
activity 
MF 5.10 0.0061 0.10 12 8188 
Establishment of cell 
polarity 
BP 5.10 0.0061 0.10 12 30010 
Cellular component 
morphogenesis 
BP 5.09 0.0061 0.10 63 32989 
Cell fate commitment BP 5.09 0.0062 0.10 26 45165 
Positive regulation of 
secretion 
BP 5.09 0.0062 0.10 40 51047 
	
 
	
367 
 
Golgi apparatus part CC 5.07 0.0063 0.10 103 44431 
Response to organic 
nitrogen 
BP 5.05 0.0064 0.10 92 10243 
Regulation of 
sequestering of 
triglyceride 
BP 5.05 0.0064 0.10 5 10889 
Platelet-derived growth 
factor binding 
MF 5.05 0.0064 0.10 5 48407 
MHC class II receptor 
activity 
MF 5.05 0.0064 0.10 5 32395 
Positive regulation of 
neuron differentiation 
BP 5.04 0.0065 0.10 16 45666 
Small conductance 
calcium-activated 
potassium channel 
activity 
MF 5.04 0.0065 0.10 3 16286 
Cardiac endothelial cell 
differentiation 
BP 5.04 0.0065 0.10 3 3348 
Endocardial cell 
differentiation 
BP 5.04 0.0065 0.10 3 60956 
N-acetylgalactosaminyl- MF 5.04 0.0065 0.10 3 50510 
	
 
	
368 
 
proteoglycan 3-beta-
glucuronosyltransferase 
activity 
Positive regulation of 
transcription of Notch 
receptor target 
BP 5.04 0.0065 0.10 3 7221 
Glossopharyngeal nerve 
morphogenesis 
BP 5.04 0.0065 0.10 3 21615 
Extracellular matrix-cell 
signaling 
BP 5.04 0.0065 0.10 3 35426 
Immunoglobulin 
production involved in 
immunoglobulin 
mediated immune 
response 
BP 5.04 0.0065 0.10 3 2381 
Nerve growth factor 
processing 
BP 5.04 0.0065 0.10 3 32455 
Enzyme binding MF 5.04 0.0065 0.10 162 19899 
Cell recognition BP 5.03 0.0066 0.10 17 8037 
Regulation of peptide 
secretion 
BP 5.02 0.0066 0.10 31 2791 
	
 
	
369 
 
Regulation of peptide 
transport 
BP 5.02 0.0066 0.10 31 90087 
Cytoplasmic vesicle part CC 4.99 0.0068 0.10 73 44433 
Skeletal system 
development 
BP 4.97 0.0069 0.11 30 1501 
Postsynaptic membrane CC 4.97 0.0070 0.11 35 45211 
Postsynaptic density CC 4.96 0.0070 0.11 22 14069 
Bone morphogenesis BP 4.95 0.0071 0.11 7 60349 
Synaptic transmission, 
glutamatergic 
BP 4.95 0.0071 0.11 7 35249 
Cortical actin 
cytoskeleton 
CC 4.95 0.0071 0.11 7 30864 
Cellular response to 
glucagon stimulus 
BP 4.95 0.0071 0.11 10 71377 
Negative regulation of 
growth 
BP 4.94 0.0071 0.11 36 45926 
Regulation of 
transcription from RNA 
polymerase II promoter 
BP 4.92 0.0073 0.11 185 6357 
Embryonic digit BP 4.91 0.0074 0.11 12 42733 
	
 
	
370 
 
morphogenesis 
Regulation of extent of 
cell growth 
BP 4.91 0.0074 0.11 12 61387 
Potassium channel 
complex 
CC 4.90 0.0075 0.11 16 34705 
Voltage-gated potassium 
channel complex 
CC 4.90 0.0075 0.11 16 8076 
Regulation of JAK-
STAT cascade 
BP 4.90 0.0075 0.11 16 46425 
Regulation of 
phosphorus metabolic 
process 
BP 4.88 0.0076 0.11 186 51174 
Gland development BP 4.84 0.0079 0.12 22 48732 
Anion binding MF 4.84 0.0079 0.12 380 43168 
Regulation of membrane 
potential 
BP 4.83 0.0080 0.12 34 42391 
Regulation of phosphate 
metabolic process 
BP 4.81 0.0081 0.12 184 19220 
Epithelial cell 
development 
BP 4.80 0.0082 0.12 24 2064 
	
 
	
371 
 
Embryonic heart tube 
morphogenesis 
BP 4.79 0.0083 0.12 14 3143 
Inner ear morphogenesis BP 4.79 0.0083 0.12 14 42472 
Regulation of vesicle-
mediated transport 
BP 4.79 0.0084 0.12 40 60627 
Clathrin-coated vesicle 
membrane 
CC 4.77 0.0085 0.12 19 30665 
Cell migration BP 4.77 0.0085 0.12 91 16477 
Central nervous system 
neuron differentiation 
BP 4.77 0.0085 0.12 15 21953 
Negative regulation of 
axon extension 
BP 4.75 0.0086 0.12 6 30517 
Protein kinase C activity MF 4.75 0.0086 0.12 6 4697 
Regulation of cellular 
catabolic process 
BP 4.75 0.0086 0.12 75 31329 
Response to growth 
factor stimulus 
BP 4.75 0.0086 0.12 83 70848 
Organic substance 
biosynthetic process 
BP 4.75 0.0087 0.12 500 1901576 
L-amino acid 
transmembrane 
MF 4.73 0.0088 0.12 10 15179 
	
 
	
372 
 
transporter activity 
Embryo implantation BP 4.73 0.0088 0.12 10 7566 
Endocytic vesicle 
membrane 
CC 4.73 0.0088 0.12 22 30666 
Glycogen metabolic 
process 
BP 4.73 0.0088 0.12 12 5977 
Transcription-coupled 
nucleotide-excision 
repair 
BP 4.73 0.0088 0.12 12 6283 
Neuron projection 
morphogenesis 
BP 4.72 0.0089 0.12 32 48812 
Epidermis development BP 4.69 0.0092 0.13 28 8544 
Regulation of actin 
filament-based process 
BP 4.68 0.0093 0.13 37 32970 
Cellular response to 
growth factor stimulus 
BP 4.68 0.0093 0.13 81 71363 
Response to nicotine BP 4.67 0.0094 0.13 9 35094 
Midbrain development BP 4.67 0.0094 0.13 9 30901 
Cell body CC 4.67 0.0094 0.13 44 44297 
Positive regulation of BP 4.67 0.0094 0.13 13 90277 
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peptide hormone 
secretion 
G-protein coupled 
receptor signaling 
pathway 
BP 4.67 0.0094 0.13 84 7186 
Cellular nitrogen 
compound biosynthetic 
process 
BP 4.66 0.0095 0.13 366 44271 
Pancreas development BP 4.65 0.0095 0.13 7 31016 
Ventricular septum 
morphogenesis 
BP 4.65 0.0095 0.13 7 60412 
Protein localization BP 4.65 0.0096 0.13 51 8104 
Regulation of actin 
cytoskeleton 
organization 
BP 4.64 0.0096 0.13 35 32956 
Regulation of cyclic 
nucleotide metabolic 
process 
BP 4.64 0.0096 0.13 25 30799 
Binding, bridging MF 4.64 0.0097 0.13 27 60090 
Neuronal cell body CC 4.64 0.0097 0.13 40 43025 
Canonical Wnt receptor BP 4.62 0.0099 0.13 17 60070 
	
 
	
374 
 
signaling pathway 
Atrial septum 
morphogenesis 
BP 4.61 0.0099 0.13 5 60413 
Outer membrane-
bounded periplasmic 
space 
CC 4.61 0.0099 0.13 5 30288 
Periplasmic space CC 4.61 0.0099 0.13 5 42597 
Detection of bacterium BP 4.61 0.0099 0.13 5 16045 
Endocytic recycling BP 4.61 0.0099 0.13 5 32456 
Microtubule CC 4.61 0.01 0.13 58 5874 
Positive regulation of 
transport 
BP 4.61 0.01 0.13 79 51050 
Hepatocyte 
differentiation 
BP 4.59 0.01 0.13 4 70365 
Glomerular visceral 
epithelial cell 
development 
BP 4.59 0.01 0.13 4 72015 
Hydrogen peroxide 
biosynthetic process 
BP 4.59 0.01 0.13 4 50665 
RNA-induced silencing CC 4.59 0.01 0.13 4 16442 
	
 
	
375 
 
complex 
Rnai effector complex CC 4.59 0.01 0.13 4 31332 
Regulation of dendritic 
cell antigen processing 
and presentation 
BP 4.59 0.01 0.13 4 2604 
Left/right axis 
specification 
BP 4.59 0.01 0.13 4 70986 
CARD domain binding MF 4.59 0.01 0.13 4 50700 
Neuron migration BP 4.59 0.01 0.13 21 1764 
Cellular localization BP 4.59 0.01 0.13 49 51641 
Regulation of cell 
morphogenesis involved 
in differentiation 
BP 4.59 0.01 0.13 34 10769 
Regulation of cellular 
component movement 
BP 4.58 0.01 0.13 73 51270 
Glucan metabolic 
process 
BP 4.55 0.01 0.13 12 44042 
Cellular glucan 
metabolic process 
BP 4.55 0.01 0.13 12 6073 
Brain development BP 4.55 0.01 0.13 32 7420 
	
 
	
376 
 
Transcription regulatory 
region DNA binding 
MF 4.55 0.01 0.13 58 44212 
Cell proliferation BP 4.55 0.01 0.13 88 8283 
Regulation of 
interleukin-1 beta 
production 
BP 4.53 0.01 0.13 10 32651 
Biosynthetic process BP 4.52 0.01 0.13 507 9058 
Cytoplasmic vesicle CC 4.51 0.01 0.14 97 31410 
Positive regulation of 
peptide secretion 
BP 4.51 0.01 0.14 13 2793 
Positive regulation of 
cytokine biosynthetic 
process 
BP 4.49 0.01 0.14 14 42108 
Appendage 
morphogenesis 
BP 4.48 0.01 0.14 21 35107 
Limb morphogenesis BP 4.48 0.01 0.14 21 35108 
Embryonic forelimb 
morphogenesis 
BP 4.45 0.01 0.14 9 35115 
Tight junction assembly BP 4.45 0.01 0.14 9 70830 
Positive regulation of BP 4.45 0.01 0.14 25 45785 
	
 
	
377 
 
cell adhesion 
Cellular response to acid BP 4.44 0.01 0.14 11 71229 
Golgi membrane CC 4.43 0.01 0.14 80 139 
Asymmetric protein 
localization 
BP 4.42 0.01 0.14 6 8105 
Positive regulation of 
developmental process 
BP 4.42 0.01 0.14 106 51094 
Neuron development BP 4.41 0.01 0.15 22 48666 
Potassium channel 
activity 
MF 4.41 0.01 0.15 22 5267 
Regulation of camp 
metabolic process 
BP 4.41 0.01 0.15 22 30814 
Cytoplasmic part CC 4.40 0.01 0.15 888 44444 
Intrinsic to plasma 
membrane 
CC 4.40 0.01 0.15 156 31226 
Coated vesicle CC 4.40 0.01 0.15 26 30135 
Clathrin-coated vesicle CC 4.40 0.01 0.15 24 30136 
Negative regulation of 
developmental growth 
BP 4.40 0.01 0.15 8 48640 
Insulin-like growth MF 4.40 0.01 0.15 8 5520 
	
 
	
378 
 
factor binding 
Regulation of 
locomotion 
BP 4.39 0.01 0.15 73 40012 
Intracellular organelle CC 4.39 0.01 0.15 1114 43229 
Cellular response to 
vascular endothelial 
growth factor stimulus 
BP 4.38 0.01 0.15 7 35924 
Positive regulation of 
epithelial to 
mesenchymal transition 
BP 4.38 0.01 0.15 7 10718 
DNA-dependent 
transcription, initiation 
BP 4.37 0.01 0.15 38 6352 
Calcium channel activity MF 4.37 0.01 0.15 21 5262 
Lung development BP 4.36 0.01 0.15 17 30324 
Regulation of 
gliogenesis 
BP 4.34 0.01 0.15 14 14013 
Regulation of axon 
extension 
BP 4.34 0.01 0.15 10 30516 
Positive regulation of 
cyclase activity 
BP 4.34 0.01 0.15 10 31281 
	
 
	
379 
 
Aromatic compound 
biosynthetic process 
BP 4.34 0.01 0.15 355 19438 
Organic cyclic 
compound biosynthetic 
process 
BP 4.32 0.01 0.15 370 1901362 
Organelle lumen CC 4.32 0.01 0.15 90 43233 
Cellular_component CC 4.30 0.01 0.15 2166 5575 
Aminoglycan metabolic 
process 
BP 4.30 0.01 0.15 29 6022 
Digestive tract 
development 
BP 4.27 0.01 0.16 11 48565 
Cortical cytoskeleton CC 4.27 0.01 0.16 11 30863 
Inorganic cation 
transmembrane 
transporter activity 
MF 4.26 0.01 0.16 74 22890 
Anterior/posterior axis 
specification 
BP 4.25 0.01 0.16 9 9948 
Cytoskeleton CC 4.23 0.01 0.16 106 5856 
Cellular membrane 
organization 
BP 4.23 0.01 0.16 64 16044 
	
 
	
380 
 
Plasma membrane CC 4.23 0.01 0.16 488 5886 
Dopaminergic neuron 
differentiation 
BP 4.23 0.01 0.16 5 71542 
Regulation of respiratory 
gaseous exchange by 
neurological system 
process 
BP 4.23 0.01 0.16 5 2087 
Positive regulation of 
Wnt receptor signaling 
pathway 
BP 4.22 0.01 0.16 16 30177 
Phosphoglucomutase 
activity 
MF 4.22 0.01 0.16 3 4614 
Microvillus assembly BP 4.22 0.01 0.16 3 30033 
Microvillus organization BP 4.22 0.01 0.16 3 32528 
Noradrenergic neuron 
differentiation 
BP 4.22 0.01 0.16 3 3357 
Positive regulation of 
Wnt receptor signaling 
pathway, planar cell 
polarity pathway 
BP 4.22 0.01 0.16 3 2000096 
Response to oleic acid BP 4.22 0.01 0.16 3 34201 
	
 
	
381 
 
Chemorepellent activity MF 4.22 0.01 0.16 3 45499 
Positive regulation of 
steroid hormone 
biosynthetic process 
BP 4.22 0.01 0.16 3 90031 
Membrane-bounded 
organelle 
CC 4.19 0.02 0.17 1000 43227 
Generation of precursor 
metabolites and energy 
BP 4.17 0.02 0.17 63 6091 
Non-canonical Wnt 
receptor signaling 
pathway 
BP 4.17 0.02 0.17 8 35567 
Microtubule-based 
movement 
BP 4.16 0.02 0.17 28 7018 
Heterocycle biosynthetic 
process 
BP 4.16 0.02 0.17 354 18130 
Nucleobase-containing 
compound biosynthetic 
process 
BP 4.15 0.02 0.17 345 34654 
Glycogen biosynthetic 
process 
BP 4.13 0.02 0.17 6 5978 
Glucan biosynthetic BP 4.13 0.02 0.17 6 9250 
	
 
	
382 
 
process 
Cell differentiation in 
hindbrain 
BP 4.13 0.02 0.17 6 21533 
MHC class II protein 
complex 
CC 4.13 0.02 0.17 6 42613 
Regulation of timing of 
cell differentiation 
BP 4.11 0.02 0.17 4 48505 
Glomerular epithelial 
cell development 
BP 4.11 0.02 0.17 4 72310 
Negative regulation of 
catenin import into 
nucleus 
BP 4.11 0.02 0.17 4 35414 
Negative regulation of 
smooth muscle cell 
differentiation 
BP 4.11 0.02 0.17 4 51151 
Pinocytosis BP 4.11 0.02 0.17 4 6907 
Semaphorin receptor 
activity 
MF 4.11 0.02 0.17 4 17154 
RNA polymerase II core 
binding 
MF 4.11 0.02 0.17 4 993 
Regulation of glial cell BP 4.10 0.02 0.17 11 45685 
	
 
	
383 
 
differentiation 
Regulation of stem cell 
proliferation 
BP 4.10 0.02 0.18 16 72091 
Extracellular matrix 
organization 
BP 4.09 0.02 0.18 43 30198 
Regulation of DNA 
binding 
BP 4.08 0.02 0.18 15 51101 
Organic cyclic 
compound binding 
MF 4.07 0.02 0.18 721 97159 
Regulation of 
chemokine production 
BP 4.07 0.02 0.18 12 32642 
Phagocytic vesicle 
membrane 
CC 4.07 0.02 0.18 12 30670 
Palate development BP 4.06 0.02 0.18 14 60021 
Regulation of cyclase 
activity 
BP 4.06 0.02 0.18 14 31279 
Cellular biosynthetic 
process 
BP 4.06 0.02 0.18 482 44249 
Positive regulation of 
gliogenesis 
BP 4.05 0.02 0.18 9 14015 
	
 
	
384 
 
Tissue homeostasis BP 4.04 0.02 0.18 18 1894 
Regulation of cell 
projection organization 
BP 4.03 0.02 0.18 44 31344 
Extracellular structure 
organization 
BP 4.02 0.02 0.18 43 43062 
Actin binding MF 4.01 0.02 0.19 58 3779 
Endosome membrane CC 4.00 0.02 0.19 51 10008 
Regulation of cell 
growth 
BP 3.98 0.02 0.19 48 1558 
Positive regulation of 
lyase activity 
BP 3.98 0.02 0.19 10 51349 
Response to fatty acid BP 3.98 0.02 0.19 10 70542 
Regulation of epithelial 
to mesenchymal 
transition 
BP 3.98 0.02 0.19 10 10717 
Tube morphogenesis BP 3.97 0.02 0.19 19 35239 
Macromolecule 
biosynthetic process 
BP 3.97 0.02 0.19 384 9059 
Embryo development 
ending in birth or egg 
BP 3.97 0.02 0.19 37 9792 
	
 
	
385 
 
hatching 
Growth factor binding MF 3.96 0.02 0.19 21 19838 
Antigen processing and 
presentation of 
exogenous peptide 
antigen 
BP 3.96 0.02 0.19 30 2478 
Positive regulation of 
phagocytosis 
BP 3.96 0.02 0.19 8 50766 
Vesicle-mediated 
transport 
BP 3.94 0.02 0.19 112 16192 
Coated pit CC 3.94 0.02 0.19 11 5905 
Membrane organization BP 3.94 0.02 0.19 64 61024 
Glycosaminoglycan 
metabolic process 
BP 3.94 0.02 0.19 27 30203 
Divalent inorganic 
cation transmembrane 
transporter activity 
MF 3.94 0.02 0.19 27 72509 
Protein localization to 
membrane 
BP 3.93 0.02 0.19 14 72657 
Heart looping BP 3.92 0.02 0.20 12 1947 
	
 
	
386 
 
Cell morphogenesis 
involved in 
differentiation 
BP 3.92 0.02 0.20 22 904 
Anchoring junction CC 3.90 0.02 0.20 37 70161 
Regulation of 
transcription involved in 
cell fate commitment 
BP 3.89 0.02 0.20 5 60850 
Spinal cord association 
neuron differentiation 
BP 3.89 0.02 0.20 5 21527 
Intrinsic to internal side 
of plasma membrane 
CC 3.89 0.02 0.20 5 31235 
Dorsal/ventral axis 
specification 
BP 3.89 0.02 0.20 5 9950 
Regulation of respiratory 
system process 
BP 3.89 0.02 0.20 5 44065 
Lens morphogenesis in 
camera-type eye 
BP 3.89 0.02 0.20 5 2089 
DNA-directed RNA 
polymerase II, core 
complex 
CC 3.89 0.02 0.20 5 5665 
Actin monomer binding MF 3.89 0.02 0.20 5 3785 
	
 
	
387 
 
Central nervous system 
neuron development 
BP 3.89 0.02 0.20 7 21954 
Mesenchymal cell 
development 
BP 3.89 0.02 0.20 7 14031 
Positive regulation of 
glial cell differentiation 
BP 3.89 0.02 0.20 7 45687 
Zinc ion binding MF 3.88 0.02 0.20 280 8270 
Positive regulation of 
adenylate cyclase 
activity 
BP 3.86 0.02 0.20 9 45762 
Endosomal part CC 3.86 0.02 0.20 53 44440 
Neurotransmitter:sodium 
symporter activity 
MF 3.85 0.02 0.20 6 5328 
Regulation of 
transcription regulatory 
region DNA binding 
BP 3.85 0.02 0.20 6 2000677 
Cytoskeletal protein 
binding 
MF 3.85 0.02 0.20 97 8092 
Regulation of cellular 
biosynthetic process 
BP 3.84 0.02 0.20 458 31326 
Regulation of molecular BP 3.84 0.02 0.21 254 65009 
	
 
	
388 
 
function 
Anion transmembrane 
transporter activity 
MF 3.83 0.02 0.21 40 8509 
Polysaccharide 
metabolic process 
BP 3.83 0.02 0.21 15 5976 
Regulation of stem cell 
differentiation 
BP 3.83 0.02 0.21 15 2000736 
Anatomical structure 
homeostasis 
BP 3.82 0.02 0.21 29 60249 
Regulation of 
interleukin-1 production 
BP 3.81 0.02 0.21 10 32652 
Stem cell proliferation BP 3.81 0.02 0.21 10 72089 
Antigen processing and 
presentation of 
exogenous antigen 
BP 3.81 0.02 0.21 30 19884 
Myosin complex CC 3.80 0.02 0.21 14 16459 
Membrane part CC 3.80 0.02 0.21 808 44425 
Voltage-gated channel 
activity 
MF 3.80 0.02 0.21 31 22832 
Voltage-gated ion MF 3.80 0.02 0.21 31 5244 
	
 
	
389 
 
channel activity 
Regulation of adenylate 
cyclase activity 
BP 3.79 0.02 0.21 13 45761 
Regulation of cartilage 
development 
BP 3.79 0.02 0.21 11 61035 
Positive regulation of 
lipase activity 
BP 3.78 0.02 0.21 17 60193 
Organelle membrane CC 3.78 0.02 0.21 307 31090 
Positive regulation of 
JNK cascade 
BP 3.78 0.02 0.21 12 46330 
Regulation of cell 
motility 
BP 3.78 0.02 0.21 66 2000145 
Synapse CC 3.78 0.02 0.21 34 45202 
Positive regulation of 
cytoskeleton 
organization 
BP 3.77 0.02 0.21 21 51495 
Regulation of neuron 
projection development 
BP 3.77 0.02 0.21 36 10975 
Cell part morphogenesis BP 3.77 0.02 0.21 38 32990 
Cell differentiation in BP 3.76 0.02 0.21 8 21515 
	
 
	
390 
 
spinal cord 
Face morphogenesis BP 3.76 0.02 0.21 8 60325 
Stem cell development BP 3.76 0.02 0.21 8 48864 
Activation of adenylate 
cyclase activity 
BP 3.76 0.02 0.21 8 7190 
Embryo development BP 3.74 0.02 0.21 52 9790 
Heterocyclic compound 
binding 
MF 3.72 0.02 0.22 709 1901363 
Regulation of 
macromolecule 
metabolic process 
BP 3.72 0.02 0.22 565 60255 
Stress-activated MAPK 
cascade 
BP 3.72 0.02 0.22 18 51403 
Regulation of RNA 
metabolic process 
BP 3.71 0.02 0.22 406 51252 
Hexose metabolic 
process 
BP 3.71 0.02 0.22 33 19318 
Cell projection 
organization 
BP 3.70 0.02 0.22 75 30030 
Positive regulation of 
chemokine biosynthetic 
BP 3.70 0.02 0.22 4 45080 
	
 
	
391 
 
process 
Hematopoietic stem cell 
proliferation 
BP 3.70 0.02 0.22 4 71425 
Regulation of 
development, 
heterochronic 
BP 3.70 0.02 0.22 4 40034 
Apical protein 
localization 
BP 3.70 0.02 0.22 4 45176 
Ventricular trabecula 
myocardium 
morphogenesis 
BP 3.70 0.02 0.22 4 3222 
Positive regulation of 
protein sumoylation 
BP 3.70 0.02 0.22 4 33235 
Pre-mrna binding MF 3.70 0.02 0.22 4 36002 
Peripheral nervous 
system neuron 
development 
BP 3.70 0.02 0.22 4 48935 
Metaphase BP 3.70 0.02 0.22 4 51323 
Regulation of 
superoxide anion 
generation 
BP 3.70 0.02 0.22 4 32928 
	
 
	
392 
 
Activation of 
transmembrane receptor 
protein tyrosine kinase 
activity 
BP 3.70 0.02 0.22 4 7171 
DNA synthesis involved 
in DNA repair 
BP 3.70 0.02 0.22 4 731 
Positive regulation of 
SMAD protein import 
into nucleus 
BP 3.70 0.02 0.22 4 60391 
Basal transcription 
machinery binding 
MF 3.70 0.02 0.22 4 1098 
Basal RNA polymerase 
II transcription 
machinery binding 
MF 3.70 0.02 0.22 4 1099 
Protein domain specific 
binding 
MF 3.69 0.03 0.22 79 19904 
Cellular response to 
endogenous stimulus 
BP 3.69 0.03 0.22 100 71495 
Heterotrimeric G-protein 
complex 
CC 3.69 0.03 0.22 9 5834 
Regulation of lyase BP 3.68 0.03 0.22 14 51339 
	
 
	
393 
 
activity 
Amino acid 
transmembrane 
transporter activity 
MF 3.68 0.03 0.22 14 15171 
Voltage-gated cation 
channel activity 
MF 3.68 0.03 0.22 24 22843 
Axon part CC 3.68 0.03 0.22 24 33267 
Positive regulation of 
protein catabolic process 
BP 3.68 0.03 0.22 17 45732 
Endoderm development BP 3.67 0.03 0.22 7 7492 
Chondroitin sulfate 
biosynthetic process 
BP 3.67 0.03 0.22 7 30206 
Dorsal/ventral pattern 
formation 
BP 3.66 0.03 0.22 13 9953 
Positive regulation of 
cell projection 
organization 
BP 3.65 0.03 0.22 25 31346 
Recycling endosome CC 3.64 0.03 0.22 12 55037 
Response to organic 
substance 
BP 3.64 0.03 0.22 261 10033 
	
 
	
394 
 
Voltage-gated potassium 
channel activity 
MF 3.63 0.03 0.22 16 5249 
Regulation of 
biosynthetic process 
BP 3.63 0.03 0.22 460 9889 
Regulation of 
chemotaxis 
BP 3.63 0.03 0.22 20 50920 
Response to acid BP 3.62 0.03 0.22 18 1101 
Wnt receptor signaling 
pathway, calcium 
modulating pathway 
BP 3.62 0.03 0.22 3 7223 
Adenylate cyclase 
binding 
MF 3.62 0.03 0.22 3 8179 
Regulation of bile acid 
biosynthetic process 
BP 3.62 0.03 0.22 3 70857 
Neutrophil 
degranulation 
BP 3.62 0.03 0.22 3 43312 
Coumarin metabolic 
process 
BP 3.62 0.03 0.22 3 9804 
N-methyl-D-aspartate 
selective glutamate 
receptor activity 
MF 3.62 0.03 0.22 3 4972 
	
 
	
395 
 
FACIT collagen CC 3.62 0.03 0.22 3 5593 
WINAC complex CC 3.62 0.03 0.22 3 71778 
COPI-coated vesicle CC 3.62 0.03 0.22 3 30137 
Eukaryotic initiation 
factor 4E binding 
MF 3.62 0.03 0.22 3 8190 
Opioid receptor 
signaling pathway 
BP 3.62 0.03 0.22 3 38003 
Nerve growth factor 
binding 
MF 3.62 0.03 0.22 3 48406 
Somatic muscle 
development 
BP 3.62 0.03 0.22 3 7525 
Positive regulation of 
non-canonical Wnt 
receptor signaling 
pathway 
BP 3.62 0.03 0.22 3 2000052 
Positive regulation of 
sequestering of 
triglyceride 
BP 3.62 0.03 0.22 3 10890 
Coronary vasculature 
morphogenesis 
BP 3.62 0.03 0.22 3 60977 
Forebrain BP 3.62 0.03 0.22 3 21797 
	
 
	
396 
 
anterior/posterior pattern 
specification 
Glycine transmembrane 
transporter activity 
MF 3.62 0.03 0.22 3 15187 
Laminin-1 binding MF 3.62 0.03 0.22 3 43237 
Growth plate cartilage 
development 
BP 3.62 0.03 0.22 3 3417 
Gene silencing by mirna BP 3.62 0.03 0.22 3 35195 
Retina vasculature 
morphogenesis in 
camera-type eye 
BP 3.62 0.03 0.22 3 61299 
Immunoglobulin 
production 
BP 3.62 0.03 0.22 3 2377 
JUN kinase binding MF 3.62 0.03 0.22 3 8432 
Mitotic metaphase BP 3.62 0.03 0.22 3 89 
Sensory perception of 
sweet taste 
BP 3.62 0.03 0.22 3 50916 
Chloride channel 
regulator activity 
MF 3.62 0.03 0.22 3 17081 
Collagen biosynthetic BP 3.62 0.03 0.22 3 32964 
	
 
	
397 
 
process 
Endothelial cell 
differentiation 
BP 3.60 0.03 0.22 6 45446 
Activation of Rho gtpase 
activity 
BP 3.60 0.03 0.22 6 32862 
Intracellular ligand-
gated ion channel 
activity 
MF 3.60 0.03 0.22 6 5217 
Microfilament motor 
activity 
MF 3.60 0.03 0.22 6 146 
Positive regulation of 
endocytosis 
BP 3.59 0.03 0.22 15 45807 
Carbohydrate 
homeostasis 
BP 3.59 0.03 0.22 21 33500 
Glucose homeostasis BP 3.59 0.03 0.22 21 42593 
Response to arsenic-
containing substance 
BP 3.59 0.03 0.22 5 46685 
Alpha-mannosidase 
activity 
MF 3.59 0.03 0.22 5 4559 
Nua4 histone 
acetyltransferase 
CC 3.59 0.03 0.22 5 35267 
	
 
	
398 
 
complex 
Axonemal dynein 
complex 
CC 3.59 0.03 0.22 5 5858 
Tubulin-tyrosine ligase 
activity 
MF 3.59 0.03 0.22 5 4835 
Extracellular region part CC 3.58 0.03 0.22 160 44421 
Negative regulation of 
cell growth 
BP 3.57 0.03 0.22 25 30308 
Regulation of lipid 
biosynthetic process 
BP 3.57 0.03 0.22 19 46890 
Tissue remodeling BP 3.56 0.03 0.23 14 48771 
Regulation of cell 
morphogenesis 
BP 3.56 0.03 0.23 49 22604 
Intracellular membrane-
bounded organelle 
CC 3.54 0.03 0.23 990 43231 
Potassium ion 
transmembrane 
transporter activity 
MF 3.53 0.03 0.23 23 15079 
Metalloendopeptidase 
activity 
MF 3.53 0.03 0.23 20 4222 
	
 
	
399 
 
Negative regulation of 
cell projection 
organization 
BP 3.53 0.03 0.23 16 31345 
Regulation of exocytosis BP 3.53 0.03 0.23 16 17157 
Endocytic vesicle CC 3.53 0.03 0.23 16 30139 
Stress-activated protein 
kinase signaling cascade 
BP 3.52 0.03 0.23 18 31098 
Adenyl ribonucleotide 
binding 
MF 3.52 0.03 0.23 212 32559 
Cellular response to 
amino acid stimulus 
BP 3.52 0.03 0.23 9 71230 
In utero embryonic 
development 
BP 3.51 0.03 0.23 35 1701 
Phosphotransferase 
activity, alcohol group 
as acceptor 
MF 3.51 0.03 0.23 107 16773 
Intracellular organelle 
lumen 
CC 3.51 0.03 0.23 80 70013 
Neurotrophin TRK 
receptor signaling 
pathway 
BP 3.51 0.03 0.23 44 48011 
	
 
	
400 
 
Embryonic organ 
development 
BP 3.50 0.03 0.23 21 48568 
Regulation of lipase 
activity 
BP 3.50 0.03 0.23 21 60191 
Skin development BP 3.50 0.03 0.23 10 43588 
Amide biosynthetic 
process 
BP 3.50 0.03 0.23 11 43604 
Protein kinase activity MF 3.48 0.03 0.24 91 4672 
Regulation of cell-cell 
adhesion 
BP 3.48 0.03 0.24 15 22407 
Epithelial cell 
differentiation 
BP 3.48 0.03 0.24 41 30855 
Embryonic limb 
morphogenesis 
BP 3.47 0.03 0.24 17 30326 
Embryonic appendage 
morphogenesis 
BP 3.47 0.03 0.24 17 35113 
ATP binding MF 3.47 0.03 0.24 208 5524 
Negative regulation of 
intracellular steroid 
hormone receptor 
signaling pathway 
BP 3.46 0.03 0.24 7 33144 
	
 
	
401 
 
Vesicle docking 
involved in exocytosis 
BP 3.46 0.03 0.24 7 6904 
Glutamate receptor 
activity 
MF 3.46 0.03 0.24 7 8066 
Ephrin receptor 
signaling pathway 
BP 3.46 0.03 0.24 7 48013 
Negative regulation of 
stress-activated MAPK 
cascade 
BP 3.46 0.03 0.24 7 32873 
Negative regulation of 
stress-activated protein 
kinase signaling cascade 
BP 3.46 0.03 0.24 7 70303 
Neurotrophin signaling 
pathway 
BP 3.45 0.03 0.24 44 38179 
Transporter activity MF 3.43 0.03 0.24 170 5215 
Monosaccharide 
catabolic process 
BP 3.42 0.03 0.25 16 46365 
Notch signaling pathway BP 3.41 0.03 0.25 21 7219 
Positive regulation of 
stress-activated MAPK 
cascade 
BP 3.41 0.03 0.25 13 32874 
	
 
	
402 
 
Positive regulation of 
cell-substrate adhesion 
BP 3.41 0.03 0.25 13 10811 
Organelle localization BP 3.41 0.03 0.25 13 51640 
Lysosomal membrane CC 3.41 0.03 0.25 26 5765 
Adenyl nucleotide 
binding 
MF 3.40 0.03 0.25 212 30554 
Proteinaceous 
extracellular matrix 
CC 3.39 0.03 0.25 36 5578 
Calcium ion 
transmembrane 
transporter activity 
MF 3.39 0.03 0.25 22 15085 
Chordate embryonic 
development 
BP 3.39 0.03 0.25 35 43009 
Endoplasmic reticulum 
lumen 
CC 3.39 0.03 0.25 29 5788 
Regulation of Ras gtpase 
activity 
BP 3.39 0.03 0.25 29 32318 
Antigen processing and 
presentation of peptide 
antigen 
BP 3.38 0.03 0.25 31 48002 
Response to amino acid BP 3.37 0.03 0.25 15 43200 
	
 
	
403 
 
stimulus 
Positive regulation of 
phospholipase activity 
BP 3.37 0.03 0.25 15 10518 
Transition metal ion 
binding 
MF 3.37 0.03 0.25 308 46914 
Negative regulation of 
response to external 
stimulus 
BP 3.37 0.03 0.25 23 32102 
Regulation of gene 
expression 
BP 3.37 0.03 0.25 455 10468 
Regulation of embryonic 
development 
BP 3.37 0.03 0.25 17 45995 
Macromolecule 
metabolic process 
BP 3.37 0.03 0.25 834 43170 
Cellular macromolecule 
biosynthetic process 
BP 3.37 0.03 0.25 355 34645 
Polysaccharide catabolic 
process 
BP 3.37 0.03 0.25 6 272 
Adipose tissue 
development 
BP 3.37 0.03 0.25 6 60612 
Cardiac cell BP 3.37 0.03 0.25 6 55006 
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development 
Homeostasis of number 
of cells within a tissue 
BP 3.37 0.03 0.25 6 48873 
Negative regulation of 
protein kinase B 
signaling cascade 
BP 3.37 0.03 0.25 6 51898 
Regulation of 
interleukin-4 production 
BP 3.37 0.03 0.25 6 32673 
Regulation of RNA 
biosynthetic process 
BP 3.36 0.03 0.25 395 2001141 
Negative regulation of 
muscle cell 
differentiation 
BP 3.36 0.03 0.25 9 51148 
Negative regulation of 
ERBB signaling 
pathway 
BP 3.36 0.03 0.25 9 1901185 
Negative regulation of 
epidermal growth factor 
receptor signaling 
pathway 
BP 3.36 0.03 0.25 9 42059 
Positive regulation of 
proteasomal protein 
BP 3.36 0.03 0.25 9 1901800 
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catabolic process 
Integral to plasma 
membrane 
CC 3.35 0.04 0.25 145 5887 
MHC protein complex CC 3.35 0.04 0.25 10 42611 
RNA polymerase 
activity 
MF 3.35 0.04 0.25 10 34062 
DNA-directed RNA 
polymerase activity 
MF 3.35 0.04 0.25 10 3899 
Regulation of organ 
morphogenesis 
BP 3.34 0.04 0.25 25 2000027 
Glandular epithelial cell 
development 
BP 3.34 0.04 0.25 4 2068 
Negative chemotaxis BP 3.34 0.04 0.25 4 50919 
Intramolecular 
transferase activity, 
phosphotransferases 
MF 3.34 0.04 0.25 4 16868 
Positive regulation of 
translational initiation 
BP 3.34 0.04 0.25 4 45948 
Platelet alpha granule CC 3.34 0.04 0.25 4 31091 
Heart trabecula BP 3.34 0.04 0.25 4 61384 
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morphogenesis 
Myelin maintenance BP 3.34 0.04 0.25 4 43217 
Regulation of Wnt 
receptor signaling 
pathway, planar cell 
polarity pathway 
BP 3.34 0.04 0.25 4 2000095 
Regulation of antigen 
processing and 
presentation 
BP 3.34 0.04 0.25 4 2577 
Dipeptidyl-peptidase 
activity 
MF 3.34 0.04 0.25 4 8239 
Positive regulation of 
steroid biosynthetic 
process 
BP 3.34 0.04 0.25 4 10893 
RNA polymerase core 
enzyme binding 
MF 3.34 0.04 0.25 4 43175 
Phosphorylation BP 3.34 0.04 0.25 96 16310 
Positive regulation of 
organ growth 
BP 3.32 0.04 0.25 5 46622 
Translation initiation 
factor binding 
MF 3.32 0.04 0.25 5 31369 
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Nitric oxide mediated 
signal transduction 
BP 3.32 0.04 0.25 5 7263 
Organ formation BP 3.32 0.04 0.25 5 48645 
Vitamin D receptor 
binding 
MF 3.32 0.04 0.25 5 42809 
H4/H2A histone 
acetyltransferase 
complex 
CC 3.32 0.04 0.25 5 43189 
Negative regulation of 
toll-like receptor 
signaling pathway 
BP 3.32 0.04 0.25 5 34122 
Nucleotide-sugar 
biosynthetic process 
BP 3.32 0.04 0.25 5 9226 
Regulation of cellular 
macromolecule 
biosynthetic process 
BP 3.31 0.04 0.25 426 2000112 
Calcium ion binding MF 3.29 0.04 0.25 99 5509 
Positive regulation of 
stress-activated protein 
kinase signaling cascade 
BP 3.29 0.04 0.25 13 70304 
Positive regulation of BP 3.29 0.04 0.25 13 10863 
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phospholipase C activity 
Monosaccharide 
metabolic process 
BP 3.27 0.04 0.25 36 5996 
Basement membrane CC 3.27 0.04 0.25 15 5604 
Hexose catabolic 
process 
BP 3.27 0.04 0.25 15 19320 
Positive regulation of 
neural precursor cell 
proliferation 
BP 3.27 0.04 0.25 7 2000179 
Substrate adhesion-
dependent cell spreading 
BP 3.27 0.04 0.25 7 34446 
Calcium-dependent cell-
cell adhesion 
BP 3.27 0.04 0.25 7 16339 
Enhancer sequence-
specific DNA binding 
MF 3.27 0.04 0.25 7 1158 
Regulated secretory 
pathway 
BP 3.27 0.04 0.25 7 45055 
Autophagic vacuole CC 3.27 0.04 0.25 7 5776 
Positive regulation of 
stem cell proliferation 
BP 3.26 0.04 0.25 12 2000648 
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Activation of 
phospholipase C activity 
BP 3.26 0.04 0.25 12 7202 
Chondroitin sulfate 
metabolic process 
BP 3.26 0.04 0.25 12 30204 
Calmodulin binding MF 3.25 0.04 0.25 28 5516 
Positive regulation of 
interleukin-6 production 
BP 3.22 0.04 0.25 8 32755 
Regulation of actin 
filament 
depolymerization 
BP 3.22 0.04 0.25 8 30834 
Negative regulation of 
cell-substrate adhesion 
BP 3.22 0.04 0.25 8 10812 
Cell projection 
morphogenesis 
BP 3.21 0.04 0.25 35 48858 
Actin cytoskeleton 
reorganization 
BP 3.20 0.04 0.25 9 31532 
Extracellular matrix 
binding 
MF 3.20 0.04 0.25 9 50840 
Ammonium 
transmembrane transport 
BP 3.20 0.04 0.25 2 72488 
Prostaglandin-E MF 3.20 0.04 0.25 2 50220 
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synthase activity 
Trehalose metabolic 
process 
BP 3.20 0.04 0.25 2 5991 
Seminiferous tubule 
development 
BP 3.20 0.04 0.25 2 72520 
Cardiac atrium 
morphogenesis 
BP 3.20 0.04 0.25 2 3209 
Regulation of collateral 
sprouting in absence of 
injury 
BP 3.20 0.04 0.25 2 48696 
Spemann organizer 
formation 
BP 3.20 0.04 0.25 2 60061 
Regulation of exocyst 
localization 
BP 3.20 0.04 0.25 2 60178 
Dehydroascorbic acid 
transporter activity 
MF 3.20 0.04 0.25 2 33300 
D-glucose 
transmembrane 
transporter activity 
MF 3.20 0.04 0.25 2 55056 
Production of mirnas 
involved in gene 
BP 3.20 0.04 0.25 2 35196 
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silencing by mirna 
Melatonin receptor 
activity 
MF 3.20 0.04 0.25 2 8502 
Hypothalamus cell 
differentiation 
BP 3.20 0.04 0.25 2 21979 
Collagen type IX CC 3.20 0.04 0.25 2 5594 
Negative regulation of 
transcription by 
transcription factor 
localization 
BP 3.20 0.04 0.25 2 10621 
Detection of endogenous 
stimulus 
BP 3.20 0.04 0.25 2 9726 
Autonomic nervous 
system development 
BP 3.20 0.04 0.25 2 48483 
Trophectodermal 
cellular morphogenesis 
BP 3.20 0.04 0.25 2 1831 
Sec61 translocon 
complex 
CC 3.20 0.04 0.25 2 5784 
Translocon complex CC 3.20 0.04 0.25 2 71256 
Brain segmentation BP 3.20 0.04 0.25 2 35284 
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Cell migration involved 
in endocardial cushion 
formation 
BP 3.20 0.04 0.25 2 3273 
Transcription initiation 
from RNA polymerase 
III promoter 
BP 3.20 0.04 0.25 2 6384 
Calcium ion-dependent 
exocytosis of 
neurotransmitter 
BP 3.20 0.04 0.25 2 48791 
Dendritic growth cone CC 3.20 0.04 0.25 2 44294 
Natriuretic peptide 
receptor activity 
MF 3.20 0.04 0.25 2 16941 
Metencephalon 
development 
BP 3.20 0.04 0.25 2 22037 
Diencephalon 
morphogenesis 
BP 3.20 0.04 0.25 2 48852 
Cardiac vascular smooth 
muscle cell development 
BP 3.20 0.04 0.25 2 60948 
Vasoactive intestinal 
polypeptide receptor 
activity 
MF 3.20 0.04 0.25 2 4999 
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Transcription initiation 
from mitochondrial 
promoter 
BP 3.20 0.04 0.25 2 6391 
G-quadruplex DNA 
binding 
MF 3.20 0.04 0.25 2 51880 
Butyrate metabolic 
process 
BP 3.20 0.04 0.25 2 19605 
Chromosome movement 
towards spindle pole 
BP 3.20 0.04 0.25 2 51305 
Phenylpropanoid 
catabolic process 
BP 3.20 0.04 0.25 2 46271 
Cerebral cortex 
regionalization 
BP 3.20 0.04 0.25 2 21796 
Regulation of defense 
response to bacterium 
BP 3.20 0.04 0.25 2 1900424 
Regulation of 
phagocytosis, 
engulfment 
BP 3.20 0.04 0.25 2 60099 
Positive regulation of 
phagocytosis, 
engulfment 
BP 3.20 0.04 0.25 2 60100 
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Cellular pigmentation BP 3.20 0.04 0.25 2 33059 
Synaptic cleft CC 3.20 0.04 0.25 2 43083 
Regulation of nodal 
signaling pathway 
involved in 
determination of 
left/right asymmetry 
BP 3.20 0.04 0.25 2 1900145 
Regulation of nodal 
signaling pathway 
involved in 
determination of lateral 
mesoderm left/right 
asymmetry 
BP 3.20 0.04 0.25 2 1900175 
Establishment or 
maintenance of 
neuroblast polarity 
BP 3.20 0.04 0.25 2 45196 
Establishment of 
neuroblast polarity 
BP 3.20 0.04 0.25 2 45200 
Sensory system 
development 
BP 3.20 0.04 0.25 2 48880 
Cardiac muscle cell 
myoblast differentiation 
BP 3.20 0.04 0.25 2 60379 
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Collagen V binding MF 3.20 0.04 0.25 2 70052 
Forebrain neuron fate 
commitment 
BP 3.20 0.04 0.25 2 21877 
Regulation of 
transcription from RNA 
polymerase II promoter 
involved in spinal cord 
motor neuron fate 
specification 
BP 3.20 0.04 0.25 2 21912 
Neural plate pattern 
specification 
BP 3.20 0.04 0.25 2 60896 
Neural plate 
regionalization 
BP 3.20 0.04 0.25 2 60897 
Synaptic vesicle 
clustering 
BP 3.20 0.04 0.25 2 97091 
Bombesin receptor 
activity 
MF 3.20 0.04 0.25 2 4946 
Locomotion involved in 
locomotory behavior 
BP 3.20 0.04 0.25 2 31987 
Regulation of 
transcription from RNA 
polymerase II promoter 
BP 3.20 0.04 0.25 2 1900094 
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involved in 
determination of 
left/right symmetry 
Nodal signaling pathway 
involved in 
determination of lateral 
mesoderm left/right 
asymmetry 
BP 3.20 0.04 0.25 2 1900164 
Nodal signaling pathway 
involved in 
determination of 
left/right asymmetry 
BP 3.20 0.04 0.25 2 38107 
Smooth muscle cell 
proliferation 
BP 3.20 0.04 0.25 2 48659 
Pre-mrna intronic 
binding 
MF 3.20 0.04 0.25 2 97157 
Intestinal epithelial cell 
development 
BP 3.20 0.04 0.25 2 60576 
Negative regulation of 
cholesterol biosynthetic 
process 
BP 3.20 0.04 0.25 2 45541 
Negative regulation of BP 3.20 0.04 0.25 2 90206 
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cholesterol metabolic 
process 
Actin polymerization-
dependent cell motility 
BP 3.20 0.04 0.25 2 70358 
Protein poly-ADP-
ribosylation 
BP 3.20 0.04 0.25 2 70212 
Viral assembly, 
maturation, egress, and 
release 
BP 3.20 0.04 0.25 2 19067 
Retinal blood vessel 
morphogenesis 
BP 3.20 0.04 0.25 2 61304 
Ornithine decarboxylase 
activator activity 
MF 3.20 0.04 0.25 2 42978 
Intestine smooth muscle 
contraction 
BP 3.20 0.04 0.25 2 14827 
Calcium-dependent 
protein kinase C activity 
MF 3.20 0.04 0.25 2 4698 
Calcium-dependent 
protein serine/threonine 
kinase activity 
MF 3.20 0.04 0.25 2 9931 
Laminin-11 complex CC 3.20 0.04 0.25 2 43260 
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Positive regulation of 
hydrolase activity 
BP 3.19 0.04 0.25 69 51345 
Regulation of MAPK 
cascade 
BP 3.19 0.04 0.25 71 43408 
Ubiquitin protein ligase 
binding 
MF 3.19 0.04 0.25 26 31625 
Small conjugating 
protein ligase binding 
MF 3.19 0.04 0.25 26 44389 
Transcription initiation 
from RNA polymerase 
II promoter 
BP 3.19 0.04 0.25 31 6367 
Regulation of purine 
nucleotide biosynthetic 
process 
BP 3.18 0.04 0.25 20 1900371 
Regulation of nucleotide 
biosynthetic process 
BP 3.18 0.04 0.25 20 30808 
Transcriptional repressor 
complex 
CC 3.18 0.04 0.25 13 17053 
Ion transport BP 3.17 0.04 0.25 130 6811 
Regulation of 
transcription, DNA-
BP 3.17 0.04 0.25 391 6355 
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dependent 
Positive regulation of 
purine nucleotide 
metabolic process 
BP 3.17 0.04 0.25 15 1900544 
Negative regulation of 
binding 
BP 3.17 0.04 0.25 15 51100 
Wnt receptor signaling 
pathway, planar cell 
polarity pathway 
BP 3.16 0.04 0.25 6 60071 
Regulation of 
establishment of planar 
polarity 
BP 3.16 0.04 0.25 6 90175 
Negative regulation of 
glial cell differentiation 
BP 3.16 0.04 0.25 6 45686 
Motor neuron axon 
guidance 
BP 3.16 0.04 0.25 6 8045 
Laminin binding MF 3.16 0.04 0.25 6 43236 
Regulation of cytokine 
secretion involved in 
immune response 
BP 3.15 0.04 0.25 3 2739 
Galactose catabolic BP 3.15 0.04 0.25 3 19388 
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process 
Filtration diaphragm CC 3.15 0.04 0.25 3 36056 
Slit diaphragm CC 3.15 0.04 0.25 3 36057 
Relaxation of smooth 
muscle 
BP 3.15 0.04 0.25 3 44557 
Embryonic process 
involved in female 
pregnancy 
BP 3.15 0.04 0.25 3 60136 
Regulation of neuron 
migration 
BP 3.15 0.04 0.25 3 2001222 
Cellular extravasation BP 3.15 0.04 0.25 3 45123 
Interkinetic nuclear 
migration 
BP 3.15 0.04 0.25 3 22027 
CD4-positive or CD8-
positive, alpha-beta T 
cell lineage commitment 
BP 3.15 0.04 0.25 3 43369 
H3 histone 
acetyltransferase 
complex 
CC 3.15 0.04 0.25 3 70775 
MOZ/MORF histone 
acetyltransferase 
CC 3.15 0.04 0.25 3 70776 
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complex 
Trna transcription BP 3.15 0.04 0.25 3 9304 
Neuronal cell body 
membrane 
CC 3.15 0.04 0.25 3 32809 
Cell body membrane CC 3.15 0.04 0.25 3 44298 
MAP-kinase scaffold 
activity 
MF 3.15 0.04 0.25 3 5078 
Positive regulation of 
dendritic cell antigen 
processing and 
presentation 
BP 3.15 0.04 0.25 3 2606 
Nuclear envelope lumen CC 3.15 0.04 0.25 3 5641 
Laminin-1 complex CC 3.15 0.04 0.25 3 5606 
Cell cortex part CC 3.15 0.04 0.25 18 44448 
Enzyme activator 
activity 
MF 3.15 0.04 0.25 64 8047 
Protein secretion BP 3.14 0.04 0.26 12 9306 
Regulation of cell 
migration 
BP 3.13 0.04 0.26 61 30334 
Regulation of BP 3.12 0.04 0.26 16 1505 
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neurotransmitter levels 
Visual perception BP 3.12 0.04 0.26 30 7601 
Dendrite CC 3.12 0.04 0.26 30 30425 
Detection of external 
stimulus 
BP 3.12 0.04 0.26 26 9581 
Monocarboxylic acid 
biosynthetic process 
BP 3.12 0.04 0.26 28 72330 
Central nervous system 
development 
BP 3.10 0.04 0.26 20 7417 
Activating transcription 
factor binding 
MF 3.10 0.04 0.26 11 33613 
Negative regulation of 
cellular response to 
growth factor stimulus 
BP 3.09 0.05 0.27 17 90288 
G-protein coupled 
peptide receptor activity 
MF 3.09 0.05 0.27 21 8528 
E-box binding MF 3.08 0.05 0.27 7 70888 
Myeloid cell activation 
involved in immune 
response 
BP 3.08 0.05 0.27 7 2275 
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Vesicle docking BP 3.08 0.05 0.27 7 48278 
Excretion BP 3.07 0.05 0.27 10 7588 
Negative regulation of 
steroid biosynthetic 
process 
BP 3.07 0.05 0.27 5 10894 
SMAD protein signal 
transduction 
BP 3.07 0.05 0.27 5 60395 
External encapsulating 
structure part 
CC 3.07 0.05 0.27 5 44462 
RNA polymerase II 
distal enhancer 
sequence-specific DNA 
binding 
MF 3.07 0.05 0.27 5 980 
Mannosidase activity MF 3.07 0.05 0.27 5 15923 
Positive regulation of 
neuroblast proliferation 
BP 3.07 0.05 0.27 5 2052 
Protein phosphatase 2A 
binding 
MF 3.07 0.05 0.27 5 51721 
Histone 
acetyltransferase binding 
MF 3.07 0.05 0.27 5 35035 
Regulation of alpha- BP 3.07 0.05 0.27 5 2000311 
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amino-3-hydroxy-5-
methyl-4-isoxazole 
propionate selective 
glutamate receptor 
activity 
Protein targeting to 
plasma membrane 
BP 3.07 0.05 0.27 5 72661 
Muscle cell proliferation BP 3.07 0.05 0.27 5 33002 
Positive regulation of 
nucleotide metabolic 
process 
BP 3.07 0.05 0.27 15 45981 
Cellular polysaccharide 
metabolic process 
BP 3.07 0.05 0.27 13 44264 
Potassium ion transport BP 3.06 0.05 0.27 18 6813 
Lateral plasma 
membrane 
CC 3.06 0.05 0.27 8 16328 
Defense response to 
Gram-positive bacterium 
BP 3.06 0.05 0.27 8 50830 
Positive regulation of 
exocytosis 
BP 3.06 0.05 0.27 8 45921 
Receptor regulator MF 3.06 0.05 0.27 9 30545 
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activity 
Cardiocyte 
differentiation 
BP 3.06 0.05 0.27 9 35051 
Forelimb morphogenesis BP 3.06 0.05 0.27 9 35136 
Positive regulation of 
axonogenesis 
BP 3.06 0.05 0.27 9 50772 
Phagocytosis BP 3.06 0.05 0.27 9 6909 
Cell-cell adhesion BP 3.06 0.05 0.27 54 16337 
Transcription regulatory 
region sequence-specific 
DNA binding 
MF 3.05 0.05 0.27 28 976 
Regulation of 
macromolecule 
biosynthetic process 
BP 3.05 0.05 0.27 434 10556 
Chemical homeostasis BP 3.04 0.05 0.27 107 48878 
Oxidation-reduction 
process 
BP 3.04 0.05 0.27 73 55114 
Leydig cell 
differentiation 
BP 3.04 0.05 0.27 4 33327 
Trabecula BP 3.04 0.05 0.27 4 61383 
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morphogenesis 
Positive regulation of 
interferon-gamma 
biosynthetic process 
BP 3.04 0.05 0.27 4 45078 
Positive regulation of 
insulin-like growth 
factor receptor signaling 
pathway 
BP 3.04 0.05 0.27 4 43568 
Mitogen-activated 
protein kinase kinase 
binding 
MF 3.04 0.05 0.27 4 31434 
Regulation of non-
canonical Wnt receptor 
signaling pathway 
BP 3.04 0.05 0.27 4 2000050 
Chronic inflammatory 
response 
BP 3.04 0.05 0.27 4 2544 
Regulation of SMAD 
protein import into 
nucleus 
BP 3.04 0.05 0.27 4 60390 
Regulation of steroid 
hormone biosynthetic 
process 
BP 3.04 0.05 0.27 4 90030 
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Histone H2A acetylation BP 3.04 0.05 0.27 4 43968 
Negative regulation of 
JUN kinase activity 
BP 3.04 0.05 0.27 4 43508 
Fibrillar collagen CC 3.04 0.05 0.27 4 5583 
Cellular response to 
chemical stimulus 
BP 3.03 0.05 0.27 214 70887 
Regulation of 
phospholipase activity 
BP 3.03 0.05 0.27 16 10517 
Positive regulation of 
locomotion 
BP 3.02 0.05 0.27 39 40017 
Fatty acid biosynthetic 
process 
BP 3.02 0.05 0.27 20 6633 
Telomere maintenance BP 3.02 0.05 0.27 12 723 
Steroid metabolic 
process 
BP 3.01 0.05 0.27 38 8202 
Golgi cisterna 
membrane 
CC 3.01 0.05 0.27 14 32580 
Peptide receptor activity MF 3.01 0.05 0.27 21 1653 
Epidermal growth factor 
receptor signaling 
BP 3.00 0.05 0.27 31 7173 
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pathway 
Regulation of cytokine 
biosynthetic process 
BP 3.00 0.05 0.27 17 42035 
Positive regulation of 
MAPK cascade 
BP 3.00 0.05 0.27 30 43410 
Cellular chemical 
homeostasis 
BP 3.00 0.05 0.27 80 55082 
Nervous system 
development 
BP 2.99 0.05 0.27 44 7399 
Endopeptidase inhibitor 
activity 
MF 2.99 0.05 0.28 28 4866 
Endoplasmic reticulum-
Golgi intermediate 
compartment 
CC 2.98 0.05 0.28 11 5793 
Extrinsic to internal side 
of plasma membrane 
CC 2.98 0.05 0.28 11 31234 
Regulation of striated 
muscle cell 
differentiation 
BP 2.97 0.05 0.28 15 51153 
Regulation of interferon-
gamma production 
BP 2.96 0.05 0.28 13 32649 
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Positive regulation of 
interleukin-1 beta 
production 
BP 2.96 0.05 0.28 6 32731 
Calcium activated cation 
channel activity 
MF 2.96 0.05 0.28 6 5227 
Regulation of 
oligodendrocyte 
differentiation 
BP 2.96 0.05 0.28 6 48713 
Neural tube 
development 
BP 2.96 0.05 0.28 6 21915 
Phosphatidylinositol 3-
kinase binding 
MF 2.96 0.05 0.28 6 43548 
Middle ear 
morphogenesis 
BP 2.96 0.05 0.28 6 42474 
Positive regulation of 
cellular component 
biogenesis 
BP 2.96 0.05 0.28 6 44089 
Cellular homeostasis BP 2.95 0.05 0.28 91 19725 
ERBB signaling 
pathway 
BP 2.94 0.05 0.28 31 38127 
Cellular macromolecule BP 2.94 0.05 0.29 36 70727 
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localization 
Regulation of ERK1 and 
ERK2 cascade 
BP 2.93 0.05 0.29 21 70372 
Regulation of hydrolase 
activity 
BP 2.93 0.05 0.29 110 51336 
Regulation of 
intracellular protein 
kinase cascade 
BP 2.93 0.05 0.29 101 10627 
Protein binding, 
bridging 
MF 2.93 0.05 0.29 22 30674 
Response to oxygen-
containing compound 
BP 2.92 0.05 0.29 135 1901700 
Ventricular cardiac 
muscle tissue 
morphogenesis 
BP 2.92 0.05 0.29 9 55010 
Neuron-neuron synaptic 
transmission 
BP 2.92 0.05 0.29 9 7270 
Hindlimb 
morphogenesis 
BP 2.92 0.05 0.29 9 35137 
Regulation of cellular 
response to growth 
BP 2.92 0.05 0.29 26 90287 
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factor stimulus 
Homophilic cell 
adhesion 
BP 2.92 0.05 0.29 24 7156 
Cellular response to 
organic substance 
BP 2.92 0.05 0.29 184 71310 
Protein tyrosine kinase 
activity 
MF 2.92 0.05 0.29 25 4713 
Locomotory behavior BP 2.92 0.05 0.29 25 7626 
Receptor activator 
activity 
MF 2.91 0.05 0.29 7 30546 
Negative regulation of 
gliogenesis 
BP 2.91 0.05 0.29 7 14014 
Golgi-associated vesicle CC 2.91 0.05 0.29 7 5798 
Positive regulation of 
proteolysis 
BP 2.91 0.05 0.29 14 45862 
Extracellular ligand-
gated ion channel 
activity 
MF 2.91 0.05 0.29 14 5230 
Telomere organization BP 2.91 0.05 0.29 12 32200 
Negative regulation of BP 2.91 0.05 0.29 8 30514 
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BMP signaling pathway 
Frizzled binding MF 2.91 0.05 0.29 8 5109 
Delayed rectifier 
potassium channel 
activity 
MF 2.91 0.05 0.29 8 5251 
BP, Biological process; MF, molecular function; cellular component; #, number of; GO ID, 
gene ontology identification. 
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Chapter 8 General discussion 
The overarching purpose of this thesis was to determine the impact of strenuous exercise 
training on leukocyte telomere, DNA methylation and corresponding gene expression 
changes measured in context with cardiovascular health and fitness in humans. Accordingly, 
two cross-sectional studies were conducted to establish the differences in leukocyte telomere 
dynamics between endurance athletes, who perform copious amounts of aerobic endurance 
exercise, and apparently healthy controls. The second focus of this thesis was on the exercise 
training-induced changes to DNA methylation. In order to assess this, two training studies in 
young men, using a relatively new and effective type of exercise that improves 
cardiovascular health and fitness – sprint interval training – was used to assess the DNA 
methylation changes in leukocytes and sperm. 
The results from each manuscript presented in this thesis have been discussed in Chapters 
3,4, 6 and 7. This general discussion will integrate the results from the previous Chapters and 
provide direction for future investigations.  
Endurance exercise training preserves leukocyte telomeres 
The first study was designed to establish the long-term impact strenuous endurance exercise 
training has on leukocyte telomere length and whether any associations were mediated by 
cardiovascular risk factors and circulating markers of inflammation – interleukin-6 (IL-6), c-
reactive protein (CRP), leptin, intercellular adhesion molecule-1 (ICAM-1) and e-selectin (E-
selectin) (Chapter 3).202 It was found ultra-marathon runners had significantly longer 
leukocyte telomeres compared to controls, but the difference was not explained by their 
excellent cardiovascular health.202 The second study attempted to replicate the findings in 
independent cohorts of endurance athletes and healthy controls. In accordance with the 
previous results, the athletes had longer leukocyte telomeres despite being chronologically 
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five years older. Furthermore, resting heart rate and VO2max emerged as important mediators 
of the longer leukocyte telomeres and up-regulated TERT and TPP1 mRNA expression found 
in athletes. Werner et al. 200 revealed endurance athletes have up-regulated telomerase 
activity, which supports my data at the transcriptional level. Together, the data included in 
this thesis and data from other laboratories 200 suggests endurance exercise training may 
preserve leukocyte telomeres by up-regulating TPP1 and TERT mRNA expression, which in 
turn, increases the processivity and activity of the enzyme telomerase, through the 
modulation of currently unknown molecular signalling cascades.   
Inflammatory and oxidative stress pathways are prime candidate pathways that could play a 
role in exercise-induced telomere dynamics. Low-grade chronic inflammation and elevated 
reactive oxygen species (ROS) are phenotypes shared by many of age-related cardio-
metabolic diseases associated with excessive telomere shortening.312,620,621 Indeed, in vitro168 
and in vivo622 experiments suggest inflammation shortens human fibroblast telomeres and 
culminates in cellular senescence through excessive ROS.622 Interestingly, chronic exercise 
training lowers circulating markers of inflammation36,280 and prevents excessive ROS by 
enhancing antioxidant capacity.623,624 This considered and the fact that no statistically 
significant associations between telomere length and circulating markers of inflammation 
were observed in my first study, the endurance exercise training may attenuate telomere 
attrition by mitigating circulating ROS-induced telomere shortening and senescence, though 
this will require future investigations. 
Exercise training reconfigures the DNA methylome 
Telomere length is linked to chromatin structure, regulated by epigenetic modifications such 
as DNA and histone methylation and histone acetylation.45,46,101,625 Therefore, the second 
theme of this thesis included two investigations on the influence of sprint interval training 
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(SIT) on DNA methylation in leukocytes (somatic cells) and sperm (germ cells). Given the 
more profound change to DNA methylation is observed after high-intensity exercise in 
humans,526 the aim of Chapter 6 was to analyse the genome-wide leukocyte DNA 
methylation changes after four weeks of sprint interval training;248 an emerging form of 
exercise training that improves cardiorespiratory fitness and cardiovascular health parameters 
rapidly and with less of a time demand than traditional longer duration, moderate intensity 
exercise.626  
The four week SIT intervention was associated with marked changes across the leukocyte 
methylome, particularly in cardiovascular and cancer pathways.248 These changes occurred 
concurrently with decreased and increased low-density lipo-protein cholesterol and 
cardiorespiratory fitness in young men, respectively. This study was the first to 
comprehensively characterise the genome-wide DNA methylation changes associated with 
intense aerobic exercise training and contributed the accumulating evidence indicating 
exercise training as a lifestyle strategy that effectively regulates the DNA methylome of 
multiple tissue types, such as muscle,522,605 fat523 and immune cells.248 Many of the DNA 
methylation changes found in my study were found in genes enriched for molecular pathways 
that are also altered after longer (6-month) moderate-intensity aerobic exercise interventions. 
For example, Charlotte Ling’s group found a six month exercise programme in middle-aged 
subjects elicited skeletal muscle CpG methylation changes in genes involved in the MAPK, 
Wnt, Hedgehog, calcium signalling pathways, respectively, as well as melanogenesis, 
progesterone-mediate oocyte maturation – identical pathways modulated in leukocytes after 
four weeks of SIT.522 Moreover, the MAPK signalling pathway, known for its role in 
metabolism and mitochondrial function, is particularly modified after exercise training as 
genes enriched for this pathway were differentially methylated in three different tissues from 
three separate studies.248,522,627 Therefore, exercise training seems to systemically influence 
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DNA methylation landscapes throughout numerous somatic cells in the body, potentially via 
a ROS-mediated mechanism.583,628 
Some epigenetic modifications, including DNA methylation, are somewhat heritable, 
particularly at metabolic and paternally imprinted genes614,615 – areas that escape the global 
de-methylation event upon fertilisation. In order to gain insight into whether exercise training 
affects the cells involved in the fertilisation process (germ cells – male sperm and female 
oocyte), and those cells that transfer the necessary genetic material that contributes to the 
offspring’s genome, the aim of Chapter 7 was to ascertain whether the human sperm 
methylome is vulnerable to changes caused by three months of SIT.627 Interestingly, SIT-
induced genome-wide DNA methylation changes in human sperm occurred at CpG sites in 
genes enriched for known pathways involved in exercise training adaptations, such as MAPK 
signalling, PI3K-Akt signalling and ErbB signalling. The CpG sites with increased 
methylation after SIT were in genes with roles in many human diseases; the top 5 were 
schizophrenia, Parkingson’s disease, autism, cervical cancer and leukaemia. As not all CpG 
sites escape the DNA methylation erasure associated with fertilisation, a disease association 
analysis was conducted, using the bioinformatics tool, DAVID,538 on paternally imprinted 
CpG sites that are exempt from this process. Two of the 16 genes with DNA methylation 
modifications after SIT were associated with metabolic diseases that are prevented and 
controlled by regular exercise training – type 2 diabetes mellitus, hypertension and 
atherosclerosis (IGF2 and INS-IGF2). Taken together, these novel investigations have 
provided evidence indicating SIT is an effective type of strenuous aerobic exercise that 
improves cardiovascular health and fitness, and reconfigures the DNA methylome in 
leukocytes and sperm. While these findings are not expected to directly change physical 
activity guidelines or policy, the premise of exercise-induced transgenerational inheritance of 
epigenetic modifications and the corresponding health outcomes may. 
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Limitations 
There are a number of limitations associated with this thesis. Particular limitations associated 
with each study have already been discussed in Chapters 3,4,6 and 7. This section reiterates 
the important limitations from my studies. 
Whole-blood leukocyte telomere and DNA methylation were analysed in context with 
exercise training. Leukocytes are made up of numerous subsets with different roles in 
immunity and these have different telomere lengths31,309 and DNA methylation landscapes.629 
Leukocyte subset numbers or whole-blood leukocytes numbers were not analysed in my 
participants, which could have influenced results from the telomere and epigenetic studies. 
However, to minimise the effect of leukocyte subset variations, preprandial blood samples 
were collected from subjects in a rested state, 24 to 48 hours after previous physical activity 
or exercise sessions, to avoid any subset shifts or leucocytosis immediately after a bout of 
exercise training.630,631 Additionally, it is unlikely that a particular type of leukocyte 
contributes to the overall health and fitness adaptations to exercise training and as such, the 
leukocyte telomere length and DNA methylation analyses performed in whole-blood 
leukocytes seemed a sensible starting point.  
Chapters 3 and 4 included cross-sectional comparisons between endurance athletes and 
healthy controls. Although the athletes possessed longer leukocyte telomeres and increased 
expression of telomere-regulating genes (TERT and TPP1), causation cannot be assumed. 
Therefore, it is possible that regular endurance exercise does not maintain telomere length, 
rather the endurance athletes are genetically configured to have longer telomeres and elevated 
expression of telomere-regulating genes. It is, however, likely that the regular involvement in 
endurance exercise training causes up-regulation of telomerase activity and maintains 
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telomere length. Other data from the Charchar laboratory have indicated increased TERT 
mRNA expression in leukocytes after a 30-min bout of running at 80% of VO2peak.230  
The exercise induced telomere length maintenance is expected to involve the regulation of a 
network of genes and molecular pathways. An additional limitation of Chapter 4 is that only 
the seven known telomere length-regulating genes were chosen a priori for analysis. 
However, this type of analysis was chosen due to the limited amount of RNA and funding. 
Furthermore, protein analysis was not performed, as protein was not extracted from 
leukocytes and Western blot analyses would not have been possible given the amount of 
samples.  
A common limitation associated with exercise studies is the lack of control for the impacts of 
diet. Particular diets rich in processed foods or vitamins are associated with shorter and 
longer leukocyte telomeres, respectively. Diet is also associated with particular DNA 
methylation changes in leukocytes. Therefore, it is possible that diet may have affected the 
results presented in this thesis.  
Genome-wide DNA methylation analyses were performed using microarray technology 
(450K array, Illumina). This technology is prone to false positives and also false negatives 
and should be validated with other techniques with higher resolution. The 450K results from 
Chapter 6 were not validated by the use of the EpiTYPER (Sequenom) due to the problematic 
genomic location of the CpGs of interest. It was not financial feasible to validate the DNA 
methylation changes in Chapter 7. Whole genome bisulfite sequencing (WGBS) or 
methylated DNA immunoprecipitation sequencing (MeDIP-seq) are superior to the 450K 
array such that they have higher resolution.632 These technologies are, however, significantly 
more expensive and less throughput compared to the 450K array,632 making the use of these 
impossible due the limited budget associated with the PhD. 
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Future directions 
Molecular exercise physiology research is in its infancy. Our understanding of the impact of 
exercise training on telomere biology and epigenetic modifications is fairly rudimentary. 
Consequently, there is a breadth of future directions appropriate for these topics and I have 
emphasised the important ones below: 
• Efforts should be made to determine the influence of habitual exercise on telomere 
length and underlying telomere regulating genes and proteins, longitudinally over 
multiple years. The inclusion of a control group who does little or no exercise will 
help support the premise that exercise training prevents telomere length shortening. I 
will follow-up my athletes and controls from Chapter 4 in an observational study 
aimed at assessing telomere dynamics across multiple years (3 to 5 years). 
Additionally, analysing telomere length changes in context with epigenetic 
modifications may provide insight into the underlying molecular signals driving the 
telomere length changes or maintenance.  
 
• Data from our laboratory has shown the major protein component of telomerease, 
TERT mRNA, expression is increased in leukocytes after an acute bout of aerobic 
exercise.230 An extension of this work would be to measure telomerase activity and 
assess whether the accumulated and repeated exposure to exercise training may 
maintain telomeres through up-regulated telomerase activity. Data collection for this 
project is planned for late 2015.  
 
• Considering exercise training prevents, manages and regresses many symptoms of 
age-related chronic diseases related to short telomeres, the identification of whether 
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exercise training exerts these functions through telomere and DNA methylation 
regulation is warranted. This would improve our understanding of the underlying 
mechanism by which exercise training stabilises health and may lead to novel 
pharmaceutical developments. Conducting randomised controlled trials with clinical 
populations, using different exercise intensities and new, robust analysis platforms 
could help achieve this aim.  
 
• Functional studies analysing whether telomere length and/or DNA methylation (or 
other epigenetic modifications) changes directly influence gene expression and 
protein abundance are required. Ideally, these experiments would be performed in 
vitro and in vivo. 
 
• Telomeres have a heritability estimate of approximately 0.62–0.86.633 Therefore, it 
would be interesting to elucidate if, like DNA methylation changes, exercise training 
can affect telomere length in germ cells (female oocyte and male sperm). 
 
• The most crucial question for the area of exercise epigenetics would be: are exercise-
induced epigenetic modifications transgenerationally inherited by offspring and do 
these changes govern health and fitness? There are examples where particular in utero 
environmental stressors – plastics and pesticides (reviewed in66), undernourishment634 
and low protein diet59,635 – modifies the rodent offsprings’ epigenetic profile and 
causes metabolic consequences. Although rodent studies could help our 
understanding of the capacity for exercise to elicit such an affect, large human studies, 
across four generations would be ideal and would also have an exorbitant cost and 
effort related to them. The Framingham Heart Study is, however, a large, ongoing 
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study analysing cardiovascular disease risk factors in its third generation of human 
subjects and may soon provide insight on the transgenerational inheritance of heart 
disease. 
 
Conclusions  
This thesis has presented novel data from four investigations involving the analysis of 
telomere and DNA methylation in context with strenuous aerobic exercise and corresponding 
cardiovascular health and fitness adaptations. It was found that regular engagement in aerobic 
exercise training is associated with longer leukocyte telomeres with paralleled increased 
expression of leukocyte TERT and TPP1 mRNA expression – two genes known for their role 
in telomere length maintenance. These anti-ageing effects were related to resting heart rate 
and VO2peak. Moreover, short- and long-term SIT significantly modulates the leukocyte and 
sperm methylomes, respectively, in numerous genes and common signalling pathways 
modified in other somatic cells by other moderate-intensity exercise progammes.522,523 The 
regulation of microRNAs by DNA methylation caused by SIT was also presented. Notably, 
these epigenetic changes occurred concurrently with improvements to cardiovascular health, 
fitness and performance. It is possible that telomere length maintenance and epigenetic 
modifications underpin the positive cardiovascular health and fitness benefits and prevention 
of premature ageing conferred by regular engagement in aerobic exercise. Further, exercise-
induced germ line epigenetic modifications may influence the health of future generations 
and this paradigm deserves detailed attention in future investigations. These results may pave 
the way for more robust exercise training guidelines and national policies and contribute to 
the development of precision exercise.   
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Abstract 
Background 
Telomere length is indicative of biological age. Shorter telomeres have been associated with 
several disease and health states. There are inconsistencies throughout the literature amongst 
relative telomere length measured by quantitative PCR (qPCR) and different extraction 
methods or kits used. We quantified whole-blood leukocyte telomere length using the 
telomere to single copy gene (T/S) ratio by qPCR in 20 young (18-25yrs) men after 
extracting DNA using three common extraction methods: Lahiri and Nurnberger (high salt) 
method, PureLink Genomic DNA Mini kit (Life Technologies) and QiaAmp DNA Mini kit 
(Qiagen). Telomere lengths differences of DNA extracted from the three extraction methods 
was assessed by one-way analysis of variance (ANOVA). 
Results 
DNA purity differed between extraction methods used (P = 0.01). Telomere length was 
impacted by the DNA extraction method used (P = 0.01). Telomeres extracted using the 
Lahiri and Nurnberger method (mean T/S ratio: 2.43, range: 1.57 – 3.02) and PureLink 
Genomic DNA Mini Kit (mean T/S ratio: 2.57, range: 2.24 – 2.80) did not differ (P = 0.13). 
Likewise, QiaAmp and Purelink-extracted telomeres were not statistically different (P = 
0.14). The Lahiri-extracted telomeres, however, were significantly shorter than those 
extracted using the QiaAmp DNA Mini Kit (mean T/S ratio: 2.71, range: 2.32 – 3.02; P = 
0.003). DNA purity were associated with telomere length. 
Conclusion 
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There are discrepancies between the length of leukocyte telomeres extracted from the same 
individuals according to the DNA extraction method used. DNA purity could be responsible 
for the discrepancy in telomere length but this will require validation studies. We recommend 
using the same DNA extraction kit when quantifying leukocyte telomere length by qPCR or 
when comparing different cohorts to avoid erroneous associations between telomere length 
and traits of interest. 
 
Keywords: Telomeres, leukocyte, T/S ratio, qPCR, DNA extraction, High salt method 
Background 
In mammalian cells, telomeres are the repetitive sequence (TTAGGGn) that prevent 
end-to-end fusion and maintains chromosomal stability 67. Leukocytes circulate through 
many organs and their telomere length correlate to that of other tissues, including fat, muscle, 
skin and synovial tissue in humans 24,637,638. Without the reverse transcriptase enzyme, called 
telomerase, somatic cell telomeres shorten during mitosis 68. For this reason and due to ease 
of accessibility, leukocyte telomere length has become an important biomarker for cellular 
and biological age. Leukocyte telomere length is shorter in individuals with atherosclerosis 
70, type 2 diabetes 143 and cancer 639, and is inversely associated with age and mortality risk 
640. Conversely, lifestyle factors such as a healthy diet, vitamin intake and exercise are 
associated with longer leukocyte telomeres 185,202,641.  
There are a number of inconsistencies throughout the literature related to telomere 
length. For example, leukocyte telomere length quantified by real-time quantitative 
polymerase chain reaction (qPCR) using the telomere to single copy gene ratio (T/S ratio), in 
which the 36B4 gene is commonly used, varies dramatically throughout the literature and 
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associations between telomere lengths and diseases are sometimes equivocal 642. The 
discrepancies could potentially be partially explained by the quantification of telomere 
lengths after extraction by different DNA extraction methods. We hypothesized that the DNA 
extraction method used to harvest DNA from leukocytes would impact their telomere length 
(T/S ratio) quantified by qPCR. Recently, it was demonstrated in a cohort of cancer patients 
and healthy individuals that telomere length of buffy coat leukocytes was dependent on the 
DNA extraction method used 642. Whether telomeres from whole-blood leukocytes are 
influenced by using other DNA extraction methods remained to be tested. Also, the 
mechanism by which telomere length varies between extraction methods is not yet 
understood. Here we compared whole-blood leukocyte telomere length of DNA extracted 
using three different extraction methods; including two extraction kits that have not been 
studied in context with telomere length previously. 
Methods 
Sample collection 
A resting blood sample was collected from 20 young (18–25yr) men. Participants self-
reported that they were free from any infections and chronic diseases, and were otherwise 
healthy. Blood was drawn from the antecubital vein into EDTA tubes (BD Vacutainer, 
Australia) and was immediately stored on ice. DNA was extracted using three individual 
DNA extraction methods within 12 hours of collection to prevent any ex vivo impacts on 
telomere integrity. DNA yield and purity was checked using a Nanodrop 2000 
Spectrophotometer (Thermo Scientific, Australia) before being stored at  
-20°C. All blood collections were performed in the morning. 
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All participants gave written informed consent and this study was approved by the 
Federation University Australia Human Research Ethics Committee.  
DNA extraction 
DNA was extracted from whole-blood using the PureLink Genomic DNA Mini Kit 
(Life Technologies), QiaAmp DNA Mini Kit (Qiagen) and the Lahiri and Nurnberger 
(high salt) method, a non-commercial, relatively cheap, toxic reagent-free protocol 643. 
Reagents for the Lahiri and Nurnberger method were prepared according to guidelines 
described elsewhere 643. All DNA extractions were performed according the manufacturers 
recommendations by one researcher only.  
Telomere assays 
Relative telomere length was quantified by qPCR using the T/S ratio 644. This is a 
relative measure of telomere length that is strongly correlated to telomere restriction 
fragments quantified by Southern Blot 644.The telomere assays were run on the ViiA7 Real 
Time PCR System (Life Technologies, Australia). Briefly, reactions were run in 384-well 
plate format with duplicates for samples, an exogenous positive and negative controls. 
Reaction were comprised of the following constituents: SensiFAST SYBR Lo-ROX master 
mix (Bioline, Australia), 300nmol/l of telomere-specific forward and reverse primers, or 
300nmol/l of the single copy gene (36B4) forward and 500nmol/l of the 36B4 reverse primers 
and 30ng of DNA to make a total reaction volume of 10µl. The telomere assay primer-sets 
have been described elsewhere 14. Difference of less than one cycle threshold (Ct) between 
duplicates was required. The telomere assays were repeated on 80% of samples on a separate 
day to assess the reproducibility of the data.  
Statistics  
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Kolmogorov-Smirnov and Shapiro-Wilk test were performed and demonstrated the 
T/S ratios were normally distributed. An ANOVA was performed to determine differences in 
T/S ratio and DNA purity between the extraction methods studied. Pearson’s Correlations 
were used to assess linear associations between DNA purity and T/S ratios. Statistical 
analyses were performed using the IBM SPSS statistics software (version 19) and 
significance was set at P < 0.05. 
Results 
DNA extracted from each of the three extraction methods showed significantly 
different purities (P = 0.01, Table 1). Specifically, Lahiri and Nurnberger and Purelink-
extracted DNA had lower 260/280 ratios compared with the QiaAmp-extracted DNA (mean 
± SEM, 1.7 ± 0.08 vs 1.93 ± 0.01, P = 0.003 and 1.78 ± 0.03 vs 1.93 ± 0.01, P = 0.048, 
respectively). There were no statistically significant differences between DNA 260/230 ratios 
of DNA extracted using the three different extraction methods (P > 0.05, Table 1). 
The inter-assay coefficient of variation between independent replicates for the T/S 
ratio was 9.7% and r-value was 0.82 (P < 0.001, Figure 1). The intra-assay coefficient of 
variation was 1.5% for the telomere primer-set and 0.75% for the 36B4 primer-set, 
respectively. Therefore, the data showed acceptable reproducibility.  
There were significant differences in the average T/S ratio between DNA extracted 
using the three methods (n = 20, P = 0.01). The QiaAmp and Purelink-extracted telomeres 
were not statistically different (P = 0.14). Similarly, telomeres of DNA extracted using the 
Lahiri and Nurnberger method (T/S ratio: 2.43, range: 1.57 – 3.02) and PureLink Genomic 
DNA Mini Kit (T/S ratio: 2.57, range: 2.24 – 2.80) did not differ (P = 0.13), but Lahiri and 
Nurnberger extracted telomeres were significantly shorter than those extracted using the 
QiaAmp DNA Mini Kit (T/S ratio: 2.71, range: 2.32 – 3.02, P = 0.003) (Figure 2). There 
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were no statistically significant correlations between the T/S ratios of DNA extracted using 
the three extraction methods (P > 0.05, Figure 3).  
 Finally, there were modest but statistically significant correlations between DNA 
purity and telomere length (260/280 and T/S ratio: r = 0.31, P = 0.015; and 260/230 and T/S 
ratio: r = 0.33, P = 0.01, Figure 4). 
Discussion 
Here we demonstrated leukocyte telomere length quantified by qPCR differs depending 
on the DNA extraction kit used to isolate the DNA. Furthermore, to our knowledge, we are 
the first to report telomere length could vary depending on the purity of DNA used for qPCR. 
Telomere length of DNA extracted from leukocytes using the Lahiri and Nurnberger method 
were different compared to those extracted using the QiaAmp DNA Mini method. The 
QiaAmp and Purelink-extracted telomeres were not statistically different. Moreover, telomere 
length of DNA extracted from the same individual using the three methods were not 
correlated. Whereas DNA extracted from leukocytes using the Lahiri and Nurnberger method 
demonstrated the largest variation in telomere length and the shortest average telomere 
length, the PureLink Genomic DNA Mini method had the least variation in telomere length 
and the QiaAmp DNA Mini method produced the longest telomeres. There was no statistical 
significant difference in the length of telomeres extracted using the Lahiri and Nurnberger 
and PureLink Genomic DNA Mini methods. Additionally, there was no statistically 
significant difference between telomeres extracted using the QiaAmp and Purelink methods. 
Our findings extend previous data on relative telomere length differences between the 
QiaAmp DNA Mini method and other DNA extraction methods, specifically, the Gentra 
PureGene Blood Kit and a phenol/chloroform DNA extraction methods (both from Qiagen) 
642. Consistent with a previous report 642, the two column-based extraction methods used in 
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our study, the Purelink and QiaAmp protocols, yielded the smallest range of telomere 
lengths; the Lahiri and Nurnberger method had the largest telomere length range. Conversely, 
our data show column-based extraction methods produce longer telomeres compared to a 
high salt  protocol. Particularly relevant is the Lahiri and Nurnberger method, which is a 
cheap and commonly used method before kits started to be used. In addition to extending 
previous findings 642, our data demonstrate other DNA extraction methods produce different 
leukocyte telomere lengths in a relatively modest number of participants.  
Our novel finding that DNA purity (260/280 and 260/230 ratios) is correlated to 
telomere length suggests chemical contamination during DNA extraction could influence the 
qPCR reaction and telomere length. Interestingly, the QiaAmp-extracted DNA had the 
longest telomeres and the highest 260/280 ratio and the Lahiri and Nurnberger-extracted 
DNA had the shortest telomeres and lowest 260/280 ratio. The Lahiri and Nurnberger method 
contains high concentrations of salt which could contaminate extracted DNA. Certainly, 
additional studies will be required to confirm that differences in telomere length from DNA 
extracted using different extraction methods is due to DNA purity. We would, however, 
recommend caution when quantifying and comparing telomeres from DNA with different 
purities. 
The leukocyte telomere length discrepancies observed in the present study could also 
be a result of telomere damage during the extraction process. The different reagents used in 
the extraction methods may affect telomere integrity during extraction. For example, both 
column-based extraction kits (QiaAmp and Purelink DNA Mini) include proteinase K and 
digestion buffers which effectively lyse proteins and inactivates nucleases. The Lahiri and 
Nurnberger (high salt) method 643, however, uses non-toxic reagents and a non-ionic 
detergent, octylphenoxypolyethoxyethanol (Nonidet P-40, Signma-Aldrich), and unlike the 
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column-based kits, may cause residual reagents in isolated DNA during the extraction 
procedure. This would lead to a decreased DNA purity which might inevitably affect 
telomere length assessed by qPCR. Shearing of DNA and low molecular weight may also 
explain differences in telomere length amongst different extraction methods 642. Both the 
QiaAmp and Purelink DNA Mini kits isolate DNA 20–50kb in length. Alternatively, 
telomere structure may influence telomere length measured by qPCR. Telomeres can form 
quadruplex structures 645 and telomeric DNA is vulnerable to oxidative damage 169, which 
may be influenced by some reagents or high concentrations of Na+/K+ 646,647. This may 
inevitably contribute to altered telomere amplification during qPCR and consequently 
telomere length. Epigenetic modifications, such as histone acetylation and DNA methylation, 
are abundant at telomeres and sub-telomeric regions 45, and could also modify the DNA 
amplification during qPCR. It has been suggested that telomere length differences arising 
from different DNA extraction methods used are likely to be related to DNA quality and not 
qPCR amplification effects 642, yet this was not directly analysed. We, however, have 
demonstrated DNA purity correlates to leukocyte telomere length in healthy young men.  
Our results have implications to already published and future research. Any 
investigations involving telomere length quantification should be required to extract DNA 
using the same method in order to make justified conclusion regarding the phenotypic 
association with telomere length. This may be problematic for meta-analyses and large 
studies that are analyzing a phenotype in context with telomere dynamics, as they involve 
large data-sets from multiple laboratories, yet the utilization of different extraction methods 
could yield misleading results. Telomere length has been identified as a clinical relevant 
prognostic biomarker of disease and disease risk 18,19,176,648, and according to our data and that 
of others 642 the use of different extraction methods across multiple time-points should be 
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avoided. Moreover, as DNA purity could influence telomere length, it could be advantageous 
to control for DNA purity in statistical analyses when comparing telomere length. 
A limitation of our study is that we quantified leukocyte telomere length of 20 young 
men, a relatively modest number. We have, however, clearly shown that even in a small 
cohort of young men leukocyte telomere length is impacted by the DNA extraction method 
used.  
Future work should aim at replicating our findings and previous published data 642 
suggesting DNA extraction methods influence leukocyte telomere length quantified by 
qPCR, to confirm results and identify explanations for the discrepancies. The investigation 
into the effect of other commercial and non-commercial DNA kits on leukocyte and 
additional cell-type telomere lengths is also warranted. Establishing the cause of the different 
telomere lengths from different extraction kits is also required. Lastly, it would be beneficial 
to validate which DNA extraction method is the most valid estimate of telomere length 
quantified by other methods such as Southern Blot or quantitative fluorescent in situ 
hybridization (Q-FISH). Interestingly, QiaAmp-extracted leukocyte telomeres were, on 
average, shorter compared to telomeres extracted by both phenol/chloroform and PureGene 
protocols when quantified by qPCR but were similar to phenol/chloroform-extracted 
telomeres when quantified by Southern Blot 642.    
Conclusions 
By comparing the length of telomeres extracted from whole-blood leukocytes using 
three different extraction methods, we have demonstrated that the method of DNA extraction 
impacts leukocyte telomere length possibly by yielding different DNA purity. We 
recommend the adherence to a single type of DNA extraction method when performing 
comparative and prospective telomere length studies in context with health and disease traits. 
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qPCR - quantitative polymerase chain reaction 
T/S ratio – telomere to single copy gene  
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Figure  legends 
 
Figure 1. Linear correlation between telomere assays. Telomere assays were repeated on 
80% of samples on a separate day to assess the reproducibility of the data. Telomere length 
(T/S ratio) data showed acceptable reproducibility (r = 0.82, P < 0.001).  
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Figure 2. DNA extraction method impacts leukocyte telomere length (T/S ratio). Bars are 
mean telomere length and error bars are standard deviations. 
DNA was extracted using the Purelink, QiaAmp and Lahiri and Nurnberger methods, 
respectively. **P = 0.003. 
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Figure 3. Correlations between 20 individuals telomeres from DNA extracted from three 
different extraction methods. The x and y axis represents leukocyte telomere length (T/S 
ratio). 
 
Figure 4. Correlation between leukocyte telomere length (T/S ratio) with DNA purity 
(260/280 and 260/230 ratios).Table 
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Table 1. DNA quality of samples extracted using three extraction methods. 
 
 
 
 
 
Data are expressed as mean ± SEM from 20 DNA samples extracted using three different 
extraction methods. 
† Lahiri and Nunberger vs QiaAmp (P = 0.003)‡ Purelink vs QiaAmp (P = 0.048) 
 
 
 
 
 
 
 
 
 
 
Extraction method DNA quality 
 260/280 260/230 
Lahiri and Nunberger 1.7 ± 0.08† 1.45 ± 0.23  
Purelink 1.78 ± 0.03‡ 1.62 ± 0.1 
QiaAmp 1.93 ± 0.01 1.41 ± 0.09 
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ABSTRACT 
Sprint interval training (SIT) rapidly improves cardio-respiratory fitness but demands less 
training time than traditional endurance training. While the health and fitness gains caused by 
SIT are understood, the effect of short-term SIT on 5 km run performance remains elusive. 
Thirty healthy untrained participants (aged 18–25 years) were allocated to a control (n = 10) 
or a SIT (n = 20) group. SIT involved three to eight sprints at maximal intensity, three times a 
week for four weeks. Sprints were progressed to eight by the 12th session. All participants 
completed a 5 km time-trial on a public running track and an incremental treadmill test in an 
exercise physiology laboratory to determine 5 km run performance and maximum oxygen 
uptake, respectively, before and after the 4 week intervention. Relative to the controls, sprint 
interval trained participants improved 5 km run performance by 4.5% (p < 0.001) and this 
was accompanied by improvements in absolute and relative maximum oxygen uptake (4.9%, 
p = 0.04 and 4.5%, p = 0.045, respectively). Short-term SIT significantly improves 5 km run 
performance in untrained young men. We believe SIT is a time-efficient means of improving 
cardio-respiratory fitness and 5 km endurance performance. 
 
KEYWORDS: Time-trial, training load, SIT, VO2max 
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INTRODUCTION 
Sprint interval training (SIT) is a form of run or bicycle training of short, maximal efforts of 
approximately 30 s, repeated several times interspersed with 3-5 mins of recovery, aimed at 
improving cardio-respiratory fitness and performance. SIT is proposed as an alternative mode 
of training to traditional constant-rate training. SIT improves cardio-respiratory fitness to a 
similar degree as constant-rate training but requires 90% less weekly energy expenditure and 
66% less total training time 626.  
 
The efficacy of SIT to improve run endurance performance, however, is only beginning to be 
elucidated. Ten weeks of two times a week SIT involving twelve 30 s efforts improved 3 km 
time-trial by 3.4% in moderately trained runners 649. SIT may be more efficacious at 
improving endurance performance than both continuous running and other high-intensity 
interval training (HIT) programmes. For example, 20 individuals who completed seven to 
twelve efforts of 30 s sprints thrice weekly for 6 weeks, improved 3 km run performance 
greater than individuals who completed constant rate running or four to six 4 minute efforts at 
3 km average running velocity over 6 weeks 609. Others have, however, demonstrated 
recreationally active participants similarly improve 2 km run performance after either 6 
weeks of SIT (4.6%) or constant rate running (5.9%) 608. Therefore, SIT seems to enhance 
run performance over 2-3 km, but whether these endurance benefits improve run performance 
in untrained participants over longer distances is unknown. Furthermore, the lack of inclusion 
of experimental controls in previous studies 608,609,649 makes understanding the efficacy of SIT 
at improving run performance difficult.  
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Run performance is important for individuals of average cardio-respiratory fitness who aspire 
to improve their fitness and performance quickly and efficiently. The impact of SIT, in the 
form of running, on untrained subjects’ 5 km run performance and maximum oxygen uptake 
(VO2max), has not been reported previously. Moreover, considering the importance of cardio-
respiratory fitness in ball sports such as soccer, Australian Rules Football and cricket 650-652, 
where participants run distances often exceeding 5 km, there is immense coaching emphasis 
on reducing training load to minimise injury risk, but maximise training time to focus on 
other skills important to the sport. To that end, the impact of SIT on endurance performance 
exceeding distances previously investigated warrants attention. Furthermore, SIT training 
simultaneously develops endurance, speed and repeated sprint capability 609, all important 
fitness components of team-sports. 
 
Therefore, the purpose of our study was to determine whether 4 weeks of three sessions a 
week SIT improves cardio-respiratory fitness and 5km run performance. We hypothesised 
that SIT would significantly improve VO2max and 5km run performance. 
 
METHODS 
Experimental approach to the problem 
This study is a controlled trial, where healthy participants performed either 4 weeks of SIT or 
no training, to evaluate its effect on 5 km run performance and VO2max. VO2max was measured 
during a maximal treadmill test conducted in the university exercise physiology laboratory 
and the 5 km time-trial was assessed at a public running track. These tests were performed on 
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separate days within one week of commencing the initial SIT session and within one week 
after the final SIT session. 
 
Subjects 
Thirty, apparently healthy young men (18–25 years) were recruited for this study. 
Participants were initially screened to ensure they were not currently engaging in any 
structured high-intensity aerobic exercise training. All participants reported they had not 
completed any structured aerobic exercise training in the past year. 20 participants were 
allocated to the SIT (cases) group and 10 participants were allocated to the control group. 
 
Participants gave written informed consent and this study was approved by the University’s 
Human Research Ethics Committee.  
 
Procedures 
Participant VO2max was assessed during a maximal treadmill test, by pulmonary analysis 
conducted in an exercise physiology laboratory at the university. Before the VO2max test 
participants were fitted with a two-way breathing valve (Hans Rudolph) and expired air was 
collected into an online metabolic system (Moxus) for gas (O2 and CO2) analysis. The 
metabolic system was calibrated before each test using ambient air and gas of known 
composition. Participants were given a standardised 3 min warm-up at 10 km.h-1. The VO2max 
test commenced at 10 km.h-1, and treadmill speed was progressively increased by 1 km.h-1 
every second minute. The treadmill speed was progressively increased until volitional 
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exhaustion. VO2max was determined as the highest O2 value averaged over 60 s. 
_ENREF_7All laboratory testing was performed preprandially at the same time of day (8–10 
AM). Participants were encouraged to stay hydrated the night before and morning of testing. 
Within a week of the VO2max assessment each participant completed a supervised 5 km run 
time-trial on a flat running track in a local park. Briefly, participants completed a short 10 
min warm-up including some light aerobic exercise and dynamic stretches. Participants were 
supervised and instructed to run maximally at their own pace.  
 
Cases completed a standardised SIT programme performed three times a week over four 
weeks (total of 12 sessions). The sprint duration and recovery period was controlled at 30 s 
and 4 mins (passive), respectively. Participants were requested to run maximally for each 30 s 
sprint. An Accredited Exercise Physiologist (with Exercise and Sport Science Australia) 
provided participants with verbal encouragement and supervised each training session. SIT 
was progressively overloaded by increasing the number of sprints (Table 1). Before each 
training session, participants completed a standardised warm-up entailing a 5 min aerobic 
warm-up, dynamic stretches and some short (20 m) runs at approximately 70, 80, 90 and 
100% effort. 
<<Table 1 about here>> 
Cases and controls were instructed not to deviate from their current physical activity and 
exercise habits during the 4 week intervention period. All participants were requested not to 
change their diet.  
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Statistical analyses 
All statistical analyses were performed using SPSS (version 20). Data were tested for 
normality and non-parametric data was log-transformed before further analysis. T-tests were 
used to examine fitness and performance changes after SIT, relative to the control group. 
Significance was set at p < 0.05.  
 
RESULTS 
Test-retest reliability data is outlined in Table 2. The 5 km time-trial test had excellent 
reliability with an intraclass correlation coefficient of 0.99 and a 3.4% coefficient of 
variation. 
<<Table 2 about here>> 
Table 3 outlines the fitness and performance changes after 4 weeks of SIT. While absolute 
and relative VO2max increased after SIT in cases (4.9%, p = 0.04 and 4.5%, p = 0.045, 
respectively), absolute and relative VO2max were unchanged in controls (0.6%, p = 0.73 and -
0.6%, p = 0.72, respectively). Relative to the control group who showed a marginal increase 
in 5 km time-trial performance (-2%, p = 0.20, Table 3), cases had a significant improvement 
in 5 km time-trial performance by an average of 65 s (-4.5%, p < 0.001) following 4 weeks of 
SIT (Table 3).  
<<Table 3 about here>> 
DISCUSSION 
The purpose of this study was to investigate whether a 4 week SIT intervention improves 5 
km run performance in previously untrained males. To our knowledge, we are the first to 
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demonstrate that 5 km run performance is significantly improved following short-term (4 
weeks) SIT. Considering the marginal but not statistically significant improvement in the 
controls (31 s, 2%), the marked (96 s, 6.5%) improvement after 4 weeks of SIT translated to a 
mean 65 s (4.5%) faster 5 km run performance in cases. Notably, 5 km run performance was 
improved in conjunction with increased VO2max. 
 
The increased 5 km run performance in our study is similar to previously observed 
improvements after traditional constant-rate endurance training. It was reported, an 
intervention of three running sessions per week at 75% of VO2max for 6 weeks improved 5 km 
run time by approximately 80 s (~5%) in 39 untrained individuals 653. Additionally, others 
have shown 5 km time-trial improved by 78 s (5%) in a group that ran for 20 mins three times 
per week for 6 weeks, initially starting at 0.8 km.hr-1 below their individual lactate threshold 
speed with progression to 0.8 km.hr-1 above their individual pre-training lactate threshold 
speed 654. Importantly, a control group was not included in these studies to establish the effect 
of  being familiar with the 5 km distance, which we established was 31 s. Collectively, it 
appears SIT improves 5 km run performance to a similar extent than constant-rate training 
and in a quicker time frame (4 vs. 6 weeks) and training duration (249 mins vs. 360 mins 654).  
 
Our data showing SIT enhances 5 km run performance corroborates others’ showing SIT 
enhances 2 km 608 and 3 km 609,649 run performance in recreationally trained individuals. We 
are the first to demonstrate 4 weeks of three times per week SIT, in the form of running, 
significantly improves 5 km run performance – a prestigious and Olympic running distance. 
Interestingly, the impact of SIT on 5 km endurance performance is established in other 
exercise modalities. A similar short-term (2-week) cycle SIT intervention improved 5 km 
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cycle performance to a similar magnitude of our protocol (5.2%) 655. Whether SIT improves 
run performance over longer distances warrants attention. Additionally, whether SIT benefits 
already well-trained runners is yet to be fully understood, as data has, to date, been equivocal 
656,657. Nevertheless, we verify SIT as an effective means of improving running endurance 
performance in untrained young men.  
_ENREF_3 
The improvement in run performance was accompanied by a corresponding improvement in VO2max. Although previous constant-rate training studies have demonstrated participants 
increased their VO2max to a similar magnitude observed in the our study (3.8–7.7%), they also 
showed marked improvements in their participants lactate threshold, which could contributed 
to the improvements in run performance 653,654. Alternatively, an improvement in cardiac 
output may have facilitated the improvement in 5 km run speed, as opposed to improvements 
in muscle oxidative capability, based on the concepts VO2max is chiefly governed by the 
maximal cardiac output and the lactate threshold by muscle oxidative capability 658. Other 
mechanisms by which SIT may enhance 5 km run performance include improved run 
economy, running mechanics and potassium regulation. It was previously reported that 
moderately-trained runners’ run economy was improved by 7% after 4 weeks of SIT, but 
these subject did not improve their 10 km time-trial performance 657. Moreover, increases in 
knee flexor endurance, coupled with decreases in knee flexion torque and knee 
flexion/extension ratios are also adaptations associated with sprint training that could have 
contributed to the improvement in 5 km run performance observed in our study 659. Others 
have shown in well-trained runners, SIT enhanced key components of the Na+/K+ pump that 
would aid to minimise disturbances in nerve membrane potential and maintain sprint 
performance, and this was associated with an approximate 3% improvement in 3 km and 10 
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km run performance 656. The increase in muscle oxidative and anaerobic enzyme activity are 
adaptations gained from SIT and is another possible mechanism for the facilitated endurance 
performance observed in participants from our study 543,660-662.  
A limitation of our study is that both experimental and control groups did not complete any 
familiarisation sessions before 5 km time-trial testing. We did, however, assess the reliability 
of the 5 km time-trial test using the controls and found it had excellent reliability with values 
substantially less than the observed training changes, thereby excluding the possibility that 
the SIT-induced performance benefits were largely due to a learning effect. We did not 
include females in this study. Some of the benefits gained from SIT seem to be dependent of 
gender. For example, males had greater muscle protein synthesis of proteins important for 
mitochondrial biogenesis after nine sessions of SIT compared to their female counterparts 663. 
Given these muscle adaptations are vital for endurance performance 661,662,664, whether short-
term SIT improves 5 km run performance in females is left for future investigations. 
 
Future research could focus on optimising training variables, such as the recovery time 
between sprints, number of sprint repetitions, time required of each sprint, number of sessions 
required per week and the optimal length of SIT. In fact the efficiency of HIT in evoking 
positive adaptations may even be more potent than originally envisaged. It was recently 
revealed one maximal 4 min effort at 90% of heart rate maximum on a cycle ergometer, 
performed three times a week for 10 weeks improves VO2max by an average of 10% 665. 
In conclusion our data reveals SIT is a highly effective strategy to improve endurance 
running quickly in previously untrained young men. 
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PRACTICAL APPLICATIONS 
We believe our findings have practical implications for recreational runners and for team-
sport coaches who aim to improve the endurance of their players efficiently within periodised 
programmes and limited time-frames associated with pre-season training. Moreover, SIT is 
feasible for and may appeal to individuals who perceive time as an obstacle to exercising, as 
it can rapidly enhance not only cardio-respiratory fitness but also endurance performance.  
 
REFERENCES  
1. Bangsbo J, Gunnarsson TP, Wendell J, Nybo L, and Thomassen M. Reduced volume 
and increased training intensity elevate muscle Na+-K+ pump alpha2-subunit 
expression as well as short- and long-term work capacity in humans. J Appl Physiol 
107: 1771-1780, 2009. 
2. Burgomaster KA, Heigenhauser GJ, and Gibala MJ. Effect of short-term sprint 
interval training on human skeletal muscle carbohydrate metabolism during exercise 
and time-trial performance. J Appl Physiol (1985) 100: 2041-2047, 2006. 
3. Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, Macdonald MJ, 
McGee SL, and Gibala MJ. Similar metabolic adaptations during exercise after low 
volume sprint interval and traditional endurance training in humans. J Physiol 586: 
151-160, 2008. 
4. Cicioni-Kolsky D, Lorenzen C, Williams MD, and Kemp JG. Endurance and sprint 
benefits of high-intensity and supramaximal interval training. Eur J Sport Sci 13: 304-
311, 2013. 
 
SIT improves 5 km run performance 
 
 
512 
5. Dawson B, Hopkinson R, Appleby B, Stewart G, and Roberts C. Player movement 
patterns and game activities in the Australian Football League. J Sci Med Sport 7: 
278-291, 2004. 
6. Esfarjani F and Laursen PB. Manipulating high-intensity interval training: effects on 
VO2max, the lactate threshold and 3000 m running performance in moderately 
trained males. J Sci Med Sport 10: 27-35, 2007. 
7. Gibala MJ, Little JP, Macdonald MJ, and Hawley JA. Physiological adaptations to 
low-volume, high-intensity interval training in health and disease. J Physiol 590: 
1077-1084, 2012. 
8. Gibala MJ, Little JP, van Essen M, Wilkin GP, Burgomaster KA, Safdar A, Raha S, 
and Tarnopolsky MA. Short-term sprint interval versus traditional endurance training: 
similar initial adaptations in human skeletal muscle and exercise performance. J 
Physiol 575: 901-911, 2006. 
9. Gibala MJ and McGee SL. Metabolic adaptations to short-term high-intensity interval 
training: a little pain for a lot of gain? Exerc Sport Sci Rev 36: 58-63, 2008. 
10. Hazell TJ, Macpherson RE, Gravelle BM, and Lemon PW. 10 or 30-s sprint interval 
training bouts enhance both aerobic and anaerobic performance. Eur J Appl Physiol 
110: 153-160, 2010. 
11. Iaia FM, Hellsten Y, Nielsen JJ, Fernstrom M, Sahlin K, and Bangsbo J. Four weeks 
of speed endurance training reduces energy expenditure during exercise and maintains 
muscle oxidative capacity despite a reduction in training volume. J Appl Physiol 106: 
73-80, 2009. 
12. Joyner MJ and Coyle EF. Endurance exercise performance: the physiology of 
champions. J Physiol 586: 35-44, 2008. 
 
SIT improves 5 km run performance 
 
 
513 
13. Macpherson RE, Hazell TJ, Olver TD, Paterson DH, and Lemon PW. Run sprint 
interval training improves aerobic performance but not maximal cardiac output. Med 
Sci Sports Exerc 43: 115-122, 2011. 
14. McNicol AJ, O'Brien BJ, Paton CD, and Knez WL. The effects of increased absolute 
training intensity on adaptations to endurance exercise training. J Sci Med Sport 12: 
485-489, 2009. 
15. Petersen CJ, Pyne DB, Portus MR, and Dawson BT. Comparison of player movement 
patterns between 1-day and test cricket. J Strength Cond Res 25: 1368-1373, 2011. 
16. Rodas G, Ventura JL, Cadefau JA, Cusso R, and Parra J. A short training programme 
for the rapid improvement of both aerobic and anaerobic metabolism. Eur J Appl 
Physiol 82: 480-486, 2000. 
17. Scalzo RL, Peltonen GL, Binns SE, Shankaran M, Giordano GR, Hartley DA, 
Klochak AL, Lonac MC, Paris HL, Szallar SE, Wood LM, Peelor FF, 3rd, Holmes 
WE, Hellerstein MK, Bell C, Hamilton KL, and Miller BF. Greater muscle protein 
synthesis and mitochondrial biogenesis in males compared with females during sprint 
interval training. FASEB J 28: 2705-2714, 2014. 
18. Scanlan AT, Dascombe BJ, Reaburn P, and Dalbo VJ. The physiological and activity 
demands experienced by Australian female basketball players during competition. J 
Sci Med Sport 15: 341-347, 2012. 
19. Shealy MJ, Callister R, Dudley GA, and Fleck SJ. Human torque velocity adaptations 
to sprint, endurance, or combined modes of training. Am J Sports Med 20: 581-586, 
1992. 
20. Stratton EM, O'Brien BJ, Harvey JT, Blitvich J, McNicol AJ, Janissen D, Paton CD, 
and Knez WL. Final treadmill velocity best predicts 5 km run performance. 
International Journal of Sports Medicine 30: 40-45., 2009. 
 
SIT improves 5 km run performance 
 
 
514 
21. Tjonna AE, Leinan IM, Bartnes AT, Jenssen BM, Gibala MJ, Winett RA, and Wisloff 
U. Low- and high-volume of intensive endurance training significantly improves 
maximal oxygen uptake after 10-weeks of training in healthy men. PLoS One 8: 
e65382, 2013. 
 
 
ACKNOWLEDGEMENTS 
J.D and S.A.F are both supported by Australian Post-Graduate Award (APA) Scholarships. 
 
 
 
 
 
 
 
 
 
 
 
 
SIT improves 5 km run performance 
 
 
515 
TABLES 
Table 1. Description of the 4-week SIT regimen.  
Week Session # Training load 
(sprints)* 
Training sprint 
time 
(s) 
Total session 
time 
(mins) 
1 1 3  90 9.5 
2 4  120 14 
3 5  150 18.5 
2 4 4  120 14 
5 5  150 18.5 
6 6  180 23 
3 7 5  150 18.5 
8 6  180 23 
9 7  210 27.5 
4 10 6  180 23 
11 7  210 27.5 
12 8  240 32 
 Total 
time 
 
66 
 
1980 
 
249 
All sprints were completed at maximum intensity and separated by 4 minutes of passive rest. 
Legend: # number.
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T
able 2. Test-retest reliability data for the 5 km
 tim
e-trial test. 
V
ariable 
M
ean trial 1 
M
ean trial 2 
M
ean difference 
M
ean 
difference 
(%
) 
P-value 
(m
ean 
change) 
IC
C
 
C
V
 (%
) 
5 km
 tim
e-trial (s) 
1478.1 ± 349.9 
1447.5 ± 347.2 
-30.6 (-78.02–17.2) 
-2.1 
0.18 
0.99 (0.95–0.99) 
3.4 (2.4–6.4) 
R
esults of the 5 km
 tim
e-trial test in the control group (n=10), reliability as m
easured by m
ean difference, m
ean difference as a percentage of the 
m
ean of 2 trials, intraclass correlation (IC
C
), p-value (paired t-test), and typical error as a coefficient of variation (C
V
) percentage (%
). U
pper 
and low
er confidence intervals are expressed in parentheses; confidence intervals are set at 95%
. SD
s are represented after the m
ean of trials 1 
and 2.  
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ABSTRACT 
Endurance exercise training is improves cardiovascular health and reduces mortality risk. 
Augmentation index [AIx] indicates the adverse loading exerted on the heart and large 
arteries and predicts future cardiovascular disease. The first purpose of this study was to 
determine whether central blood pressure (BP) and AIx differs between endurance athletes 
and recreationally active controls, and in the event of any differences, a second aim was to 
identify whether any potential differences can be attributed to cardiovascular risk factors, 
physical activity parameters or cardiorespiratory fitness. 
Forty-four endurance athletes and 50 recreationally active controls completed physical 
activity/inactivity questionnaires, and underwent central BP and AIx measurements by non-
invasive applanation tonometry. VO2peak was assessed during graded exercise testing.  
Relative to controls, athletes had significantly lower brachial and central BP (all p ≤ 0.01). In 
age, height and heart rate-adjusted analyses, athletes had significantly lower AIx (p = 0.001), 
a difference ameliorated after adjustment BP parameters and VO2peak (p = 0.31). Relative to 
men with low VO2peak, those with moderate and high VO2peak had significantly lower AIx (p = 
0.007). No statistically significant associations between fitness tertiles and AIx in women (p 
= 0.2).  
In conclusion, the lower AIx in endurance athletes is partly mediated by VO2peak. Considering 
the comparable AIx between moderately and highly fit men, the strenuous, high-volume 
exercise training practiced by endurance athletes to maximise VO2peak may not be required to 
prevent adverse loading on the heart and large arteries, rather exercise training facilitating an 
achievable VO2peak, above 45 ml.kg-1.min-1 is sufficient.  
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Key words: Central blood pressure, cardiovascular health,  VO2peak 
INTRODUCTION 
High central (aortic) blood pressure (BP) is related to cardiovascular disease and is predictive 
of future adverse cardiovascular events – more so than brachial BP.666-668Arterial stiffening 
occurs with ageing and contributes to an increased load inflicted on the central arterial and 
left ventricular walls, and hence an increase in risk of organ damage, coronary artery disease 
and heart failure.669 Aortic augmented pressure (AP) and augmentation index (AIx) are 
surrogate measures of the load inflicted on the central arterial and left ventricular walls,670 
such that AP is the difference between the first and second systolic peaks and AIx is AP 
expressed as a percentage of pulse pressure. Indeed, AIx is an independent marker of 
premature coronary artery disease671 and AIx is a strong, independent predictor of congestive 
heart failure672 and all-cause mortality673 in healthy and clinical populations.  
Endurance athletes have favourable cardiovascular risk factors, including low BMI, resting 
heart rate, cholesterol and serum C-reactive protein.202,279,280,674,675 Although long-term 
endurance exercise training typically attenuates these cardiovascular risk factors, recent 
findings indicate chronic, strenuous endurance exercise may cause stiffening of the heart and 
large arteries.675-677 The potential for long-term extensive endurance exercise to stiffen the 
heart and central arteries could be explained by an increased loading to the these structures; 
owing to elevated central BP and/or AIx.  
The effect long-term and regular endurance exercise training has on central BP and AIx is 
currently unclear, due to contrasting findings between studies.674,678-682 For example, some 
revealed endurance athletes have lower678 or comparable674,679,682 AIx when compared to 
healthy controls. Consistent with the AIx, data on central blood pressures between athletes 
and controls are equally equivocal.674,678,680 The lack of adjustment for confounding factors 
		 521 
(age, height, resting hear rate or brachial BP) or differences in subject ages, diets, 
cardiorespiratory fitness levels, or study methodologies (e.g. pre-race haemodynamic 
measurements), including statistical power, could contribute to the discordant findings in 
previous literature. Consequently, more research is needed to determine whether endurance 
athletes have altered central BP and AIx. Identification of the cardio-vascular risk factors of 
which endurance exercise potentially mediates AIx would shed light on the mechanism by 
which exercise may influence adverse excessive loading of the heart and large arteries.  
Therefore, the primary aim of our study was to investigate whether central BP and AIx are 
different between endurance athletes and healthy controls. Upon identification of any 
differences, a secondary aim was to identify which cardiovascular risk factors or physical 
activity/fitness parameters mediate the effect on central BP and AIx in endurance athletes and 
controls. We hypothesised endurance athletes possess lower central BP and AIx compared to 
their less-active peers and that particular physical activity parameters or VO2peak would 
mediate any differences. 
MATERIALS AND METHODS 
Participants  
All subjects were recruited from the general public and University by flyers, Internet 
advertising and word-of-mouth. Subjects were non-smokers, free from age-related diseases 
(including cardiovascular disease, type 2 diabetes and cancer) and not taking any 
medications. Forty-four male and female endurance-trained athletes and recreationally active 
controls aged 18–55 y were recruited for cross-sectional analysis. Endurance-trained 
individuals (athletes) had trained >3 days a week for a minimum of one year and consisted of 
four cyclists, 24 triathletes, 14 runners and two ultra-marathon runners; including 21 
recreationally competitive, 12 State, three National and eight International level athletes. The 
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healthy controls were recreationally active but were not engaging in any structured resistance 
or aerobic exercise training. Athlete and control characteristics are outlined in Table 1. 
All participants gave written informed consent and this study was approved by Federation 
University Australia’s Human Research Ethics Committee. 
Procedures 
Athletes and controls attended one testing session conducted in the morning (8–10AM) after 
an overnight (10 hour) fast. Subjects were requested to abstain from caffeine, alcohol and 
physical exercise 24 hours before testing. Physical activity readiness questionnaire (PARQ), 
the self-administered International Physical Activity Questionnaire (IPAQ) Long form,299 
Perceived Stress Scale (PSS)300 and a medical questionnaires were completed. Data cleaning 
and analysis was performed according to the IPAQ guidelines and average weekly Metabolic 
Equivalent of task (MET) – minutes and sitting were calculated and included as continuous 
variables in statistical analyses. Height, weight and body mass index (BMI) were recorded 
and subjects were seated for approximately 10 minutes before BP assessment. Brachial and 
central BP was averaged from three separate measurements, taken one minute apart with 
subjects seated. The same researcher (JD) recorded all BP measurements. Brachial and 
central BP and AIx were assessed by non-invasive applanation tonometry using the 
SphygmoCor (AtCor Medical, Australia). The SphygmoCor quantifies radial arterial blood 
pressure and waveform reflections using a validated generalised transfer function to 
accurately measure central BP and AIx.683 
Subjects’ cardiorespiratory fitness, determined as peak oxygen consumption (VO2peak), was 
assessed through a maximal graded treadmill or cycle ergometer test via pulmonary analysis. 
While control subjects completed a maximal treadmill test, the endurance-trained cyclist 
completed a cycle ergometer test. Triathletes obtain a comparable VO2peak value regardless of 
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exercise mode301 and as such, triathletes from the present study completed either a cycle or 
treadmill test.  Before maximal exercise testing subjects were fitted with a two-way breathing 
valve (Hans Rudolph) and expired air was collected into an online metabolic system (Moxus, 
Modular) for O2 and CO2 analysis. The metabolic system was calibrated prior to each test 
using ambient air and gas of known composition. The treadmill commenced at 10 km.h-1 and 
was progressively increased by 1 km.h-1 every two minutes until volitional exhaustion. Cycle 
ergometer VO2max tests commenced at 100 W and the load was increased by 30 W.min-1 every 
two minutes until pedalling cadence dropped below 50 RPM for 10 seconds or until volitional 
exhaustion. Subjects were asked to maintain 90–100 RPM throughout cycle ergometer-
assessed exercise tests. Individual VO2peak was determined as the highest O2 value averaged 
over 60 seconds.  
Statistical analyses 
All statistical analyses were performed using IBM SPSS Statistics for Windows (Version 21, 
IBM Corp, NY). A 10% absolute increase in central AIx is associated with a 32% and 38% 
increased risk of future cardiovascular events and all-cause mortality, respectively.673 Our 
priori power analysis revealed that in order to detect a 10% difference (Cohen’s d = 0.8) in 
AIx between athletes and controls, we required 42 subjects in each group (n = 84) to achieve 
>90% power (two-sided alpha = 0.05) (G*Power 3.1.5). Data were tested for normality using 
the Kolmogorov-Smirnov and Shapiro-Wilk tests. Two-tailed independent samples t-tests or 
Mann-Whitney U-tests were used to examine physical, hemodynamic and fitness differences 
between athletes and controls. To control for covariates, an ANCOVA was used to establish 
differences between athletes and control BP and AIx. Bonferroni-corrected Pearson’s and 
Spearman’s Correlation p-values were used to determine statistically significant associations 
between brachial BP, physical activity,  VO2peak, central SBP and AIx. Stepwise linear 
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regression was performed to identify predictors of AIx. Statistical significance was set at p < 
0.05. 
 
RESULTS 
The physical characteristics of athletes and controls are outlined in Table 1. Relative to the 
controls, athletes had a lower body weight, BMI, brachial systolic and diastolic BP and mean 
arterial pressure (MAP), central systolic BP (SBP) and resting heart rate, were less physically 
inactive (sitting) and had higher cardiorespiratory fitness, expended more energy and were 
more physically active (all p < 0.05, Table 1). Brachial systolic and diastolic BP (DBP) and 
central SBP remained significantly different after adjusting for age (p = 0.02, p = 0.002 and p 
= 0.004, respectively). Considering AIx is sensitive to age, resting heart rate and height670 
and the linear relationships between age, height and AIx (Figure 1), we compared AIx 
between athletes and controls after adjustment for these variables. Age, height and resting 
heart rate-adjusted AIx was lower in athletes compared to controls (athletes vs controls mean 
[%] ± SE [95% CI]: -3.7 ± 2.04 [-7.79 – 0.31] vs 6.9 ± 1.87 [3.15 – 10.62], p = 0.001, Figure 
2). This difference remained statistically significant after further adjustment for BMI, 
brachial SBP and DBP, and central SBP (-0.56 ± 1.29 [-3.12 – 2.01] vs 4.09 ± 1.17 [1.75 – 
6.42], p = 0.03). The lower AIx observed in athletes compared to controls were however 
ameliorated in the fully adjusted model when accounting for VO2peak (0.73 ± 1.45 [-2.16 – 
3.62] vs 3.19 ± 1.29 [0.62 – 5.76], p = 0.31).  
Table 2 outlines results from Pearson’s or Spearman’s Correlations that were performed to 
determine associations between physical activity and hemodynamic parameters in athletes 
and controls. VO2peak was inversely correlated to brachial DBP and AIx (r = -0.27, p = 0.01 
and r = -0.45, p = 2.0 × 10-5, respectively, Table 2). While weekly estimated energy 
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expenditure was positively associated with brachial pulse pressure (r = 0.34, p = 0.005), 
weekly METs were negatively correlated to brachial diastolic BP (r = -0.31, p = 0.01, Table 
2). No statistically significant correlations were observed between physical activity 
parameters, BP measures or AIx (Table 2). 
We then performed a stepwise regression to explore what blood pressures (brachial SBP/DBP 
and central SBP) physical (age, height, weight and BMI) and fitness parameters (resting HR 
and  VO2peak) predicted AIx. Notably, VO2peak, brachial SBP and DBP, and central SBP 
emerged as independent predictor of AIx, and together explained 81% of the variance (Table 
3).  
When accounting for age, we found men had higher cardiorespiratory fitness compared to 
women (Men vs Women mean VO2peak: 42.7 vs 51.7 ml.kg-1.min-1, p = 0.0003) and larger 
studies have reported a similar gender difference (45.4 vs 37.0 ml.kg-1.min-1, n = 3678),684 we 
conducted the same analysis with men and women separate. Relative to those men with low 
cardiorespiratory fitness (mean AIx [%] ± SE [95% CI]: 9.65 ± 3.14 [3.39 – 15.92], n = 17), 
those with moderate and high fitness had lower AIx (mean AIx [%] ± SE [95% CI]: -1.16 ± 
2.02 [-5.19 – 2.87], n = 32, p = 0.004 and (-4.00 ± 2.62 [-9.23 – 1.23], n = 25,  p = 0.004); yet 
no difference were found between moderately and highly fit men (p = 0.41, Figure 3A). 
When we performed the same analysis in women, we observed no statistically significant 
differences in AIx between subjects in cardiorespiratory fitness tertiles (p = 0.2, Figure 3B); a 
result probably owing to a much smaller sample size (n = 20).  
DISCUSSION 
The aim of our study was to explore differences in BP (brachial and central) and AIx between 
highly endurance-trained athletes and recreationally active controls, and to determine whether 
differences were influenced by  VO2peak or physical activity parameters. A novel finding of 
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this study is that AIx are lower in highly endurance athletes compared to recreationally active 
individuals and that the difference in AIx was partially mediated by VO2peak. We also found 
linear correlations between BP indices and AIx, physical activity parameters and  VO2peak. 
Interestingly, VO2peak emerged as independent predictor of AIx and when analysed in 
conjunction with brachial SBP and DBP, and central SBP, accounted for 81% of the variance. 
Finally, our study is the first to demonstrate that men with moderate and high VO2peak defined 
as 45–55 and 55+ ml.kg-1.min-1, respectively, exhibited lower AIx compared to their less-fit 
(<45 ml.kg-1.min-1) peers.  
The reduction in cardiovascular disease and mortality risk through regular aerobic exercise 
training is undoubtable,75,685 yet whether high amounts of endurance exercise further benefits 
cardiovascular health is unclear. Indeed, chronic endurance exercise training for triathlons, 
ultra/marathons and endurance cycling events could cause an elevated risk for cardiovascular 
complications, in particular, stiffening of the heart and large arteries.677 Elevated central BP 
(a correlate of pulse wave velocity) exerts adverse load on the heart and aorta during 
systole,670 which could inevitably contribute to the downstream sequalea of cardiac strain. 
We found that individuals regularly performing endurance exercise training exhibit 
significantly lower AIx. Furthermore, the endurance athletes had significantly lower brachial 
and central BP (SBP, DBP and MAP) compared to recreationally active subjects. Considering 
the predictive value of central BP and AIx on future cardiovascular disease, 
outcomes667,671,672 and mortality risk,666,673 the lower central hemodynamic profile observed 
in the athletes from our study indicates these athletes may have ameliorated risk for future 
adverse cardiovascular events and mortality. 
Whilst our data corroborates previous studies678,686 on AIx in endurance athletes, it refutes 
others.674,679,680,682 Current data on central BP between endurance athletes and controls are 
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equally inconclusive.674,678,680-682,687 These inconsistencies could partly be explained by 
subject ages, exercise habits and training histories,  VO2peak differences and also by 
methodological consideration, including timing of BP parameter measurements (i.e. day 
before competition). Central AIx is a more sensitive marker of arterial stiffening in 
individuals younger than 50 years old,688 which could also account for some discrepancies 
throughout the current literature.  
Intriguingly, the significantly lower AIx observed in the athletes compared to controls was 
ameliorated after  VO2peak adjustment, indicating the difference was dependent on  VO2peak. 
Interestingly, data from a recent meta-analysis of randomised controlled trials revealed a dose 
and intensity-dependent relationship in the aerobic exercise-induced reduction in wave 
reflections.689 We did not find any correlations between energy expenditure parameters 
(METs/Kj/training/sitting) and AIx. We did, however, find linear correlations between 
objectively assessed  VO2peak and AIx. Whereas  VO2peak was independently associated with 
AIx previously, it was not analysed in context with athlete and control status.686 Thus, we 
have verified that  VO2peak is an independent predictor of AIx, and partly explains the 
differences in AIx between endurance athletes and controls.  
We are the first to show individuals with low  VO2peak have higher AIx compared to those 
with moderate or high  VO2peak. This novel finding supports the concept that  VO2peak may be 
an unmeasured confounding factor in previous cross-sectional studies including endurance-
trained individuals.674,679,680 This finding suggests that healthy individuals may not require an 
exceptionally high  VO2peak to lower AIx; rather a more achievable (45–55 ml.kg-1.min-1) 
cardiorespiratory fitness may be enough. The risk of cardiovascular disease 
development690,691 and cardiovascular disease-related mortality692,693 is markedly attenuated 
by possessing higher  VO2peak.  
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A higher  VO2peak, reflects the cardio-vascular and muscle skeletal adaptations associated with 
regular exercise training. Acute694-696 and long-term565,697 exercise training also increases 
circulating endothelial progenitor cells (EPCs) that have a known function in maintaining the 
integrity of the inner arterial wall. Elevated laminar shear stress, the subsequent release of 
endothelial nitric oxide (eNO) by nitric oxide synthase (eNOS) and increased circulating 
EPCs caused by repeated, prolonged bouts of endurance exercise,233 could account for the 
lowered BP and AIx observed in the endurance athletes. Alternatively, chronic endurance 
exercise training reduces circulating inflammation and oxidative stress; 202,698 both of which 
contribute to arterial stiffening.699  
The relatively large sample size and adequate statistical power are strengths of our study. The 
athletes and controls had their BP and AIx measured in a rested condition and not before an 
endurance event. Furthermore, we completed a comprehensive analysis on AIx after 
adjusting for confounding variables – height, resting heart rate and brachial and central BP. 
We do, however, acknowledge that like every study, ours has some limitations. First, our 
study included correlations and cross-sectional analyses, and as such causality cannot be 
assumed. It is, however, likely that the endurance athletes lowered BP and AIx are due to 
cardiorespiratory fitness and health benefits adaptations from long-term involvement in 
exercise training and data from randomised controlled trials supports this claim.689 We did 
not quantify dietary habits, insulin resistance or control for the effects of the menstrual cycle 
on central BP and AIx in our subjects. Further, we were underpowered to detect a difference 
between cardiorespiratory fitness tertiles and AIx in women. Therefore, this deserves 
attention in future investigations. Future research is also warranted to elucidate the 
mechanisms responsible for the impact of cardiorespiratory fitness on BP and AIx and may 
include eNO availability, decreased sympathetic tone, and molecular mechanisms such as 
microRNA molecules, telomere regulation or epigenetics.  
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In conclusion, we have shown for the first time that the lower aortic AIx in endurance 
athletes compared to controls is partly mediated by  VO2peak. We also demonstrate that 
moderate cardiorespiratory fitness is associated with decreased aortic AIx, an affect not 
augmented by possessing a higher VO2peak. Together, these data suggest that regular 
endurance exercise training is associated with lower central BP and AIx, but also emphasises 
that a cardiorespiratory fitness of 45–55 ml.kg-1.min-1 is an achievable target associated with 
low AIx. Given the relationship between AIx, cardiovascular disease and ageing, health 
professionals should advocate aerobic exercise aimed at improving VO2peak. 
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SUMMARY TABLE 
What is known about this topic 
• Aerobic exercise training improves cardiovascular health though the ideal dose is 
currently unknown. 
• Data on aortic AIx in endurance athletes have been equivocal. 
What this study adds 
• This study shows correlations between exercise training, blood pressure parameters 
and AIx. 
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• After controlling for confounding variables, this study shows that endurance athletes 
have significantly lower AIx and that this effect is likely explained by 
cardiorespiratory fitness.   
• Relative to unfit subjects, lower AIx are observed in those with moderate and high 
cardiorespiratory fitness to a comparable level. 
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FIGURE LEGENDS 
Figure 1. Older and shorter subjects exhibit higher AIx. Pearson’s correlation coefficients of 
AIx with age (A) and height (B).  
Figure 2. Augmentation index difference between athletes and controls. Data are expressed as 
mean ± standard error from ANCOVA adjusted for age, height and resting heart rate. 
Athletes have lower AIx compared to controls (athletes vs controls mean [%] ± SE [95% CI]: 
-3.7 ± 2.04 [-7.79 – 0.31] vs 6.9 ± 1.87 [3.15 – 10.62], p = 0.001).  
Legend: AIx, augmentation index; ** p < 0.01 vs athletes.  
Figure 3. Impact of low, moderate and high cardiorespiratory fitness on AIx in men and 
women. Data are expressed as mean ± standard error from ANCOVA adjusted for age, height 
and resting heart rate. A) Compared to men with low (<45 ml.kg.min-1, n = 17) 
cardiorespiratory fitness, those with moderate (45.1–55 ml.kg-1.min-1, n = 32) and high (55.1+ 
ml.kg-1.min-1, n = 25) fitness had lower AIx (low vs moderate vs high; mean [%] ± SE [95% 
CI]: 9.65 ± 3.14 [3.39 – 15.92] vs -1.16 ± 2.02 [-5.19 – 2.87] vs (-4.00 ± 2.62 [-9.23 – 1.23], 
p = 0.007). B) Compared to women with low (<35 ml.kg.min-1, n = 7) cardiorespiratory 
fitness, those with moderate (35.1–45 ml.kg-1.min-1, n = 5) and high (45.1+ ml.kg-1.min-1, n = 
8) fitness had lower AIx (low vs moderate vs high; mean [%] ± SE [95% CI]: 14.95 ± 5.87 
[2.35 – 27.55] vs 13.01 ± 6.07 [0.003 – 26.03] vs -2.09 ± 5.78 [-14.48 –10.3], p = 0.2). 
Legend: AIx, augmentation index; ** p < 0.01 vs < 45 ml.kg.min-1.  
 
